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Abstract 
 
This reference document provides summary information on the animal, plant, zoonotic, 
and human pathogens and toxins regulated and categorized by 9 CFR 331 and 7 CFR 
121, “Agricultural Bioterrorism Protection Act of 2002; Possession, Use and Transfer of 
Biological Agents and Toxins,” and 42 CFR 73, “Possession, Use, and Transfer of 
Select Agents and Toxins.”  Summary information includes, at a minimum, a description 
of the agent and its associated symptoms; often additional information is provided on 
the diagnosis, treatment, geographic distribution, transmission, control and eradication, 
and impacts on public health. 
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PREFACE 
 
This summary guide was compiled verbatim from the referenced sources.  Minor 
differences among the sources in style, approach, diction, and organization do not 
detract from the accuracy or value of the provided reference material. 
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1.  ANIMAL PATHOGENS 
This section introduces the 23 animal pathogens regulated by 9 CFR 331.  Summary reference 
information is provided.  Citations and internet addresses for each pathogen are provided in 
footnotes.  This section includes summary information for the following pathogens:   
• African horse sickness virus 
• African swine fever virus 
• Akabane virus 
• Avian influenza virus (highly pathogenic) 
• Bluetongue virus (exotic) 
• Bovine spongiform encephalopathy agent 
• Camel pox virus 
• Classical swine fever virus 
• Cowdria ruminantium (Heartwater) 
• Foot-and-mouth disease virus 
• Goat pox virus 
• Japanese encephalitis virus 
• Lumpy skin disease virus 
• Malignant catarrhal fever virus (exotic) 
• Menangle virus 
• Mycoplasma capricolum/M. F38/M. mycoides capri (contagious caprine 
pleuropneumonia) 
• Mycoplasma mycoides mycoides (contagious bovine pleuropneumonia) 
• Newcastle disease virus (VVND) 
• Peste des petits ruminants virus 
• Rinderpest virus 
• Sheep pox virus 
• Swine vesicular disease virus 
• Vesicular stomatitis virus (exotic) 
1.1 African horse sickness virus1 
(Perdesiekte, Pestis Equorum, La Peste Equina)  
Definition:  African horsesickness (AHS) is a highly fatal, viscerotropic, insect-borne viral disease of 
horses and mules and generally a subclinical disease in other Equidae. The clinical signs and lesions 
result from selective increased vascular permeability and are characterized by an impairment of the 
respiratory and circulatory systems.  
Etiology:  The etiological agent of AHS is a typical orbivirus measuring 68-70 nm in diameter, and the 
virion is composed of a double-layered protein shell.  
The virus is present in the blood and certain organs such as spleen, lung, and lymph nodes in reasonably 
high concentration, whereas only traces are found in serum, tissue fluids, excretions, and secretions. 
Viremia generally lasts for about 4-8 days and roughly parallels the febrile reaction. In exceptional cases, 
viremia may last as long as 17 days in the horse and 28 days in zebra and donkeys.  
                                                 
1Committee on Foreign Animal Diseases of the United States Animal Health Association, revised 1998.  Foreign 
Animal Diseases, “The Gray Book,”  Part IV,  Library of Congress Catalog Card Number 17-12842, Pat Campbell 
& Associates and Carter Printing Company, Richmond, VA.  http://www.vet.uga.edu/vpp/gray_book/FAD/ahs.htm  
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The AHS virus is relatively heat stable, particularly in the presence of protein. It can be stored for at least 
6 months at 4° C in saline containing 10 percent serum. Blood in OCG preservative (500 ml glycerin, 500 
ml distilled water, 5 g sodium oxalate, and 5 g carbolic acid) can remain infective for more than 20 years; 
lyophilization may preserve infectivity for as long as 40 years. The virus is readily inactivated at pH 
values lower than 6.3, but it is relatively stable between values ranging from 6.5 to 8.5.  
Nine distinct serotypes of AHS virus are known, the last of which was isolated in 1960. This suggests 
that, despite its segmented genome, the virus can be regarded as genetically stable and that new serotypes 
do not readily develop. The present nine serotypes probably evolved over many centuries.  
Host Range:  Horses, mules, and donkeys have historically been known as hosts for AHS virus, as 
reflected in the name of the disease. In view of the high mortality rate suffered by horses and mules, these 
species should be regarded as accidental or indicator hosts. That AHS failed to establish itself outside the 
tropical regions of Africa tends to indicate that neither horses nor mules or donkeys remain long-term 
carriers of AHS virus and are therefore not essential for the permanent persistence of the infection in a 
particular region. Zebra may fulfill this role, but no irrevocable proof has been found to substantiate this 
view.  
The dog has long been known to be susceptible to experimental infection. Infection of dogs also readily 
occurs following ingestion of infected horse meat. However, it is extremely unlikely that this species 
becomes infected by insect bites, and it is generally accepted that dogs play no role in the spread or 
maintenance of AHS.  
Camels can ostensibly become inapparently infected with AHS virus, but few details are available as to 
the level and duration of viremia in this species and its role, if any, in the epizootiology of the disease. A 
high percentage of African elephant serum samples reacted positively against AHS virus in complement 
fixation tests, but no neutralizing antibodies could be demonstrated in such samples. No evidence of virus 
replication could be found in elephants artificially infected with AHS virus. It can therefore be concluded 
that the African elephant is not susceptible to infection and that the putative serological evidence resulted 
from abnormal reactions of elephant sera in a complement fixation test.  
Geographic Distribution:  African horse sickness appears to be endemic in tropical regions of central 
Africa from where it regularly spreads southwards to southern Africa. The Sahara Desert forms a 
formidable barrier against northward spread. Occasionally the infection does reach northern African 
countries, either by spread along the Nile valley or along the West Coast of Africa. The disease has also 
occurred outside Africa on a few occasions, the most notable of which was the major outbreak in the Near 
and Middle East from 1959 through 63 and in Spain (1966 and 1987-1990).  
In temperate regions such as South Africa, AHS has a definite seasonal occurrence. The first cases are 
usually noticed towards midsummer, and the disease disappears abruptly after the onset of cold weather in 
autumn. The disease is most prevalent in warm, low-lying moist areas such as valleys and marshes.  
Transmission:  African horse sickness is a noncontagious disease, and the virus was the first shown to be 
transmitted by midges (Culicoides spp.). The most significant vector seems to be Culicoides imicola, but 
other species, such as C. variipennis, which is common in many parts of the United States, should also be 
considered as potential vectors.  
The virus is transmitted biologically by midges, and these insects are most active just after sunset and at 
about sunrise.  
Although other insects such as mosquitoes have been implicated as biological vectors, and large biting 
flies (e.g., Stomoxys, Tabanus) may transmit AHS virus mechanically, the role of these insects in the 
epizootiology of the disease is regarded as absolutely minimal compared with that played by the 
Culicoides species.  
Generally, midges disperse only a few kilometers from their breeding sites, but it has been postulated that 
they can be borne for longer distances on air currents. Analysis of field observations on the progression of 
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outbreaks indicates that wind-borne spread of midges may assist the short-distance spread of the disease 
but that long-distance jumps of the infection are invariably the result of movement of infected Equidae.  
Incubation Period:  In experimentally induced cases the incubation period usually varies between 5 and 7 
days, but it may be as short as 2 days and rarely as long as 14 days. Circumstantial evidence indicates 
that, following natural infection, the incubation period varies from 7 to 14 days.  
Clinical Signs:  Four clinical forms of AHS can be distinguished.  
The Peracute or Pulmonary Form  
This form is characterized by very marked and rapidly progressive respiratory involvement. An acute 
febrile reaction may be the only clinical sign for a day or two, reaching a maximum of about 104-106° F 
(40-41° C). This is followed by various degrees of respiratory distress. The breathing may increase to 60 
or even 75 respirations per minute, and the animal tends to stand with its forelegs spread apart, its head 
extended, and the nostrils fully dilated. Expiration is frequently forced with the abdomen showing heave 
lines. Profuse sweating is common, and spasmodic coughing may be observed terminally with frothy, 
serofibrinous fluid exuding from the nostrils. The onset of dyspnea is usually very sudden, and death 
often occurs within 30 minutes to a few hours after its appearance.  
The Subacute Edematous or Cardiac Form  
The incubation period of this form varies between 7 and 14 days, and the onset of the clinical disease is 
marked by a febrile reaction of 102-106° F (39-41° C) that lasts for 3-6 days. Shortly before the decline of 
the fever, characteristic edematous swellings appear. These initially involve the supraorbital fossae and 
the eyelids and later extend to the lips, cheeks, tongue, intermandibular space, and laryngeal region. 
Subcutaneous edema sometimes extends a variable distance down the neck towards the chest, often 
obliterating the jugular groove. Interestingly, no edema of the lower limbs is observed. Terminally, 
petechial hemorrhages develop in the conjunctivae and under the ventral surface of the tongue. The 
animal becomes very depressed and may lie down frequently but for very short periods only. 
Occasionally, signs of colic may develop. Finally, the animal remains prostrate and dies from cardiac 
failure about 4-8 days after the onset of the febrile reaction. In cases that recover, swellings gradually 
subside within a period of 3-8 days.  
The Acute or Mixed Form  
This form represents a mixture of the pulmonary and cardiac forms. Although seldom diagnosed 
clinically, it is seen at necropsy in the majority of fatal cases of AHS in horses and mules. The disease 
manifests itself in various ways. Initial pulmonary signs of a mild nature that do not progress are followed 
by edematous swellings and effusions, and death results from cardiac failure. In the majority of cases, 
however, the subclinical cardiac form is suddenly followed by marked dyspnea and other signs typical of 
the pulmonary form.  
Horsesickness Fever  
This is the mildest form and is frequently overlooked in natural outbreaks. The febrile reaction is usually 
of the remittent type, with morning remissions and afternoon exacerbation, and lasts for 3-8 days but 
rarely exceeds 104° F (40° C). Apart from the febrile reaction, other clinical signs are rare and 
inconspicuous. The conjunctivae may be slightly congested, the pulse rate may be increased, and a certain 
degree of anorexia and depression may be present. This form of the disease is usually observed in 
donkeys and zebra or in immune horses infected with a heterologous serotype of AHS virus.  
Gross Lesions:  The lesions observed at necropsy examination depend largely on the clinical form of 
disease manifested by the animal before death. In the peracute form the most characteristic changes are 
edema of the lungs or hydrothorax. In very peracute cases, extensive alveolar edema and mottled 
hyperemia of the lungs are seen, whereas in cases with a somewhat more protracted course extensive 
interstitial and subpleural edema is also present, but hyperemia is less evident. Occasionally the lungs 
may appear reasonably normal, but the thoracic cavity may contain as much as 8 L of fluid. Other less 
commonly observed lesions are periaortic and peritracheal edematous infiltration, diffuse or patchy 
  
 
12
hyperemia of the glandular fundus of the stomach, hyperemia and petechial hemorrhages in the mucosa 
and serosa of the small and large intestines, subcapsular hemorrhages in the spleen, and congestion of the 
renal cortex. Most of the lymph nodes are enlarged and edematous, especially those in the thoracic and 
abdominal cavities. Cardiac lesions are usually not conspicuous, but epicardial and endocardial petechial 
hemorrhages are sometimes evident.  
In the cardiac form the prominent lesion is a yellow gelatinous infiltration in the subcutaneous and 
intermuscular fascia primarily of the head, neck, and shoulders. Occasionally the lesion may also involve 
the brisket, ventral abdomen and rump. Hydropericardium is a common feature, and there are extensive 
petechial and ecchymotic hemorrhages on the epicardium and endocardium, particularly of the left 
ventricle. The lungs are usually normal or only slightly engorged, and the thoracic cavity rarely contains 
excess fluid. The lesions in the gastrointestinal tract are generally similar to those found in the pulmonary 
form, except that submucosal edema of the cecum, large colon, and rectum tends to be far more 
pronounced.  
In the mixed form the lesions seem to represent a combination of those found in the pulmonary and 
cardiac forms.  
Morbidity and Mortality:  In susceptible horse populations, the fatalities range between 70 and 95 
percent, and the prognosis is extremely poor. In mules, the mortality rate is about 50 percent and in the 
European and Asian donkey about 5-10 percent. No mortality is observed among African donkeys and 
zebra.  
In enzootic regions, the mortality rate is modified in proportion to the immunity acquired by the equine 
population as a result of previous vaccination or exposure to natural infection.  
Diagnosis  
Field Diagnosis  
During the early febrile phase of AHS, a field diagnosis may be virtually impossible. However, a 
presumptive diagnosis should be possible once the characteristic clinical signs have developed and, more 
particularly, at necropsy.  
Specimens for the Laboratory  
Confirmation of a presumptive diagnosis is based on virus isolation and identification. This is of 
particular importance whenever outbreaks occur outside the enzootic regions. The AHS virus can be 
isolated quite readily from blood collected during the early febrile phase (preferably in heparin or else in 
other anticoagulants) as well as from spleen, lung, and lymph nodes collected at necropsy.  
Specimens for virus isolation should be shipped to the laboratory refrigerated, NOT FROZEN.  
Horses that survive infection develop specific antibodies within 10-14 days after infection that reach a 
peak about 10 days later. It is always advisable to use paired (acute and convalescent phase) serum 
samples. Serological tests can demonstrate AHS antibodies for 1 to 4 years after infection.  
Differential Diagnosis  
The clinical signs of AHS, particularly when not fully developed, may be confused with other infections, 
notably equine encephalosis and equine viral arteritis (EVA). The former disease occurs under the same 
epizootiological conditions as AHS, and in South Africa the two diseases frequently occur 
simultaneously. Horses suffering from equine encephalosis usually do not have characteristic lung edema 
or subcutaneous edema, and the mortality rate is considerably lower than in AHS.  
Severe cases of EVA may readily be confused with AHS. The presence of ventral edema (in EVA), 
particularly of the lower limbs, and the much lower mortality rate should allow differentiation. In 
countries where piroplasmosis occurs, the early stage of this disease, before blood parasites can be 
demonstrated and anemia develops, may be confused with AHS.  
The necropsy lesions of AHS can be confused with those found in cases of purpura hemorrhagica. In the 
latter condition, the hemorrhages and edema seem to be more severe and widely distributed than in AHS 
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and usually involve the limbs and lower abdomen. The highly sporadic occurrence of purpura also aids in 
differentiation.  
Vaccination:  The work of Alexander and de Toit has resulted in the development of a live attenuated 
vaccine that has been used successfully for several decades. However, the adaptation of the virus to the 
brains of adult mice resulted in a neurotropic vaccine that occasionally caused encephalitis in horses 
mules and particularly in donkeys. This necessitated an alternate and safer method of attenuation achieved 
by plaque selection in Vero cell cultures. The vaccine currently used in South Africa consists of two 
quadrivalent vaccines that are administered 3 weeks apart. Strategic reserves of monovalent vaccines are 
also maintained.  
Extensive work is presently under way to develop potent inactivated and recombinant vaccines that 
should widen the choice in the near future.  
Control and Eradication  
Preventive Measures  
The most important means of introducing AHS into a hitherto disease free country is by the introduction 
of equid animals incubating the disease. Zebra and African donkeys that do not develop any clinical sign 
of disease are particularly dangerous. Equid animals imported from infected countries should be 
quarantined in insect-proof facilities at the point of entry. At present, there is a minimum 60-day 
quarantine period for horses brought into the United States from Asia, Africa, and the Mediterranean 
countries.  
Once the disease is introduced into a country, several preventive measures should be taken to prevent 
further spread and eventually to eradicate the scourge in the shortest possible time. It is essential to isolate 
and identify the causal virus, but it is imperative that control measures be implemented even before the 
final diagnosis has been made.  
Officials should delineate area of control, taking into consideration geographical borders such as 
mountains and rivers. The movement of all equid animals within, into, and out of the control zone should 
be stopped and this restriction rigidly enforced. Furthermore, all equid animals should be stabled, at least 
from dusk to dawn, and sprayed with insect repellents to reduce the risk of insects feeding on the animals. 
If sufficient stabling facilities are not available, barns could be used. Even if not insect-proof, such 
housing will reduce the risk of infection. Additionally, the rectal temperatures of all equid animals in the 
zone should be taken regularly (preferably twice daily) to detect infected animals as early as possible 
because overt disease is generally preceded by viremia for about 3 days. Animals with fever should be 
killed or housed in insect-free stables until the cause of the fever has been established.  
Once the diagnosis has been finalized, vaccination of all susceptible animals with the relevant monovalent 
AHS vaccine should be considered. This decision will be guided largely by the success of measures 
already taken.  
Natural Immunity  
Animals that recover from the disease develop a solid life-long immunity against the infecting virus and a 
partial immunity against heterologous serotypes. Foals from immune dams have a passive immunity that 
may protect them for up to 6 months.  
Public Health:  There is no evidence that man can become infected with field strains of AHS virus, either 
through contact with infected animals or from working in laboratories. However, it has been shown that 
certain neurotropic vaccine strains may cause encephalitis and retinitis in humans following transnasal 
infection.  
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1.2 African swine fever virus2 
(Peste porcine Africaine, fiebre porcina Africana, maladie de Montgomery)  
Definition:  African swine fever (ASF) is a tickborne and contagious, febrile, systemic viral disease of 
swine.  
Etiology:  The ASF virus is a large (about 200 nm) lipoprotein-enveloped, icosahedral, double-stranded 
DNA virus. For many years the agent was classified as an iridovirus, but in recent years it was found to 
have many characteristics of poxvirus; thus, researchers have suggested establishment of a new family for 
ASF virus (ASFV).  
This virus is quite stable and will survive over a wide range of pH. In serum-free medium, ASFV is 
inactivated at pH 3.9 or lower and at pH 11.5 or higher. In the presence of 25 percent serum, ASFV will 
remain viable for 7 days at pH 13.4. The virus will survive for 15 weeks in putrefied blood, 3 hours at 50o 
C, 70 days in blood on wooden boards, 11 days in feces held at room temperature, 18 months in pig blood 
held at 4o C, 150 days in boned meat held at 39o F, and 140 days in salted dried hams.  
Over the years, ASFV isolates with lower virulence have emerged — particularly in the Iberian peninsula. 
Virulence of isolates varies from highly virulent (essentially 10 percent mortality in 7-10 days after 
exposure), to moderately virulent (acute illness in which a high percentage of the pigs survive), to low 
virulence (only seroconversion occures).  
Host Range:  Initially, domestic and wild pigs (Africa: warthog, bush pig, and giant forest hog; Europe: 
feral pig) were thought to be the only hosts of ASFV. In 1963, Spanish workers isolated ASFV from the 
soft tick Ornithodoros erraticus collected from ASF-infected farms. Subsequently, researchers showed 
that ASFV replicates in the tick and that there is transstadial, transovarial, and sexual transmission in 
Ornithodoros ticks. O. moubata collected from warthog burrows in Africa were shown to be infected with 
ASFV. African swine fever in wild pigs in Africa is now believed to cycle between soft ticks living in 
warthog burrows and newborn warthogs. Ornithodoros ticks collected from Haiti, the Dominican 
Republic, and southern California have been shown to be capable vectors of ASFV, but in contrast to the 
African ticks, many of the ticks from California died after being infected with ASFV. Many researchers 
believe that ASFV is really a tick virus and the pig is an accidental host.  
Because ASFV-infected ticks can infect pigs, ASFV is the only DNA virus that can qualify as an 
arbovirus.  
Geographic Distribution:  African swine fever is present in several African countries and on the island of 
Sardinia.  
Transmission:  Even though the soft tick has been shown to be a vector (and in Africa probably the 
reservoir of ASFV), the primary method of spread from country to country has been through the feeding 
of uncooked garbage containing ASFV-infected pork scraps to pigs. Once a pig becomes infected, ASFV 
spreads by direct contact, and contaminated people, equipment, vehicles, and feed. The role of carrier pigs 
has been difficult to prove experimentally, but circumstantial evidence from the field incriminates carrier 
pigs. An outbreak of ASF in a contained swine operation in Africa was traced to workers feeding the 
entrails of guinea fowl to pigs. It was shown that the guinea fowl feed on soft ticks; thus, ASFV was 
present in the guinea fowl intestines fed to the pigs.  
The amount of ASFV needed to infect a pig depends on the route of exposure. Experimentally, a pig can 
be infected by intramuscular or intravenous inoculation with a 0.13 hemadsorbing dose (HAD50); 
intranasal-oral inoculation required 18,200 HAD50.  
In an ASF endemic area where there are soft ticks, ticks can be the source of infection. However, in these 
areas in Africa, pigs can be very successfully raised in confinement with double fencing, proper isolation, 
                                                 
2Committee on Foreign Animal Diseases of the United States, revised 1998.  Animal Health Association, Foreign  
Animal Diseases, “The Gray Book,” Part IV, Library of Congress Catalog Card Number 17-12842, Pat Campbell 
& Associates and Carter Printing Company, Richmond, VA.   http://www.vet.uga.edu/vpp/gray_book/FAD/asf.htm  
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and sanitary procedures. In Africa, the production system with the highest risk of ASF is the village pig, 
for these pigs roam. The owners do not practice isolation procedures when the pigs are confined.  
In other areas, the disease has to be introduced by infected live pigs or by feeding uncooked garbage 
containing ASFV-infected pork. Once the disease is introduced into a herd, it spreads by direct and 
indirect contact with secretions and excretions from infected pigs. Aerosol transmission is not important 
in the spread of ASF. Because ASFV does not replicate in epithelial cells, the amount of virus shed by an 
ASF-infected pig is much less than the amount of virus shed by a hog-cholera-infected pig. The blood of 
a recently infected pig contains a very high ASFV titer: 105.3 to 109.3 HAD50 per milliliter. Therefore, if 
pigs fight, an infected pig develops bloody diarrhea, or an infected pig is necropsied, blood is shed, and 
there is massive environmental contamination.  
Piglets born of ASF-convalescent dams are free of ASFV and ASF antibody at birth but seroconvert after 
ingesting colostrum. When piglets from noninfected (control) and ASF-convalescent dams were 
challenge-inoculated when 7 weeks old, the control piglets developed an average viremia of 107.6 and 
died, whereas the piglets from convalescent gilts developed an average viremia of 104.9 and survived. 
However, because of persistent infection by ASFV, reestablishing a herd using pigs from convalescent 
animals will not result in an ASFV- free herd. When farmers in Cameroon repopulated their herds using 
ASF-convalescent animals, the herds experienced recurring periods of high mortality due to ASF.  
Incubation Period:  After intranasal-oral exposure, pigs usually develop fever and leukopenia in 48 to 72 
hours.  
Clinical Signs  
Highly and Moderately Virulent ASF Isolates  
The clinical signs of ASF are influenced by the virulence of the virus and the physiological state (age and 
pregnancy) of the pig. After inoculation of feeder pigs with either a highly virulent or moderately virulent 
isolate, the clinical course for both isolates is similar for the first 4-6 days post infection. About 2 DPI, the 
pigs will develop a fever of 105-107o F (40.5-41.7o C) and white pigs will have a reddened skin, moderate 
anorexia, and leukopenia. When disturbed the pigs will get up and move about but if left alone will after a 
short time lie down.  
After 4-6 DPI, a difference between the pigs inoculated with the different isolates will become apparent.  
Highly Virulent Isolate  
The pigs become progressively sicker (eat and move less), and most die between 7 and 10 DPI. It is not 
unusual to see a pig walking and a short time later to find it dead.  
Moderately Virulent Isolate  
Pigs infected by moderately virulent ASFV usually have a high fever for 10-12 DPI. Some mortality 
usually occurs at this time. After 12-14 DPI, temperatures and leukocyte counts start to return to normal 
levels. It is not unusual to have one or more pigs die as early as 7-8 DPI, but when these pigs are 
necropsied, the cause of death is frequently hemorrhage into the stomach; the underlying mechanism of 
death was that ASFV infection caused a thrombocytopenia, resulting in a prolonged bleeding time and 
hemorrhage from a preexisting gastric ulcer. Very young pigs may have a high mortality and have lesions 
similar to infection by highly virulent virus.  
Pigs affected with either isolate, in addition to the reddened skin, may develop dark red to purple 
discoloration of the skin on the ears, tail, extremities of the legs, or skin on the hams. This is a nonspecific 
sign also seen in other diseases. Some groups of pigs will develop diarrhea; this is probably due to 
disturbed gut physiology and flora rather than a direct effect of the virus because the virus does not 
replicate in epithelium. In contrast to hog cholera, ASFV-infected pigs do not develop a conjunctivitis or 
encephalitis, and, despite the high fever, the ASFV-infected pigs stay in good condition, whereas hog 
cholera-infected pigs quickly lose much weight.  
Pregnant animals infected with a high-, moderate-, or low-virulence ASF isolate abort.  
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Low Virulence Isolates  
Nonpregnant animals infected by certain low-virulence ASFV may only seroconvert; pregnant animals 
will abort.  
Other low-virulence ASFV isolates will cause a low fever for 2-3 weeks and then reddened areas 1 cm2 to 
many centimeters in size may develop in the skin. These areas then become raised and necrotic. These 
pigs may also have painless enlargements of joints—particularly the carpal and tarsal joints. This form is 
referred to as chronic ASF. Many of these pigs will have recurring episodes of a more acute disease and 
eventually die during an acute episode.  
Gross Lesions  
Highly Virulent ASFV Infection  
Pigs that die peracutely from an infection with a highly virulent ASFV may have poorly developed 
lesions. Animals that die 7 or more DPI have more classic lesions. Three lesions most consistently found 
and highly suggestive of ASF infection are as follows:  
• Greatly enlarged dark red to black friable spleen  
• Very enlarged hemorrhagic gastrohepatic lymph nodes  
• Very enlarged hemorrhagic renal lymph nodes  
Other lesions described for ASF are more variable and are as follows:  
• Dark red to purple areas of skin on ears, feet, and tail  
• Petechial hemorrhages on serosal surfaces  
• Petechial to ecchymotic hemorrhages in the renal cortex  
• Perirenal edema  
• Edema of the gall bladder 
• Swollen liver  
• Edema of the lung.  
In pigs infected orally, the submandibular lymph node may be enlarged and have some hemorrhage. 
Other peripheral lymph nodes may have only edema.  
Moderately Virulent Virus  
The gross lesions 8-12 DPI in pigs infected with a moderately virulent ASFV are similar to those infected 
by a highly virulent ASFV. The main difference in the lesions between these two types of isolates is that 
in infections by a moderately virulent ASFV, the spleen although enlarged, has a more normal color and 
is not friable.  
Low Virulent Virus  
The most common lesions in chronic ASF are necrotic skin lesions, consolidated lobules in the lung, 
generalized lymphadenopathy, swollen joints, and pericarditis.  
Aborted fetuses may be anasarcous, and there may be petechial hemorrhages in the placenta, skin, and 
myocardium, and a mottled liver.  
Morbidity and Mortality:  The warthog and bush pig develop a viremia but have a very mild or 
subclinical disease, whereas ASF infection in domestic pigs and European feral pigs can cause a high 
mortality.  
Morbidity in a previously unexposed herd will usually be 100 percent in pigs that have contact with each 
other. Mortality varies with the virulence of the isolate. Highly virulent isolates will cause about 100 
percent mortality. Infection by lesser virulent isolates can cause mortality that varies from a low 
percentage to 60-70 percent. Factors that can increase mortality in infections by the lesser virulent isolates 
are concurrent disease, a young age, and pregnancy.  
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Diagnosis  
Field Diagnosis  
The highly virulent form of ASF will be easiest to diagnose because essentially 100 percent of the pigs 
will die. African swine fever caused by the lesser virulent isolates will be more difficult to diagnose but 
should always be suspected when there are febrile pigs and necropsy findings include the following:  
• Greatly enlarged dark red to black spleen  
• Very enlarged hemorrhagic gastrohepatic lymph nodes  
• Very enlarged hemorrhagic renal lymph nodes.  
African swine fever has frequently been misdiagnosed as hog cholera. In contrast to hog cholera, ASFV-
infected pigs do not develop a conjunctivitis or encephalitis, and despite the high fever, the ASFV-
infected pigs stay in good condition. In contrast, hog cholera-infected pigs are severely depressed and 
quickly lose much weight; moreover, they usually have a foul smelling diarrhea.  
Specimens for Laboratory  
The ASFV is present in the blood starting about 2 DPI. In infections by lesser virulent isolates, ASFV can 
usually be isolated from the blood for 25 or more DPI. Specimens for laboratory diagnosis are as follows:  
• Heparinized blood  
• Clotted blood or serum  
• Submandibular lymph node  
• Inguinal lymph node  
• Tonsil  
• Spleen  
• Gastrohepatic lymph node  
• Lung  
• Liver  
• Kidney  
Bone marrow should be submitted if there are considerable postmortem changes.  
The specimens should be shipped refrigerated or frozen. Pieces of the preceeding tissues, the brain, and 
any other gross lesion should be submitted in 10 percent buffered formalin.  
Aborted fetuses are usually free of virus; therefore, it is necessary to submit a blood sample from the dam.  
Laboratory Diagnosis  
The initial diagnosis of ASF in a free area requires isolation and identification of the virus. After the 
initial diagnosis, confirmation of a diagnosis can be made by demonstrating ASF antigen in tissue or ASF 
antibody.  
Differential Diagnosis  
Differential diagnoses for ASF should include hog cholera, erysipelas, salmonellosis, and 
eperythrozoonoisis.  
Vaccination:  There is no vaccine.  
Control and Eradication  
Prevention  
Introduction of the disease into free areas can be prevented by cooking all garbage fed to pigs (this applies 
to commercial and backyard pigs and pets [potbellied pigs]) and importing only ASF-disease free pigs.  
  
 
18
Eradication  
Control and eradication of ASF in developed countries can be accomplished by slaughter and disposal of 
all acutely infected pigs, widespread testing and elimination of all seropostive animals, and good herd 
isolation and sanitary practices.  
Today (1996), ASF is not as great a threat to the United States as it was several years ago. The major 
pork-exporting countries have eradicated the disease in domestic pigs.  
Public Health:  Human beings are not susceptible to ASFV infection.  
1.3 Akabane virus3 
(Congenital arthrogryposis-hydranencephaly syndrome, A-H syndrome, Akabane disease, congenital 
bovine epizootic A-H syndrome, acorn calves, silly calves, curly lamb disease, curly calf disease, dummy 
calf disease)  
Definition:  Congenital arthrogryposis-hydranencephaly (A-H) syndrome is an infectious disease of the 
bovine, caprine, and ovine fetus caused by intrauterine infection and interference with fetal development 
after transmission to the dam by biting gnat- or mosquito-transmitted Akabane virus and some other 
antigenically related members of the Simbu group of arboviruses. Fetal infection may cause abortions, 
stillbirths, premature births, mummified fetuses, and various dysfunctions or deformities of fetuses or 
liveborn neonates. Adult animals are not clinically affected while actively infected with virus.  
Etiology:  The etiologic agents of congenital A-H syndrome are arboviruses of the Simbu group of the 
family Bunyaviridae. Akabane virus was the first member of the Simbu group to be incriminated in 
congenital A-H syndrome, but other members (namely Aino, Peaton, and Tinaroo viruses) have the 
capacity to produce fetal defects. In recent years, Cache Valley virus, a mosquito-borne member of the 
Bunyaviridae outside the Simbu group, has been found to reproduce a similar syndrome in ruminants 
within the United States. The Simbu group of viruses is spread only by insect vectors. Spread by contact, 
infected tissues, exudates, or fomites does not occur.  
Host Range:  Congenital A-H syndrome associated with Akabane virus and other Simbu group viruses 
has been reported only in cattle, sheep, and goats. Although antibody against these viruses has been 
detected in horses, no clinical evidence of fetal infection has been reported. Infections of wild ruminants 
do occur, and fetal damage must be considered but has not been reported.  
Geographic Distribution:  In Japan, the periodic outbreaks of AH syndrome have been reported since 
1949. Enzootic Akabane virus (and presumably other Simbu group virus) activity has occurred in the 
northern half of Australia since at least 1931 with occasional temporary epizootic incursions southward 
dependent on favorable seasons. Reports of A-H syndrome in Israel and other countries in the Middle 
East, Cyprus, Korea, Zimbabwe, and South Africa have been published in the last decade. Serological 
surveys indicate that the virus occurs throughout Africa, Asia, and Australia but not Papua New Guinea, 
the Pacific Islands, or the Americas.  
Transmission:  The occurrence of A-H syndrome is seasonally and geographically restricted. The 
location and timing of the infection of the fetus during early pregnancy is consistent with the seasonality 
of transmission by hematophagous insects. Akabane virus has been isolated from Aedes vexans and Culex 
triteeniorhynchus mosquitoes in Japan; Anopheles funestus mosquitoes in Kenya; Culicoides milnei and 
C. imicola in Africa; C. oxystoma in Japan; and C. brevitarsis and C. wadei gnats in Australia. 
Confirmation of the biologic transmission by these species is lacking; however, epidemiologic evidence 
incriminates them. In Australia, C. brevitarsis is believed to be the principal vector of Akabane virus. 
Cache Valley virus has been isolated from at least nine different mosquito species, and antibodies to this 
virus have been detected in man, as well as wild and domestic animals in the Americas.  
                                                 
3Committee on Foreign Animal Diseases of the United States Animal Health Association, revised 1998.  Foreign 
Animal Diseases, “The Gray Book,” Part IV, Library of Congress Catalog Card Number 17-12842, Pat Campbell 
& Associates and Carter Printing Company, Richmond, VA.  http://www.vet.uga.edu/vpp/gray_book/FAD/aka.htm  
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There is no indication that Akabane virus; other Simbu group viruses or Cache Valley virus is transmitted 
in any other way than by a vector. Transmission happens months before disease in the fetus is evident.  
Incubation Period:  Infection of adult animals produces no overt clinical sign, but viremia generally 
occurs 1-6 days after infection. A natural viremia may last 4 to 6 days before antibodies to Akabane virus 
are detectable. However, infection of pregnant animals during the first months of gestation may result in 
fetal infection that is not apparent until much later in pregnancy or at term.  
Timing of the infection relative to the stage of gestation is critical to the development of defects in the 
fetus. In pregnant sheep, the gestational period for the occurrence of fetal abnormalities has been shown 
to vary from 30-36 days to 30-50 days. This variation in the reported results has been ascribed to (a) 
differences in the virulence of virus strains used, (b) differences in the passage level of the virus strain 
used, or (c) differences caused after growth of the virus in the arthropod vectors. Inoculation of pregnant 
cattle with virus between 62 and 96 days of gestation resulted in fetal lesions; in pregnant goats, the 
critical period in the gestational cycle was about 40 days.  
Clinical Signs:  Congenital A-H syndrome is manifested as a seasonally sporadic epizootic of abortions, 
stillbirths, premature births, and deformed or anomalous bovine, caprine, and ovine fetuses or neonates. 
The pregnant dam has no clinical manifestation at the time of infection with virus. Sentinel cattle under 
close observation have no clinical sign during viremia induced by natural infection. If infection develops 
during the first third of pregnancy, gross fetal damage may occur. At the other end of the disease 
spectrum, damage to the central nervous system (CNS) may be minor and produce changes in behavior of 
the new born or young animal. Dystocia at parturition may occur owing to the deformities in the fetus. 
Badly deformed fetuses are usually dead at birth, and the limbs are locked in the flexed or extended 
position. Most live neonates have central nervous system degeneration and muscle lesions that prevent the 
animal from standing or suckling. Torticollis, scoliosis, brachygnathism, and kyphosis may coexist with 
arthrogryposis. Lesions in the central nervous system are manifested clinically as blindness, nystagmus, 
deafness, dullness, slow suckling, paralysis, and incoordination.  
Mildly affected calves or lambs may improve their mobility with time. However, most eventually die by 6 
months as a result of blindness and other neurological defects.  
Gross Lesions:  An individual fetus or newborn may have arthrogryposis and hydranecephaly or both 
syndromes. Lesions are associated with damage to the enervation of the musculature and to the central 
nervous system. Arthrogryposis is the most frequently observed lesion. Affected joints cannot be 
straightened even by application of force because of ankylosis of the joint in the extended or flexed 
position. Torticollis, scoliosis, and brachygnathism are observed. There may be shallow erosions about 
the external nares and muzzle and between the distal digits. Hypoplasia of the lungs and skeletal muscles, 
fibrinous polyarticular synovitis, fibrinous navel infection, ophthalmia, cataracts, and presternal steatosis 
occur. Within the CNS, hydranencephaly, hydrocephalus, agenesis of the brain, microencephaly, 
porencephaly and cerebellar cavitation, fibrinous leptomeningitis, fibrinous ependymitis, and agenesis or 
hypoplasia of the spinal cord are variously reported. The cerebellum appears intact. Lesions due to 
Akabane tend to be symmetrical. However, some asymmetry occurs when Aino virus is involved. 
Akabane virus was isolated from fetuses of naturally infected pregnant cows or ewes by the use of 
predictive serology. When the mothers seroconverted from negative to positive in Akabane virus 
neutralization tests, Akabane virus was isolated from the fetus.  
Morbidity and Mortality:  In endemic areas, animals are exposed and become immune before becoming 
pregnant; thus, congenital abnormalities are seldom seen in native animals, for antibodies prevent virus 
from spreading from the site of the bite to the fetus. However, when the infected vector spreads (e.g., 
during an extended humid summer) to an area where the animals are not immune, A-H syndrome can 
occur months later in many animals. The disease can also appear when pregnant animals from a disease-
free area are moved into an endemic area.  
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There is no reported damage to the dam in congenital A-H syndrome. Most live-born affected calves, 
lambs, or kids die shortly after birth or must be slaughtered for humane reasons. Some mildly affected 
calves do improve gait and learn to follow the herd.  
Diagnosis  
Field Diagnosis  
A field diagnosis of congenital A-H syndrome can be made on the basis of the clinical condition, gross 
pathologic lesions, and the epidemiology. The sudden onset of aborted, mummified, premature, or 
stillborn fetuses with arthrogryposis and hydranencephaly should be suggestive. The dam will have had 
no clinical history of disease. A retrospective study would indicate that the first third of pregnancy 
occurred during a time of biting insect activity.  
Specimens for Laboratory  
The following specimens should collected for virus isolation: placenta, fetal muscle, cerebrospinal fluid, 
and fetal nervous tissue; for serology: fetal or precolostral serum, and serum from the dam. For 
histopatholgy send pieces of spleen, liver, lung, kidney, heart, lymph nodes, affected muscle, spinal cord 
and brain in 10 percent buffered formalin.  
If the specimens can be delivered to a laboratory within 24 hours, they should be placed on ice. If delivery 
will take longer, quickfreeze the specimens and do not allow them to thaw during transit.  
Laboratory Diagnosis  
Virus isolation should be attempted from placenta, fetal muscle, or fetal nervous tissue. The chances of 
success are very low except with a fetus and placenta aborted before antibodies are generated within an 
immunocompetent fetus. In the absence of viral isolations, a serologic diagnosis is usually made by 
demonstrating antibodies in precolostral or fetal serum samples. In adult animals, seroconversion or a 
demonstrable rise in antibody titer indicates that there was infection. A microtiter neutralization test and 
an immunofluorescence test are available for detecting and assaying antibodies. Tissues of the dam are 
free of virus by the time the damage is observed in the fetus or newborn. Low titers (<10) in unpaired 
serum samples should not be taken as diagnostic because of cross-reaction problems.  
Differential Diagnosis  
The demonstration that Cache Valley virus, a Bunyavirus that is ubiquitous within the United States, can 
cause the A-H syndrome means that serological tests are essential to distinguish exotic from enzootic 
etiologies. It is a reasonable assumption that other Bunyaviridae will be proven to be teratogenic in 
livestock in the Americas. A variety of nutritional, genetic, toxic, and infectious diseases will produce 
fetal wastage and deformities. Fetal brain lesions resulting from bluetongue vaccine virus infections of 
pregnant ewes are similar to those produced within the congenital A-H syndrome. Bluetongue presents 
the greatest difficulty in the initial differential diagnosis of hydranencephaly. Bovine virus diarrhea 
infection can cause cerebellar dysplasia in calves. Border disease virus infection can cause undersized, 
excessively hairy lambs with muscular tremors and skeletal defects. Wesselsbron virus infection can 
cause congenital porencephaly and cerebral hypoplasia in calves. Serology of the dam and fetus will 
resolve any confusion.  
Vaccination:  A formalin-inactivated, aluminum phosphate, gel-absorbed vaccine and an attenuated 
vaccine have been developed in Japan for Akabane virus. An effective killed vaccine for Akabane virus 
has been developed but not marketed in Australia. These vaccines induce immunity in the cow or ewe, 
and the circulating antibodies prevent the virus from reaching the fetus. The vaccines are used prior to 
exposure to infected vectors. Vaccine is no longer available for economic reasons. Immunizing agents for 
other Simbu group viruses are not currently available and are not expected to be developed.  
Control and Eradication:  Techniques for the control of the viral agents that cause congenital A-H 
syndrome are those typically recommended for other vector-transmitted agents. Control of the vector 
depends upon disruption of breeding sites, reduction of vector populations with pesticides, and protection 
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of host animals from feeding by the vectors. In addition to these procedures, animals should be vaccinated 
before breeding.  
Public Health:  There is no evidence that humans can be infected by Akabane virus.  
1.4 Avian influenza virus4 
(Fowl Plague)  
Definition:  Avian influenza (AI) is a disease of viral etiology that ranges from a mild or even 
asymptomatic infection to an acute, fatal disease of chickens, turkeys, guinea fowls, and other avian 
species, especially migratory waterfowl.  
Etiology:  Fowl plague was described in 1878 as a serious disease of chickens in Italy. It was determined 
in 1955 that fowl plague (FP) virus is actually one of the influenza viruses. The AI viruses, along with the 
other influenza viruses, make up the virus family Orthomyxoviridae. The virus particle has an envelope 
with glycoprotein projections with hemagglutinating and neuraminidase activity. These two surface 
antigens, hemagglutinin (HA) and neuraminidase (NA), are the basis of describing the serologic identity 
of the influenza viruses using the letters H and N with the appropriate numbers in the virus designation 
e.g., H7N2. There are now 15 hemagglutinin and 9 neuraminidase antigens described among the Type A 
influenza viruses. The type designation (A, B, or C) is based upon the antigenic character of the M protein 
of the virus envelope and the nucleoprotein within the virus particle. All influenza viruses affecting 
domestic animals (equine, swine, avian) belong to Type A, and Type A influenza virus is the most 
common type producing serious epidemics in humans. Types B and C do not affect domestic animals.  
Classical fowl plague viruses have H7 as one of the surface antigens but can have different N antigens. It 
was once believed that all H7 viruses are highly pathogenic fowl plague viruses and that no other avian 
influenza viruses could produce a fowl-plague-like disease. When avirulent AI viruses with the H7 
antigens were demonstrated in turkeys in 1971 and highly virulent AI viruses with the H5 antigen were 
first found in chickens in 1959, the necessity for redefining the term fowl plague or using other 
terminology became apparent. Because there are highly virulent AI viruses that possess H antigen other 
than the H7 and H7 AI viruses that do not produce clinical fowl plague, an international assembly of 
avian influenza specialists proposed that the term fowl plague no longer be used. They suggested that any 
AI virus, regardless of its HA designation, meeting specified virulence requirements in the laboratory be 
designated highly pathogenic avian influenza (HPAI). The criteria that serve as the basis for classifying 
an AI virus as HPAI has more recently been modified to include molecular considerations such as the 
type of amino acids at the cleavage site of its HA. This chapter will be limited to describing the HPAI and 
not the AI viruses of less virulence and pathogenicity.  
Host Range:  Most avian species appear to be susceptible to at least some of the AI viruses. A particular 
isolate may produce severe disease in turkeys but not in chickens or any other avian species. Therefore, it 
would be impossible to generalize on the host range for HPAI, for it will likely vary with the isolate. This 
assumption is supported by reports of farm outbreaks where only a single avian species of several species 
present on the farm became infected. Swine appear to be important in the epidemiology of infection of 
turkeys with swine influenza virus when they are in close proximity. Other mammals do not appear to be 
involved in the epidemiology of HPAI. The infection of humans with an H5 avian influenza virus in 
Hong Hong in 1997 has resulted in a reconsideration of the role of the avian species in the epidemiology 
of human influenza.  
Geographic Distribution:  Highy pathogenic avian influenza viruses have periodically occurred in recent 
years in Australia (H7), England (H7), South Africa (H5), Scotland (H5), Ireland (H5), Mexico (H5), 
Pakistan (H7), and the United States (H5). Because laboratory facilities are not readily available in some 
                                                 
4Committee on Foreign Animal Diseases of the United States Animal Health Association, revised 1998.  Foreign 
Animal Diseases, “The Gray Book,” Part IV, Library of Congress Catalog Card Number 17-12842, Pat Campbell 
& Associates and Carter Printing Company, Richmond, VA.  http://www.vet.uga.edu/vpp/gray_book/FAD/avi.htm   
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parts of the world to differentiate Newcastle disease and HPAI, the actual incidence of HPAI in the 
world's poultry flocks is difficult to define. It can occur in any country, regardless of disease control 
measures, probably because of its prevalence in wild migratory waterfowl, sea birds and shore birds.  
Avian influenza has produced losses of variable severity, primarily in turkeys in the United States, since 
the mid-1960's. The disease outbreaks in turkeys in the United States have been caused by AI viruses with 
many of the HA designations. It was in the fall of 1983 that a highly virulent H5 virus produced severe 
clinical disease and high mortality in chickens, turkeys, and guinea fowl in Pennsylvania. This severe 
disease, clinically indistinguishable from classical fowl plague, occurred after a serologically identical but 
apparently mild virus had been circulating in poultry in the area for 6 months.  
Outbreaks of less virulent AI have frequently been described in domestic ducks in many areas of the 
world. The AI viruses are often recovered from apparently healthy migratory waterfowl, shore birds, and 
sea birds worldwide. The epidemiologic significance of these isolations relative to outbreaks in domestic 
poultry has led to the generally accepted belief that waterfowl serve as the reservoir of influenza viruses.  
Transmission:  There is a considerable body of circumstantial evidence to support the hypothesis that 
migratory waterfowl, sea birds, or shore birds are generally responsible for introducing the virus into 
poultry. Once introduced into a flock, the virus is spread from flock to flock by the usual methods 
involving the movement of infected birds, contaminated equipment, egg flats, feed trucks, and service 
crews, to mention a few. Preliminary trapping evidence indicates that garbage flies in the Pennsylvania 
outbreak were sources of virus on the premises of the diseased flocks. Virus may readily be isolated in 
large quantities from the feces and respiratory secretions of infected birds. It is logical to assume, 
therefore, that because virus is present in body secretions, transmission of the disease can take place 
through shared and contaminated drinking water. Airborne transmission may occur if birds are in close 
proximity and with appropriate air movement. Birds are readily infected via instillation of virus into the 
conjunctival sac, nares, or the trachea. Preliminary field and laboratory evidence indicates that virus can 
be recovered from the yolk and albumen of eggs laid by hens at the height of the disease. The possibility 
of vertical transmission is unresolved; however, it is unlikely infected embryos could survive and hatch. 
Attempts to hatch eggs in disease isolation cabinets from a broiler breeder flock at the height of disease 
failed to result in any AI-infected chickens. This does not mean that broken contaminated eggs could not 
be the source of virus to infect chicks after they hatch in the same incubator. The hatching of eggs from a 
diseased flock would likely be associated with considerable risk.  
Incubation Period:  The incubation period is usually 3 to 7 days, depending upon the isolate, the dose of 
inoculum, the species, and age of the bird.  
Clinical Signs:  Infections of HPAI result in marked depression with ruffled feathers, inappetence, 
excessive thirst, cessation of egg production, and watery diarrhea. Mature chickens frequently have 
swollen combs, wattles, and edema surrounding the eyes. The combs are often cyanotic at the tips and 
may have plasma or blood vesicles on the surface with dark areas of ecchymotic hemorrhage and necrotic 
foci. The last eggs laid, after the onset of illness, are frequently without shells. The diarrhea begins as 
watery bright green and progresses to almost totally white. Edema of the head, if present, is often 
accompanied by edema of the neck. The conjunctivae are congested and swollen with occasional 
hemorrhage. The legs, between the hocks and feet, may have areas of diffuse hemorrhage. Respiratory 
signs can be a significant feature of the disease, depending on the extent of tracheal involvement. Mucus 
accumulation can vary. It is not unusual in caged layers for the disease to begin in a localized area of the 
house and severely affect birds in only a few cages before it spreads to neighboring cages.  
Death may occur within 24 hours of first signs of disease, frequently within 48 hours, or be delayed for as 
long as a week. Some severely affected hens may occasionally recover.  
In broilers, the signs of disease are frequently less obvious with severe depression, inappetence, and a 
marked increase in mortality being the first abnormalities observed. Edema of the face and neck and 
neurologic signs such as torticollis and ataxia may also be seen.  
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The disease in turkeys is similar to that seen in layers, but it lasts 2 or 3 days longer and is occasionally 
accompanied by swollen sinuses.  
In domestic ducks and geese the signs of depression, inappetence, and diarrhea are similar to those in 
layers, though frequently with swollen sinuses. Younger birds may exhibit neurologic signs.  
Gross Lesions:  Birds that die with the peracute disease and young birds may not have significant gross 
lesions other than severe congestion of the musculature and dehydration. In the less acute form, and in 
mature birds, significant gross lesions are frequently observed. They may consist of subcutaneous edema 
of the head and neck area, which is evident as the skin is reflected. Fluid may exit the nares and oral 
cavity as the bird is positioned for postmortem examination. The conjunctivae are severely congested— 
occasionally with petechiation. The trachea may appear relatively normal except that the lumen contains 
excessive mucous exudate. It may also be severely involved with hemorrhagic tracheitis similar to that 
seen with infectious laryngotracheitis. When the bird is opened, pinpoint petechial hemorrhages are 
frequently observed on the inside of the keel as it is bent back. Very small petechia may cover the 
abdominal fat, serosal surfaces, and peritoneum, which appears as if it were finely splattered with red 
paint. Kidneys are severely congested and may occasionally be grossly plugged with white urate deposits 
in the tubules.  
In layers, the ovary may be hemorrhagic or degenerated with darkened areas of necrosis. The peritoneal 
cavity is frequently filled with yolk from ruptured ova, causing severe airsacculitis and peritonitis in birds 
that survive for 7 to 10 days.  
Hemorrhages may be present on the mucosal surface of the proventriculus — particularly at the juncture 
with the gizzard. The lining of the gizzard peels easily and frequently reveals hemorrhages and erosions 
underneath. The intestinal muscosa may have hemorrhagic areas — especially in the lymphoid foci such 
as the cecal tonsils. The gross lesions are not distinctly different from those observed with velogenic 
viscerotropic Newcastle disease (VVND). The lesions in turkeys and domestic ducks are similar to those 
in chickens but may not be as marked.  
Morbidity and Mortality:  The prognosis for flocks infected with HPAI is poor. Morbidity and mortality 
rates may be near 100 percent within 2 to 12 days after the first signs of illness. Birds that survive are 
usually in poor condition and resume laying only after a period of several weeks.  
Diagnosis  
Field Diagnosis  
Highly pathogenic avian influenza is suspected with any flock where sudden deaths follow severe 
depression, inappetence, and a drastic decline in egg production. The presence of facial edema, swollen 
and cyanotic combs and wattles, and petechial hemorrhages on internal membrane surfaces increases the 
likelihood that the disease is HPAI. However, an absolute diagnosis is dependent upon the isolation and 
identification of the causative virus. Commercially available type A influenza antigen-capture enzyme 
linked immunosorbent assay kits designed for use in human influenza have recently shown promise as a 
possible rapid diagnositic test for poultry.  
Specimens for Laboratory  
Specimens sent to the laboratory should be accompanied by a history of clinical and gross lesions, 
including any information on recent additions to the flock. Diagnosis depends upon the isolation and 
identification of the virus from tracheal or cloacal swabs, feces, or from internal organs. Specimens 
should be collected from several birds. It is not unusual for many of the submitted specimens to fail to 
yield virus. Swabs are the most convenient way to transfer AI virus from tissues or secretions of the 
suspect bird to brain and heart infusion broth or other cell culture maintenance medium containing high 
levels of antibiotics. Dry swabs should be inserted deeply to ensure obtaining ample epithelial tissue. 
Trachea, lung, spleen, cloaca, and brain should be sampled. If large numbers of dead or live birds are to 
be sampled, cloacal swabs from up to five birds can be pooled in the same tube of broth. An alternative 
technique is to place 0.5 cm3 of each tissue into the broth. Blood for serum should be collected from 
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several birds. If the specimens can be delivered to a laboratory within 24 hours, they should be placed on 
ice. If delivery will take longer, quickfreeze the specimens and do not allow them to thaw during transit.  
Laboratory Diagnosis  
Nine to 11-day-old embryonated chicken eggs are inoculated with swab or tissue specimens. Avian 
influenza virus will usually kill embryos within 48-72 hours. If the virus isolated is identified as a Type A 
influenza virus, through the AGP or ELISA tests, it is then tested using a battery of specific antigens to 
identify its serologic identity (HA and NA type).  
Sera from infected chickens usually yield positive antibody tests as early as 3 or 4 days after first signs of 
disease.  
Differential Diagnosis  
Highly pathogenic avian influenza is easily confused with VVND, because the disease signs and 
postmortem lesions are similar, and may also be confused with infectious laryngotracheitis and acute 
bacterial diseases such as fowl cholera and Escherichia coli. However, in an area where AI is prevalent, 
such as during an outbreak, sound presumptive diagnoses can be made by flock history, signs, and gross 
lesions.  
Treatment:  Amantadine hydrochloride has been licensed for use in humans to treat influenza since 1966. 
The medication is effective in reducing the severity of influenza Type A in humans. Experimental 
evidence indicated possible efficaciousness in poultry when the drug was administered in drinking water 
to reduce disease losses, but drug-resistant viruses quickly emerged, negating the initial beneficial effects. 
Thus, the drug is not recommended for use in poultry.  
Vaccination:  Inactivated oil-emulsion vaccines, although fairly expensive, have been demonstrated to be 
effective in reducing mortality, preventing disease, or both, in chickens and turkeys. These vaccines may 
not, however, prevent infection in some individual birds, which go on to shed virulent virus. More 
economical viable vaccines prepared using naturally avirulent or attenuated strains have the disadvantage 
of the possible creation of reassortant influenza viruses with unpredictable characteristics. These 
reassortants could result when a single host bird is simultaneously infected with both the vaccine and 
another AI virus. Owing to the segmented nature of the influenza virus genome, a reassortment of genetic 
material can readily occur, creating new influenza viruses. The basic drawback to any vaccine approach 
for the control of HPAI is the large number of HA subtypes that can cause the disease. Because there is 
no cross-protection among the 15 known HA subtypes, either a multivalent vaccine will be needed or 
vaccination postponed until the prevalent disease-causing subtype in the area is identified. A recombinant 
fowl pox virus vaccine containing the gene that codes for the production of the H5 antigen has recently 
been licensed. The use of a recombinant insect virus containing the gene for either the H5 or H7 antigen 
has been used to make these vaccine proteins in insect cell cultures.  
Control and Eradication:  The practice of accepted sanitation and biosecurity procedures in the rearing of 
poultry is of utmost importance. In areas where waterfowl, shore birds, or sea birds are prevalent, the 
rearing of poultry on open range is incompatible with a sound AI prevention program. Appropriate 
biosecurity practices should be applied, including the control of human traffic and introduction of birds of 
unknown disease status into the flock. Cleaning and disinfection procedures are the same as those 
recommended in the chapter on velogenic Newcastle disease.  
Public Health:  The AI viruses are Type A influenza viruses, and the possibility exists that they could be 
involved in the development, through genetic reassortment, of new mammalian strains. An influenza virus 
isolated from harbor seals that died of pneumonia had the HA and NA surface antigens of an influenza 
virus isolated from turkeys a decade earlier. The infection and deaths of 6 of 18 humans infected with an 
H5 avian influenza virus in Hong Hong in 1997 has resulted in a reconsideration of the portentous role 
that the avian species have on the epidemiology of human influezna. Previously there was only one report 
of a human becoming infected with an H7 AI virus. Is is impossible to predict the importance of AI virus 
in determining the strains of virus that infect humans. There was no evidence to indicate that humans 
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coming in contact with large quantities of the H5N2 virus during depopulation efforts in the HPAI 
outbreak of 1983 in Pennsylvania became infected with the virus.  
1.5 Bluetongue virus5 
(Sore muzzle, pseudo foot-and-mouth disease, muzzle disease)  
Definition:  Bluetongue (BT) is an insect-borne viral diseases of ruminants characterized by acute or 
subacute clinical courses in susceptible ruminants. The BT virus (BTV) has also been associated with 
congenital disease in sheep and cattle.  
Etiology:  Bluetongue is caused by orbiviruses in the family Reoviridae. Other orbiviruses include 
Ibaraki, Palyam, Eubenangee, and Tilligerry. The viruses are resistant to lipid solvents, which is typical of 
nonenveloped viruses. The viruses are relatively acid-labile, and slow freezing at -10 to -20 degrees C (14 
– 4 degrees F) is deleterious to the virus.  
Worldwide, 24 serotypes of BTV have been identified. Five serotypes of BTV have been isolated in the 
United States. However, only BTV serotypes 10, 11, 13, and 17 are currently active. BTV serotype 2, 
originally isolated from animals imported into Florida, may not have established itself in the United 
States; however, epidemiologic studies will be required to resolve this issue.  
Acetic acid is an effective disinfectant.  
Host Range:  The host range of BTV is very broad and includes all ruminant species tested to date. 
However, the expression of clinical disease varies in different species. Sheep are fully susceptible to 
BTV.   
Geographic Distribution:  The geographic distribution of the orbiviruses is extensive, but current 
knowledge is still incomplete. Virus distribution is based on the presence of certain Culicoides species, 
including C. variipennis, C. imicola, C. brevitaris, and others. Orbivirus infections are common in 
tropical, subtropical, and temperate climates. Areas with year- round vector activity could easily maintain 
the virus by a continuous vector-host cycle. Virus persistence in areas with severe winters is not 
understood. Reintroduction of virus into the area in the warm months by transportation of infected 
animals or infected Culicoides being carried on the wind is probably common. Some research reports 
suggest that overwintering of the virus in these areas occurs by mechanisms such as (1) prolonged 
viremias (up to 3 months) in certain animals, (2) transplacental transmission of BTV in the late fall and 
early winter to the late-term developing fetus with subsequent birth of a viremic calf, and (3) 
overwintering of the virus in Culicoides that may survive through the winter at very low population 
densities. Virological and serological testing has suggested that BTV exists in North, Central, and South 
America; Africa; and parts of Asia; Europe; the Middle East; and the South Pacific.  
Transmission:  Transmission of orbiviruses is primarily by Culicoides species, which are biological 
vectors. Limited experimental studies have also demonstrated that ticks are capable of mechanically or 
biologically transmitting BTV; however, their role in the epidemiology of BTV is probably minimal. 
Virus can also be transferred from viremic dams (sheep and cattle) to the developing fetus. Although 
BTV can be found in the semen of certain rams and bull, it is only isolated at the time of peak viremia; 
this presence of virus would appear to be the result of blood cells in the semen. Extensive field and 
experimental studies suggest that transmission of BTV via semen is of not importance in the 
epidemiology of BTV. The potential for BTV transmission also exists owing to poor management 
practices such as using the same needle or infected surgical equipment on several animals (mechanical 
transmission).  
                                                 
5Committee on Foreign Animal Diseases of the United States Animal Health Association, revised 1998.  Foreign 
Animal Diseases, “The Gray Book,” Part IV, Library of Congress Catalog Card Number 17-12842, Pat Campbell 
& Associates and Carter Printing Company, Richmond, VA.  http://www.vet.uga.edu/vpp/gray_book/FAD/blt.htm 
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Incubation Period:  The incubation period of BT in sheep is usually 7-10 days; however, viremia may 
appear as early as 3 to 4 days after infection. In cattle, viremia occurs as early as 4 days postinfection, but 
clinical signs are uncommon. Development of clinical BT in cattle may be the result of 
hypersensitization. Under laboratory conditions such animals develop clinical signs 10 to 12 days 
following reexposure to the virus. The incubation of BTV infection in deer is 7 to 12 days.  
Clinical Signs of Bluetongue 
BT in Sheep  
The classic signs of BT in sheep are those of an acute to subacute infection by a virulent strain of virus in 
fully susceptible animals belonging to the fine wool or mutton breeds. However, the signs of BT are 
variable. Not all strains of BTV that infect sheep cause clinical disease. In some flocks, no clinical sign is 
apparent, whereas in other flocks infected by the same virus up to 30 percent may develop signs of 
disease.  
The first sign of illness which begins 7 to 8 days after infection, is a rise in temperature to 106-107o F 
(41.6-41.7o C). Temperatures may be elevated for 4 to 12 days following the initial rise. Within 24 hours 
of the initial rise in temperature, excessive salivation and frothing at the mouth develop and are associated 
with hyperemia and swelling of the buccal and nasal mucosa. If forced to move, sheep may pant like a 
dog. During the next 2 to 3 days, erosions and ulcerations may develop in the buccal mucosa. By 4 to 7 
days in severe cases, extensive ulcerations may be covered by gray necrotic tissue on the dental pad and 
dorsal surface of the tongue. In addition, affected animals being fed rough feed (stemmy alfalfa) may 
have more severe lesions of the oral mucosa.  
Hyperemia is often observed around the coronary bands of the hooves. Often the hooves are tender and 
varying degrees of lameness are apparent. In more severe cases, the animals stand with an arched back. If 
the animals are driven during this time, they may slough their hooves. Animals that recover may have a 
dark line in the wall of the hoof.  
The lesions in the mouth, the reluctance to move, and the necrosis of striated musculature lead to 
weakness, depression, and rapid weight loss. These can result in prostration and eventual death in 
severely affected animals. Sheep that recover from severe infections may have a break in the wool 3 to 4 
weeks after the fever has subsided. This can lead to partial or complete shedding of wool.  
Bluetongue virus infection of pregnant ewes in the first trimester can cause fetal death and resorption, 
abortion, or birth of "dummy" lambs. Attenuated BTV vaccines can also cause reproductive failure.  
BT in Cattle  
Bluetongue virus infection in cattle usually does not cause any clinical sign of disease. Subclincal disease 
is only evidenced by changes in the leukocyte and lymphocyte subpopulation counts in the peripheral 
blood and a mild acute eosinophilic dermatitis. A consistent fluctuation in rectal temperature is indicative 
of viremia and a mild disease. Occasionally, field outbreaks of BT disease occur in which as many as 30 
percent of the cattle have clinical signs. Experimental data support the contention that clinical BT in cattle 
occurs as result of prior sensitization to a related orbivirus followed by a later second exposure. After 
secondary exposure, clinical signs become apparent in 10-12 days. Clinical signs consist of mild 
hyperemia in the buccal cavity and around the coronary band; vesicular lesions, which lead to ulcerations, 
in the buccal mucosa; erect hair over the cervical and dorsal thoracic areas; and a definite hyperesthesia. 
In addition, the dermis becomes thickened with prominent folds apparent in the cervical areas, and a dry 
crusty exudate leads to matting of hair in affected areas. These lesions may persist for 10 to 20 days. 
Similar lesions have been reported on teats of cattle with clinical BT. Hoof lesions may be associated with 
lameness. In some instances severe breaks in the hooves occur 40 to 60 days after infection and are 
usually followed by foot rot.  
Bluetongue virus infection can cause reproductive failure in cattle. Some infected bulls will become 
temporarily sterile following acute infections. After recovery, production of sperm resumes, and the bulls 
are capable of settling cows.  
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Certain strains of BTV are capable of causing fetal death, resorption and or abortion; cell-culture-adapted 
live virus may be more effective than field virus in establishing fetal infection. Teratogenic effects of 
BTV in the bovine fetus include hydranencephaly and cerebral cysts that result in "dummy" calves.  
Critical factors for fetal infection include the stage of embryonic or fetal development when infection 
occurs, the immune status of the dam, and the strain(s) of BTV causing infection. The most susceptible 
period for fetal infections occurs between 60 and 140 days gestation in nonimmune dams. Experimental 
studies suggest 15 to 20 percent of viremic dams will transmit virus to their fetuses. In areas where strains 
of BTV are endemic, there is little evidence that BTV has adverse affects on reproduction.  
BT in Goats  
Bluetongue infection of goats is typically an inapparent infection similar to that described for cattle.  
Gross Lesions 
BT in Sheep  
The lesions of BT in sheep vary greatly depending on (1) the strain of virus, (2) individual animal and 
breed susceptibility and (3) environmental (stress) factors. Prominent lesions include facial edema, 
edematous ears, and dry, crusty exudate over the nostrils. Lesions in the oral cavity include focal 
petechial (pinhead-size) hemorrhages that progress to gray necrotized debris over erosions and ulcerations 
on the lips; on the dorsal, lateral, and ventral surfaces of the tongue; and on the dental pad. The buccal 
mucosa may be cyanotic. Hyperemia and occasional erosions can occur on papillae and laminae in the 
reticulum and omasum.  
Lesions in the respiratory system include cyanosis and edema of the nasal mucosa and pharynx, and there 
may be tracheal hyperemia and congestion. Froth in the trachea is present only when there is pulmonary 
congestion and edema.  
Lesions in the vascular system cause hyperemia, edema, and hemorrhages. A characteristic lesion is 
hemorrhage at the base of the pulmonary artery. Petechial and ecchymotic (larger than pinhead-size) 
hemorrhages may be observed at times in the endocardium. Focal gray-white areas of necrosis are often 
found in the papillary muscles and less frequently in other areas of the myocardium.  
The most prominent changes in the skin include dermal and subcutaneous edema of the head and ears. 
Sometimes an irregular rash (exanthematous eruptions) may progress into serous and crusty exudates on 
the skin. Hyperemia is prominent at the coronet of the hoof. Often, this reddening is accompanied by 
petechial or ecchymotic hemorrhages that extend down the horn.  
A yellow gelatinous exudate is common in the fascia (connective tissue) along and between skeletal 
muscles. On the cut surface of the heavy muscle there may be focal hemorrhages and areas that appear 
dry and gray-white.  
Newborn lambs with congenital BT have hydranencephaly or porencephaly. These lesions are 
characterized by fluid-filled cavities, either occupying the whole of the cranial vault or as cystic cavities 
in the gray and white matter of the cerebral cortex. Cerebellar dysplasia (abnormal development) with 
rudimentary medial and lateral lobes may be present. The spinal cord may be dysplastic (abnormal 
development) and lack white matter. Skeletal deformities may consist of scoliosis (lateral curvature of the 
spine) and torticollis (twisted neck).  
BT in Cattle  
Gross lesions in cattle differ in some respects from those observed in sheep. The most prominent lesions 
involve the skin, mouth, and hooves. Skin lesions are characterized by marked edema that leads to thick 
folds — particularly in the cervical areas. Lesions may form in the folds as serous exudate accumulates 
and dries. Dry, crusty exudate is present on the skin over the cervical and thoracic areas. The crusty 
material results from vesicular eruptions and ulcerations.  
The external nares may have erosions covered by crusty exudate that sloughs. Lesions in the mouth start 
as vesicles and proceed to ulcers covered with grayish necrotic debris. These lesions are more common on 
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the buccal mucosa and dental pad and rarely the tongue. Hyperemia occurs at the coronary band. In some 
instances, fissures occur 6 to 8 weeks following infection.  
In utero BTV infection may lead to fetal death and resorption, abortion, hydranencephaly, or cerebral 
cysts.  
BT in Deer  
Bluetongue in susceptible deer causes widespread hemorrhages throughout the body. These lesions are 
associated with intravascular thromboses and hemorrhages varying in size from petechial to ecchymotic. 
In chronic BT, deer may develop severe fissures and even sloughing of hooves. Ulcers covered with gray 
necrotic debris are found in the buccal mucosa, dental pad, and tongue.  
Morbidity and Mortality:  In sheep, BT can range from inapparent to severe, depending on the breed, 
strain of virus, and environmental stress on the animals. Morbidity can reach 100 percent; mortality can 
vary from 0 to 50 percent. Many animals will recover within a few days to 2 weeks.  
In cattle, BTV infection is usually subclinical. Although morbidity can approach 5 percent, cattle 
typically recover within a few weeks. However, lameness and unthriftiness may persist for prolonged 
period.  
The morbidity and mortality for BTV infection in other species are as follows:  
• Goats - - minimal clinical signs  
• White-tailed deer - - morbidity approaching 100 percent and a mortality of 80-90 pecent  
• Pronghorn antelope - - morbidity approaching 100 percent and a mortality of 80-90 percent  
• Bighorn sheep - - morbidity approaching 100 percent and a mortality of 0 to 50 percent  
• North American elk - - similar to cattle; the disease is usually subclinical.  
Diagnosis  
Field Diagnosis  
Tentative diagnosis of BT can be made when (1) clinical signs appear in populations known to be 
susceptible, (2) the occurrence of disease coincides with a prevalence of insect vectors, (3) necropsy of 
sheep reveals characteristic gross lesions, and (4) a flock history of recent wasting (loss of weight) and 
pododermatitis (foot rot).  
Specimens for Laboratory  
Preferred samples for confirmatory diagnosis include sterile heparinized blood samples from animals with 
clinical signs or spleen or bone marrow, or both, from dead animals. Samples from aborted and 
congenitally infected newborn animals should include heparinized blood and, if possible, spleen, lung, 
brain, and serum. If possible, the heparinized whole blood (erythrocytes and white cells) should be 
washed in saline containing antibiotics and resuspended in saline prior to shipping. This procedure will 
reduce the antibody that may neutralize the virus if blood-cell lysis occurs.  
Specimens should be shipped refrigerated, not frozen. Freezing makes virus isolation difficult.  
Laboratory Diagnosis  
Confirmatory diagnosis is based on isolation and identification of virus from blood or tissues. Diagnosis 
for lambs and calves infected in utero is based on serology (if no colostrum has been ingested) or virus 
isolation, or both.  
Differential Diagnosis  
Differential diagnoses include plant photosensitization, foot-and-mouth disease, vesicular stomatitis, 
bovine virus diarrhea, malignant catarrhal fever, infectious bovine rhinotracheitis, parainfluenza-3, 
contagious ecthyma, and actinobacillosis.  
Vaccination:  Vaccination has been the primary means of controlling BT disease in sheep. To date, only 
modified-live (attenuated) virus vaccines have been used. Because of the multiplicity of BTV serotypes 
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and variable cross-protection between serotypes, vaccination has resulted in varying degrees of success. 
The serotypes incorporated into the vaccine must be the same as those causing infection in the field. The 
practice of administering multiple virus serotypes in a single vaccination is argued against by some 
scientists because (1) an immune response (virus neutralizing antibody) is typically only induced to one, 
or at best two of the serotypes incorporated in the vaccine and (2) reassortment between the genome 
segments of the multiple vaccine viruses may occur in the host of a vector feeding on such a vaccinated 
animal. Although simultaneous infection of sheep, cattle, or Culicoides can result in creation of 
reassortant viruses, there is no evidence that this process has resulted in generation of new serotypes. 
However, such reassortant events may result in altered virulence and biological transmissibility.  
No inactivated or subunit vaccines are currently available, though several experimental vaccine 
preparations have been studied, including inactivated virus vaccines, subunit vaccines prepared by 
purification of natural VP2 (viral protein responsible for inducing virus neutralizing antibody), and 
recombinant VP2 expressed in a baculovirus system.  
Control and Eradication:  Vaccination can be used in endemic areas.  
Vector control measures to impede the spread of BTV infection are not commonly used. However, certain 
measures have potential effectiveness such as water management (reduction of Culicoides breeding sites), 
use of insecticides and larvacides (spraying breeding areas), and insect repellents in which animals are 
dipped.  
The only applicable treatment available is to minimize animal stress and administer broad-spectrum 
antibiotics to combat secondary infection.  
Public Health:  There is only one documented human infection, and that was in a laboratory worker  
1.6 Bovine spongiform encephalopathy6 
BSE is caused by a prion.  The term prion derives from 'proteinaceous infectious particle'; it refers to the 
initially heretical hypothesis that the infectious agent causing those diseases consists only of protein, with 
no nucleic acid genome. (All previously known pathogens, such as bacteria and viruses, contain nucleic 
acids, which enable them to reproduce.) The prion hypothesis explained why the mysterious infectious 
agent is resistant to ultraviolet radiation, which breaks down nucleic acids, but is susceptible to substances 
that disrupt proteins. 7 
Definition:  Bovine spongiform encephalopathy (BSE), widely known as "mad cow disease," is a 
chronic, afebrile, degenerative disease affecting the central nervous system (CNS) of cattle.  
Bovine spongiform encephalopathy belongs to the family of diseases known as the transmissible 
spongiform encephalopathies (TSE's). These diseases are caused by a transmissible agent that is yet to be 
fully characterized. They share the following common characteristics:  
a. A prolonged incubation period of months or years;  
b. A progressive debilitating neurological illness that is always fatal;  
c. When examined by electron microscopy, detergent-treated extracts of brain tissue from animals 
or humans affected by these diseases reveal the presence of scrapie-associated fibrils (SAF's);  
d. Pathological changes appear to be confined to the CNS and include vacuolation and 
astrocytosis;  
                                                 
6Committee on Foreign Animal Diseases of the United States Animal Health Association, revised 1998.  Foreign 
Animal Diseases, “The Gray Book,” Part IV, Library of Congress Catalog Card Number 17-12842, Pat Campbell 
& Associates and Carter Printing Company, Richmond, VA.   
http://www.vet.uga.edu/vpp/gray_book/FAD/Search/search.htm  
7Scientific American.com, Ask the Experts:  Medicine:  What is a prion? 
http://www.sciam.com/askexpert_question.cfm?articleID=000B256E-B042-1C71-9EB7809EC588F2D7&catID=3 
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e. The transmissible agent elicits no detectable specific immune response in the host.  
Specific types of TSE's include scrapie, which affects sheep and goats; transmissible mink 
encephalopathy; feline spongiform encephalopathy; chronic wasting disease of deer and elk; and five rare 
diseases in humans: kuru, Creutzfeldt-Jakob disease (CJD), Gerstmann-Sträussler-Scheinker syndrome, 
fatal familial insomnia (FFI), and new variant Creutzfeldt-Jakob disease (nvCJD).  
Etiology:  The clinical, pathological, and molecular genetic features of BSE, as well as other 
transmissible spongiform encephalopathies, have led to speculation on the nature of the etiologic agent 
and the pathogenic mechanisms of the disease. There are three main theories on the nature of the scrapie 
agent:  
1. The virus theory, in which the virus would have to have unusual biochemical and biophysical 
characteristics that would help explain the remarkable physicochemical properties.  
2. The prion theory, in which the agent is conceived of being composed exclusively of a host-
coded normal cellular protein (PrPc) that becomes partially protease resistant (PrPBSE) — most 
likely through a post-translational conformation change after infection. In this theory there is no 
nonhost component of the agent. That is, a specific informational molecule (nucleic acid e.g., 
RNA or DNA) is not present.  
3. The virino theory, which states that the agent consists of a host-derived protein coat, (PrP being 
one of the candidates for this protective protein) and a small noncoding regulatory nucleic acid.  
All of the proposed theories have some degree of validity. Proponents of the virus and virino theories 
have concluded that the existence of different scrapie strains unequivocally proves the presence of a 
nucleic acid component of the infectious agent which, as in conventional viruses, may undergo mutations 
responsible for phenotypic variations. The problem with these theories is that no agent-specific nucleic 
acid has been convincingly identified to copurify with infectivity. Moreover, chemical, enzymatic, or 
physical treatments that usually inactivate or degrade nucleic acids have no effect on the transmissible 
properties of the infectious agent. Possible reasons for this are that the amount of nucleic acid of the 
putative agent is too small to be detected with available techniques and that its tight bond to the protein 
protects it from chemical or physical inactivation. Also weakening the virus and virino theories is the 
inability to identify any virus particles under the electron microscope, and the failure of an infected host 
to generate an immune response. Recently small particles resembling virus structures have been observed 
by electron microscopy.  
The prion model involves propagation of a protein-only agent (PrPBSE) whereby PrPc can assume various 
tertiary structures caused by a combination of host genetics and the introduction of altered (infectious) 
PrP (PrPBSE). More simply stated, the structure of the infecting PrPBSE imprints upon the normal cellular 
precursor (PrPc) and results in a conformation change to the protease-resistant form. It is suspected that 
"strain" differences result from mutations in the PrP gene that may cause proteins "flip" and change 
shape. Several explanations for scrapie strain genetics in the context of the prion theory have been 
suggested but none have been proven.  
It should be pointed out that the prion theory fails to explain a) how the PrP of the infecting agent 
originally assumed the aberrant structure associated with infectivity, and b) how the different structures 
originated as a function of the different strains. Although numerous scrapie strains can be differentiated in 
a single host (i.e., sheep), the PrP agents associated with these strains have not shown any biochemical 
and molecular differences; thus, BSE seems to be caused by a single strain type. This BSE strain is 
different from historical or contemporary isolates from sheep or goats with natural scrapie, as determined 
by study of incubation periods and brain "lesion profiles" in mice.  
Regardless of whether the prion (PrPBSE) is or is not the etiologic agent, the partially protease-resistant 
form of the prion protein is a marker of infection.  
Host Range:  Bovine spongiform encephalopathy has been experimentally transmitted to the following 
species via intracerebral (IC) inoculation: cattle, sheep, and goats, mink, pigs, marmosets, macaques, and 
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mice. Intracerebral transmission was attempted in hamsters but was not successful. Via the oral route, 
BSE has been successfully transmitted to cattle, sheep, and goats; mice; and mink. Oral transmission has 
not been successful in swine. Parenteral and oral transmission has also been attempted in chickens with 
no evidence of disease thus far.  
A transmissible spongiform encephalopathy has been diagnosed in eight species of captive wild 
ruminants as well as exotic (cheetahs, pumas, a tiger, and an ocelot) and domestic cats. There have been 
about 81 domestic cat cases of feline spongiform encephalopathy (FSE) in Great Britain and in 1 
domestic cat each in Norway, Northern Ireland, and Liechtenstein. The agent isolated from several of 
these cases using strain typing in mice is indistinguishable from BSE in cattle, which suggests that FSE is 
actually BSE in exotic and domestic cats. This also appears to be true for the other ruminants. 
Epidemiological evidence suggests BSE-contaminated feed to be the primary source of infection in these 
species.  
Other cases of spongiform encephalopathy have been reported in kudu, eland, nyala, gemsbok, and a few 
exotic cats. These too are thought to be linked to contaminated feed.  
It has also been suggested that 23 cases (as of January 31, 1998) of a variant form of CJD (nvCJD) (a 
human disease) in Great Britain (U.K. Department of Health, March 2, 1998) and 1 case in France may be 
linked to exposure to BSE before the introduction of a specified bovine offal (SBO) ban at slaughter in 
1989. The SBO ban excludes from human consumption brain, spinal cord, and other tissues with potential 
BSE infectivity.  
Geographic Distribution:  Worldwide there have been more than 170,000 cases since the disease was 
first diagnosed in 1986 in Great Britain. Over 95 percent of these cases have occurred in the United 
Kingdom. The disease has also been confirmed in native-born cattle in Belgium, France, Ireland, 
Luxembourg, the Netherlands, Northern Ireland, Portugal, and Switzerland but is not known to exist in 
the United States.  
Transmission: Different scientific hypotheses have been advanced concerning the origins of BSE. The 
epidemiologic data suggest that BSE in Great Britain is an extended common source epidemic involving 
feed containing TSE-contaminated meat and bone meal as a protein source. The causative agent is 
suspected to be from either scrapie-affected sheep or cattle with a previously unidentified TSE.  
Changes in rendering operations in the early 1980's — particularly the removal of a solvent-extraction 
process that included a steam-heat treatment — may have played a part in the appearance of the disease 
and the subsequent amplification of the agent in the food chain. A ban on feeding animal protein of 
ruminant origin to ruminants was enacted in Great Britain in July 1988.  
In Great Britain the epidemic peaked in 1992-93, when approximately 1,000 cases were being reported 
per week. In 1998 it remains on the decline with approximately 100 cases reported per week. Cases that 
have been detected in other countries appear be a result of importations of live cattle or, more 
significantly, contaminated feed from Great Britain.  
There is no evidence that BSE spreads horizontally; that is, by contact between unrelated adult cattle or 
from cattle to other species.  
New evidence suggests that maternal transmission may occur at an extremely low level. Results of British 
research show low levels of transmission of BSE from affected cows to their offspring. These results 
demonstrated that there is approximately a 9 percent increase in the occurrence of BSE in offspring of 
BSE-affected dams as compared with calves born to dams where BSE was not detected. The study did not 
ascertain if this was the result of genetic factors or true transmission. The research did, however, point out 
that, at this level, if maternal transmission does occur, it alone will not sustain the epidemic.  
In the naturally infected animals, the agent has been identified by mouse bioassay in the brain, spinal 
cord, and retina. The route of inoculation into the mice was intracranial. The naturally infected animals 
were adult cattle exhibiting clinical signs of disease.  
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Mice fed milk, mammary gland, placenta, lymph nodes, or spleen have failed to develop the disease or to 
establish subclinical infection of the lymphoreticular system within their natural lifespan.  
Another study was conducted to examine the pathogenesis of BSE in cattle; that is the replication (tissue 
distribution) of the agent during the incubation period. This study, which has not yet been completed, has 
identified the agent via mouse bioassay in the distal ileum of the experimentally infected calves. It is 
thought that the agent may be associated with the lymphoid tissue of the intestines. The calves were 4 
months of age at the time of oral dosing. First isolation of the agent in the distal ileum was made at 6 
months after oral dosing. Subsequent isolations from the distal ileum were made at 10, 14, and 18 months 
after dosing. Recently this study has also identified infectivity in bone marrow, trigeminal ganglion, 
dorsal root ganglion, brain, and spinal cord.  
No infectivity has been found by parenteral or oral challenge, or both, in over 40 other tissues from 
clinically ill cattle using the mouse bioassay. It appears as if the distribution of the BSE agent is not as 
diverse as the scrapie agent in sheep. However, there is a possibility that the agent is present but is at such 
low levels that the bioassay is not sensitive enough to detect it.  
Incubation Period:  The incubation period usually ranges from 2 to 8 years. Following the onset of 
clinical signs, the animal's condition gradually deteriorates until the animal becomes recumbent, dies, or 
is destroyed. This usually takes from 2 weeks to 6 months. Most cases in Great Britain have occurred in 
dairy cows (Friesians) between 3 and 6 years of age. The youngest confirmed case occurred in a 20-
month-old heifer, and the oldest case was found in a cow 18 years of age.  
Clincial Signs:  Cattle affected by BSE develop a progressive degeneration of the nervous system. 
Affected animals may display changes in temperament, abnormalities of posture and movement, and 
changes in sensation. More specifically, the signs include apprehension, nervousness or aggression, 
incoordination, especially hind-limb ataxia, tremor, difficulty in rising, and hyperaesthesia to sound and 
touch. In addition, many animals have decreased milk production or loss of body condition, or both, 
despite continued appetite.  
Gross Lesions:  There is no gross lesion associated with BSE.  
Morbidity and Mortality:  In Great Britain, 19 percent of the dairy herds and 1.6 percent of the beef herds 
have had one or more cases of BSE. This difference is believed to result from the fact that dairy calves 
were fed a higher level of protein supplement. The average incidence in herds in Great Britian has been 
1.75 cases. However, there have been a few herds with over 30 cases. Affected animals die.  
Diagnosis  
Field Diagnosis  
A field diagnosis of BSE is based on the occurrence of clinical signs of the disease. A bovine animal that 
has signs of a CNS disturbance should be observed over time (at least 2 weeks) to determine whether the 
signs become progressively more severe. If, after this interval, improvement or recovery has not taken 
place, BSE should be suspected and the animal humanely euthanized.  
Specimens for Laboratory  
Because the BSE agent is considered a human pathogen, protective clothing, gloves, and face protection 
should be worn when performing the necropsy. The entire brain should be removed intact with a portion 
of the cranial cervical spinal cord attached. Portions should be placed in a plastic bag and submitted 
unfixed. The remainder of the brain should be fixed in 10 percent buffered formalin solution. One 
cerebral hemisphere is removed by cutting the brain stem through the space between the cerebellum and 
cerebrum with a longitudinal cut between the cerebral hemispheres.  
Laboratory Diagnosis  
Bovine spongiform encephalopathy currently must be confirmed by histopathological examination of 
brain tissue. Bilaterally symmetrical degenerative changes are usually seen in the gray matter of the brain 
stem. These changes are characterized by vacuolation or microcavitation of nerve cells in the brain stem 
nuclei. The neural perikarya and axons of certain brain stem nuclei contain intracytoplasmic vacuoles of 
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various sizes that give the impression of a spongy brain. Hypertrophy of astrocytes often accompanies the 
vacuolation. A diagnosis may also be made by the detection of SAF's using electron microscopy.  
Two supplemental tests are available to enhance the diagnostic capabilities for BSE. These are 
immunohistochemistry and the Western blot technique. In the past, if the brain tissue was not harvested 
shortly after the animal's death, autolysis often made it very difficult to confirm a diagnosis by 
histopathology. These tests allow for the possibility of confirming a diagnosis of BSE by detecting PrPBSE 
even if the brain has been frozen or autolytozed.  
Differential Diagnosis  
Differentials for BSE include rabies, listeriosis, nervous ketosis, milk fever, grass tetany, lead poisoning, 
and other toxicities or etiological agents affecting the nervous or musculoskeletal system of adult cattle.  
Treatment:  There is no known treatment for BSE or any of the TSE's.  
Vaccination:  There is no preventative vaccine.  
Control and Eradication:  Bovine spongiform encephalopathy from foreign sources may be prevented by 
the implementation of import regulations prohibiting live ruminants and ruminant products (especially 
meat, bone meal, and offal) from countries where BSE may exist. Because the origin of BSE remains 
unknown, preventing an epidemic of BSE would involve, at a minimum, the prohibition of feeding rum-
inant proteins to ruminants. The prevention program of any country should also include an active sur-
veillance effort focused on high-risk cattle for the early detection of BSE. Most countries of the world 
have prohibited the importation of cattle and bovine products from countries known to have BSE. In addi-
tion many countries have taken steps to enact regulations prohibiting the feeding of ruminant proteins to 
ruminants. This is true even in countries such as Australia and New Zealand with no known animal TSE's.  
Agricultural officials in countries known to have BSE have taken a series of actions to control and, it is to 
be hoped, eradicate BSE. These include making BSE a notifiable disease, prohibiting the inclusion of 
certain animal proteins in ruminants' rations (the feed bans vary depending on the amount of BSE 
detected), and depopulating certain populations of cattle thought to be of higher risk because of 
epidemiological findings.  
To prevent human exposure to the BSE agent numerous countries have established prohibitions on the 
inclusion of high risk material in foods, pharmaceuticals, cosmetics, and so forth.  
U.S. Actions  
With an active surveillance program in place for 8 years, BSE has not been detected in the United States. 
The United States Department of Agriculture (USDA), Food and Drug Administration (FDA), and 
industry groups are actively working to maintain this status. The measures USDA, Animal and Plant 
Health Inspection Service (APHIS), has taken in this regard include prohibitions or restrictions, or both, 
on certain animal and product imports, ongoing surveillance for the disease in the United States, 
preparation of an emergency response plan in the unlikely event an introduction were to occur, and 
continuing educational efforts. The Animal and Plant Health Inspection Service actively shares 
information and coordinates closely with other Federal agencies, as well as the States, livestock and 
affiliated industries, veterinary and research communities, and consumer groups, to ensure that the United 
States has a uniform approach to transmissible spongiform encephalopathies based on sound scientific 
information.  
A comprehensive surveillance program has been implemented by APHIS in the United States to ensure 
timely detection and swift response in the unlikely event that an introduction of BSE were to occur. This 
surveillance program entails the location of imports from countries known to have BSE and targeted 
active and passive surveillance for either BSE or any other TSE in cattle.  
To locate each of the 496 British cattle that were imported into this country between January 1, 1981, and 
July 1989, APHIS has conducted a traceback effort. In July 1989, the United States prohibited the 
importation of ruminants from countries affected with BSE. As of March 1998, only 17 of these animals 
are known to be alive in the United States, and these are being carefully monitored by APHIS personnel 
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on an ongoing basis. In addition, five head of cattle imported from Belgium in 1996 are now under 
quarantine. In cooperation with the states and industry, APHIS continues to purchase these animals for 
diagnostic purposes. No evidence of BSE has been found in any of these imported animals.  
The United States has had an aggressive, active surveillance program for BSE since May 1990. Bovine 
spongiform encephalopathy is a notifiable disease, and there are more than 250 Federal and State 
regulatory veterinarians specially trained to diagnose foreign animal diseases, including BSE. The Animal 
and Plant Health Inspection Service leads an interagency surveillance program, which includes the Food 
Safety Inspection Service (FSIS) and the Centers for Disease Control (CDC). The surveillance samples 
include field cases of cattle exhibiting signs of neurological disease, cattle condemned at slaughter for 
neurological reasons, rabies-negative cattle submitted to public health laboratories, neurological cases 
submitted to veterinary diagnostic laboratories and teaching hospitals, and random sampling of cattle that 
are nonambulatory at slaughter. As of February 21, 1998, over 6,600 brains had been examined for BSE 
or another form of a transmissible spongiform encephalopathy in cattle. No evidence of either condition 
has been detected by histopathology or immunohistochemistry.  
As of December 12, 1997, APHIS has prohibited the importation of live ruminants and most ruminant 
products from all of Europe until a thorough assessment of the risks can be made. The new restrictions 
apply to Albania, Austria, Bosnia-Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Federal 
Republic of Yugoslavia, Finland, Germany, Greece, Hungary, Italy, Former Yugoslav Republic of 
Macedonia, Norway, Poland, Romania, Slovak Republic, Slovenia, Spain, and Sweden.  
This action was taken because, in the past year, the Netherlands, Belgium, and Luxembourg have reported 
their first cases of BSE in native-born cattle. There is evidence that European countries may have had 
high BSE risk factors for several years and less than adequate surveillance. Additionally, Belgium 
reported that the cow diagnosed with BSE was processed into the animal food chain.  
The Food and Drug Administration (FDA) has recently established regulations that prohibit the feeding of 
most mammalian proteins to ruminants. The effective date of this regulation was August 4, 1997.  
Public Health 
BSE and CJD — Human Health Concerns  
On March 20, 1996, the U.K.'s Spongiform Encephalopathy Advisory Committee (SEAC) announced the 
identification of 10 cases of a new variant form of CJD (nvCJD). All of the patients developed onset of 
illness in 1994 or 1995. The following features describe how these 10 cases differed from the sporadic 
form of CJD:  
• The affected individuals were much younger than the sporadic CJD patient. Typically, sporadic 
CJD patients are over 63 years old. The average patient age for the variant form of CJD is 27.5 
(range of 16 to 42) years.  
• The course of the disease in the nvCJD averaged 13 months. Sporadic CJD cases average a 6-
month duration.  
• In the variant cases, electroencephalographic (EEG) electrical activity was not typical of 
sporadic CJD.  
• Although brain pathology was recognizable as CJD, the pattern was different from normal CJD, 
and evidenced large aggregates of prion protein plaques.  
Epidemiologic and case studies have not revealed a common risk factor among the cases of nvCJD. 
According to the SEAC, all victims were reported to have eaten beef or beef products in the last 10 years, 
but none had knowingly eaten brain material. One of the affected individuals had been a vegetarian since 
1991.  
The SEAC concluded that, although there was no direct scientific evidence of a link between BSE and 
nvCJD, on the basis of current data and in the absence of any credible alternative, the most likely 
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explanation was that the cases were linked to exposure to BSE before the introduction of control 
measures; namely, the specified bovine offal (SBO) ban in 1989.  
Research reported in later 1996 and 1997 has presented further evidence to support a causal association 
between nvCJD and BSE. Two significant studies published in the October 2, 1997, edition of Nature led 
the SEAC to conclude that the BSE agent is very likely to be the cause of nvCJD. Dr. Moira Bruce and 
colleagues at the Institute for Animal Health in Edinburgh, Scotland, inoculated three panels of inbred 
mice and one panel of crossbred mice with BSE, nvCJD, and sporadic CJD. Interim results indicate that 
mice inoculated with BSE show the same pattern of incubation time, clinical signs, and brain lesions as 
mice inoculated with tissues from patients with nvCJD. This provides evidence that BSE and nvCJD have 
the same signature or are the same "strain." In addition classical CJD and known scrapie strains were not 
similar to nvCJD or BSE.  
Results from another study published by Dr. John Collinge and colleagues of Imperial College School of 
Medicine, London, United Kingdom, strongly support Bruce's results. Collinge's paper reports 
experimental transmission of BSE to transgenic mice expressing only human PrP.  
The Health and Safety Executive in the United Kingdom now advises that BSE must be considered a 
biological agent (human pathogen) within the meaning of the Control of Substances Hazardous to Health 
Regulations 1994.  
1.7 Camel pox virus8 
 Camelpox Virus Orthopoxvirus (see description above under Vaccinia) 
• generalized pustular disease 
• limited to Middle East, parts of Africa & Asia 
Vaccinia Virus 
• Orthopoxvirus 
   - vesicular (blister) lesions (start as rash or papule) 
   - may be localized or generalized 
   - transmission: direct contact, air, fomites 
   - diagnosis: electron microscopy, virus isolation 
 Vaccinia: 
   - infects cattle via handling (milking) by infected personnel 
   - lesions are on teats 
   - was used for vaccination of people against smallpox  
1.8 Classical swine fever virus9 
Hog Cholera (Note: The preferred term for this disease is now classical swine fever.) 
(Classical swine fever, peste du porc, colera porcina, Virusschweinepest)  
Definition:  Hog cholera (HC) is a highly contagious viral disease of swine that occurs in an acute, a 
subacute, a chronic, or a persistent form. In the acute form, the disease is characterized by high fever, 
severe depression, multiple superficial and internal hemorrhages, and high morbidity and mortality. In the 
                                                 
8Texas A&M University, Department of Veterinary Pathobiology, College of Veterinary Medicine,  Poxviridae.  
http://vtpb-www.cvm.tamu.edu/vtpb/vet_micro/descriptions_viruses/pox.html#5 
9Committee on Foreign Animal Diseases of the United States Animal Health Association, revised 1998.  Foreign 
Animal Diseases, “The Gray Book,” Part IV, Library of Congress Catalog Card Number 17-12842, Pat Campbell & 
Associates and Carter Printing Company, Richmond, VA.  http://www.vet.uga.edu/vpp/gray_book/FAD/HOC.htm 
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chronic form, the signs of depression, anorexia, and fever are less severe than in the acute form, and 
recovery is occasionally seen in mature animals. Transplacental infection with viral strains of low 
virulence often results in persistently infected piglets, which constitute a major cause of virus 
dissemination to noninfected farms.  
Etiology:  Although minor antigenic variants of hog cholera virus (HCV) have been reported, there is 
only one serotype. Hog cholera virus is a lipid-enveloped pathogen belonging to the family Flaviviridae, 
genus Pestivirus. The organism has a close antigenic relationship with the bovine viral diarrhea virus 
(BVDV) and the border disease virus (BDV), as demonstrated in the immunodiffusion and 
immunofluorescence tests. The serum neutralization test can, however, differentiate between HCV and 
BVDV. In a protein-rich environment, HCV is very stable and can survive for months in refrigerated meat 
and for years in frozen meat. The virus is sensitive to drying (desiccation) and is rapidly inactivated by a 
pH of less than 3 and greater than 11.  
Host Range:  The hosts of HCV are the pig and wild boar.  
Geographic Distribution:  According to the FAO—WHO—OIE Animal Health Yearbook 1989, HC is 
recognized in 36 countries and is suspected of being present in another 2. The disease has been eradicated 
in Australia, Canada, and the United States. Constant progress toward eradication has been made in the 
countries of the European Economic Community since the guidelines for HC control in individual 
member states were accepted in 1980.  
Transmission:  The pig is the only natural reservoir of HCV. Blood, tissues, secretions and excretions 
from an infected animal contain HCV. Transmission occurs mostly by the oral route; though infection can 
occur through the conjunctiva, mucous membrane, skin abrasion, insemination, and percutaneous blood 
transfer (e.g., common needle, contaminated instruments). Airborne transmission is not thought to be 
important in the epizootiology of HC, but such transmission could occur between mechanically ventilated 
units within close proximity to each other.  
Introduction of infected pigs is the principal source of infection in HC-free herds. Farming activities such 
as auction sales, livestock shows, visits by feed dealers, and rendering trucks are also potential sources of 
contagion. Feeding of raw or insufficiently cooked garbage is a potent source of HCV. During the warm 
season, HCV may be carried mechanically by insect vectors that are common to the farm environment. 
There is no evidence, however, that HCV replicates in invertebrate vectors. Husbandry methods also play 
an important role in HC transmission. Large breeding units (100 sows) have a higher risk of recycling 
infection than small herds. In large breeding units where continuous farrowing is practiced, strains of low 
virulence may be perpetuated indefinitely until the cycle is interrupted by stamping-out procedures and a 
thorough cleaning and disinfection are carried out.  
Incubation Period:  The incubation period is usually 3 to 4 days but can range from 2 to 14 days.  
Clinical Signs:  The clinical signs of HC are determined by the virulence of the strain and the 
susceptibility of the host pigs. Virulent strains cause the acute form of the disease, whereas strains of low 
virulence induce a relatively high proportion of chronic infections that may be inapparent or atypical. 
These strains are also responsible for the "carrier-sow" syndrome from which persistently infected piglets 
are produced.  
Acute Hog Cholera  
In acute HC, the pigs look and act sick. Their disease progresses to death within 10 to 15 days, and 
remissions are rare. In an affected herd, some pigs will become drowsy and inactive and will stand with 
arched backs. Other pigs will stand with drooping heads and straight tails. Some pigs may vomit a yellow 
fluid containing bile. The sick pigs will huddle and pile up on each other in the warmest corner of the 
enclosure and will rise only if prompted vigorously. Anorexia and constipation will accompany a high 
fever that may reach 108° F (42.2° C) with an average of 106° F (41.1° C). Pigs may continue to drink 
and may have diarrhea toward the end of the disease process. Conjunctivitis is frequent and is manifested 
by encrustation of the eyelids and the presence of dirty streaks below the eyes caused by the accumulation 
of dust and feed particles. Sick pigs become gaunt and have a weak, staggering gait related to posterior 
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weakness. In terminal stages, pigs will become recumbent, and convulsions may occur shortly before 
death. In the terminal stage, a purplish discoloration of the skin may be seen; if present, the lesions are 
most numerous on the abdomen and the inner aspects of the thighs.  
Chronic Hog Cholera  
Chronic HC is characterized by prolonged and intermittent disease periods with anorexia, fever, 
alternating diarrhea and constipation, and alopecia. A chronically infected pig may have a 
disproportionately large head relative to the small trunk. These runt pigs may stand with arched backs and 
their hind legs placed under the body. Eventually, all chronically infected pigs will die.  
Congenital Hog Cholera  
Congenital HCV infection by virulent strains will likely result in abortions or in the birth of diseased pigs 
that will die shortly after birth. Transplacental transmission with low-virulence strains may result in 
mummification, stillbirth, or the birth of weak and "shaker" pigs. Malformation of the visceral organs and 
of the central nervous system occurs frequently. Some pigs may be born virtually healthy but persistently 
infected with HCV. Such infection usually follows exposure of fetuses to HCV of low virulence in the 
first trimester of fetal life. Pigs thus infected do not produce neutralizing antibodies to HVC and have a 
lifelong viremia. The pigs may be virtually free of disease for several months before developing mild 
anorexia, depression, conjunctivitis, dermatitis, diarrhea, runting, and locomotive disturbance leading to 
paresis and death. In breeding herds affected with lowvirulence strains of HCV, poor reproductive 
performance may be the only sign of disease.  
Gross Lesions 
Acute Hog Cholera  
The most common lesion observed in pigs dying of acute HC is hemorrhage. Externally, a purplish 
discoloration of the skin is the first observation. There may be necrotic foci in the tonsils. Internally, the 
submandibular and pharyngeal lymph nodes are the first to be affected and become swollen owing to 
edema and hemorrhage. Because of the structure of the pig lymph node, hemorrhages are located at the 
periphery of the node. As the disease progresses, the hemorrhage and edema will spread to other lymph 
nodes. The surface of the spleen, and particularly the edge of the organ, may have raised, dark wedge-
shaped areas. These are called splenic infarcts. Infarcts are frequently observed in pigs infected 
experimentally with older strains of HCV but are less commonly seen with the contemporary strains.  
Pinpoint to ecchymotic hemorrhages on the surface of the kidney are very common in HC. Such lesions 
are easier to see in the decapsulated kidney. Hemorrhages are also found on the surface of the small and 
large intestine, the larynx, the heart, the epiglottis, and the fascia lata of the back muscles. All serous and 
mucosal surfaces may have petechial or ecchymotic hemorrhages.  
Accumulation of straw-colored fluids in the peritoneal and thoracic cavities and in the pericardial sac may 
be present.  
The lungs are congested and hemorrhagic and have zones of bronchopneumonia.  
Chronic Hog Cholera  
In chronic HC, the lesions are less severe and are often complicated by secondary bacterial infections. In 
the large intestine, button ulcers are an expression of such a secondary bacterial infection. In growing pigs 
surviving for more than 30 days, lesions may be seen at the costochondral junction of the ribs and at the 
growth plates of long bones.  
Congenital Hog Cholera  
In pigs infected transplacentally with HCV strains of low virulence, the most commonly seen lesions are 
hypoplasia of the cerebellum, thymus atrophy, ascites, and deformities of the head and of the limbs. 
Edema and petechial hemorrhages of the skin and of the internal organs are seen at the terminal stage of 
the disease.  
Morbidity and Mortality:  In acute HC, the morbidity and mortality are high.  
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Diagnosis  
Field Diagnosis  
Septicemic conditions in which pigs have high fever should be investigated carefully. A thorough history 
from the herd owner should be obtained to determine if raw garbage was fed, if unusual biological 
products were used, or if recent additions were made to the herd. Careful observation of the clinical signs 
and of the necropsy lesions should be recorded. In acute HC, it is helpful to necropsy four or five pigs to 
increase the probability of observing the representative lesions.  
A marked leukopenia is detectable at the time of initial rise in body temperature and persists throughout 
the course of the acute and chronic disease. This feature was once widely used in the field diagnosis of 
HC. Nowadays, with the development of more specific laboratory diagnostic methods, which are aimed at 
demonstrating the virus or its structural antigens in tissues or at detecting specific antibodies in the serum, 
the white blood count is not as widely used. In endemic areas it could be helpful.  
Specimens for Laboratory  
For virus isolation and antigen detection, the tonsils are considered essential. In addition, submandibular 
and mesenteric lymph nodes, spleen, kidneys, and the distal part of the ileum should be collected. In live 
pigs, tonsil biopsies and whole blood collected with anticoagulants are useful to diagnose HC. Sample 
collection should be targeted to pigs having fever or showing other signs of the disease. Each sample of 
tissue should be placed in a separate plastic bag and identified. The samples should not be frozen 
(interference with fluorescent antibody tissue section test) but kept at refrigeration temperature. The 
material should be transported and stored in leak-proof containers in accordance with national regulations 
for transportation of diagnostic biologic samples.  
Serum samples for antibody detection should be collected from animals that have recovered from 
suspected infection or from sows known to have been in contact with infected or suspected cases. A 
sufficient number of samples should be collected to ensure a high probability of detecting infection.  
A complete set of tissues, including the whole brain, should be submitted in 10 percent buffered formalin.  
Laboratory Diagnosis  
Any clinical diagnosis of HC must be confirmed by the submission of specimens to a specialized 
diagnostic laboratory that should also have the capability to distinguish between HC and African swine 
fever.  
The laboratory diagnostic procedures for HC have evolved in parallel with the emergence of new 
technologies. Until the 1960's, laboratory diagnosis was restricted to recognition of gross lesions and 
confirmation by histopathology. Inoculation of susceptible pigs was often used as final confirmatory test 
and to determine the virulence of the viruses. Numerous laboratory techniques have been described to 
diagnose HC, but only a few have gained international acceptance and have been integrated into national 
HC control programs. Only these will be discussed in this presentation.  
In the fluorescent antibody tissue section test (FATST), direct fluorescent antibody technique is applied to 
detect HC viral antigens in frozen tissues of organs from dead pigs, in biopsy material, or in impression 
smears. Theoretically, a diagnosis can be confirmed within hours from the reception of the specimen. In 
countries where the disease has been eradicated, the diagnosis of the "index case" by the FATST alone 
may be difficult, and confirmation in cell culture may be needed. The FATST may not differentiate HC 
from BVDV infection; an accurate distinction between the two viruses has to be made before releasing a 
final diagnosis. Differentiation between HCV and BVDV can readily be made with the 
immunoperoxidase test using monoclonal antibodies or the serum neutralization test.  
The isolation of HCV in cell culture and the identification using fluorescein-labeled hog cholera antibody 
(fluorescent antibody cell culture test) can provide confirmation in cases where the results of investigation 
of frozen tissue sections are inconclusive.  
As control measures for HC are implemented in a country, virulent strains of HCV will be reduced, and 
there will be a relative increase of low-virulence strains. As the proportion of subclinical cases in a 
  
 
39
national herd increases, it will become increasingly difficult to recognize the disease. The antigen 
detection systems previously described become less effective; thus, serological tests are essential for a 
successful control and eventual eradication program.  
Approximately 75 percent of pigs infected with acute HC have microscopic lesions of an encephalitis 
characterized by perivascular cuffing, endothelial proliferation, and microgliosis. This feature is easily 
recognized in a nonspecialized diagnostic laboratory and may constitute the most important single factor 
that will cause the pathologist to suspect HC.  
Differential Diagnosis  
Differential diagnosis of HC should include African swine fever, erysipelas, salmonellosis, 
eperythrozoonosis, and salt poisoning.  
Vaccination:  Over the years, numerous regimens of vaccination have been advocated with a variable 
degree of success. In the past two decades, modified live vaccines (MLV) with no residual virulence for 
pigs have become available. The lapinized Chinese (C) strain, the Japanese guinea pig cell culture-
adapted strain, and the French Thiverval strain have been widely used. All three strains are considered 
innocuous for pregnant sows and piglets over 2 weeks old.  
Control and Eradication:  In countries where HC is enzootic, a systematic vaccination program is 
effective in preventing losses. Experience in the United States and in some countries of the European 
Union has proven that a strict regimen of vaccination will reduce the number of outbreaks to a level at 
which complete eradication by sanitary measure alone will be feasible. At that point, vaccination must be 
stopped. A successful eradication program requires a massive input of funds from a central government 
and cooperation from the government, the swine industry, and the veterinary profession. Eradication 
measures will be assisted by strictly enforcing the garbage cooking laws, having an effective swine 
identification system, and using serological surveys targeted primarily to breeding sows to detect 
subclinical infections.  
In countries where HC has been eradicated and in which the threat of reintroduction is significant, it is 
essential to initiate an effective serological monitoring system. Sampling may be limited to strategic 
locations such as the border of an infected neighbor country or be intensified to target populations such as 
the garbage-fed herds. Such a system has been in effect in the United States since successful eradication 
in 1976; several thousand samples have been accessed annually.  
Public Health:  Human beings are not susceptible to HCV infection.  
1.9 Cowdria ruminantium (Heartwater)10 
(Cowdriosis)  
Definition:  Heartwater (HW) is an acute noncontagious infectious disease of ruminants affecting cattle, 
sheep, goats, and antelope and is caused by the rickettsial organism Cowdria ruminantium, which is 
transmitted by ticks of the genus Amblyomma. The disease is characterized by fever, nervous signs, 
hydropericardium, hydrothorax, ascites, edema of the lungs, and high mortality. In some wild ruminants 
the agent causes subclinical infection. The name "heartwater" is derived from the hydropericardium, 
which is commonly seen with this disease.  
Etiology:  The disease is caused by Cowdria ruminantium, a rickettsial agent. It is the only species of the 
genus Cowdria, in the tribe Ehrlichia, family Rickettsiaceae, order Rickettsiales. The organism multiplies 
in vascular endothelial cells throughout the body and in the reticulum cells of the lymph nodes. The agent 
is pleomorphic, usually coccoid, occasionally ring-formed, and measures from 400 to over 1,000 nm in 
diameter. It usually occurs in clumps of from less than five to several thousand organisms within the 
                                                 
10Committee on Foreign Animal Diseases of the United States Animal Health Association, revised 1998.  Foreign 
Animal Diseases, “The Gray Book,” Part IV, Library of Congress Catalog Card Number 17-12842, Pat Campbell 
& Associates and Carter Printing Company, Richmond, VA.  
http://www.vet.uga.edu/vpp/gray_book/FAD/HEA.htm  
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cytoplasm of infected capillary endothelial cells, especially in the brain. The HW organism is extremely 
fragile and cannot persist outside of a host for more than a few hours. Because of its fragility, the 
organism must be stored in dry ice or liquid nitrogen to preserve its infectivity.  
Heartwater strains vary in virulence, and although all are apparently pathogenic for sheep and goats, at 
least one strain is nonpathogenic for cattle.  
Host Range:  Heartwater causes severe disease in cattle, sheep, goats, and water buffalo; mild disease in 
some indigenous African breeds of sheep and goats; and inapparent disease in several species of antelope 
indigenous to Africa. The blesbok (Damaliscus albifrons), the black wildebeest (Connochaetes gnu), the 
eland (Taurotragus oryx oryx) and the springbok (Antidorcas marsupialis) have experimentally been 
shown to be susceptible to HW, and although the natural disease in these animals is usually mild, deaths 
in springbok have been attributed to HW. The blesbok and wildebeest are known carriers of C. 
ruminantium and are believed to play a role in the maintenance of the disease in nature.  
Nonruminant hosts of C. ruminantium, such as guinea-fowl, leopard tortoises, and scrub hare, may also 
be important in the maintenance of the organism in nature because they are all known carriers of the 
agent. Although the striped mouse and the multimammate mouse have been shown to be susceptible to C. 
ruminantium, they are not hosts of the vector ticks and are not believed to play a role in the epizootiology 
of HW.  
In the United States the most common deer species, Odocoileus virginianus (the white-tailed deer), has 
been shown by experimental inoculation to be susceptible to C. ruminantium. Severe clinical signs were 
noted along with typical postmortem lesions. The mortality rate was high. Amblyomma maculatum, an 
experimentally proven vector of HW, is a common parasite of white-tailed deer in the southern United 
States.  
The ferret and the albino mouse are susceptible to C. ruminantium under experimental conditions, and a 
mouse agent resembling C. ruminantium has been isolated in South Africa.  
Geographic Distribution:  Heartwater occurs only where vector ticks of the genus Amblyomma are 
active. For decades, the disease has been known to occur in most countries of Africa south of the Sahara 
Desert and on the island of Madagascar. The disease has also been reported from Tunisia and the former 
Yugoslavia; however, the Yugoslavian report is probably erroneous. For the last half-century or more, the 
disease has been considered one of the most important livestock diseases in Africa and has been surpassed 
only by trypanosomiasis and East Coast fever.  
Heartwater is now known to occur in the Caribbean, where the vector tick A. variegatum (tropical bont 
tick) has been recognized for many years. This tick, now known to occur on numerous Caribbean islands 
(e.g., Puerto Rico, Antigua, Guadeloupe, Martinique, St. Lucia, Nevis, St. Kitts) was probably introduced 
to the French Antilles with a shipment of cattle from Senegal in the 1830's. A fatal disease of cattle with 
neurologic and hemorrhagic signs, which in retrospect could have been HW, was described from 
Guadeloupe in 1932. Rapid spread of the tropical bont tick in the West Indies is believed to have occurred 
only after the introduction of the cattle egret from Africa in the early 1960's. Egrets are now known to be 
efficient porters of the tick. Heartwater has been diagnosed on the islands of Antigua, Guadeloupe, and 
Marie Galante. A disease closely resembling HW has also been reported from other Caribbean islands 
(e.g., Cuba and Antigua), but the diagnoses have not been confirmed. Cowdria ruminantium is far more 
widespread in the Caribbean than was formerly believed. Recent serological surveys have demonstrated 
HW antibodies in cattle from 10 Caribbean islands (Antigua, Dominica, Granada, Guadeloupe, 
Martinique, Montserrat, St. Kitts, St. Lucia, St. Martin, and St. Vincent).  
Transmission:  Heartwater is transmitted only by ticks of the genus Amblyomma. Of the 12 species 
known to transmit the disease, A. variegatum (tropical bont tick) is by far the most important, for it is 
widely distributed in Africa and has extended its range to include Yemen, Reunion, the Cape Verde 
islands, and several islands of the West Indies (26). Other major vector species are the bont tick A. 
hebraeum (in southern Africa), and A. lepidum (in East Africa and the Sudan). Amblyomma astrion 
(mainly on buffalo) and A. pomposum are also natural vectors of the disease, and five other African ticks 
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— A. sparsum, A. gemma, A. cohaerans, A. marmoreum and A. tholloni (the elephant tick) — have 
experimentally been shown to be capable of transmitting HW.  
Two North American species of Amblyomma ticks have been shown by Uilenberg (1982) to be capable of 
transmitting the disease. They are A. maculatum (the Gulf Coast tick) and A. cajennense, but neither of 
these ticks has been incriminated as natural vectors of HW. The former tick is widely distributed in the 
eastern, southern, and western United States, and was shown by Uilenberg to be as good a vector as one 
of the principal African vectors, A. hebraeum.  
Amblyomma ticks are three-host ticks whose life cycles may take from 5 months to 4 years to complete. 
Because the ticks may pick up the infection as larvae or nymphs and transmit it as nymphs or as adults, 
the infection can persist in the tick for a very long time. The infection does not pass transovarially. 
Amblyomma ticks are multihost and will feed on a wide variety of livestock, wild ungulates, ground birds, 
small mammals, reptiles, and amphibians.  
Incubation Period:  The incubation period is generally shorter in sheep and goats than in cattle. 
Experimental intravenous inoculation usually results in a febrile response between the 7th and 10th day 
after inoculation in sheep and goats, and between the 10th and 16th day after inoculation in cattle. Under 
field conditions, susceptible animals can be expected to show signs of the disease 14 to 28 days after 
introduction into an HW-infected area.  
Clincial Signs:  Heartwater occurs in four different clinical forms determined by variations in 
susceptibility of the hosts and the virulence of various strains of the HW agent.  
The relatively rare peracute form of the disease is usually seen in Africa in nonnative breeds of cattle, 
sheep, and goats introduced to an HW enzootic area. Heavily pregnant cows are especially prone to 
develop the peracute disease. Sudden death occurs, usually preceded only by a fever, severe respiratory 
distress, and terminal convulsions. Severe diarrhea may be seen in some breeds of cattle (e.g., Jersey, 
Guernsey).  
The acute form of the disease, by far the most commonly observed syndrome, is seen in nonnative and 
indigenous domestic ruminants. A sudden fever of up to 107° F (42° C) is followed by inappetance, 
depression, listlessness, and rapid breathing. Nervous signs then develop, the most prominent being 
chewing movements, twitching of the eyelids, protrusion of the tongue and circling, often with 
highstepping gait. The animal may stand with its legs apart and head lowered. The nervous signs increase 
in severity, and the animal goes down in convulsions. Galloping movements and opisthotonos are 
commonly seen before death. Hyperesthesia is often observed in the terminal stages of the disease, as is 
nystagmus and frothing at the mouth. Diarrhea is occasionally seen, especially in younger animals. The 
acute disease is usually fatal within a week of the onset of signs.  
Rarely, the disease may run a subacute course characterized by prolonged fever, coughing (a result of 
lung edema), and mild incoordination; recovery or death occurs in 1 to 2 weeks. A mild or subclinical 
form of the disease, known as "heartwater fever," is seen in partially immune cattle or sheep, in calves 
less than 3 weeks old, in antelope, and in some indigenous breeds of sheep and cattle with high natural 
resistance to the disease. The only clinical sign in this form of the disease is a transient febrile response.  
Gross Lesions:  The gross lesions in cattle, sheep, and goats are very similar. Heartwater derives its name 
from one of the prominent lesions observed in the disease, namely pronounced hydropericardium. The 
accumulation of straw-colored to reddish fluid in the pericardium is more consistently observed in sheep 
and goats than in cattle. Ascites, hydrothorax, mediastinal edema, and edema of the lungs, all resulting 
from increased vascular permeability with consequent transudation, are frequently encountered. 
Subendocardial petechial hemorrhages are usually seen, and submucosal and subserosal hemorrhages may 
occur elsewhere in the body. Degeneration of the myocardium and liver parenchyma, splenomegaly, 
edema of lymph nodes, nephrosis, and catarrhal and hemorrhagic abomasitis and enteritis are all 
commonly encountered. Meningeal congestion and edema are often present. Brain congestion may occur, 
but brain lesions can be remarkably few when one considers the severity of the nervous signs observed in 
this disease.  
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Morbidity and Mortality:  Once signs of the disease have developed, the prognosis is poor for nonnative 
sheep, goats, and cattle infected with the more virulent strains of the HW organism. The mortality rate in 
merino sheep may be 80 percent in contrast to 6 percent mortality observed in Persian or Afrikander 
sheep. Angora goats are extremely susceptible to HW. In cattle, mortality of about 60 percent is not 
uncommon.  
Diagnosis  
Field Diagnosis  
The presence of Amblyomma ticks plus the rather characteristic signs and lesions of heartwater allows 
tentative field diagnosis of the disease, which must then be confirmed by demonstration of the causative 
organism, its antigens, or its DNA.  
Specimens for Laboratory  
From live animals, collect 10 ml of blood using heparin as an anticoagulant and add sufficent DSMO to 
make a 10 percent concentration; freeze on dry ice. Collect an additional 50 ml of heparinized blood and 
10 ml of serum. From a dead animal, submit smears of cerebral cortex or half of the brain unpreserved 
and a set of tissues in 10 percent buffered formalin.  
Laboratory Diagnosis  
Demonstration of the Organism: The HW organism stains purplish-blue with Giemsa stain and can be 
seen by microscopic examination of brain smears prepared as follows: A small piece of cerebrum, 
cerebellum, hippocampus, or other well-vascularized portion of the brain is macerated between two 
microscope slides. The resultant pulp is then drawn across a slide with varying pressure, which results in 
“ridges and valleys” on the slide. The slide is then air-dried, fixed with methanol, and stained with 
Giemsa. Under low magnification, the capillaries will be found extending from the “thick” areas of the 
slide. Examination of the capillary endothelial cells under oil immersion will reveal the blue to reddish-
purple clumps of organisms. A rapid method for obtaining brain tissue for examination is to drive a large 
nail through the unopened skull and make a smear from the tissue adhering to the nail. The HW 
organisms can also be observed in smears prepared from the intima of large blood vessels or in stained 
sections of kidney glomeruli and lymph nodes.  
Although microscopic examination of Giemsa-stained brain smears is still widely employed in HW 
diagnosis, newer and more sensitive techniques such as the use of DNA probes have been applied to 
detect Cowdria nucleic acids in tissues of infected livestock and ticks. These newer techniques should 
supplant the older methods of diagnosis as facilities and equipment become more available in HW-
enzootic areas.  
Antibody Detection: The indirect fluorescent antibody (IFA) test has extensively been used for HW 
antibody detection, and the newer competitive enzyme-linked immunosorbent assay (CELISA) promises 
to be a useful addition to the meager array of tests available for the detection of HW antibodies. The 
cross-reactions described with several Ehrlichia spp. Can now be eliminated with the use of more specific 
antigens and monoclonal antibodies.  
Differential Diagnosis  
The peracute form of HW can be confused with anthrax. The acute nervous form of HW can be confused 
with rabies, tetanus, chlamydiosis, bacterial meningitis or encephalitis, cerebral trypanosomiasis, 
piroplasmosis or theileriosis, and various intoxications such as with strychnine, lead, organophosphates, 
or chlorinated hydrocarbons. Heavy helminth infestations may produce accumulations of fluid similar to 
those seen in HW. Arsenical poisoning may resemble the enteric form of the disease, and certain 
poisonous plants (e.g., Cestrum laevigatum, Pachystigma spp., Pavetta spp.) may produce signs and 
lesions similar to those seen in HW.  
Treatment:  Tetracycline antibiotics (especially oxytetracycline) are very effective in the treatment of 
HW, especially when animals are treated early in the course of the disease. Tetracycline antibiotics  
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administered before signs appear will suppress the disease entirely, but will allow immunity to develop. 
Doxycycline and rifamycin are both very effective, and a wide variety of sulfonamides have successfully 
been used in HW treatment. Treatment for ruminal atony, a commonly observed sequel to this disease, 
may be indicated, and diuretics may be useful to control fluid accumulations in body cavities.  
Vaccination:  Animals recovering from the natural disease or from artificial exposure to the organism are 
solidly immune for a variable period ranging from 6 months to 18 months. Animals exposed to 
reinfection during this period of resistance will have their immunity reinforced and will remain immune 
as long as they are periodically reinfected. There is now conclusive evidence that immunity to HW is T-
cell mediated and that circulating antibodies play a minor role in immunity.  
Calves and lambs are very resistant to C. ruminantium in the first 4 weeks of life. This resistance seems to 
be a true age resistance and has successfully been used in the immunization of cattle and sheep. Calves of 
less than 4 weeks of age, and lambs in the first week of life can be immunized by intravenous inoculation 
of HW-infected blood. The infection that follows is usually mild, and upon recovery animals are immune 
to reinfection because immunity is continuously stimulated by natural exposure to the organism. Older 
animals or very valuable calves should be examined daily after immunization and should be treated with 
antibiotics as soon as the febrile response commences. A subcutaneous implant of doxycycline at the time 
of immunization will eliminate the labor-intensive tetracycline treatment method. The immunity will not 
be affected by the antibiotic treatment. Flock immunization of sheep and goats can be accomplished by 
inoculation followed by mass treatment at the end of the incubation period.  
Immunologically different strains of the organism do exist, but present evidence indicates that there is 
considerable cross-protection between different strains, thus allowing successful immunization. However, 
there are some stains between which there is little cross-protection.  
A strain of C. ruminantium, attenuated by serial passage in bovine umbilical endothelium cells has been 
shown to confer solid HW immunity to sheep and goats. This finding suggests that a live-attenuated 
vaccine to HW may soon be available, but because other strains of the organism have not become 
attenuated by cell-culture passage, the degree of cross-protection between strains still needs clarification. 
A universally effective vaccine is probably not imminent.  
Control and Eradication 
Tick Control  
The HW organism is extremely fragile and cannot persist outside of a host for more than a few hours. The 
principal mode of bringing the disease into an area is thus through introduction of infected ticks or carrier 
animals. It is not known for how long wild or domestic ruminants can be a source of infection for ticks in 
nature, but Andrew and Norval (1989) have shown that experimentally infected sheep, cattle, and African 
buffalo can be a source of infection for nymphs of the bont tick (A. hebraeum) for 223, 246, and 161 days, 
respectively. After molting to adults, the ticks transmit the disease to susceptible sheep. This prolonged 
carrier state needs to be considered when animals are moved from HW-enzootic to HW-free areas. It is 
also not known for how long a tick can remain a carrier of the organism. Careful dipping and hand-
dressing followed by inspection to ensure the absence of ticks is recommended for animals in transit to 
HW free areas.  
Vector control measures aimed at eradication of Amblyomma ticks by dipping of cattle have failed 
principally because the vector is a multihost tick with a high rate of reproduction. The development of 
acaricide resistance has further complicated attempts at tick control. In enzootic areas, tick levels are now 
allowed to remain at levels high enough to permit reinfection of immune animals to booster the immunity.  
Chemoprophylaxis  
Cattle, sheep, and goats moving into an HW-enzootic area can be protected from HW by prophylactic 
treatment with tetracycline (short or long-acting) either by feeding or by inoculation. However, they 
should be kept under surveillance and individually treated if clinical signs are seen.  
Public Health: Humans are not known to be susceptible to Cowdria ruminantium.  
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1.10 Foot-and-mouth disease11 
(Afta epizootica, Bek-en-klouseer, Fiebra aftosa, Fievre aphteuse, Maul-und-Klauenseuche)  
Definition:  Foot-and-mouth disease (FMD) is a highly contagious viral infection primarily of cloven-
hoofed domestic animals (cattle, pigs, sheep, goats, and water buffalo) and cloven-hoofed wild animals. 
The disease is characterized by fever and vesicles with subsequent erosions in the mouth, nares, muzzle, 
feet, or teats.  
Etiology:   
The FMD virus (FMDV) is a member of the genus Aphthovirus in the family Picornaviridae. There are 
seven serotypes of FMDV: A, O, C, Asia 1, and Southern African Territories (SAT) 1, 2 and 3. Within 
these serotypes, over 60 subtypes have been described, and new subtypes occasionally arise 
spontaneously. However, at a specific time, there are only a few subtypes causing disease throughout 
FMD endemic areas. The importance of subtypes is that a vaccine may have to be tailored to the subtype 
present in the area in which the vaccine is being used.  
The FMD virus is pH sensitive; the virion is inactivated when exposed to pH below 6.5 or above 11. 
However, in milk and milk products, the virion is protected and can survive at 70o C for 15 seconds and 
pH 4.6. Between pH 6.7 and 9, stability increases with decreasing temperature; the virus in cell culture 
medium will remain viable for a year at 4o C. The virus in serum or other organic material will survive 
drying and can be carried on inanimate objects. In meat, the virus can survive for long periods in chilled 
or frozen bone marrow and lymph nodes.  
Host Range:  Cloven-footed domestic and wild animals are primarily affected. Examples of other 
susceptible species are hedgehogs, armadillos, nutrias, elephants, capybaras, rats, and mice. 
Geographic Distribution:  Foot-and-mouth disease, after World War II, was widely distributed 
throughout the world. In 1996, endemic areas were Asia, Africa, and parts of South America. In South 
America, Chile is free, and Uruguay and Argentina have not had an outbreak since April 1994. Most 
European countries have been recognized as free. Countries belonging to the European Union have 
stopped FMD vaccination. North and Central America, Australia, New Zealand, Japan, and the British 
Isles have been free of FMD for many years.  
Geographic Serotype Prevalence of FMD:  It is interesting how certain serotypes tend to be restricted to 
certain areas of the world.  
Some examples are as follows:  
Europe (historically) A (5) O (1) C (1) 
Asia  
Near East A (22) O (1) 
Middle East A (22) O (1) C Asia (1) 
Far East A O (1) C Asia (1) 
                                                 
11Committee on Foreign Animal Diseases of the United States Animal Health Association, revised 1998. Foreign 
Animal Diseases, “The Gray Book,” Part IV,  Library of Congress Catalog Card Number 17-12842, Pat Campbell 
& Associates and Carter Printing Company, Richmond, VA. 
http://www.vet.uga.edu/vpp/gray_book/FAD/FMD.htm 
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Africa  Serotype C is 
uncommon in Africa 
Central East to West A O 
Northeast Central and South SAT 1 and 2 
South SAT 3 
South America A (24), (27) O (1) C (3) 
 
 
Transmission  
The FMD virus can be introduced into a free area by the following means:  
1. Direct or indirect contact with infected animals.  
2. Spread of aerosol from infected animals (requires proper humidity and temperature). Aerosol from bulk 
milk trucks spread FMD in England. A person in contact with infected animals can have sufficient FMDV 
in his or her respiratory tract for 24 hours to serve as a source of infection for susceptible animals.  
3. Feeding contaminated garbage (meat, milk, blood, glands, bones, cheese, etc.)  
4. Contact with contaminated objects (hands, footwear, clothing).  
5. Artificial insemination.  
6. Contaminated biologicals such as hormones (extraction procedure may not inactivate the virus).  
After an animal becomes infected by any means, the primary mode of spread is then via respiratory 
aerosols. Other important means of spread are direct and indirect contact. In an outbreak of FMD, the 
roles of the three primary hosts in transmission are as follows:  
• Sheep act as maintenance hosts,  
• Pigs act as amplifiers,  
• Cattle act as indicators.  
When sheep or goats become infected with FMDV, the disease may not be diagnosed for a considerable 
time because signs and lesions can be very mild. However, during this time, the animals will be 
producing infectious aerosols, contaminating fomites, and spreading the virus by contact.  
Foot-and-mouth disease in pigs spreads very rapidly, for they produce 30 to 100 times more virus in 
aerosols than sheep or cattle. An infected pig can produce a hundred million infectious doses per day.  
When cattle are infected with FMDV, signs and lesions usually develop more rapidly and are more severe 
than in pigs, sheep, or goats. If cattle, sheep, and pigs are exposed together, cattle will usually get sick 
first. This may result from increased exposure due to a greater pulmonary tidal volume.  
Some animals can be carriers of FMDV. Most ruminant species can harbor the virus in their pharyngeal 
tissues for a long period. Recovered cattle or vaccinated cattle exposed to diseased animals can become 
healthy carriers for 6-24 months. Sheep can be carriers for 4-6 months. Although under experimental 
conditions it has been difficult to demonstrate transmission of FMD from carriers to susceptible livestock, 
there is strong circumstantial field evidence that carriers may have been the occasional cause of  
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outbreaks. Also it has been shown that the virus was maintained for many years in a relatively small, 
isolated group of African buffaloes without the appearance of clinical signs.  
Some strains of FMDV seem to have a predilection for certain species. There have been strains that affect 
pigs but not cattle. In South America, mature cattle have had clinical signs of FMD, when sheep in an 
adjacent pasture were normal.  
Incubation Period:  After experimental exposure, signs may develop as early as 12 hours. The usual 
interval is 24 to 48 hours.  
When susceptible animals are in contact with clinically infected animals (peak time of transmission is 
generally when vesicles rupture), clinical signs usually develop in 3 to 5 days.  
Pigs fed infected garbage usually develop signs in 1 to 3 days. Intact oral epithelium is resistant to 
infection, but during the process of ingesting food there may be injury, and the virus may also enter 
through the tonsils.  
Clinical Signs 
Cattle  
Initial signs are fever of 103-105o F (39.4-40.6o C), dullness, anorexia, and fall in milk production. These 
signs are followed by excessive salivation; drooling, serous nasal discharge; shaking, kicking of the feet 
or lameness; and vesicle (blister) formation. Sites of predilection for vesicles are the tongue, dental pad, 
gums, soft palate, nostrils, muzzle, interdigital space, coronary band, and teats. Vesicles may be difficult 
to see. The animal may need to be tranquilized to facilitate a thorough examination.  
After vesicle formation, drooling may be more marked, and nasal discharge, lameness or both may 
increase. Pregnant cows may abort, and young calves may die without developing any vesicle.  
The course of an FMD infection is 2 to 3 weeks. Secondary infection may delay recovery. A lactating 
animal may not recover to preinfection production because of damage to the secretory tissue.  
Sequelae to FMD in Cattle  
Secondary infection — mouth, nose, feet  
Hoof deformation  
Low milk production  
Mastitis  
Unthriftiness — failure to gain weight  
Breeding problems  
Panting — associated with pituitary gland damage  
Diabetes mellitus  
Swine  
Initial signs are fever of 104-105o F (40-40.6o C), anorexia, reluctance to move, and squeal when forced to 
move. These signs are followed by vesicles on the coronary band, vesicles on the heals, vesicles in the 
interdigital space (foot involvement is usually severe), and vesicles on the snout. Mouth lesions are not 
too common and when they occur are smaller and of shorter duration than in cattle and tend to be a "dry"-
type lesion. There is no drooling. Sows may abort. Piglets may die without showing any clinical sign.  
Sheep and Goats  
Clinical signs, if they occur, tend to be very mild, and may include dullness; fever; and small vesicles or 
erosions on the dental pad, lips, gums, and tongue. Mild lameness may be the only sign. In lame animals 
there may be vesicles or erosion on the coronary band or in the interdigital space. Infected animals may 
abort. Nursing lambs may die without showing any clinical sign.  
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Gross Lesions 
Cattle  
The diagnostic lesions are single or multiple vesicles ranging from 2 mm to 10 cm. These can occur at all 
sites of predilection. Gross lesions on the tongue usually progress in the following manner:  
1. A small blanched whitish area develops in the epithelium.  
2. Fluid fills the area, and a vesicle (blister) is formed.  
3. Vesicle enlarges and may coalesce with adjacent ones.  
4. Vesicle ruptures.  
5. Vesicular covering sloughs leaving an eroded (red) area.  
6. Gray fibrinous coating forms over the eroded area.  
7. Coating becomes yellow, brown or green.  
8. Epithelium is restored, but line of demarcation remains; line then gradually fades.  
Occasionally "dry" FMD lesions develop. Instead of forming a vesicle, the fluid is apparently lost as it 
forms and the upper layers of the epithelium become necrotic and discolored. The lesion therefore appears 
necrotic rather than vesicular.  
Gross Lesions on the Feet:  
The vesicle in the interdigital space is usually large because of the stress on the epithelium caused by 
movement and weight. The lesion at the coronary band at first appears blanched; then there is separation 
of the skin and horn. When healing occurs, new horn is formed, but a line resulting from the coronitis is 
seen on the wall of the hoof.  
Gross Cardiac and Skeletal Lesions:  
Animals that die may have grayish or yellowish streaking in the myocardium - degeneration and necrosis. 
These findings are known as "tiger heart". Skeletal muscle lesions occur but are rare.  
Swine  
Vesicles on the snout can be large and filled with clear or bloody fluid. Mouth lesions are usually the 
"dry" type and appear as necrotic epithelium. Feet lesions are usually severe, and the hoof can become 
detached. Animals that die may have grayish or yellowish streaking in the myocardium with degeneration 
and necrosis ("tiger heart").  
Sheep  
Lesions in the mouth and vesicles on the coronary band may be few, small, and difficult to find. Animals 
that die may have grayish or yellowish streaking in the myocardium with degeneration and necrosis 
("tiger heart").  
Morbidity and Mortality:  The morbidity rate is essentially 100 percent in a susceptible population of 
domestic animals. Mortality is usually less than 1 percent, but in young animals and with certain isolates 
mortality can be high. In an FMD outbreak in Israel, there was a high mortality (at least 50 percent) in 
wild mountain gazelles. The same virus caused typical low mortality in cattle. In the gazelles, there was a 
severe viral pancreatitis that accounted for the high mortality.  
Diagnosis  
Field Diagnosis  
In cattle, FMD should be considered whenever salivation and lameness occur simultaneously and a 
vesicular lesion is seen or suspected. Fever often precedes other clinical signs; therefore, febrile animals 
should be carefully examined. Early diagnostic lesions may be found before animals start to salivate, have 
a nasal discharge, or become lame. To avoid missing a diagnosis, examine the mouth of a lame animal 
and the feet of any animal with signs or lesions involving the mouth or nostrils. Typically, FMD spreads 
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rapidly and there is a high clinical attack rate; however, this cannot be counted upon, for a relatively 
avirulent strain could appear, or more resistant animals (sheep) could be affected.  
In pigs, sheep, and goats, FMD should be considered when animals have sore feet, vesicular lesion is 
suspected, or both.  
Specimens for Laboratory Diagnosis  
Because the various vesicular diseases have similar clinical signs, a laboratory diagnosis is mandatory. 
Oral, nasal, foot, or mammary lesions are good sources of specimens. The following should be collected 
from each of two or three animals:  
1. Vesicular fluid (as much as possible).  
2. Epithelium covering a vesicle.  
3. Flaps of epithelial tissue still attached.  
(For 2 and 3 above, try to collect about 0.5 gm.)  
Old necrotic or fibrinous material that is difficult to remove is undesirable and often is highly 
contaminated with bacteria.  
4. About 5 ml of blood with anticoagulant (viremia ends about 5 days after the onset of disease).  
5. Esophageal—pharyngeal (OP) fluid from convalescent cattle, sheep, or goats.  
This should immediately be diluted with an equal volume of cell culture fluid (e.g., Hanks balanced salt 
solution with lactalbumin hydolysate) and shaken vigorously for about 1 minute. If the solution turns 
yellow, the pH is low and the virus could be inactivated; discard and collect another sample.  
6. Blood for serum (10 ml of serum).  
7. From dead animals, collect samples of epithelial lesions, lymph nodes, thyroid, adrenal gland, kidney, 
and heart (about 10 gm).  
8. Full set of tissues in formalin.  
If the specimens can be delivered to a laboratory within 24 hours, they should be placed on ice. If delivery 
will take longer, quickfreeze the specimens, and do not allow them to thaw during transit. If dry ice is 
used, be sure that the vials are tightly sealed with stopper and tape so that no carbon dioxide enters the 
vial. The carbon dioxide will lower the pH and inactivate FMDV. Epithelium can also be placed in 
buffered glycerin and kept at 39o F (4o C) or -4o F (-20o C). Ratio of epithelium to glycerin should not 
exceed 1:10.  
Laboratory Diagnosis  
To confirm the initial case of FMD, the virus has to be isolated and identified. After confirmation of the 
initial case, diagnosis can be made by antigen or nucleic acid detection, or both.  
Serological tests are available to detect antibody and differentiate infected and vaccinated animals.  
Differential Diagnosis  
Differential diagnosis for FMD should include vesicular stomatitis, swine vesicular disease, vesicular 
exanthema of swine, foot rot, and chemical and thermal burns. In cattle, oral lesions caused by rinderpest, 
infectious bovine rhinopneumonitis, bovine virus diarrhea, malignant catarrhal fever, and bluetongue can 
be similar to the later lesions in FMD. In sheep, lesions caused by bluetongue, contagious ecthyma, and 
lip and leg ulceration can be similar to the later lesions of FMD.  
Vaccination:  Starting about 1951, FMD vaccine was produced by the Frenkel method. Normal tongue 
epithelium was removed, minced, placed in a nutrient broth, and inoculated with FMDV. After replication 
of FMDV, the virus was inactivated with formalin, and aluminum hydroxide was added as an adjuvant. 
This method as well as virus propagation in cell culture is being used today to produce FMD vaccine.  
Outbreaks of FMD have been traced to use of formalin-inactivated vaccine. Apparently, in some cases, 
vaccine contained viable virus. Today (1996) the classical FMD vaccines are prepared using binary-
ethyleneimine (BEI) inactivated virus and aluminum hydroxide-saponin or oil as an adjuvant. Double 
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emulsion oil vaccines have been shown to produce an immunity of longer duration than aluminum 
hydroxide-saponin vaccine.  
To date, molecular-engineered vaccines have not been as effective or as economical as the cell culture 
vaccines.  
When vaccinating animals, it is important that the vaccine contain the same subtype of virus as is in the 
area. This necessitates frequent checking of the serotype and subtype during an outbreak because FMD 
virus frequently changes during natural passage through various species.  
Protection induced by a good aluminum hydroxide vaccine decreases rapidly in 4-6 months. A double 
emulsion oil vaccine can protect for up to 1 year.  
Vaccinated animals that are not completely protected can be a source of infection. The virus may replicate 
and be shed, but the animals may not show any clinical sign of infection.  
Control and Eradication:  The official attitude of a country regarding control of a disease depends on 
how seriously the disease affects the country, the financial and technical ability of the country, and what 
its neighbors are doing. The degree of control of FMD varies as follows:  
1. Virtually no control in some Asian and African countries where FMD is enzootic.  
2. Protection of valuable or accessible animals or vaccination along a border to provide a buffer zone. 
(May vaccinate cattle because of severity of the disease but not sheep and goats.)  
3. Large-scale vaccination and quarantine with or without slaughter of infected animals.  
4. Regulatory measures to prevent entry of FMD virus and quarantine and implementation of an 
eradication program.  
A country where FMD is endemic should be as concerned about introduction of FMD virus as a country 
that is free of FMD because the introduced virus may be a serotype to which the native animals have no 
immunity.  
The following are the essential features of a control and eradication program:  
1. Stop movement of animals and animal products in the area affected.  
2. Slaughter infected animals (and known contact animals).  
3. Destroy carcasses.  
4. Disinfect vehicles leaving the infected area.  
5. Perform vaccination.  
If eradication by slaughter fails, vaccination may be used to control the outbreak. There are experimental 
results indicating that potent vaccine may induce significant immunity in 4 days to protect exposed cattle 
to FMD.  
6. Inform and educate the community.  
Most developed countries have detailed plans to deal with an outbreak of FMD.  
Public Health:  In a review of the zoonotic aspects of FMD by K. Bauer in 1997, he reported that, since 
1921, FMD virus has been isolated and typed from slightly over 40 human cases. The cases occurred on 
three continents: Europe, Africa, and South America. Type O predominated, followed by C, and rarely A. 
Because infection is uncommon, FMD is not considered to be a public health problem.  
1.11 Goat pox virus12 
Sheep and Goat Pox  
                                                 
12Committee on Foreign Animal Diseases of the United States Animal Health Association, revised 1998. Foreign 
Animal Diseases, “The Gray Book,” Part IV, Library of Congress Catalog Card Number 17-12842, Pat Campbell 
& Associates and Carter Printing Company, Richmond, VA. 
http://www.vet.uga.edu/vpp/gray_book/FAD/SGP.htm  
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Definition:  Sheep and goat pox (SGP) is an acute to chronic disease of sheep and goats characterized by 
generalized pox lesions throughout the skin and mucous membranes, a persistent fever, lymphadenitis, 
and often a focal viral pneumonia with lesions distributed uniformly throughout the lungs. Subclinical 
cases may occur.  
Etiology:  The virus that causes SGP is a capripoxvirus, one of the largest viruses (170-260 nm by 300-
450 nm). It is closely related to the virus that causes lumpy skin disease; SGP virus and lumpy skin 
disease virus cannot be distinguished serologically. There is only one serotype of SGP virus (SGPV). 
Various strains of SGPV cause disease only in sheep, others only in goats, and some in both sheep and 
goats.  
The SGPV is very resistant to physical and chemical agents.  
Host Range:  Sheep and goat pox virus causes clinical disease in sheep and goats. The virus replicates in 
cattle but does not cause clinical disease. The disease has not been detected in wild ungulate populations.  
Geographic Distribution:  The disease is endemic in Africa, the Middle East, the Indian subcontinent, 
and much of Asia.  
A goat-pox-like disease was reported in the western United States, but no attempt was made to indentify 
the agent with a reference serum against SGPV. Serum samples from animals representing the affected 
group of goats were submitted to the Foreign Animal Disease Diagnostic Laboratory (FADDL) at Plum 
Island, NY, and tested for antibody to SGPV; no antibodies were found against SGPV. The serums were 
not tested for antibodies to bovid herpesvirus 2 or contagious ecthyma at the FADDL. Unfortunately, the 
viral isolate was not available for study. It is conclusive that what was reported in the literature was not 
goat pox.  
Transmission:  Contact is the main means of transmission of SGPV. Inhalation of aerosols from acutely 
affected animals, aerosols generated from dust contaminated from pox scabs in barns and night holding 
areas, and contact through skin abrasions either by fomites or by direct contact are the natural means of 
transmitting SGPV. Insect transmission is possible. The virus can cause infection experimentally by 
intravenous, intradermal, intranasal, or subcutaneous inoculation.  
Incubation Period:  Under field conditions, the incubation of SGP is between 4 and 8 days. 
Experimentally, the first sign (fever) may appear within 3 to 5 days after inoculation. The course of the 
disease is 4 to 6 weeks with various stages of pox lesions present at the same time. Full recovery may take 
up to 3 months.  
Clinical Signs:  Sheep and goat pox virus may cause subclinical infection; clinical cases vary from mild 
to severe. The course of the disease in sheep and goats is similar. The first signs may include fever, 
depression, conjunctivitis, lacrimation, and rhinitis. Within a few days of the prodromal signs, pox lesions 
develop in the skin. These are more easily observed on the wool-free or hair-free parts of the body such as 
the perineum, inguinal area, scrotum, udder, axilla, and muzzle. Lesions do occur in wooled or haired 
skin. Generally, more severe (extensive) skin lesions correlate with more severe illness. The skin lesion 
first appears as an erythematous area (macula). This lesion progress to a raised, slightly blanched lesion 
that presents erythema with edema in the central part of the lesion (papule). Pox lesions with a transudate, 
representing the vesicular stage of the lesion, may be noted, but rarely is there any gross vesicle in the 
skin. The center of the lesion then becomes depressed and gray (necrotic) and is surrounded by an area of 
hyperemia. Late in the course of the disease (2 to 4 weeks after the first signs), the lesions become dry, 
and a scab forms. A characteristic feature of a pox lesion is that lesions involve the entire epidermis and 
dermis and penetrate into the subcutaneous tissue; it feels like a nodule. Depending on the severity of the 
skin lesion, there may be a scar, an area devoid of wool or hair, after the lesion heals. Secondary bacterial 
infection may complicate the healing process. The muzzle may be swollen, and the nares and oral mucosa 
may have extensive lesions. In many cases, pneumonia may occur with labored breathing and a 
respiratory rate approaching 90 per minute. Depression, anorexia, and emaciation are common and may 
persist. Nervous signs may occur, but how these are related to the SGPV infection is not clear.  
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Lambs and kids under 1 month of age may suffer a very severe generalized form of SGP. The signs 
described above for older animals are exaggerated, and there is an increased mortality.  
Gross Lesions:  At necropsy, skin lesions have congestion, hemorrhage, edema, vasculitis, and necrosis 
and will be seen to involve all layers of the epidermis, dermis, and, in severe cases, extend into the 
adjacent musculature. Lymph nodes draining affected areas are enlarged up to eight times their normal 
size owing to extensive lymphoid proliferation, edema, congestion, and hemorrhage.  
Mucous membranes of the eye, mouth, and nose have pox lesions that, in severe cases, may coalesce. In 
severe cases of SGP, the eyelids may be so seriously affected that the proliferative lesions and 
inflammation cause the eyes to close. Lesions on the muzzle and nares may coalesce, and proliferative 
changes and inflammation may be extensive. Pox lesions may occur in the pharynx, epiglottis, and 
trachea. These usually appear as rounded blanched areas surrounded by an area of hyperemia. 
Occasionally there may be lesions in the epithelium of the rumen and omasum.  
Pox lesions in the lungs may be severe and extensive; the lesions are focal and uniformly distributed 
throughout the lungs as the result of hematogenous infection. Early lesions are congested areas; these then 
progress to discrete areas of congestion and edema and finally to white nodules. Areas distal to the pox 
lesions have lobular atelectasis. Mediastinal lymph nodes are often enlarged up to five times their normal 
size and may be congested, hemorrhagic, and edematous.  
Pox lesions also may be present on the vulva, prepuce, testicles, udder, and teats.  
Morbidity and Mortality:  The severity of SGP varies depending on the strain of the virus and the age and 
breed of the animals affected. In adult sheep and goats, morbidity may range to 80 percent with some 
subclinical infections. Mortality can approach 50 percent. In susceptible lambs and kids under 1 month of 
age, morbidity may approach 100 percent, and mortality may be as high as 95 perent. Factors that may 
complicate the course of the disease and increase the mortality are poor nutrition, heavy parasitism, and 
severe climatic conditions.  
Diagnosis  
Field Diagnosis  
A tentative diagnosis of SGP can be made on the basis of clinical signs consisting of skin lesions, which 
on, palpation involve the whole thickness of the skin, a persistent fever, lymphadenitis, and often 
pneumonia; mortality may approach 50 percent in adults and 95 percent in lambs and kids under 1 month 
of age.  
Specimens for Laboratory  
For laboratory diagnosis of SGP, skin biopsies of early lesions can be used for virus isolation and 
histopathologic and electron microscopic studies. Samples aspirated from enlarged lymph nodes can be 
used for virus isolation. Necropsy samples should include a full set of tissues, but samples of the lungs, 
trachea, and rumen containing gross lesions are especially valuable for histopathology. Samples for virus 
isolation should be shipped to the laboratory under wet ice if they will arrive in 2 days and shipped under 
dry ice if delivery will take longer (send in screw-capped vials with the caps secured with electrical tape). 
Samples for histopathology should be preserved in 10 percent buffered formalin (DO NOT FREEZE). 
Serum samples should be taken from acute and chronic cases. Followup serum samples from acute cases 
may be taken 2 to 3 weeks after the first sample.  
Laboratory Diagnosis  
The laboratory procedures for the diagnosis of SGP include virus isolation; observation of the virus by 
electron microscopy; detection of antibody by virus neutralization, the indirect fluorescent antibody test, 
or both; and characteristic histopathologic lesions.  
Differential Diagnosis  
Following are several diseases to consider in the differential diagnosis for SGP:  
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Bluetongue — Animals are depressed and have a nonpurulent conjunctivitis. The muzzle is swollen, 
congested, and edematous, and there may be a coronitis. Deformed aborted fetuses and deformed 
newborn sheep and goats may be encountered.  
Peste des Petits Ruminants — Conjunctivitis, rhinitis, and oral lesions that are white, raised, and necrotic 
are common. Pneumonia, diarrhea, and mortality approaching 90 percent in lambs and kids under 1 
month of age are characteristic signs.  
Contagious Ecthyma (contagious pustular dermatitis, ORF) — This disease is most severe in lambs and 
kids. The proliferative pox lesions are common on the muzzle and eyes of affected neonates; mortality 
may approach 50 percent. Nursing females may have proliferative pox lesions on the teats and muzzle. 
This is a zoonotic disease; lesions in attendants are not uncommon.  
Photosensitization — Dry, flaky, inflamed areas are confined to the nonpigmented parts of the skin.  
Insect bites — The trauma from insect bites may cause local inflammation, edema, and pruritus. Insects 
seldom bite mucous membranes.  
Parasitic pneumonia — Severe signs of respiratory distress may occur with extensive parasitic lesions; in 
these cases, there is no pox lesion in the skin.  
Caseous lymphadenitis — Focal, raised lesions in the skin represent caseous abscesses; abscesses are not 
seen in SGP.  
Streptothricosis (Dermatophilus congolensis infection) — Lesions are superficial and often moist. 
Lesions are common in the skin of the neck, axillary region, inguinal region, and perineum. The organism 
may be demonstrated by Giemsa staining.  
Mange - Scab-like skin lesions are seen in psoroptic mange. Itching and scratching are not seen in SGP.  
Vaccination:  In endemic areas, vaccination is an effective means of controlling losses from SGP. Killed 
vaccines have not proven to be practical under field conditions because they do not provide solid lasting 
immunity. Several modified live virus vaccines have been used for protection against SGP. The most 
widely employed vaccine is probably the Romanian strain that has been used effectively for many years. 
The Kenya O 180 strain is possibly the vaccine with the best safety and efficacy.  
Control and Eradication 
Prevention  
The most likely manner for SGP to enter a new area is by introduction of infected animals. Restrictions 
on the movement of animals and animal products (meat, hair, wool, and hides) are essential to prevent 
introduction of SGP. Wool, hair, and hides must be subjected to suitable decontamination procedures 
before entry into nonendemic areas.  
Control  
If a new case is confirmed in a new area before extensive spread occurs, the area should be quarantined, 
infected and exposed animals should be slaughtered, and the premises cleaned and disinfected. 
Vaccination of susceptible animals on premises surrounding the infected flock(s) should be considered.  
If the disease has spread over a large area, the most effective means of controlling losses from SGP is 
vaccination; however, consideration should be given to eliminating infected and exposed flocks by 
slaughter; properly disposing of animals and contaminated material; and cleaning and disinfecting 
contaminated premises, equipment, and facilities.  
Eradication  
A carrier state has not been shown for SGPV. However, the virus may persist for many months on 
contaminated premises. The imposition of quarantines on areas and premises containing infected or 
exposed animals is required to prevent disease spread. Depopulation of infected and exposed flocks 
should be used if limited spread has occurred. If the disease has spread extensively, massive vaccination 
followed by cessation of vaccination and control of animal movements from the area represent a strong 
strategy to control and then eradicate SGP.  
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Public Health:  There is no conclusive evidence that SGPV infects humans. A report from India that 
implied that goat pox caused human infection was merely based on clinical signs. There was no attempt to 
isolate the causative virus or perform serology on the convalescent serums of the three patients to 
differentiate the infection from contagious ecthyma, which is a known zoonotic agent that occurs 
worldwide. A report from Sweden indicated that human infection occurred during an outbreak of goat 
pox. Although serological studies seemed to indicate that the apparent causative agent of the outbreak was 
not vaccinia or contagious ecthyma, no virus was isolated. Therefore, it cannot be said that goat pox virus 
caused human infection.  
1.12 Japanese encephalitis virus13 
(Japanese B encephalitis)  
Definition:  Japanese encephalitis (JE) is an arthropod-borne virus disease affecting the central nervous 
system (CNS) of human beings and, less frequently, horses. The infection also results in the birth of litters 
of pigs with a high percentage of stillbirths or pigs affected with encephalitis.  
Etiology:  The JE virus is a member of the family Flaviviridae and is in the genus Flavivirus. Host range 
and other characteristics are described in detail in the International Catalogue of Arboviruses.  
Host Range:  People and horses are victims of the JE virus infection but appear to be dead-end hosts from 
an epidemiologic standpoint. Viremia levels in infected human beings and equine species are generally 
too low to provide potential mosquito vectors with an infective blood meal. Under experimental 
conditions, however, Gould et al. demonstrated horse to horse transmission by Culex tritaeniorhynchus. 
Cattle are frequently infected in enzootic areas but do not develop sickness or viremia.  
Swine in Japan and Taiwan are both victims of disease as well as amplifiers of infection in nature. This is 
particularly true when swine are bred to farrow at a time when infected mosquitoes make their first 
appearance. This type of breeding program is practiced in Japan where, because of immunity or natural 
seasonal lows in transmission, gilts resist infection during pregnancy, and thus losses due to abnormal 
litters resulting from JE infection are reduced. However, normal newborn piglets soon lose maternally 
acquired antibody and are fully susceptible to infection from arthropod vectors.  
Although JE infection in shoats is subclinical, viremias are sufficiently high to provide emerging broods 
of Cu. tritaeniorhynchus, which feed readily on swine, with a plentiful source of virus-containing blood. 
Following a period of extrinsic incubation of virus, the mosquitoes are able to transmit the infection to 
susceptible vertebrate hosts.  
In Japan, herons and egrets play a role in the spread of infection to man and other vertebrates and may be 
responsible for carrying the virus from rural to urban areas. Cu. tritaeniorhynchus feeds readily on herons 
and egrets and ranges sufficiently high off the ground to feed on the young nesting birds.  
Geographic Distribution:  Human encephalitis in Japan was recognized as early as 1871, and Japanese 
encephalitis in epidemic form has been known since 1924 when 4,000 human deaths were recorded in 
Japan. The epidemiology of the disease was studied extensively after World War II in Japan by scientists 
of the U.S. Army's 406th Medical General Laboratory. Concurrent with vaccination of people and 
extensive use of agricultural pesticides in the last three decades, the disease has practically disappeared 
from Japan.  
Japanese encephalitis virus infection is widespread throughout temperate and tropical Asia; increasing 
numbers of human and equine cases have appeared in India, Nepal, China, Philippines, Sri Lanka, and 
northern Thailand. The disease in humans is sporadic in Indonesia and northern Australia but is not 
known in the rest of the world.  
                                                 
13Committee on Foreign Animal Diseases of the United States Animal Health Association, revised 1998.  Foreign 
Animal Diseases, “The Gray Book,” Part IV, Library of Congress Catalog Card Number 17-12842, Pat Campbell 
& Associates and Carter Printing Company, Richmond, VA. 
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Transmission:  The virus is maintained in nature in a cycle involving Culex mosquitoes of the genera 
tritaeniorhynchus, annulus, fuscocephala, gelidus, and vishnui complex. Mosquitoes transmit the virus to 
many species of birds and to swine.  
The sequence of events in temperate Asia is initiated by appearance of virus in mosquitoes in late spring 
followed by the infection and disease in susceptible horses and swine. This is followed by the appearance 
of disease in man in August and September. In tropical and semitropical areas of Asia, the seasonal nature 
of the disease is less marked.  
Basically, however, it appears the Culex mosquitoes and birds are common factors in the epidemiology of 
JE, regardless of the region of occurrence, and that swine are involved where they are numerous in Asia.  
The mechanism of maintaining the virus over the winter in temperate areas has not been elucidated. 
Overwintering in mosquitoes is a possibility either in infected hibernating mosquitoes or by transovarial 
passage. It is also possible that bats may carry the virus for prolonged periods.  
Incubation Period:  In horses, the incubation period is 8 to 10 days. The time between exposure of 
pregnant swine to an infectious dose of JE virus and delivery of abnormal litters does not seem to be 
clearly established, although exposure early in gestation appears more likely to result in abnormal litters 
than later exposure.  
Clinical Signs:  In horses, initial signs are fever, impaired locomotion, stupor, and grinding of teeth. 
Blindness, coma, and death follow in more severe cases. Although the clinical signs resemble those seen 
in horses with Western equine encephalomyelitis and Eastern equine encephalomyelitis, mortality is 
relatively low. Inapparent or subclinical infections in horses are far more common than cases of 
recognizable encephalitis.  
The principal manifestation of disease in swine is the expulsion of litters of stillborn or mummified 
fetuses, usually at term. Viable piglets frequently die shortly after birth and exhibit tremor and 
convulsions before expiring. Experimental infection of boars leads to diminished sperm count and 
decreased mobility of sperm. Virus has been transmitted to gilts by way of infected semen.  
Gross Lesions:  In horses, gross lesions are similar to those observed in animals dying from Eastern 
equine encephalomyelitis and Western equine encephalomyelitis virus infections and are not specific 
enough to establish an etiologic diagnosis. Litters from infected pigs contain fetuses that are mummified 
and dark in appearance. Hydrocephalus, cerebellar hypoplasia, and spinal hypomyelinogenesis have been 
noted.  
Morbidity and Mortality:  The equine mortality caused by JE has been reported at about 5 percent in 
Japan and may actually be less than this in Southeast Asia. Mortality in adult pigs is close to zero. Litters 
of pigs from infected sows may be dead at delivery or, if living, may be quite weak and apt to succumb to 
encephalitis shortly after birth.  
Diagnosis  
Field Diagnosis  
Presumptive diagnosis can be made in horses that manifest CNS disease accompanied by fever, 
particularly in an epizootic period. It has been observed that illness in horses at race tracks in Malaysia is 
frequently due to JE infection. The infection is manifested only by fever and a short period of lethargy. In 
temperate zones, the disease appears during late summer and early fall.  
A presumptive diagnosis in swine is based on the birth of litters with a high percentage of stillborn or 
weak piglets.  
Specimens for Laboratory  
One half of a brain from animals having signs of encephalitis should be submitted unfixed and the other 
half fixed in 10 percent formalin. Paired serum samples collected at least 14 days apart should be 
submitted from animals that survive. Cerebrospinal fluid from horses with CNS signs should be submitted 
for detection of JE-specific IgM.  
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Laboratory Diagnosis  
Confirmation of JE can be accomplished by demonstrating seroconversion in animals that survive long 
enough to yield properly spaced blood samples. Neutralization, complement fixation, hemagglutination 
inhibition, immunofluorescence, and enzyme-linked immonosorbent assay tests are used to show a rise in 
titer from the acute stage to death or recovery. Reliance on seroconversion or IgM as a means of diagnosis 
in horses is not definitive because seroconversion may have resulted from exposure to another 
nonpathogenic Flavivirus.  
Demonstration of JE-specific IgM in serum of an encephalitic equine is presumptive evidence of the 
diagnosis.  
Further confirmation of JE in horses can be obtained by examination of the cerebrospinal fluid and the 
brain. Specific IgM in the spinal fluid is excellent evidence of CNS infection. Although microscopic 
lesions of the brain are of value, definitive confirmation is based on isolation and identification of the 
virus from the brain. Virus isolations are more likely to be successful from brains of animals that died 
after a short course of the disease.  
Confirmation of JE in diseased litters of pigs is accomplished by isolation of the virus from fetal brains or 
brains of piglets that die after manifesting signs of encephalitis. Demonstration of antibody increase in 
dams bearing affected litters is probably not a reliable measure because seroconversion in such animals 
would probably have occurred earlier in infection.  
Differential Diagnosis  
The disease in horses must be differentiated from other viral encephalitides. In Asia, JE is the only 
recognized arboviral infection causing encephalitis in horses. Because there are many mild or subclinical 
infections, laboratory confirmation is essential.  
Various forms of toxic encephalitis must be considered in differential diagnosis. In temperate-zone Asia, 
the midsummer seasonal occurrence of JE in horses aids in differential diagnosis.  
Japanese encephalitis in pigs must be differentiated from a hemagglutinating DNA virus infection that 
appears to be as commonplace in Japan as JE and causes the same pattern of disease. There is evidence 
that the DNA virus infection is established in gilts in the middle or last trimester of pregnancy. Seasonal 
patterns of DNA virus infection need more complete study, but the disease does appear concurrently with 
Japanese encephalitis and therefore requires laboratory tests for differentiation.  
Another hemagglutinating virus, myxovirus parainfluenza 1 (Sendai), has been shown capable of 
producing stillbirth in swine under experimental conditions. Encephalitis in neonatal pigs is also 
associated with a coronavirus infection. This agent is known to cause encephalitis in piglets in at least 
North America and Europe.  
Vaccination:  A live attenuated vaccine produced in hamster kidney tissue culture is in widespread use in 
horses in China. This vaccine reduced disease by about 85 percent. An inactivated vaccine prepared in 
mouse brain is licensed in Japan, Korea, Taiwan, India, and Thailand for use in humans. A similar 
inactivated product made in hamster kidney tissue culture has been used to immunize children annually in 
China since 1965. Live attenuated vaccines are used to immunize pigs in Japan and Taiwan and humans 
in China.  
Control and Eradication:  Options for control include elimination of the vectors, prevention of 
amplification of the infection cycle in birds and pigs, or immunization of horses, pigs, and people. 
Although some success in vector control was achieved by modification of irrigation methods to minimize 
breeding of Cu. tritaeniorhynchus in Southeast Asia and coincidentally by the use of agricultural 
pesticides, vector control has never been more than marginally successful. Reduction of the avian 
reservoir hosts does not appear feasible.  
The most promising approach to reducing livestock losses and at the same time reducing the totality of 
infection in nature is widespread immunization of swine. Live attenuated vaccines are in use in Japan and 
Taiwan. Immunization of shoats prevents infection in vaccinees and neutralizes their role as amplifiers of 
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infection in nature. It is anticipated that those animals retained for breeding will remain immune, and, 
because of immunity or natural seasonal lows in transmission resist infection during pregnancy and 
therefore bear normal litters. Although controlling the disease in swine dampens the spread of infection in 
nature, there is a continued threat to horses and human beings from other sources.  
The introduction of JE virus into the United States is always a possibility, but whether the infection, once 
introduced, would become established in nature is difficult to assess. Animal health authorities must 
continue to be alert to detecting and identifying agents associated with encephalitis in horses and with 
abnormal litters of pigs. The means for rapid diagnosis and identification of JE are available, although it 
is doubtful that control of the disease in Asia will be achieved in the near future.  
Public Health:  Japanese encephalitis can cause an explosive, highly fatal form of human encephalitis.  
1.13 Lumpy skin disease virus14 
(Pseudo-urticaria, Neethling virus disease, exanthema nodularis bovis, knopvelsiekte)  
Definition:  Lumpy skin disease (LSD) is an acute to chronic viral disease of cattle characterized by skin 
nodules that may have inverted conical necrosis (sitfast) with lymphadenitis accompanied by a persistent 
fever.  
Etiology:  The causative agent of LSD is a capripoxvirus. The prototype strain of LSD is the Neethling 
virus. The LSD virus (LSDV) is one of the largest viruses (170-260 by 300-450 nm). There is only one 
serotype of LSDV. The LSDV is very closely related serologically to the virus of sheep and goat pox 
(SGP) from which it cannot be distinguished by routine virus neutralization or other serological tests. 
Restriction endonuclease studies of capripoxviruses indicate that LSDV strains are essentially identical 
with each other and with a Kenyan strain (O 240/KSGP) of sheep and goat pox virus (SGPV). Other 
strains of SGPV from Kenya were different from the O 240/KSGP strain but similar to each other and 
resembled strains of SGPV from the Arabian Peninsula. The Kenyan group of SGPV strains showed 
differences when compared with ones from India, Iraq, and Nigeria.  
The LSDV is very resistant to physical and chemical agents. The virus persists in necrotic skin for at least 
33 days and remains viable in lesions in air-dried hides for at least 18 days at ambient temperature.  
Host Range:  Lumpy skin disease is a disorder of cattle. There is inconclusive evidence regarding the 
infection of water buffalo (Bubalus) with LSDV. The African Cape buffalo (Synercus caffer) and other 
wild ungulates have not been infected during epizootics of LSD in Africa. Experimental infection of some 
species is possible.  
Geographic Distribution:  Lumpy skin disease was first described in Northern Rhodesia in 1929. Since 
then, the disease has spread over most of Africa in a series of epizootics. The most recently affected 
countries include Kuwait in 1986-88 and Egypt in 1988. An outbreak of LSD occurred in Israel in 1989. 
For the first time, the disease was eradicated by slaughter and vaccination.  
Transmission:  Biting insects play the major role in the transmission of LSDV. Epidemics of LSD are 
associated with rainy seasons. The disease spreads in river basins and areas conducive to insect 
multiplication. Stomoxys calcitrans experimentally transmitted LSDV, but biting lice (Mallophaga spp.), 
sucking lice (Damalinia spp.), or Culicoides nubeculosus did not. In Kenya, Culex mirificus but also 
Aedes natronius were in heavy concentration during an LSD epizootic and were associated with 
transmission. Direct contact seems to play a minor role in the spread of LSD.  
Incubation Period:  In the field the incubation period is 2 to 5 weeks. Following experimental infection 
by intradermal inoculation, a lesion usually develops at the inoculation site within 6 to 20 days.  
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Clinical Signs:  Lumpy skin disease virus causes inapparent to severe disease in cattle. All ages of cattle 
can be affected, but young calves are usually more severely affected. The severity of the disease depends 
on the dose of the inoculum as well as the susceptibility of the host (Bos taura is more susceptible than 
Bos indicus) and the route of exposure. A fever 104 to 107o F (40-41.5o C) can occur and can be 
transitory or last up to 4 weeks. Generally within 2 days after the appearance of the fever, swellings or 
nodules 1 to 5 cm in diameter appear in the skin and generalization occurs. Depression, anorexia, 
excessive salivation, oculonasal discharge, agalactia, and emaciation are presented. Nodules 1 to 7 cm in 
diameter may occur anywhere on the body but especially in the skin of the muzzle, nares, back, legs, 
scrotum, perineum, eyelids, lower ear, nasal and oral mucosa, and tail. The hair stands erect over early 
skin lesions. The nodules are painful and involve the epidermis, dermis, and subcutaneous tissue and may 
even involve the musculature. As the disease progresses, the nodules become necrotic, and eventually a 
deep scab forms; this lesion is called a sitfast. Secondary bacterial infection can complicate healing and 
recovery. Lesions on the teats can result in severe secondary bacterial infection with loss of the quarter 
owing to mastitis.  
Where extensive generalization occurs, animals can become lame and reluctant to move because of 
edema. Lameness also may result from inflammation of the tendons, tendon sheaths (tendosynovitis), 
joints (synovitis), and laminae (laminitis). Severe edema in the brisket and legs can occur. If secondary 
bacterial infection develops in the tendon sheaths and joints, pemmanent lameness may result. Superficial 
lymph nodes such as the mandibular, parotid, prescapular, and prefemoral nodes, draining affected areas 
of skin become enlarged 4 to l0 times normal size.  
Abortion may occur as the result of prolonged fever. Davies has reported intrauterine infection of late-
term fetuses in which calves are born with LSD lesions. Temporary or pemmanent sterility in bulls can 
result from the fever or lesions of the reproductive organs. Cows may not come into estrus for several 
months after LSD.  
The lesions may persist in various stages over a course of 4 to 6 weeks. Final resolution of lesions may 
take 2 to 6 months, and nodules can remain visible 1 to 2 years. Permanent damage to the hide is 
inevitable in clinical cases.  
Gross Lesions:  The gross lesions of LSD are well described. Skin nodules have congestion, hemorrhage, 
edema, and vasculitis with consequent necrosis and involve all layers of the epidermis, dermis, 
subcutaneous tissue, and often adjacent musculature. Lymph nodes draining affected areas are enlarged 
up to 10 times normal size with extensive lymphoid proliferation, edema, congestion, and hemorrhage.  
Mucous membranes of the oral and nasal cavities can have pox lesions that coalesce in severe cases. Pox 
lesions may occur in the pharynx, epiglottis, and trachea. Pox lesions are not easily visualized in the lungs 
but appear as focal areas of atelectasis and edema. In severe cases, pleuritis can occur with enlargement of 
the mediastinal lymph nodes.  
Synovitis and tendosynovitis with fibrin in the synovial fluid can occur. Pox lesions can be present in the 
testicles and urinary bladder.  
Morbidity and Mortality:  Morbidity for LSD varies from 3 to 85 percent and likely depends on 
prevalence of the mechanical insect vector and the susceptibility of the cattle. Mortality is generally low 
(1 to 3 percent). In one outbreak in South Africa, mortality was about 20 percent when an anaplasmosis 
vaccine was prepared from bovine blood contaminated with LSDV. Unusually high mortality (75 to 85 
percent) in other outbreaks of LSD was not explained.  
Diagnosis  
Field Diagnosis  
A tentative diagnosis of LSD can be made based upon clinical signs. A contagious disease with 
generalized skin nodules having a characteristic inverted conical necrosis of skin nodules (sitfast), 
persistent fever, emaciation, and low mortality suggests LSD.  
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Specimens for Laboratory  
Skin biopsies of early lesions (ones where necrosis has not occurred) provide samples that can be used for 
virus isolation, histopathology, and electron microscopy. Samples should be taken from at least three 
animals. Samples aspirated from enlarged lymph nodes can be used for virus isolation. Samples for virus 
isolation should be shipped to the laboratory under wet ice if they will arrive in 2 days and be shipped 
under dry ice if more time will be required. Samples for histopathology should be preserved in 10 percent 
buffered formalin (DO NOT FREEZE). Serum samples should be taken from acute and chronic cases. 
Followup serum samples (convalescent samples) should be taken 2 to 3 weeks after the first appearance 
of skin lesions.  
Laboratory Diagnosis  
To confirm an initial diagnosis in an LSD-free area, the virus has to be isolated and identified. The 
laboratory procedures for the diagnosis of LSD include virus isolation in lamb testicle or fetal bovine lung 
cell cultures or both. Virions may be detected by electron microscopy. Herpesviruses may be present in 
bovine skin samples and cause confusion in cell culture studies. Serological tests include virus 
neutralization and indirect fluorescent antibody (IFA). The IFA test may measure group-reactive antibody 
that may be elicited by other pox viruses.  
Differential Diagnosis  
Listed below are several diseases that should be considered in the differential diagnosis of LSD:  
Bovine herpes mammillitis (also called Allerton virus infection caused by Bovid Herpesvirus-2) — The 
lesions are superficial (involving only the epidermis) and occur predominantly on the cooler parts of the 
body such as teats and muzzle. Generalized skin lesions can occur accompanied by a transient fever (1 to 
3 days). Resolution of the lesion is rapid and results in focal alopecia but no hide damage.  
Streptotrichosis (Dermatophilus congolensis infection) — lesions are superficial (often moist and appear 
as crusts) scabs or 0.5- to 2-cm diameter accumulations of keratinized material. Lesions are common in 
the skin of the neck, axillary region, inguinal region, and perineum. The organism can be demonstrated by 
Giemsa staining.  
Ringworm — The lesions of ringworm in cattle are grayish, raised, plaque-like, and often pruritic. The 
organism can be demonstrated with a silver stain.  
Hypoderma bovis infection —The parasitic fly larvae of this parasite have a predilection to migrate to the 
dorsal skin of the back. They cause a nodule with a small central hole through which the larva exits the 
body, which results in significant hide damage.  
Photosensitization — Dry, flaky, inflamed areas are confined to the nonpigmented parts of the skin.  
Bovine papular stomatitis — Pox-like lesions occur in the skin of the muzzle, oral cavity, and esophagus. 
There is no generalized disease.  
Insect bites — The trauma from insect bites causes local inflammation, edema, and pruritus. Insects 
seldom bite mucous membranes.  
Urticaria — Delayed hypersensitivity reactions can be confused with LSD. Such lesions generally resolve 
within 3 to 5 days. An example of this was described by Shimshony (1989) where allergic reactions 
occurred after vaccination with a foot-and-mouth disease vaccine.  
Besnoitiosis (Globidiosis) — Thick-walled cysts in the skin are caused by sporozoan parasites of the 
genus Besnoitia, which are transmitted mechanically by certain biting flies. Histologic sections will reveal 
the parasites.  
Treatment:  Treatment is directed at preventing or controlling secondary infection. Animals infected with 
LSDV generally recover (mortality is usually less than 3 percent). Complete recovery may take several 
months and may be prolonged where secondary bacterial infection occurs. Loss of production results 
from severe emaciation, lowered milk production, extensive damage to hides, and loss of draft from 
lameness. It may take up to 6 months for animals severely affected by LSDV to recover fully.  
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Vaccination:  In endemic areas, vaccination against LSD has been successfully practiced. In the Union of 
South Africa, an attenuated LSD vaccine is used. In Kenya, sheep and goat pox virus is used. In Egypt, 
the Romanian strain of sheep and goat pox vaccine has been used successfully for prophylaxis against 
LSD.  
Control and Eradication:  The most likely way for LSD to enter a new area is by introduction of infected 
animals. Biting insects that have fed on infected cattle may travel and be blown for substantial distances. 
It is likely that LSD spread to Israel via contaminated insects blown across the Sinai Desert. The 
movement of contaminated hides represents another potential means for this resistant virus to move.  
If LSD is confirmed in a new area before extensive spread occurs, the area should be quarantined, 
infected and exposed animals slaughtered, and the premises cleaned and disinfected. Vaccination of 
susceptible animals within the quarantine should be considered.  
If the disease has spread over a large area, the most effective means of controlling losses from LSD is 
vaccination. However, even with vaccination, consideration still should be given to eliminating infected 
and exposed herds by slaughter, proper disposal of animals and contaminated material, and by cleaning 
and disinfecting contaminated premises, equipment, and facilities.  
In the Union of South Africa, the control of insects was not effective in preventing the spread of LSD, but 
current insecticides together with repellents aid in the prevention of the spread of LSD.  
Public Health:  There is no evidence that LSDV infects humans.  
1.14 Malignant catarrhal fever virus15 
(Malignant head catarrh, malignant catarrh, snotsiekte)  
Definition:  Malignant catarrhal fever (MCF) is a generalized viral disease of domestic cattle and 
buffaloes and many species of wild ruminants characterized by high fever, profuse nasal discharge, 
corneal opacity, ophthalmia, generalized lymphadenopathy, leukopenia, and severe inflammation of the 
conjunctival, oral, and nasal mucosas with necrosis in the oral and nasal cavities sometimes extending 
into the esophagus and trachea. Occasionally central nervous system (CNS) signs, diarrhea, skin lesions, 
and nonsuppurative arthritis are observed.  
Etiology:  The etiologic agent of MCF in Africa is a highly cell-associated lymphotropic herpesvirus of 
the subfamily Gamma herpesvirinae. Two viral strains have recently been designated: alcelaphine 
herpesvirus-1 (AHV-1) and alcelaphine herpesvirus-2 (AHV-2), although some continue to designate this 
agent as bovid herpesvirus-3. This agent is carried as a latent infection by African antelope of the family 
Bovidae, subfamily Alcelaphinae which includes wildebeest (Connochaetes sp.), hartebeest (Alcelaphus 
sp.), and topi (Damaliscus sp.). The wildebeest herpesvirus of MCF (AHV-1) was first isolated by 
Plowright from a blue wildebeest (Connochaetes taurinus taurinus) in 1960.  
Epidemiologic evidence suggests that domestic and wild sheep and goats may be additional major 
reservoirs of a virus causing MCF. Serologic evidence also suggests this virus may be related but not 
identical to the alcelaphine herpesvirus-l.  
Sheep-associated MCF herpesviruses were isolated from domestic cattle in Minnesota in 1977 and from 
domestic cattle in Austria in 1990. On the basis of morphology and molecular DNA mapping, both 
isolates appear similar to AHV-1.  
Viruses identical or closely related to AHV-1 and AHV-2 have been isolated from several captive wild 
ruminant species in two U.S. zoos located in Oklahoma City and San Diego. Animals infected with AHV-
                                                 
15Committee on Foreign Animal Diseases of the United States Animal Health Association, revised 1998.  Foreign 
Animal Diseases, “The Gray Book,” Part IV, Library of Congress Catalog Card Number 17-12842, Pat Campbell 
& Associates and Carter Printing Company, Richmond, VA. http://www.vet.uga.edu/vpp/gray_book/FAD/ahs.htm  
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1 were white-tailed gnu, white-bearded gnu, gaur, greater kudu, Formosan sika deer, axis deer, and nilgai. 
The AHV-2 was isolated from a topi and a hartebeest at the San Diego Wild Animal Park.  
The agent of MCF on deer farms in Scotland and New Zealand has not yet been demonstrated by electron 
microscopy or isolation of cell-free virus in a cell culture system. However, it has been passaged in 
lymphocyte cultures, rabbits, and deer.  
Host Range:  All species of wildebeest, hartebeest, and topi are considered carriers of alcelaphine MCF 
virus. There is serologic evidence that several other African wild ruminants, such as various species of 
oryx and addax, may also be reservoir hosts, although MCF virus has not been isolated from these 
species.  
Domestic and wild sheep and goats are also considered reservoir hosts for MCF virus.  
Many exotic ruminant species in zoos have been reported affected with MCF, including several wild 
bovines such as bison, water buffalo, gaur and banteng, and several deer (including white-tailed deer) and 
antelope species. Interestingly, no cases of MCF have been reported from antelope species that normally 
cohabitate wildebeest grazing areas in Africa.  
In cattle and susceptible wild ruminants, MCF affects all ages, breeds, and sexes.  
Geographic Distribution:  Sheep-associated MCF occurs worldwide. The alcelaphine antelope-associated 
form in cattle occurs chiefly in Africa in the natural habitat of wildebeest, hartebeest, and topi. This form 
of MCF has, however, occurred in zoos and wild animal parks that also kept wildebeest. The increasing 
popularity in North America and other areas of the world of wild game animal ranches, often in 
association with domestic cattle raising, increases the possibility that MCF will become a more prevalent 
disease in cattle and ranched exotic ruminants. There is increasing serologic evidence that cattle may 
develop low levels of neutralizing antibodies following exposure to MCF, especially of sheep or goat 
origin, without manifesting clinical disease. There is evidence that stress or some other 
immunosuppressive effector may be necessary as a precursor of clinical sheep-associated MCF.  
Transmission:  The MCF virus in wildebeest, hartebeest, and topi is largely cell-associated in adult 
animals and hence rarely transmissible. However, neonatal wildebeests have been found to shed cell-free 
MCF virus in nasal and ocular secretions and in feces. Cell-free MCFV has also been demonstrated in 
nasal secretions of captive adult wildebeests after stress or administration of corticosteroids. Transmission 
to cattle or other susceptible species may occur by inhalation of cell-free virus in infectious aerosol 
droplets, ingestion of feed or water contaminated with infectious secretions or feces, or possibly 
mechanically by arthropods. Masai herdsmen believed cattle acquire MCF by contact with wildebeest 
placentas or birth hair of neonates. Recent studies have failed to demonstrate infective MCFV in fetal 
fluids or placentas of wildebeest probably owing to the rapid inactivation of virus by sunlight. The mode 
of transmission of sheep-associated MCF remains unknown, although relatively close contact between 
cattle and sheep, especially lambing ewes, is believed necessary. MCF-affected cattle appear to shed only 
cell-associated virus, and thus cattle-to-cattle transmission is thought to be rare or nonexistent, although 
there are documented instances where this has occurred.  
Incubation Period:  The incubation period in natural cases is not known, but epidemiologic evidence 
indicates it may be as long as 200 days. Experimentally, the incubation period has varied from 9 to 77 
days.  
Clinical Signs:  Clinical MCF in cattle has arbitrarily been divided into four forms as follows:  
1. Peracute form: Fever, severe inflammation of the oral and nasal mucosas and hemorrhagic 
gastroenteritis with a course of 1 to 3 days.  
2. Intestinal form: Fever, diarrhea, hyperemia of oral and nasal mucosas with accompanying discharges, 
and lymphadenopathy with a course of 4 to 9 days.  
3. Head and eye form: This is the typical syndrome of MCF with fever, nasal, and ocular discharges 
progressing from serous to mucopurulent and purulent. Encrustation of the muzzle and nares occurs in 
later stages, causing obstruction to the nostrils and dyspnea, open-mouthed breathing, and drooling. There 
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is intense hyperemia and multifocal or diffuse necrosis of the oral mucosa (usually on the lips, gums, and 
hard and soft palate) and buccal mucosa. Erosion of the tips of buccal papillae, leaving them reddened 
and blunted, is often encountered.  
Ocular signs referable to ophthalmia include lacrimation progressing to purulent exudation, photophobia, 
hyperemia, and edema of the palpebral conjunctiva and injection of scleral vessels. Corneal opacity, 
starting peripherally and progressing centripetally, results in partial to complete blindness. Hypopyon may 
also be seen. Corneal opacity is usually bilateral but occasionally is unilateral. Fever is common and 
usually high (104-107° F [40-41.6° C]) until the animal becomes moribund, at which time it is 
hypothermic. Clinical features at early onset have included reddening of the skin of the udder, the 
coronary bands and interdigital spaces, and marked hyperemia of the oral cavity. Increased thirst 
accompanies the fever, and anorexia is seen in late stages. Constipation is common in this form of MCF, 
but terminal diarrhea is sometimes observed.  
Nervous signs are not frequently seen but may be manifested by trembling or shivering, uncoordinated 
gait, and terminal nystagmus.  
Necrotic skin lesions occasionally are seen, and horn and hoof coverings may be loosened or sloughed in 
some cases. The course of the head and eye form, which is invariably fatal, is usually 7 to 18 days.  
4. Mild forms: These are syndromes caused by experimental infection of cattle with attenuated viruses 
and are usually nonfatal.  
There is considerable variation and overlap among these artificial categories, and their use has little value.  
Although the manifestations of the "head and eye" form of MCF are considered the typical syndrome in 
cattle, clinical signs in exotic ruminants are often less dramatic and not usually specifically diagnostic, 
except in members of the subfamily Bovinae (i.e., wild cattle). In deer and antelope species MCF tends to 
be more subtle clinically and usually is manifested by conjunctivitis, photophobia, moderate corneal 
clouding (often unilateral), fever, depression, variable lymphadenopathy, occasionally diarrhea, and 
usually a mild serous nasal discharge. Death may be sudden following a brief course of hemorrhagic 
diarrhea. Inflammation of the oral and nasal cavity is usually less severe than in cattle and only 
occasionally progresses to mucosal erosions.  
There is some suggestion from studying cases of MCF among exotic ruminants of a host-dependent 
modification with respect to the clinical and pathologic manifestations of MCF virus infection.  
Gross Lesions:  Gross lesions vary considerably, depending on the form or severity and course of the 
disease. Animals that die of the peracute disease may have few lesions other than a hemorrhagic 
enterocolitis.  
In the more protracted acute to subacute disease (intestinal and head and eye forms), the carcass may be 
normal, dehydrated, or emaciated. The muzzle is often encrusted and raw. Cutaneous lesions sometimes 
occur as a generalized exanthema with exudation of lymph causing crusting and matting of the hair. 
Where skin is unpigmented, hyperemia is apparent. These lesions are frequently seen in the ventral thorax 
and abdomen, inguinal region, perineum and loins, and sometimes on the head.  
Enlarged lymph nodes are characteristic findings in MCF. All nodes may be involved, but those in the 
head and neck and periphery are the most consistently prominent. Affected nodes are grossly enlarged 
and edematous and sometimes have patchy reddened or beige-brown areas on cut surfaces. Hemolymph 
nodes are also enlarged and prominent. The spleen is slightly enlarged, and Malpighian corpuscles are 
prominent. Pale areas may be seen in the heart muscle.  
Lesions in the respiratory system range from mild to severe. When the clinical course is short, there is 
slight serous nasal discharge and hyperemia of the nasal mucosa. Later the discharge becomes more 
copious and mucopurulent to purulent and is accompanied by intense nasal mucosal hyperemia, edema, 
and small focal erosions.  
Occasionally a croupous pseudomembrane formation is seen. Lesions in the nasal passages and turbinates 
may extend to the frontal sinuses. The pharyngeal and laryngeal mucosas are hyperemic and edematous 
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and later develop multiple erosions, often covered with gray-yellow pseudomembranes. Inflammation and 
sometimes petechiation and ulceration are seen in the tracheobronchial mucosa. The lungs are often 
edematous and sometimes emphysematous but in some cases may appear normal. A bronchopneumonia 
may complicate chronic cases.  
The alimentary tract mucosa may have no gross lesion in peracute cases. When the course is longer, 
alimentary lesions are commensurately more severe and include mild to severe mucosal inflammation 
(hyperemia and edema), erosions, and ulcerations— especially on the dental pad and gingival surfaces, 
the palate, tongue, and buccal papillae. Mucosal inflammation, hemorrhage, and erosions may also be 
found in the rest of the digestive tract including the esophagus, rumen, omasum, abomasum, small 
intestines, colon, and rectum. Petechiation may be seen. Feces are usually scant, dry, pasty, or blood 
stained.  
Urinary tract lesions include hyperemia and sometimes marked distention and prominence of bladder 
mucosal vessels and mucosal edema, perhaps with petechial to severe hemorrhage and occasionally 
epithelial erosion and ulceration. Kidneys may appear normal or mottled with patches of beige, discolored 
raised areas. Petechiae or ecchymoses may occur in the renal pelvis and ureters.  
The liver is usually slightly enlarged, and, upon close examination, has a prominent reticular pattern. 
There may be hemorrhages and erosions in the gallbladder mucosa.  
In most cases, small arterioles are very prominent and tortuous and have thickened walls. This is usually 
seen in subcutaneous vessels and those in the thorax, abdomen, and CNS.  
Fibrinous polyarthritis is seen in many cases of MCF.  
Morbidity and Mortality:  Clinical MCF in cattle in the United States is usually sporadic. However, in an 
outbreak in a Colorado feedlot, morbidity was 37 percent. Morbidity in nonalcelaphine MCF outbreaks in 
Malaysia ranged from 28 percent to 45 percent. The prognosis in MCF is poor. Once clinical signs are 
observed, mortality is usually greater than 95 percent (90-100 percent). In some parts of New Zealand, 
MCF is, along with tuberculosis, the most important cause of mortality in the deer-farming industry.  
Diagnosis  
Field Diagnosis  
A history indicating contact with sheep, goats, or alcelaphine antelope, especially around the period of 
parturition, associated with typical clinical features of MCF, provides grounds for a tentative diagnosis of 
MCF.  
Gross necropsy lesions consisting of corneal opacity; enlarged lymph nodes; inflammation and erosions 
in nasal passages, alimentary tract mucosa, and urinary bladder; and prominent tortuous small arteries in 
the subcutaneous tissue, thorax, and abdomen, provide further evidence for a presumptive diagnosis of 
MCF.  
Specimens for Laboratory  
1. For animal transmission and inoculation at least 300 to 500 ml blood in EDTA (1 mg/ml blood), 
heparin, or ACD solution should be collected and carried or shipped iced, not frozen. For virus isolation 
in cell culture, 10 to 20 ml of blood in EDTA is preferred. This should also be shipped cold but not 
frozen.  
2. Tissues for virus isolation, FA, or immunoperoxidase examination should also be refrigerated (iced) 
but NOT FROZEN and should include pieces of spleen, lung, lymph nodes, adrenals, and thyroids as well 
as unclotted blood. These should be collected as soon after death as possible, for the virus becomes 
inactivated rapidly in an animal dead more than 1 hour. The most useful specimens for animal inoculation 
or virus isolation attempts are those collected from a moribund animal immediately after euthanasia.  
3. Tissues for histopathology, fixed as thin pieces in 10 percent neutral buffered formalin, should include 
lung, kidney, liver, adrenals, lymph nodes, eyes, oral epithelium, esophagus, Peyer's patches, urinary 
bladder, carotid rete, thyroid, heart muscle, skin (if lesions are present), and whole brain.  
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4. Serum for serology should consist of paired samples taken 3 to 4 weeks apart (i.e., the first during the 
acute phase of disease and the second during convalescence or at death). Serologic methods currently 
preferred include virus neutralization and competitive inhibition enzyme-linked immuosorbent assay for 
MCF antibody.  
Laboratory Diagnosis  
Microscopic lesions of an extensive fibrinoid necrotizing vasculitis, perivasculitis, and lymphoreticular 
proliferation in lymphoid organs with mononuclear infiltrations in kidney, liver, adrenals, CNS, etc., are 
pathognomonic for MCF and are a sound, practical basis for a confirmed diagnosis.  
Virologic and serologic examinations provide additional information that may also ultimately lead to a 
better understanding of the epizootiology and differences between viral strains and the clinical 
manifestations. Methods used consist of virus isolation, identification of viral isolates, demonstration of 
the appearance, or rising titers of MCF antibodies and molecular techniques using viral DNA probes, or 
target DNA amplifying methods such as the polymerase chain reaction (PCR). Because of the presence of 
MCF antibodies in asymptomatic U.S. cattle, a single antibody positive serologic sample is of limited 
value in establishing an etiologic diagnosis. The PCR method for demonstrating MCF DNA segments is 
proving to be useful for identifying MCF carriers as well as diagnosing overtly diseased animals.  
Differential Diagnosis  
Clinical MCF must be distinguished from other diseases and factors that produce inflammation and 
erosions and ulcerations of the nasal and alimentary tract mucosas such as BVD mucosal disease, 
bluetongue, rinderpest, vesicular diseases (FMD, VS), ingested caustics, and some poisonous plants and 
mycotoxins. The inability to differentiate the alcelaphine clearly from the sheep-associated MCF by 
clinical observations, lesions, or laboratory means presents an enigma in evaluating the possibility of a 
foreign animal disease. With our current knowledge, history of association with sheep, goats, or with 
alcelaphine antelope remains the only practical means of differentiating one form from the other.  
Vaccination:  Cattle and experimentally infected rabbits recovered from MCF have a solid immunity 
against all strains of MCF virus.  
An effective vaccine is not available for MCF. Some viral strains have undergone limited attenuation after 
serial passage in cell cultures and offer hope for a future modified live virus vaccine. Experimental killed 
virus vaccines have been inconsistent in inducing protection against virulent virus challenge, although 
some have induced significant titers of serum virus neutralizing antibodies  
Control and Eradication:  Cattle should be kept separated from potential reservoir hosts such as sheep, 
goats, and wildebeest — especially during lambing, kidding, or calving seasons, respectively.  
The stocking of cattle ranches with alcelaphine antelope, wild sheep, or goats should be discouraged or 
should require a negative MCF serologic test, preferably by the serum-virus neutralization method, or a 
negative PCR test for any wild ruminants destined for such a facility. Similar testing of such wild 
ruminants before being placed in, or transferred between, zoos is also recommended as a means to prevent 
the introduction of potential carriers of MCF virus.  
Containment of an outbreak usually means the immediate separation of cattle or the susceptible host from 
sheep and goats in the case of the domestic disease and the susceptible host from alcelaphine or wild 
ruminants in the case of alcelaphine MCF.  
Public Health:  There is no evidence that MCF is infectious for humans.  
1.15 Menangle virus16 
Summary:  An outbreak in New South Wales, Australia of a new paramyxovirus (proposed name is 
Menangle virus) associated with reproductive failure in swine has been reported.  
                                                 
16APHIS, USDA, Center for Emerging Issues, November 1998.  Menangle Virus, Australia, Emerging Disease 
Notice.  http://www.aphis.usda.gov/vs/ceah/cei/menangle.htm  
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Fruit bats have been identified as a probable reservoir of infection.  
Serologic evidence and possible clinical signs of infection have been reported in two humans with intense 
occupational exposure to infected pigs.  
Australia is a minor player in the international market for swine and swine products and the proportion of 
all U.S. imports of swine products originating from Australia is less than 0.05%.  
To date, there is no evidence that the outbreak has spread beyond the three associated premises where it 
was originally identified, and therefore, has had little effect on overall swine production in Australia.  
At present, the risk to U.S. swine from this new paramyxovirus appears low. This risk could change 
however, if for example, other reservoirs are identified, new cases are reported in Australia or elsewhere, 
U.S. imports of live swine, swine products or the reservoir species from Australia increase, or research 
into this new virus reveals information that would impact transmission risk.  
Background:  A farrow to weaning swine operation in New South Wales, Australia experienced a 
decrease in the pregnancy rate and average litter size and an increase in the proportion of mummified 
fetuses and stillborn piglets from mid-April to early September 1997. An apparently new virus in the 
family Paramyxoviridae was isolated from brain, lung and heart of stillborn piglets. The virus isolation 
was conducted at the Elizabeth Macarthur Agricultural Institute in Menangle, New South Wales, 
Australia and the proposed name for the new virus is Menangle virus. An assay for neutralizing 
antibodies to the virus was also developed at the Elizabeth Macarthur Agricultural Institute. The infection 
occurred in all four breeding units at a commercial operation with 2,600 sows, and in two associated grow 
to finish operations located several hundred kilometers away from the breeding facility. These associated 
grow to finish operations received batches of pigs at varying intervals from the farrow to weaning 
operation. Porcine sera (n=1,114) from other swine operations throughout Australia were tested for 
antibodies and the results indicate that infection appears to be confined to the affected farrow to weaning 
operation and the two associated grow to finish operations. There are currently no reports of this new 
virus anywhere else in the world. 
As of October 1998, the infection was still circulating in the farrow to weaning operation and in one grow 
to finish operation. Most pigs become infected at 12 to 16 weeks of age, after colostral immunity wanes. 
Among replacement gilts raised on the affected premises, approximately two-thirds are seropositive at 
entry into the breeding herd. Infection is no longer present in the other grow to finish operation. 
Eradication of infection in this operation is thought to be due to herd immunity achieved when no 
shipments of 8 week old pigs were received at the operation for a period of 10 weeks. Eradication plans 
for the other two premises are being developed. Quarantine measures are in effect. Pigs are only allowed 
to move off the affected premises directly to slaughter. All of the affected premises are quite 
geographically isolated from other commercial swine operations. 
The pathologic lesions of affected stillborn piglets included the following: severe degeneration of the 
brain and spinal cord, arthrogryposis (rigid fixation of limbs, usually in flexion), brachygnathia (short 
lower jaw), occasional fibrinous body cavity effusions, pulmonary hypoplasia, and some had 
nonsuppurative myocarditis. No postnatal animals of any age manifested clinical disease, however greater 
than 90% of serum samples collected from pigs of all age categories at the affected operations (n=88) 
contained high titers (¥256) of neutralizing antibodies against the virus. The farrowing rate decreased to 
approximately 40% and litter size was also decreased. 
Workers at the affected swine operations, slaughter workers, and others who had contact with potentially 
infected pigs were tested for antibodies to this new virus. Of 33 workers at the farrow to weaning 
operation, one was seropositive. Five workers were tested from the weaning to finish operations and one 
was seropositive. Another 218 people who had potential exposure to infected pigs (slaughter workers, 
researchers, animal handlers, veterinarians, pathology laboratory workers, others) were tested and all were 
seronegative. The two seropositive swine operation workers had onset of an illness in early June lasting 
10-14 days, characterized by fever, chills, rigors, drenching sweats, malaise, headache and spotty red 
rash. It is suspected that the illness in these two workers was caused by the new virus. One of the 
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seropositive workers had frequent prolonged contact with birthing pigs and the other seropositive worker 
performed autopsies on pigs without wearing gloves or protective eye wear. Seroprevalence was 5.26% 
(2/38) for individuals with high occupational exposure (workers at the swine operations), and if all 
individuals at risk are included, the seroprevalence was 0.78% (2/256). This low prevalence of 
seroconversion seems to indicate that the virus is not highly infectious to humans. 
Investigators hypothesize that a large colony of fruit bats near the infected farrow to weaning operation 
were the source of the infection. Serum samples from fruit bats of several species collected both before 
and after the outbreak, were virus neutralization test positive. However, virus has not been isolated from 
bats. Samples from rodents, birds, cattle, sheep, cats and a dog were all seronegative. 
Characteristics of Paramyxovirus Diseases:  The family Paramyxoviridae includes three genera which 
contain many important viruses of both animals and humans. In the genus Morbillivirus are canine 
distemper virus, rinderpest virus, peste des petits ruminants virus, equine morbillivirus and the human 
measles virus. The genus Paramyxovirus includes Newcastle disease virus, four serotypes of 
parainfluenza viruses (including Sendai virus which affects swine), several serotypes of avian 
paramyxoviruses, and human mumps virus. The third genus, Pneumovirus, includes the respiratory 
syncytial viruses (RSV) of humans and cattle and the pneumonia virus of mice. 
Many paramyxoviruses produce a serious systemic disease (rinderpest, Newcastle disease, canine 
distemper) while others are primarily respiratory (parainfluenza, RSV). Many diseases caused by 
paramyxoviruses have a neurological component (canine distemper, Newcastle disease). Intestinal signs 
are also common. The incubation periods range from 24 hours (parainfluenza 3 in cattle) to 11 days 
(equine morbillivirus). Transmission is generally by direct contact as virus is usually shed in all 
secretions. For some paramyxoviruses transmission can also occur by airborne aerosols and dust particles 
(Newcastle, canine distemper, RSV) and by contaminated feed and water (Newcastle, rinderpest). 
Virus stability varies from stable (Newcastle) to very labile (rinderpest, canine distemper, RSV). 
Morbidity and mortality vary also; parainfluenza viruses are associated with both low morbidity and low 
mortality whereas rinderpest, canine distemper and equine morbillivirus are associated with high 
mortality. A carrier state is present in Newcastle disease with virus shedding for at least four weeks post 
infection. 
The gross pathologic lesions and histopathology described in reports of the Australian outbreak of this 
new virus, are consistent with a neurotropic paramyxovirus. Morbidity in adult sows is extremely low, 
with reproductive failure the primary clinical effect. La Piedad Michoacan Virus (LPMV) or "blue eye 
disease", first isolated in Mexico in 1980, is the only other known paramyxovirus which is associated 
with reproductive failure in pigs.  Newcastle disease virus and equine morbillivirus are other 
paramyxoviruses reported to cause zoonotic illness. 
Probable mode of transmission:  Respiratory transmission was suspected as the mode of spread in pigs 
because of the almost 100% prevalence of virus neutralizing titers in the pig population. Additional 
studies, however, using sentinel pigs in the affected operations, indicate fecal-oral transmission may be 
more likely. Transmission from fruit bats to pigs is also hypothesized to have occurred by the fecal-oral 
route. Fruit bats fly over the farrow to weaning operation buildings when departing their roost at dusk and 
when returning to the roost at dawn. Paths around the buildings which house the pigs are contaminated 
with fruit bat feces and pigs are moved on these paths. 
Lesions in the affected swine fetuses as mentioned above, indicate viremia probably occurs with the virus 
crossing the placenta. Virus may be present therefore, in meat, secretions, and excretions of affected 
animals. Research is needed to determine however, if transmission via meat to animals or humans is 
possible. 
Suspected reservoir and its distribution in the U.S.:  The suspected reservoir for this apparently new 
virus is fruit bats. Serum samples from several species of fruit bat in the family Pteropodidiae were found 
to be positive for the new virus in the virus neutralization test. These species were Pteropus poliocephalus 
(grey-headed flying fox), P. alecto (black fruit bats), and P. conspicillatus (spectacled fruit bats). 
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Pteropodids can be found in tropical and subtropical regions of southern and central Asia, Africa, 
Australia, the Phillipines and other Pacific islands. Fruit bats in Australia have recently been identified as 
the reservoir of two other new viruses, equine morbillivirus and a lyssavirus, which cause disease in 
humans and domestic animals. 
The following species in the vicinity of the affected premises were tested for neutralizing antibodies to 
Menangle virus, and were seronegative: rodents (n=19), birds (n=13), cattle (n=60), sheep (n=70), cats 
(n=25), and dog (n=1). 
Pteropodids are not naturally present in the U.S., though they may be imported and exist in U.S. zoos, 
private collections, or research facilities. The U.S. Fish and Wildlife Service maintains data files on 
wildlife imports in LEMIS (Law Enforcement Management Information System). The LEMIS system 
includes only a portion of total wildlife imports. Other imports are recorded in a U.S. Customs database 
which CEI did not have access to. According to the LEMIS database, there were no imports of the three 
bat species which tested positive for the new virus (Pteropus poliocephalus, Pteropus alecto or Pteropus 
conspicillatus ), into the U.S. during 1995, 1996 or 1997. There was however, a shipment in 1995 of 65 
live bats of the Pteropus genus, of unidentified species, imported into the U.S. from Jamaica. During 
1995, 1996 and 1997 there were 4,250 live bats, of genera other than Pteropus, imported into the U.S. 
from Canada, the Solomon Islands and Jamaica. 
CEI’s interpretation(s):  At present, the risk to the U.S. from this apparently new paramyxovirus appears 
low. The U.S. imported a small number of live swine from Australia in 1997 and 1998. Imports of swine 
meat and products from Australia to the U.S. are minimal. The outbreak was limited to three premises and 
does not appear to have spread. The suspected animal reservoir does not occur naturally in the U.S. 
The risk to the U.S. could change, however. The following circumstances would warrant a reevaluation of 
risk: other reservoirs are identified, new cases are reported in Australia or elsewhere, U.S. imports of live 
swine, swine products or the reservoir species from Australia increase, or research into this new virus 
reveals information that would impact transmission risk. 
Though at present the risk of introduction to the U.S. of this new virus appears low, should introduction 
occur, the impact on the U.S. pork industry is potentially great. 
1.16 Mycoplasma capricolum/M. F38/M. mycoides capri17 
Contagious Caprine Pleuropneumonia  
Definition:  Contagious caprine pleuropneumonia (CCPP) is an acute highly contagious disease of goats 
caused by a mycoplasma and characterized by fever, coughing, severe respiratory distress, and high 
mortality. The principal lesion at necropsy is fibrinous pleuropneumonia.  
Etiology:  For many years the causative agent of CCPP was considered to be M. mycoides capri (type 
strain PG-3) because this was the agent most commonly isolated from goats with CCPP. In 1976, 
however, MacOwan and Minette reported isolating a new mycoplasma (designated F-38) from a CCPP 
outbreak in Kenya and demonstrated it to be the cause of a highly contagious form of pneumonia 
resembling the original description of CCPP by Hutcheon in 1881. McMartin et al. presented very 
convincing arguments supporting this agent as the cause of the classical disease, at least in Africa. Both of 
these mycoplasmas are now considered to cause CCPP, although the infrequency with which M. mycoides 
capri has been isolated from CCPP in recent years suggests that it may be a minor cause of the disease. 
Neither of these agents occurs in North America. The name M. capricolum capripneumoniae proposed for 
mycoplasma F-38 by Leach et al. is not in common usage. Mycoplasma mycoides capri is easily 
                                                 
17Committee on Foreign Animal Diseases of the United States Animal Health Association, revised 1998.  Foreign 
Animal Diseases, “The Gray Book,” Part IV, Library of Congress Catalog Card Number 17-12842, Pat Campbell 
& Associates and Carter Printing Company, Richmond, VA.  
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propagated on standard mycoplasma media, but F-38 is much more fastidious and can easily be missed at 
diagnosis, which may explain its late recognition as the major cause of CCPP.  
M. mycoides mycoides has also been isolated from goats with pneumonia. This agent (the so-called large 
colony or LC variant of M. mycoides mycoides) usually produces septicemia, polyarthritis, mastitis, 
encephalitis, conjunctivitis, hepatitis, or pneumonia in goats. Some strains of this agent will cause 
pneumonia closely resembling CCPP, but the agent is not highly contagious and is not considered to 
cause CCPP. It does occur in North America. M. capricolum capricolum, a goat pathogen commonly 
associated with mastitis and polyarthritis in goats, can also produce pneumonia resembling CCPP, but it 
usually causes severe septicemia and polyarthritis. This agent (which does occur in the United States) is 
closely related to mycoplasma F-38 but can be differentiated from it using monoclonal antibodies.  
Host Range:  Contagious caprine pleuropneumonia is a disease of goats, and where the classical disease 
has been described, only goats were involved in spite of the presence of sheep and cattle. Mycoplasma F-
38, the probable cause of the classic disease, does not cause disease in sheep or cattle.  
M. mycoides capri, the other agent considered a cause of CCPP, will result in a fatal disease in 
experimentally inoculated sheep and can spread from goats to sheep. It is however, not recognized as a 
cause of natural disease in sheep.  
Geographic Distribution:  Contagious caprine pleuropneumonia has been described in many countries of 
Africa, the Middle East, Eastern Europe, the former Soviet Union, and the Far East. It is a major scourge 
in many of the most important goat-producing countries in the world and is considered by many to be the 
world's most devastating goat disease.  
The classical disease, as caused by mycoplasma F-38, has not been described in North America. The 
reports of CCPP occurring in the United States and in Mexico were erroneous in that, although similar 
syndromes were described, the agents isolated were misidentified as M. mycoides capri and were 
subsequently shown to be M. mycoides mycoides (LC type). Neither mycoplasma F-38 nor M. mycoides 
capri has been isolated in North America  
Transmission:  Contagious caprine pleuropneumonia is transmitted by direct contact through inhalation 
of infective aerosols. Of the two known causative agents, F-38 is far more contagious. Outbreaks of the 
disease often occur after heavy rains (e.g., after the monsoons in India) and after cold spells. This is 
probably because recovered carrier animals start shedding the mycoplasmas after the stress of sudden 
climatic change. It is believed that a long-term carrier state may exist.  
Incubation Period:  The incubation period can be as short as 6 to 10 days but may be very prolonged (3-4 
weeks) under natural conditions  
Clinical Signs:  The clinical signs described for CCPP from different parts of the world have varied 
enormously. This is not surprising because at least two different mycoplasmas have been regarded as 
causative agents of the disease. In many field outbreaks, the clinical picture has probably been further 
complicated by the presence of viruses and other bacteria (e.g., pasteurella) as part of the etiologic 
picture.  
The classical disease as caused by mycoplasma F-38 is a purely respiratory illness. It is characterized by a 
fever- of 106o F (41o C), coughing, and a distinct loss of vigor. Affected goats have labored breathing; 
later they may grunt or bleat in obvious pain. Frothy nasal discharges and stringy salivation are often seen 
shortly before death. In the acute disease, which occurs in fully susceptible populations of goats, death 
occurs within 7 to 10 days of the onset of clinical signs. A more chronic form of the disease is often seen 
in endemic areas and may lead to recovery of a higher percentage of infected animals, many of them 
carriers of the mycoplasmas.  
M. mycoides capri tends to cause a more generalized infection in which septicemia is frequently seen. An 
acute or peracute septicemic form of the disease involving the reproductive, respiratory and alimentary 
tracts has been described. In addition, thoracic and reproductive formes of the disease have been 
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attributed to this agent. The disease is considerably less contagious than F-38-induced disease, and the 
mortality and morbidity rates are also lower.  
Gross Lesions:  The gross lesions in classical CCPP are confined to the thoracic cavity. Pea-sized 
yellowish nodules are seen in the lungs in early cases, whereas in more established cases there is marked 
congestion around the nodules. The lesions may be confined to one lung or involve both, and an entire 
lobe may become solidified. The pulmonary pleura becomes thickened, and there may be adhesions to the 
chest wall. Hutcheon emphasized that the lesions of CCPP do not resemble those of contagious bovine 
pleuropneumonia (CBPP) in that "no thickening of the interlobular tissue" occurrs, a classical lesion of 
CBPP. He described a CCPP-diseased lung as resembling a "somewhat granular looking liver", which is 
his description of the massive hepatization seen in CCPP lungs.  
In sharp contrast, M. mycoides capri has been reported to cause lesions in a wide variety of organ systems 
and to produce lung lesions closely resembling those seen in CBPP. The generalized lesions described 
include encephalitis, meningitis, lymphadenitis, splenitis, genitourinary tract inflammations, and intestinal 
lesions, none of which are a feature of classical CCPP. The lung lesions, which resemble those seen in 
CBPP, are usually confined to one lung and reflect various stages of fibrinous pneumonia. Extensive 
pleuritis is usually present, and various stages of hepatization and marked dilation of interlobular septa is 
commonly seen. The cardiac and diaphragmatic lobes are the ones most commonly involved. Some 
describe this as a mild form of CCPP; others argue that it is not CCPP.  
Morbidity and Mortality:  Morbidity can be 100 percent and mortality may be in the range of 70 percent 
to 100 percent. Gathering or increased confinement of animals facilitates the spread of the disease.  
Diagnosis  
Field Diagnosis  
A highly contagious disease occurring in goats and characterized by severe respiratory distress, high 
mortality, and postmortem lesions of fibrinous pleuropneumonia with pronounced hepatization and 
pleural adhesions warrants a field diagnosis of CCPP.  
Specimens for Laboratory  
From a dead animal that has had severe clinical disease, the best specimens to submit are affected lung, 
swabs of major bronchi, and tracheobronchial or mediastinal lymph nodes. All samples should be 
collected aseptically and if possible, placed in transport medium (heart infusion broth, 20 percent serum, 
10 percent yeast extract, benzylpenicillin at 250 to 1000 IU/ ml). Samples should be kept cool and 
shipped on wet ice as soon as possible. If transport to the laboratory is delayed (more than a few days), 
samples may be frozen. Blood should be collected for serum.  
Laboratory Diagnosis  
Diagnosis must be confirmed by isolation of the agent (F-38). The causative agent, once isolated, can be 
identified by immunofluorescence or by growth or metabolic inhibition tests. Several serological tests can 
be used in the laboratory for the detection of antibodies to mycoplasma F-38. These include complement 
fixation (CF), passive hemagglutination (PH), and enzyme-inked immunosorbent assay (ELISA). The 
latex agglutination test is a very convenient field test for detecting antibodies in whole blood or in serum.  
Differential Diagnosis  
Clinically, CCPP may be confused with other pneumonic conditions such as pasteurellosis and peste des 
petits ruminants.  
Treatment:  The mycoplasmas are sensitive to several broad-spectrum antibiotics (notably the 
tetracyclines, tylosin, and tiamulin). Although early treatment can be effective, chemotherapy and 
chemoprophylaxis have not played important roles in CCPP control programs.  
Vaccination:  A crude vaccine prepared from goat lung was used to vaccinate goats in South Africa after 
the original outbreak of CCPP in the late 1800's. A combination of this vaccine and other control methods 
eliminated the disease from the country.  
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Vaccines to M. mycoides capri have been used with little success. This is probably because the disease is 
usually caused by mycoplasma F-38, first recognized in 1976. Since that time both live attenuated and 
inactivated F-38 vaccines have been tested with varying degrees of success. The most promising of the 
experimental vaccines is the lyophilized saponin-inactivated F-38 vaccine shown in field tests to confer 
100 percent protection to contact exposure. This vaccine could be of inestimable value in many countries 
of Africa.  
Control and Eradication:  Sufficient regulatory restrictions should be maintained to prevent introduction 
of CCPP into apparently healthy animals. Serologic testing of susceptible animals for importation is a 
recommended safeguard.  
Successful control of the spread of CCPP rests on removing susceptible animals from any possible 
contact with CCPP-infected animals, whether they are clinically affected or subclinical carriers only. On-
farm quarantine of suspicious and contact animals would be very advantageous in stemming the spread of 
the disease. In an outbreak situation, testing, slaughter, and quarantine would be the methods of choice.  
Public Health:  Human infection with these mycoplasmas has not been reported.  
1.17 Mycoplasma mycoides mycoides18 
Contagious Bovine Pleuropneumonia  
Definition:  Contagious bovine pleuropneumonia (CBPP) is a highly infectious acute, subacute, or 
chronic disease, primarily of cattle, affecting the lungs and occasionally the joints, and caused by 
Mycoplasma mycoides mycoides.  
Etiology:  Contagious bovine pleuropneumonia is caused by M. mycoides mycoides small-colony type 
(SC type). M. mycoides mycoides large-colony type is pathogenic for sheep and goats but not for cattle. 
M. mycoides mycoides (SC type) survives well only in vivo and is quickly inactivated when exposed to 
normal external environmental conditions. M. mycoides mycoides does not survive in meat or meat 
products and does not survive outside the animal in nature for more than a few days. Many of the 
routinely used disinfectants will effectively inactivate the organism.  
Host Range:  Contagious bovine pleuropneumonia is predominantly a disease of the genus Bos; both 
bovine and zebu cattle are naturally infected. There are many reported breed differences with respect to 
susceptibility. In general, European breeds tend to be more susceptible than indigenous African breeds. 
There does seem to be some age resistance, for animals less than 3 years of age are less resistant to 
experimental challenge. In zoos the infection has been recorded in bison and yak. Although it has been 
reported that the domestic buffalo (Bubalus bubalis) is susceptible, the disease is difficult to produce 
experimentally in this species.  
Geographic Distribution:  Contagious bovine pleuropneumonia is endemic in most of Africa. It is a 
problem in parts of Asia, especially India and China. Periodically, CBPP occurs in Europe, and outbreaks 
within the last decade have occurred in Spain, Portugal, and Italy. Contagious bovine pleuropneumonia 
was eradicated from the United States in the nineteenth century. It is of historical interest that the Bureau 
of Animal Industries, which is the forerunner of the USDA's Animal and Plant Health Inspection Service, 
was formed in 1884 specifically to eradicate CBPP. The United States was declared free of CBPP only 9 
years later in 1893. Currently, CBPP is not present in the Western hemisphere.  
Transmission:  Contagious bovine pleuropneumonia is spread by inhalation of droplets from an infected, 
coughing animal. Consequently, relatively close contact is required for transmission to occur. Outbreaks 
usually begin as the result of movement of an infected animal into a naive herd. It is widely believed that 
recovered animals harboring infectious organisms within a pulmonary sequestrum, may become active 
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Animal Diseases, “The Gray Book,” Part IV, Library of Congress Catalog Card Number 17-12842, Pat Campbell 
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shedders when stressed. Although this may be a factor in some outbreaks, it has not been substantiated 
experimentally. There are limited anecdotal reports of fomite transmission, but this means of transmission 
is not generally thought to be a problem.  
Incubation Period:  The time from natural exposure to overt signs of disease is variable but generally 
quite long. It has been shown that healthy animals placed in a CBPP-infected herd may begin showing 
signs of disease 20 to 123 days later. Experimentally, subsequent to instillation of large quantities of 
infective material at the tracheal bifurcation, the incubation period is 2 to 3 weeks.  
Clinical Signs:  Usually the first abnormality noticed is a depressed, inappetent animal with fever. 
Coughing may be the next sign followed by evidence of thoracic pain and an increased respiratory rate. 
As pneumonia progresses and animals become increasingly dyspneic, animals are inclined to stand with 
elbows abducted in an attempt to decrease thoracic pain and increase chest capacity. Auscultation of the 
lungs reveals any of a wide variety of sounds, depending on how severely the subjacent pulmonary 
parenchyma is affected.  
Crepitations, rales, and pleuritic friction rubs are all possible. Percussion over affected areas reveals 
dullness. When pulmonary involvement is extensive and severe, there will be very labored respiration 
and, sometimes, open-mouthed breathing. Occasionally in calves, pneumonia may be accompanied by a 
polyarthritis. Animals affected in this manner may be very reluctant to move and stand stiffly with a 
distinctly arched back. Getting up and down may cause obvious discomfort. Large joints may be 
distended and warm on palpation. If joint pain is severe, animals may be so reluctant to bend the joints 
that they lie in lateral recumbency with legs outstretched. Contagious bovine pleuropneumonia often 
evolves into a chronic disease. This form, characterized by ill thrift and recurrent low-grade fever, may be 
difficult to recognize as pneumonia. Forced exercise may precipitate coughing.  
Gross Lesions:  The gross pathologic features of CBPP are quite characteristic. If the animal dies, there is 
usually extensive and marked inflammation of the lung and associated pleurae. In severe cases there can 
be abundant fluid in the thoracic cavity. The inflammation is not uncommonly unilateral. The initial focus 
can be in any part of the lung and, in fatal cases, usually has spread locally and extensively to include a 
sizable segment. The affected pulmonary parenchyma is odorless and often has all stages of lesions with 
both acute and chronic inflammatory changes adjacent to one another. The predominant gross change is 
consolidation, or thickening, of individual lobules, which become encased in markedly widened 
interlobular septa, resulting in the very characteristic marbled appearance. Interlobular septa become 
distended first by edema, then by fibrin, and finally by fibrosis. The overlying pleura may be very 
thickened by an irregular layering of yellow fibrin which, with time, becomes fibrosed, often resulting in 
adhesions between parietal and visceral pleurae. Not uncommonly, within an affected lung will be found 
a sequestrum - a focus that has undergone coagulative necrosis and is effectively sealed off from the rest 
of the lung. Such sequestra may even be found in recovered animals. It has been shown that M. mycoides 
mycoides (SC-type) can survive within these sequestra for months or possibly longer.  
Morbidity and Mortality:  The attack rate with CBPP is variable. It is not thought to be a highly 
contagious disease. With increased confinement of animals, morbidity rises. The mortality rate with 
CBPP is quite varied and ranges from 10 to 70 percent in various outbreaks. As with many subacute and 
chronic infectious diseases, mortality may depend on other intercurrent factors such as plane of nutrition, 
level of parasitism, and general body condition  
Diagnosis  
Field Diagnosis  
Clinical diagnosis of CBPP is difficult. At postmortem the gross lesions of CBPP are somewhat distinct. 
Often there is an extensive deposition of fibrin and a large quantity of straw-colored fluid in the thoracic 
cavity with a prominent marbling of pulmonary parenchyma. Generally, all stages of pathologic changes, 
from acute through to chronic, are present in one animal. In some chronic cases the nodules of 
inflammation may not be readily apparent from the pleural surface but can be palpated within the 
parenchyma. Unlike many other pneumonias, CBPP is often unilateral.  
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Specimens for Laboratory  
From a live animal, nasal swabs, transtracheal washes, or pleural fluid obtained by thoracic puncture all 
provide good samples for isolation attempts. From a dead animal that has had severe clinical disease, the 
best specimens to submit are affected lung, swabs of major bronchi, tracheo-bronchial or mediastinal 
lymph nodes, and joint fluid from those animals with arthritis. All samples should be collected aseptically 
and, if possible, placed in transport medium (heart infusion broth, 20 percent serum, 10 percent yeast 
extract, benzylpenicillin at 250 to 1000 IU/ml). Samples should be kept cool and shipped on wet ice as 
soon as possible. If transport to the laboratory is delayed (more than a few days), samples may be frozen. 
Blood should be collected for serum.  
Laboratory Diagnosis  
A definitive diagnosis is made by isolating and identifying the organism. Serology is helpful in the 
diagnosis of CBPP. Because CBPP is a subacute to chronic disease, most animals will have developed 
antibodies by the time of clinical disease.  
Differential Diagnosis  
Clinically, CBPP may be confused with other pneumonic conditions, most especially bovine 
pasteurellosis. However, bovine pasteurellosis would likely spread much more rapidly and consequently 
the epidemiologic picture may be distinct.  
Treatment:  Mycoplasma mycoides mycoides (SC-type) is susceptible to a variety of antimicrobials, 
including streptomycin, oxytetracycline, and chloramphenicol. However, antimicrobial therapy may only 
serve to slow the progression of the disease or may even in some cases favor the formation of sequestra. 
In the case of chronically affected animals or subclinically affected carriers, the organisms may be in an 
inaccessible location within an area of coagulative necrosis, which by definition is not served by a blood 
supply.  
Vaccination: A modified live vaccine is available for use in enzootic areas. A major drawback of this 
vaccine is that it generates an unpredictable local reaction. For this reason it is often given in the tail tip, 
which may become necrotic and slough. Immunity subsequent to vaccination is generally good and lasts 
at least 12 months. The CBPP vaccine is often given in combination with the vaccine for rinderpest.  
Control and Eradication 
Prevention  
Because CBPP is a chronic disease that may exist subclinically in carrier animals, it is important to 
maintain sufficient regulatory restrictions to prevent its introduction in apparently healthy animals. 
Serologic testing of susceptible animals for importation is a recommended safeguard.  
Control and Eradication  
Successful control of the spread of CBPP rests on removing susceptible animals from any possible 
contact with CBPP-infected animals, whether they are clinically affected or subclinical carriers only. On-
farm quarantine of suspicious and contact animals would be very advantageous in stemming the spread of 
the disease. In an outbreak situation, testing, slaughter, and quarantine would be the methods of choice.  
Public Health:  There is no evidence to indicate that humans are susceptible to this disease.  
1.18 Newcastle disease virus19 
Velogenic Newcastle Disease 
(Exotic Newcastle disease, Asiatic Newcastle disease)  
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Definition:  Velogenic Newcastle disease (VND) is the most severe form of Newcastle disease and is 
likely the most serious disease of poultry throughout the world. In chickens it is characterized by lesions 
in the brain or gastrointestinal tract, morbidity rates near 100 percent, and mortality rates as high as 90 
percent in susceptible chickens. Neurologic signs or severe depression are the most obvious clinical sign, 
and some nonvaccinated birds may be found dead with no detected sign of prior illness.  
Etiology:  Newcastle disease viruses (NDV's) occur as three pathotypes: lentogenic, mesogenic, and 
velogenic, reflecting increasing levels of virulence. The most virulent (velogenic) isolates are further 
subdivided into neurotropic and viscerotropic types. The velogenic isolates are considered exotic to the 
United States, and the disease caused by these VND isolates is the subject of this chapter.  
The Newcastle disease viruses belong to the Paramyxoviridae virus family and, like other members of 
this group, possess two surface proteins that are important to the identification and behavior of the virus. 
The first, hemagglutinin/neuraminidase (HN) is important in the attachment and release of the virus from 
the host cells in addition to its serologic identification. The other very important surface protein is the 
fusion (F) protein, which has a critical role in the pathogenesis of the disease. There are at least nine 
known types of avian paramyxoviruses based on the antigenic makeup of the hemagglutinin. NDV is the 
prototype virus for Type 1 avian paramyxoviruses.  
Host Range:  Inapparently infected carriers that are the most likely source for introduction of VND 
include numerous species of exotic pet and exposition birds, waterfowl, and domestic poultry. A 
persistent carrier state has been demonstrated in psittacine and in certain other wild birds whereas virus 
can be recovered from chickens for shorter periods of time, usually 14 days or less.  
Geographic Distribution:  Velogenic Newcastle disease is endemic in many countries of Asia, the 
Middle East, Africa, and Central and South America. Some European countries are considered free of 
VND. VND has caused high mortality in wild cormorants in Canada and the United States.  
Transmission:  In many parts of the tropics VND is recurrent in the poultry populations. One possibility 
is that they are infected from a wild bird reservoir. Additional studies will be required before it can be 
established which species, if any, are true carriers and which are only transiently infected. It is not known 
whether the occurrence of VND in wild birds moving in international trade can be reduced by avoiding 
the capture of certain species or their collection at certain time periods or places. Once introduced into 
poultry, the virus spreads farm-to-farm by the movement of inapparently infected poultry species; on 
contaminated objects such as boots, sacks, egg trays, and crates; or by flies or mice. Reports from 
England that the virus can be wind-borne under certain conditions should be considered even though there 
was no evidence of airborne transmission between premises with the virus that caused the 1971 outbreak 
in California. Free-flying wild birds apparently had no role in the spread of VND during that outbreak.  
Incubation Period:  The incubation period for Newcastle disease after natural exposure varies from 2 to 
15 days. For VND in chickens, an incubation period of 2 to 6 days is common. The incubation period in 
other species of birds may be longer.  
Clinical Signs:  Velogenic Newcastle disease is a devastating malady in unvaccinated chickens of any 
age. The first sign in laying chickens is usually a marked drop in egg production followed within 24 to 43 
hours by high death losses. At the onset, 10-15 percent of a flock may be lost in 24 hours. After 7 to 10 
days, deaths usually subside, and birds surviving 12 to 14 days generally do not die but may display 
permanent paralysis and other neurologic signs. The reproductive system may be permanently impaired, 
and thus egg production does not return to previous levels. In vaccinated chickens, or chicks protected by 
parental antibodies, the clinical signs are less severe and are proportional to the level of protective 
antibodies.  
With viscerotropic strains (VVND), edema of the head, especially around the eyes may become apparent 
after birds have been sick for 2 or 3 days. This edema usually does not involve the comb and wattle to the 
extent of highly pathogenic avian influenza (HPAI). A dark ring sometimes forms around the eye, 
probably due to cyanosis and poor blood circulation in the edematous tissue. This "black eye" appearance 
is especially visible in white chickens.  
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Bile-stained, greenish-dark diarrhea may be noted 2 to 3 days after onset of illness. Some birds in an 
affected flock usually have diarrhea throughout the course of the disease.  
The most noteworthy clinical sign in unvaccinated flocks is sudden death without prior indications of 
illness. The peracute onset often causes the owner to suspect poisoning.  
Respiratory distress and signs of neurological disturbances, such as drooping wings, torticollis, and 
ataxia. may not be as marked as they are with the neurotropic forms of the disease. However, these 
neurologic signs are frequently observed in chickens that survive infection with the viscerotopic strains 
for 2 or 3 weeks. Because of lack of experience with viscerotropic strains, poultry owners throughout the 
United States and Canada may not consider Newcastle disease as a possible diagnosis unless they see the 
neurologic signs they have seen with the domestic neurotropic viruses.  
Neurotropic strains cause respiratory signs soon followed by neurologic signs, including muscular 
tremors, paralysis of legs or wings, torticollis, and opisthotonos. There is a marked decline in egg 
production but ususally no diarrhea. Disease signs may differ markedly, depending on the host species. 
Psittacines or pigeons infected with the viscerotropic strains of virus may display neurologic signs typical 
of the disease caused by the strains of neurotropic ND in chickens. These same viscerotropic viruses may 
cause typical signs and lesions of VVND when inoculated into chickens. In some species, such as finches 
and canaries, clinical disease may not be observed.  
Gross Lesions:  No gross lesion may be observed in many of the first birds dying in a commercial poultry 
operation. Peracute deaths are generally due to collapse or dysfunction of the reticuloendothelial system 
before discernible gross lesions have developed. There is no pathognomonic gross lesion for VVND, but, 
generally, sufficient lesions can be found to make a tentative diagnosis if enough birds are examined. 
Because of the marked similarities between the gross lesions of VVND and higly pathogenic avian 
influenza, a final diagnosis in the first flocks must await virus isolation and identification. In a continuing 
outbreak where numerous flocks are involved, gross observations may eventually be all that is necessary 
when typical lesions are present.  
Edema of the interstitial tissue of the neck, especially near the thoracic inlet, may be marked. After the 
trachea and esophagus are exposed during necropsy examination, straw colored fluid may drip from these 
tissues. Congestion and occasionally hemorrhage may be seen in the trachea generally corresponding to 
the rings of cartilage.  
Proventriculus  
Petechial and small ecchymotic hemorrhages may be present on the mucosa of the proventriculus. These 
small hemorrhagic foci tend to be found near the base of the papillae and concentrated around the 
posterior and anterior orifices.  
Intestine  
Peyer's patches, cecal tonsils, and other focal aggregations of lymphoid tissue in the gut wall usually are 
markedly involved and are responsible for the term viscerotropic applied to this form of Newcastle 
disease. These areas progressively become edematous, hemorrhagic, necrotic, and ulcerative. In chickens 
that have died from VVND, these involved lymphoid areas can often be observed without opening the 
gut.  
Reproductive System  
Ovaries may be edematous, hemorrhagic, or degenerated. Yolk peritonitis can frequently be observed in 
layers as a result of VVND, and rough, misshapen eggs are frequently laid by recovering hens.  
Neurotropic strains of VND may cause few gross lesions other than in the trachea and lungs. There will 
be no gross lesion in the brain of diseased birds. Gross lesion patterns usually differ markedly between the 
disease caused by the viscerotropic and neurotropic velogenic viruses.  
Morbidity and Mortality:  Clinical VND is most severe in chickens, peafowl, guineas, pheasant, quail and 
pigeons. Turkeys may develop a milder form of the disease. Severity of disease in psittacine and passerine 
birds is variable. In susceptible chickens, the morbidity and mortality rates can be as high as 100 percent 
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and 90 percent, respectively. In some species such as finches and canaries, clinical disease may not be 
observed.  
Diagnosis  
Field Diagnosis  
A tentative diagnosis of VND may be made on the basis of history, clinical signs, and gross lesions, but 
because of similarities to other diseases such as fowl cholera and highly pathogenic avian influenza, 
confirmation requires virus isolation and identification.  
Specimens for Laboratory  
Virus can readily be recovered from sick or recently dead birds. Swabs are the most convenient way to 
transfer VND virus from tissues or secretions of the suspect bird to brain and heart infusion broth or other 
cell culture maintenance medium containing high levels of antibiotics. Trachea, lung, spleen, cloaca, and 
brain should be sampled. Swabs should be inserted deeply to ensure obtaining ample epithelial tissue. If 
large numbers of dead or live birds are to be sampled, cloacal swabs from up to five birds can be pooled 
in the same tube of broth. An alternate technique is to place 0.5 cm3 of each tissue into the broth. If the 
specimens can be delivered to a laboratory within 24 hours, they should be placed on ice. If delivery will 
take longer, quick-freeze the specimens and do not allow them to thaw during transit.  
Laboratory Diagnosis  
In the laboratory, virus isolation is attempted by inoculating 9- to 11-day-old embryonating chicken eggs. 
Chorioallantoic fluid (CAF) is collected from all embryos dying after 24 hours postinoculation and tested 
for hemagglutination (HA) activity. If positive, the hemagglutination-inhibition (Hl) test is used with 
known NDV-positive serum to confirm the presence of NDV in the CAF. If NDV is found, it is 
characterized by inoculating 4- to 6-week-old chickens free of ND antibodies with the suspect CAF by 
swabbing the cloaca, instilling into the nares or conjuctival sac, or injecting into the thoracic air sac. If 
VVND virus is present, the inoculated chicks usually die in 3 to 7 days, revealing typical visceral lesions 
on postmortem examination. Neurotroph ic VVD viruses will cause severe neurologic and respiratory 
signs in inoculated chickens but no visceral lesions. If no bird dies in 10 days, the NDV is not considered 
to be the velogenic, viscerotropic type but is either a lentogen or mesogen.  
Differential Diagnosis  
The viscerotropic, velogenic Newcastle disease in poultry can be confused with highly pathogenic avian 
influenza, infectious laryngotracheitis, fowl cholera, and coryza.  
Vaccination: Vaccination with viable or inactivated oil emulsion vaccines, or both, can markedly reduce 
the losses from VND in poultry flocks. If eradication of the virus is not the goal of the control program, 
vaccines can be used to lessen the impact of the disease. Their use, however, can make the complete 
eradication of the virus much more problematic by increasing the difficulty of identifying infected flocks. 
There is little doubt, however, that vaccination makes the flock more refractive to infection when exposed 
and reduces the quantity of virus shed by infected flocks.  
Control and Eradication:  Before 1972, VND was introduced into the United States on several occasions 
by unrestricted introduction of exotic pet birds, especially psittacine birds. Because pet birds are not 
usually associated with domestic poultry, VND outbreaks were rare. Since 1973, restrictions on the 
importation of exotic birds requiring the quarantining and testing of imported birds in approved 
quarantine facilities have reduced but not eliminated the threat of VND in the United States. Illegally 
imported exotic bird species remain the source of frequent outbreaks of VND in private or commercial 
aviaries.  
The establishment of a strict quarantine and destruction of all infected and exposed birds with financial 
indemnification for losses followed by thorough cleaning and disinfection of premises were the main 
features necessary for eradication of VND virus from the poultry producing area of southern California. 
Flocks may be safely and humanely destroyed using carbon dioxide in air-tight chambers and the 
carcasses disposed of by burying, composting, or rendering, depending upon the geographic area and the 
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numbers involved. The VND virus has been recovered from effluent water for as long as 21 days and 
from carcasses for 7 days when the daytime temperatures were over 90 degrees F. It is recommended that 
premises be kept free of domestic poultry for an additional 30 days after cleaning and disinfection are 
completed.  
Insects and mice associated with the poultry should be destroyed before depopulation of a flock begins. 
Usually 48 hours is sufficient to control these vectors. As soon as all birds are killed and the manure and 
feed removed, all equipment and structural surfaces should be thoroughly cleaned using high-pressure 
spray equipment. The entire premises should then be sprayed with an approved residual disinfectant such 
as the cresylics or phenolics. Preliminary disinfection will probably inactivate most of the viruses on the 
surface of floors, equipment, cages, etc., but no disinfectant is effective unless it is applied to 
scrupulously cleaned surfaces free of all organic material.  
Cleaning and disinfecting commercial poultry premises are time-consuming and expensive operations. All 
manure must be removed down to a bare concrete floor. If the floor is earthen, at least the top inch of soil 
should be removed with the manure. Manure can be safely disposed of by burying it at least 5 feet deep or 
by composting. If composting is used, the manure piles should be tightly covered with black polyethylene 
sheets in a manner to prevent access by birds, insects, and rodents during composting. These piles of 
manure should remain tightly covered and undisturbed at least 90 days during warm weather and for 
longer periods during cold weather. Recent studies indicate that proper composting can decompose 
carcasses and manure, and thus inactivate viruses in only a few weeks.  
Feathers, usually numerous around commercial poultry premises, can be burned outside the buildings, and 
in some cases inside, with the careful use of a flame thrower, or they can be removed and the area wet 
down with disinfectant. The hot sun and high daytime temperatures will assist in destroying the virus in 
the area of the houses. Extremely cold temperatures will make the cleaning and decontamination process 
much more difficult, and the results more uncertain.  
In 1997, because neither the neurotropic or viscertropic strain of velogenic Newcastle disease was known 
to exist in the United States, USDA-APHIS declared both types to be exotic and therefore 
indistinguishable as to the response of disease control officials should they occur in the United States.  
Surveillance  
The most difficult part of the VND eradication program is locating inapparently infected and exposed 
birds.  
Repeated vaccination at 30 to 50 day intervals protects most chickens against clinical manifestation of 
VND. However, vaccine does not prevent all chickens in a flock from becoming infected, showing no 
disease sign, or shedding virulent virus. As individual chickens become susceptible and get exposed to the 
virus, they become infected and also shed the virus for a time. Thus, the virulent virus continues to be 
present in apparently healthy, vaccinated flocks. The advantages of using vaccines as part of a VND 
eradication program must be weighed against the difficulty created in finding asymptomatic but infected 
and virus-shedding flocks. In such instances owners should be encouraged to observe strict biosecurity 
measures to reduce the chances of their flocks being exposed to VND virus.  
Infected carriers in vaccinated flocks can be detected using one of two systems. In the first, all birds dying 
during a 24-hour period are collected twice a week, and cloacal swabs and brains are collected and 
cultured for the presence of VND virus using the diagnostic sampling procedures described earlier. Birds 
in VND-infected flocks that die from Marek's disease, leukosis, gout, and numerous other disease 
conditions may yield VND virus—especially if their immune system was impaired by those diseases 
before death. In the second virus detection system, susceptible sentinel birds are placed in vaccinated 
flocks. The sentinel birds must be unvaccinated and obtained from a specific pathogen-free source to be 
certain that they do not inadvertently serve as a source of diseases for the suspect flock. In most instances 
the sentinel birds die from VND within a week or so after placement if there is VND virus present in the 
flock; however, in some cases it is sometimes difficult to place sentinel birds so they are adequately 
exposed to any VND virus that may be in the flock — especially in caged-layer flocks.  
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Public Health:  Although people may become infected with VND virus, the resulting disease is typically 
limited to a conjunctivitis. Recovery is usually rapid, and the virus is no longer present in eye fluids after 
4 to 7 days. Infections have occurred mostly in laboratory workers and vaccinating crews with rare cases 
in poultry handlers. No instance of transmission to humans through handling or consuming of poultry 
products is known. Individuals with conjunctivitis from VND virus should not enter poultry premises or 
come in contact with live avian species.  
1.19 Peste des petits ruminants virus20 
(Pest of Small Ruminants, stomatitis-pneumoenteritis complex or syndrome pseudorinderpest of small 
ruminants and kata [Pidgin English for catarrh])  
Definition:  Peste des petits ruminants (PPR) is an acute or subacute viral disease of goats and sheep 
characterized by fever, erosive stomatitis, conjunctivitis, gastroenteritis, and pneumonia. Goats are 
usually more severely affected than sheep.  
Etiology:  Peste des petits ruminants is caused by a paramyxovirus of the Morbillivirus genus. Other 
members of the genus include rinderpest virus (RPV), measles virus (MV), canine distemper virus 
(CDV), and phocid distemper virus (PDV) of sea mammals (seals). For many years, PPR virus was 
considered a variant of RPV, specifically adapted for goats and sheep, that had lost its virulence for cattle. 
It is now known that the two viruses are distinct though closely related antigenically.  
Host Range:  Peste des petits ruminants is primarily a disease of goats and sheep. However, there is one 
report of naturally occurring PPR in captive wild ungulates from three families: Gazellinae (dorcas 
gazelle), Caprinae (Nubian ibex and Laristan sheep), and Hippotraginae (gemsbok). Experimentally, the 
American white-tailed deer (Odocoileus virginianus) is fully susceptible. The role of wildlife on the 
epizootiology of PPR in Africa remains to be investigated. Cattle and pigs are susceptible to infection 
with PPRV, but they do not exhibit clinical signs. Such subclinical infections result in seroconversion, 
and cattle are protected from challenge with virulent RPV. Cattle and pigs do not, however, play a role in 
the epizootidogy of PPR because they are apparently unable to transmit the disease to other animals. 
Geographic Distribution:  Presently, PPR occurs in most African countries situated in a wide belt 
between the Sahara and Equator, the Middle East (Arabian Peninsula, Israel, Syria, Iraq, Jordan), and the 
Indian subcontinent.  
Transmission:  Peste des petits ruminants is not very contagious and transmission requires close contact. 
Ocular, nasal, and oral secretions and feces are the sources of virus. Contact infection occurs mainly 
through inhalation of aerosols produced by sneezing and coughing. Fomites such as bedding may also 
contribute to the onset of an outbreak. As in rinderpest (RP), there is no known carrier state. Infected 
animals may transmit the disease during the incubation period.  
Incubation Period:  Peste des petits ruminants has an incubation period of 4 to 5 days.  
Clinical Signs:  The disease usually appears in the acute form, with an incubation period of 4 to 5 days 
followed by a sudden rise in body temperature to 104-106° F (40-41° C). The temperature usually 
remains high for about 5 to 8 days before slowly returning to normal preceeding recovery or dropping 
below normal before death. Affected animals appear ill and restless and have a dull coat, dry muzzle, and 
depressed appetite. Accompanying these nonspecific signs are a series of changes that make up a highly 
characteristic syndrome. From the onset of fever, most animals have a serous nasal discharge, which 
progressively becomes mucopurulent. The discharge may remain slight or may progress, resulting in a 
profuse catarrhal exudate, which crusts over and occludes the nostrils. At this stage, animals have 
respiratory distress, and there is much sneezing in an attempt to clear the nose. Small areas of necrosis 
                                                 
20Committee on Foreign Animal Diseases of the United States Animal Health Association, revised 1998.  Foreign 
Animal Diseases, “The Gray Book,” Part IV, Library of Congress Catalog Card Number 17-12842, Pat Campbell 
& Associates and Carter Printing Company, Richmond, VA.  
http://www.vet.uga.edu/vpp/gray_book/FAD/PDP.htm  
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may be seen on the visible nasal mucous membranes. The conjunctiva usually becomes congested, and 
the medial canthus may have some crusting. As with the nose, there may be profuse catarrhal 
conjunctivitis resulting in matting of the eyelids.  
Necrotic stomatitis is common. It starts as small, roughened, red, superficial necrotic foci on the gum 
below the incisor teeth. These areas may resolve within 48 hours or progressively increase to involve the 
dental pad, the hard palate, cheeks and their papillae, and the dorsum of the anterior part of the tongue. 
Necrosis may result in shallow irregular nonhemorrhagic erosions in the affected areas of the mouth and 
deep fissures on the tongue. Necrotic debris may collect at the oral commissures, and scabs may form 
along the mucocutaneous junction of the lips. There may be excessive salivation but not to the extent of 
drooling.  
At the height of development of oral lesions, most animals manifest severe diarrhea, often profuse but not 
hemorrhagic. As it progresses, there is severe dehydration, emaciation, and dyspnea followed by 
hypothermia, and death usually occurs after a course of 5 to 10 days. Bronchopneumonia, evidenced by 
coughing, is a common feature in the later stages of PPR. Pregnant animals may abort.  
Secondary latent infections may be activated and complicate the clinical picture.  
Gross Lesions:  The pathology caused by PPR is dominated by inflammatory and necrotic lesions in the 
mouth and the gastrointestinal tract. Unlike RP, there is also a definite, albeit inconstant, respiratory 
system component; hence, the synonym stomatitis-pneumoenteritis complex.  
Emaciation, conjunctivitis, erosive stomatitis involving the inside of the lower lip and adjacent gum, 
cheeks near the commissures, and the free portion of the tongue are frequent lesions. In severe cases, 
lesions may also be found on the hard palate, pharynx, and upper third of the esophagus. The necrotic 
lesions do not evolve into ulcers because the basal layer of the squamous epithelium is rarely penetrated.  
The rumen, reticulum, and omasum rarely have lesions. Sometimes, there may be erosions on the pillars 
of the rumen. The abomasum is a common site of regularly outlined erosions and often oozes blood.  
Lesions in the small intestine are generally moderate, being limited to small streaks of hemorrhages and, 
sometimes, erosions in the first portion of the duodenum and the terminal ileum. Peyer's patches are the 
site of extensive necrosis, which may result in severe ulceration. The large intestine is usually more 
severely affected with congestion around the ileocecal valve, at the ceco-colic junction, and in the rectum. 
In the posterior part of the colon and the rectum, discontinuous streaks of congestion ("zebra stripes") 
form on the crests of the mucosal folds.  
In the respiratory system, small erosions and petechiae may be visible on the nasal mucosa, turbinates, 
larynx, and trachea. Bronchopneumonia may be present, usually confined to the anteroventral areas and is 
characterized by consolidation and atelectasis. There may be pleuritis, which may become exudative and 
results in hydrothorax.  
The spleen may be slightly enlarged and congested. Most lymph nodes throughout the body are enlarged, 
congested, and edematous. Erosive vulvovaginitis similar to the lesions in the oral mucocutaneous 
junction may be present.  
Morbidity and Mortality:  The incidence of PPR in an enzootic area may be similar to that of rinderpest 
(RP) in that a low rate of infection exists continuously. When the susceptible population builds up, 
periodic epizootics (outbreaks) occur, that receive more attention than usual. Such epizootics may be 
characterized by almost 100 percent mortality among affected goat and sheep populations.  
The prognosis of acute PPR is usually poor. The severity of the disease and outcome in the individual is 
correlated with the extent of mouth lesions. Prognosis is good in cases where the lesions resolve within 2 
to 3 days. It is poor when extensive necrosis and secondary bacterial infections result in an unpleasant, 
fetid odor from the animal's breath. Respiratory involvement is also a poor prognostic sign. A morbidity 
rate of 80-90 percent and a casefatality rate of 50-80 percent are not uncommon — particularly in goats.  
Young animals (4 to 8 months) have more severe disease, and morbidity and mortality are higher. Both 
field and laboratory observations indicate that PPR is less severe in sheep than in goats. Nevertheless, 
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field outbreaks have been reported in the humid zones of west Africa in which no distinction could be 
made between the mortality rates in sheep and in goats. Poor nutritional status, stress of movement, and 
concurrent parasitic and bacterial infections enhance the severity of clinical signs.  
Diagnosis 
Field Diagnosis  
In the field, a presumptive diagnosis can be made on the basis of clinical, pathological, and 
epizootiological findings.  
Laboratory confirmation is an absolute requirement — particularly in areas or countries where PPR has 
not previously been reported.  
Specimens for Laboratory  
Specimens to submit include blood in EDTA anticoagulant, clotted blood or serum (if possible, paired 
sera), mesenteric lymph nodes, spleen, lung, tonsils, and sections of the ileum and large intestine.  
Swabs of serous nasal and lachrymal discharges may also be useful. All samples should be shipped fresh 
(not frozen) on ice within 12 hours after collection.  
Laboratory Diagnosis  
A wide range of laboratory procedures have been described for detecting virus or viral antigen, viral 
nucleic acid, and antibody.  
Differential Diagnosis  
Rinderpest. Clinical RP is rare in goats and sheep in Africa. In India, these species are quite often 
involved in RP outbreaks. Clinically, RP and PPR are similar, but the former should be the prime suspect 
if the disease involves both cattle and small ruminants.  
Confirmation requires virus isolation and cross-neutralization.  
Pasteurellosis. Enzootic pneumonia or the septicemic form of pasteurellosis is characterized by obvious 
respiratory signs, infrequent diarrhea, and a fatality rate rarely exceeding 10 percent.  
Contagious caprine pleuropneumonia. There is no digestive system involvement, and the clinical signs 
and lesions are confined to the respiratory system and pericardium.  
Bluetongue. Swelling of the lips, muzzle, and oral mucosa, together with edema of the head region, 
should serve to differentiate bluetongue from PPR. Coronitis, common in bluetongue, is not a feature of 
PPR. Also, sheep are more affected than goats.  
Heartwater. There is often central nervous system involvement, including convulsions. There is no 
diarrhea.  
Contagious ecthyma (contagious pustular dermatitis, orf). The orf virus causes proliferative, not necrotic 
lesions, that involve the lips rather than the whole oral cavity. The absence of nasal discharges and 
diarrhea also distinguish orf from PPR.  
Foot-and-mouth disease. This condition is comparatively mild, and the most characteristic clinical sign, 
lameness, is not a feature of PPR.  
Nairobi sheep disease. Sheep are more severely affected than goats. It is limited geographically to parts of 
east and central Africa (Kenya, Uganda, Tanzania, Ethiopia, Somalia and Congo [formerly Zaire]). 
Diagnosis requires isolation and serologic identification of the virus.  
Coccidiosis. There is no upper digestive tract and respiratory system involvement.  
Plant or mineral poisoning. Several plants and minerals may cause severe intestinal lesions. Case history 
and absence of fever should distinguish poisoning from PPR.  
Treatment:  There is no specific treatment for PPR. However, drugs that control bacterial and parasitic 
complications may decrease mortality.  
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Vaccination:  The tissue culture rinderpest vaccine at a dose of 102.5 TCID50 protects goats for at least 12 
months against PPR. The vaccine is currently used in many African countries for vaccination against 
PPR. The efficacy notwithstanding, its wide use is disadvantageous for the ongoing Pan-African 
rinderpest campaign (PARC) because it is impossible to determine if seropositive small ruminants have 
been vaccinated or naturally infected with RPV. A homologous attenuated PPR vaccine is being tested 
and may soon be commercially available.  
Control and Eradication:  Eradication is recommended when PPR appears in new areas. Methods that 
have been successfully applied for RP eradication in many areas would be appropriate for PPR. These 
should include quarantine, slaughter, and proper disposal of carcasses and contact fomites, 
decontamination, and restrictions on importation of sheep and goats from affected areas.  
Public Health:  Peste des petits ruminants is not infectious for humans.  
1.20 Rinderpest virus21 
Definition:  Rinderpest (RP) is a contagious viral disease of cattle, domestic buffalo, and some species of 
wildlife. It is characterized by fever, oral erosions, diarrhea, lymphoid necrosis, and high mortality.  
Etiology:  Rinderpest virus (RPV) is a single-stranded RNA virus in the family Paramyxoviridae, genus 
Morbillivirus. It is immunologically related to canine distemper virus, human measles virus, peste des 
petits ruminants virus, and marine mammal morbilliviruses. There is only one serotype of rinderpest 
virus, but field strains vary widely in virulence, ease of transmission, and host affinity.  
Rinderpest virus is a relatively fragile virus. Sunlight is lethal, and the vaccine must therefore be kept in a 
brown bottle and protected from light; virus in a thin layer of blood is inactivated in 2 hours. Moderate 
relative humidity inactivates the virus more quickly than either high or low humidity. The virus is very 
sensitive to heat, and both lyophilized and reconstituted virus should therefore be kept cold; lyophilized 
virus stored at -20o C is viable for years. Vaccine reconstituted in pure water quickly loses potency. 
Vaccine is more stable in a saline solution; reconstitution in a molar concentration of sulfate ions greatly 
increases resistance to heat.  
Rinderpest virus is rapidly inactivated at pH 2 and 12 (10 minutes); optimal for survival is a pH of 6.5-7. 
The virus is inactivated by glycerol and lipid solvents. 
Transmission:  Rinderpest was established as an infectious disease in 1754 when susceptible animals 
were infected by placing bits of material previously dipped in morbid discharge into an incision made in 
the dewlap. In 1899, cattle were infected with a bacteria-free filtrate.  
Secretions and excretions, particularly nasal-ocular discharges and feces, 1 to 2 days before clinical signs 
to 8 to 9 days after onset of clinical signs contain large quantities of virus. Spread of RP is by direct and 
indirect (contaminated ground, waters, equipment, clothing) contact with infected animals; aerosol 
transmission is not a significant means of transmission (it occurs only in a confined area and over a short 
distance). A major reason RP spreads in Africa is that the herds are nomadic. Cattle follow the grass and 
thus move great distances, and during the dry season, many herds will use the same well or watering area, 
and thus there is ample opportunity for cross-infection. It is said that a good fence will control RP.  
There is only one serotype of RPV; recovered or properly vaccinated animals are immune for life, and 
there is no vertical transmission, arthropod vector, or carrier state. For these reasons, RPV is an ideal 
virus to be targeted for eradication.  
Highly virulent strains of RPV are responsible for epizootics in susceptible animals and tend to die out. 
Milder strains tend to persist in an area, and the disease is not recognized as RP unless serology is 
performed.  
                                                 
21Committee on Foreign Animal Diseases of the United States Animal Health Association, revised 1998.  Foreign 
Animal Diseases, “The Gray Book,” Part IV, Library of Congress Catalog Card Number 17-12842, Pat Campbell 
& Associates and Carter Printing Company, Richmond, VA.  
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The roles the various hosts can play in the disease are as follows:  
• Cattle and domestic buffalo — highly susceptible  
• Sheep and goats in Africa — subclinical infection and seroconversion, but there is no 
transmission to other animals.  
• Sheep and goats in India — when infected by low-passage goat RP vaccine will transmit to 
domestic buffalo.  
• Pigs — Swayback pigs in Thailand and the Malay peninsula can be naturally infected and may 
die.  European pigs can be infected by ingestion of RPV-infected meat and will transmit to cattle 
and other pigs.  
Host Range:  Most wild and domestic cloven-footed animals can be infected.  
Geographic Distribution:  Rinderpest is present in the Indian subcontinent, Near East, and sub-Saharan 
Africa. 
Wild ungulates: 
Highly susceptible — African buffalo, wildebeest, kudu, eland, giraffe, warthog  
Fairly susceptible — Thompson gazelle, hippopotamus  
Wild ungulates are infected by contact with cattle and can transmit to cattle. In the absence of RP in 
cattle, the disease dies out in wildlife.  
Incubation Period:  The incubation period varies with the strain of virus, dosage, and route of exposure. 
Following natural exposure, the incubation period ranges from 3 to 15 days but is usually 4 to 5 days.  
Clinical Signs:  Depending on the strain of virus, resistance of the animal affected, and concurrent 
infection, RP can appear as a peracute, acute, or mild infection.  
Peracute Form  
This form is seen in highly susceptible and young animals. The only signs of illness are a fever of 104-
107o F (40-41.7o C), congested mucous membranes, and death within 2 to 3 days after the onset of fever.  
Acute or Classic Form  
This form of the disease progresses as follows:  
Small amounts of virus may be in nasal and ocular secretions before the onset of fever  
Fever of 104-106o F (40-41.1o C)  
Serous to mucopurulent ocular discharge  
Serous to mucopurulent nasal discharge.  
Leukopenia  
Depression  
Anorexia  
Constipation  
Oral erosions — Salivation may be abundant and frothy.  
Fever decreases and viral titer drops.  
Diarrhea — May be very watery or hemorrhagic, or both.  
Dehydration, emaciation  
Prostration and death 6 to 12 days after onset of illness.  
Gross Lesions:  Oral lesions are variable; some isolates cause good oral lesions and with others there is 
no oral lesion. Oral lesions start as small grey foci that may coalesce. The grey (necrotic) epithelium then 
sloughs off and leaves a red erosion.  
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Mouth — Lesions occur on the gums, lips, hard and soft palate, cheeks, and base of the tongue. Early 
lesions are grey, necrotic, pinhead-sized areas that later coalesce and erode and leave red areas.  
Esophagus — Brownish necrotic or eroded areas.  
Rumen and reticulum — Lesions are rare.  
Omasum — Erosions and hemorrhage are rare.  
Abomasum — Congestion and edema.  
Small intestine — Necrosis or erosion of Peyer's patches in the jejunum; necrosis or erosions over the 
lymphoid area in the ileum (ingesta adhering to the intestinal mucosa indicates areas of necrotic 
epithelium).  
Cecum and colon — The wall may be edematous, and there may be blood in the lumen and blood clots on 
the mucosa. Lesions are usually more severe in the upper colon (edema of the wall, erosions in the 
mucosa, and congestion). The lesions may be accentuated at the cecocolic junction. Further down the 
colon, the colonic ridges may be congested; this is referred to as "tiger striping". Tiger striping can occur 
in other diarrheas and probably results from tenesmus.  
Severity of intestinal lesions varies between isolates.  
Lymph nodes — Generally swollen and edematous.  
Liver — There may be petechial to ecchymotic hemorrhages in the gall bladder.  
Lung — There may be emphysema, congestion, and areas of pneumonia.  
Diagnosis  
Field Diagnosis  
Rinderpest should be considered in all ages of cattle whenever there is a rapidly spreading acute febrile 
disease accompanied by the preceeding clinical signs and lesions of RP. The all ages stipulation is 
important because this will be one of the major differences between bovine virus diarrhea-mucosal 
disease, which predominately affects animals between 4 and 24 months of age.  
Specimens for Laboratory  
Because the viral titer drops when the fever falls and diarrhea starts, specimens should preferably be 
collected from animals with a high fever and oral lesions. The following samples should be collected 
from live animals:  
• Blood in EDTA or heparin  
• Blood for serum  
• Swabs containing lacrimal fluid  
• Necrotic tissue from the oral cavity  
• Aspiration biopsies of superficial lymph nodes  
For the best specimens, a febrile animal should be slaughtered and specimens collected. If this cannot be 
done, then collect specimens from moribund animals. Collect the blood samples listed above and sections 
of:  
• Spleen  
• Lymph nodes  
• Tonsil  
The preceeding samples should be transported to the laboratory on wet ice — NOT FROZEN.  
A complete set of tissues, including sections of all lesions, should be collected in 10 percent formalin.  
Laboratory Diagnosis  
To confirm the initial diagnosis in a free area, the virus has to isolated and identified.  
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Differential Diagnosis  
The differential diagnosis for RP should include bovine virus diarrhea (mucosal disease), infectious 
bovine rhinotracheitis, malignant catarrhal fever, foot-and-mouth disease, vesicular stomatitis, 
salmonellosis, paratuberculosis, and arsenic poisoning.  
Vaccination:  The following types of RP vaccine have been used:  
• Lapinized in China and Korea  
• Avianized-lapinized in Korea  
• Goat-adapted in India  
• cell-culture-adapted in Africa, Middle East, and India.  
An experimental vaccinia-vectored vaccine containing the F and H genes of RPV has protected against 
challenge inoculation of virulent virus  
The two most commonly used vaccines today (1996) are the goat-adapted and cell-culture-adapted 
vaccines. The goat-adapted vaccine is only partially attenuated; it will cause disease in animals with low 
innate resistance or concurrent latent disease and kills sheep and goats. The cell-culture-attenuated 
vaccine was developed by Plowright in Kenya in the 1960's. This is a safe vaccine for many species and 
produces life-long immunity in cattle (animals challenge-inoculated 7 years after vaccination were 
protected). In endemic areas where cattle have been vaccinated, colostral immunity will interfere with the 
vaccination of calves up to 11 to 12 months of age. Because the duration of colostral immunity is 
variable, the recommendation is to vaccinate calves annually for 3 years.  
One of the biggest problems with the cell-culture-adapted vaccine has been stability. The lyophilized 
virus has to be kept cold (cold chain) until used. The combination of maintenance of the cold chain and 
remoteness of vaccination sites made RP vaccination very expensive. Because of the uncertainty that the 
vaccine being used was viable, in areas of Africa it is and was the policy to vaccinate animals every year 
in the hope that one of the vaccinations would immunize the animal. Researchers at Plum Island in the 
early 1990's greatly increased the stability of the lyophilized vaccine by modifying the stabilizers and 
lyophilization process. This change in production is now being used in some production facilities in 
Africa.  
Experimentally, the vaccinia-vectored RP vaccine protected cattle against challenge inoculation with 
RPV. This vaccine is undergoing field testing. This vaccine could be particularly useful in an eradication 
program because vaccinia-vectored-RP-vaccine immunized animals can be differentiated serologically 
from animals having antibody induced by live virus. The vaccinia-vectored vaccine would enable a 
country toward the end of an eradication program to maintain herd immunity to RP without using a live 
RP virus.  
Control and Eradication:  Countries and areas free of RP should prohibit unrestricted movement of RP-
susceptible animals and uncooked meat products from areas infected by RP or practicing RP vaccination. 
Because recovered animals are not carriers, and there are good serological techniques, zoological 
ruminants and swine can be imported with proper quarantine and testing. If an outbreak occurs, the area 
should be quarantined, infected and exposed animals slaughtered and buried or burned, and ring 
vaccination considered.  
Experimentally it has been shown that RPV will not be transmitted by bovine embryo transfer if the 
embryos have been processed by the technique recommended by the International Embryo Transfer 
Society and the OIE.  
High-risk countries (those trading with, or geographically close to, infected countries) can protect 
themselves by having all susceptible animals vaccinated before they enter the country or vaccinating the 
national herd, or both. If an outbreak occurs, the area should be quarantined and ring vaccinated.  
Endemic countries should vaccinate the national herd. Owing to the uncertainty of vaccine potency, the 
recommendation is to vaccinate annually for at least 4 years, followed by annual vaccination of calves. 
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Foci of infection should be quarantined and stamped out. Wildlife, sheep, and goats should be monitored 
serologically. Serological monitoring of sheep and goats could be complicated by using RP vaccine to 
protect against peste des petits ruminants.  
Public Health:  There is no report of RPV infection in a human.  
1.21 Sheep pox virus 
See Goat Pox 
1.22 Swine vesicular disease22 
Definition:  Swine vesicular disease (SVD) is an acute, contagious viral disease of swine caused by an 
enterovirus and characterized by fever and vesicles with subsequent erosions in the mouth and on the 
snout, feet, and teats.  
Etiology:  Swine vesicular disease virus is in the enterovirus group of picornaviruses and is closely 
related to the human enterovirus Coxsackie B-5 and unrelated to known porcine enteroviruses. Some 
researchers believe this is a case where a human pathogen transferred to pigs through the eating of human 
feces. The virion is a roughly spherical 28 nm single-stranded RNA virus. This pathogen is resistant over 
a wide pH range (2.5-12), relatively resistant to heat (inactivated at 157o F [69o C]), and persists for a long 
time (up to 2 years) in salted, dried, and smoked meat products.  
Host Range:  Pigs are the only natural host. Baby mice can be experimentally infected, and there has 
been accidental laboratory infection of humans.  
Geographic Distribution:  Swine vesicular disease first occurred in Italy and was subsequently 
recognized in Hong Kong, England, Scotland, Wales, Japan, Malta, Austria, Belgium, France, the 
Netherlands, Germany, Poland, Switzerland, Greece, and Spain. Outbreaks in the 1990's were reported in 
Italy, Spain, and Portugal.  
Transmission:  The disease can be introduced into a herd by feeding garbage containing infected meat 
scraps, by introducing infected animals, or by contacting infected feces (e.g., an improperly cleaned 
truck).  
Recent outbreaks in Europe appeared after the introduction of animals that had no clinical sign of SVD, 
which indicates that there is a subclinical form of the disease. After the initial infection, the disease 
spreads through contact of susceptible pigs with infected pigs and infected feces.  
Incubation Period:  Signs of SVD develop in 2 to 3 days after eating contaminated feed and in 2 to 7 
days after contact with infected pigs.  
Clinical Signs:  Clinical signs are very similar to those of foot-and-mouth disease and other vesicular 
diseases. There is a fever, vesicles in the mouth and on the snout and feet, and lameness, all of which are 
grossly indistinguishable from FMD. More suggestive of SVD is an unsteady gait, shivering, and chorea 
(jerking) type leg movements due to an encephalitis.  
Gross Lesions:  Vesicles are indistinguishable from those of foot-and-mouth disease, vesicular stomatitis, 
and vesicular exanthema of swine. See the foot-and-mouth disease chapter.  
Morbidity and Mortality:  Morbidity in SVD is lower, and lesions are less severe, than in foot-and-mouth 
disease. There is essentially no mortality in SVD.  
Diagnosis  
See Foot-and-mouth disease.  
                                                 
22Committee on Foreign Animal Diseases of the United States Animal Health Association, revised 1998.  Foreign 
Animal Diseases, “The Gray Book,” Part IV, Library of Congress Catalog Card Number 17-12842, Pat Campbell 
& Associates and Carter Printing Company, Richmond, VA.  
http://www.vet.uga.edu/vpp/gray_book/FAD/SVD.htm  
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Serology is complicated by cross reactions with other undefined porcine enteroviruses.  
Differential Diagnosis  
Differential diagnosis for SVD should include foot-and-mouth disease, vesicular stomatitis, vesicular 
exanthema of swine, and chemical and thermal burns.  
Vaccination:  There is no vaccine.  
Control and Eradication:  Prevention measures are similar to those for FMD: control of animals 
imported from infected areas, and sanitary disposal of garbage from international aircraft and ships  
Eradication measures consist of quarantining infected farms and areas, slaughtering and disposing of 
infected and contact pigs, and cleaning and disinfecting infected premises.  
Public Health:  Human infection has been reported in laboratory personnel working with the virus. 
Caution should be taken when working with infected material.  
1.23 Vesicular stomatitis virus (exotic)23 
Definition:  Vesicular stomatitis (VS) is a viral disease characterized by fever, vesicles, and subsequent 
erosions in the mouth and epithelium on the teats and feet. Horses, cattle, and pigs are naturally 
susceptible; sheep and goats are rarely affected.  
Etiology:  The vescular stomatitis virus is a Vesiculovirus in the family Rhaboviridae. The virion is a 
large bullet-shaped (65-185 nm) RNA virus. There are two serotypes of VSV: New Jersey and Indiana 1. 
In the serotype Indiana 1, there are two subtypes: Indiana 2 (Cocal) and Indiana 3 (Alagoas). In addition 
to these two serotypes of VSV, there are other viruses within the genus Vesiculovirus that can 
experimentally cause vesicular lesions in domestic animals and infect humans; these are as follows:  
Piry — first isolated from an opossum in Brazil.  
Chandipura — first isolated from a person in India.  
Isfahan — isolated from sandflies and humans in Iran.  
Effective disinfectants are 2 percent, sodium carbonate - 4 percent, sodium hydroxide - 2 percent, 
iodophore disinfectants and chlorine dioxide disinfectants.  
Host Range:  The host range in decreasing order of severity of infection are horses, donkeys, mules, 
cattle, swine, and man.  
South American cameilids develop clinical infection.  
Sheep and goats are quite resistant and rarely become affected.  
Vesicular stomatitis virus has also been shown experimentally to infect a wide host range, including deer, 
raccoons, bobcats, and monkeys.  
Geographic Distribution:  Classical VS occurs only in North and Central America and the northern part 
of South America. Serotypes New Jersey and Indiana I occur in the United States and Central America. 
Serotypes New Jersey and Indiana 1, 2, and 3 occur in South America.  
Transmission:  The vesicular stomatitis virus has been shown to be transmitted by the sand fly 
(Lutzomyia shannoni) and the black fly (Simuliidae). Transovarial transmission has been shown to occur 
in both flies. The VS-NJ serotype was isolated from a variety of field-collected hematophagous insects 
such as Culicoides (biting midges), Simuliidae (black flies), Aedes (mosquitoes) and nonbiting insects 
such as Chloropidae (eye gnats), Anthomyiidae, and Musca (house flies) during the 1982 epizootic in the 
southwestern United States. Except for Lutzomyia and Simulidae, the role of these other insects in the 
transmission of VSV is unknown. Before the 1982 outbreak in the United States, people, on the basis of 
                                                 
23Committee on Foreign Animal Diseases of the United States Animal Health Association, revised 1998.  Foreign 
Animal Diseases, “The Gray Book,” Part IV, Library of Congress Catalog Card Number 17-12842, Pat Campbell 
& Associates and Carter Printing Company, Richmond, VA.  
http://www.vet.uga.edu/vpp/gray_book/FAD/VST.htm  
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past experience, expected an outbreak to stop about 2 weeks after a killing frost. In the 1982 outbreak, 
cases and spread occurred through the winter. The winter spread of the disease is believed to have 
resulted from movement of infected animals and the resulting exposure of uninfected animals to 
contaminated waterers and feed bunks as well as contact with infected animals. It is known that VSV can 
be spread by a contaminated milking machine. Overwintering did not occur in the 1995 outbreak in the 
United States.  
Humans may be infected by contact and by aerosol.  
Epidemology:  The disease occurs throughout the year in subtropical and tropical areas of the Americas. 
The disease occurs sporadically during the warm months in southern and western United States. 
Epidemics have occurred irregularly at 10 to 15 year intervals. The virus is spread by insect vectors, 
movement of infected animals, and contaminated objects. Researchers have shown transovarial 
transmission in the sand fly and black fly; this may be a way the virus can overwinter.  
Incubation Period:  A vesicle appears in about 24 hours after intradermal lingual inoculation of VSV. 
This similar to the incubation period for foot-and-mouth disease.  
In humans, the incubation period is 24 to 48 hours.  
Clincial Signs:  Animals develop a fever ranging to 104-106o F (40-41o C).  
Horse  
Vesicles in the mouth may cause the animal to chomp its jaws, drool, and rub its mouth on the manger or 
other objects. Lesions on the coronary band can cause lameness.  
Cattle and pigs  
See the clinical signs section in the FMD chapter. The signs are very similar.  
Humans  
In humans, VSV causes an influenza-like illness; there is fever, headache, muscular aches, and blisters in 
the mouth similar to those caused by herpesvirus. The disease course is 4 to 7 days.  
Morbidity and Mortality 
Interesting data on the economic effect of VS in cattle were collected by Alderink during the 1982 
outbreak of VS in Colorado. In 13 of the dairy herds studied there were 2,404 cows and 378 cases of VS. 
Lesion distribution in these 378 was as follows:  
Oral lesions only 263 animals (69.3%)
Teat lesions only 87 animals (23%) 
Oral and teat lesions 22 animals (5.8%) 
Foot lesions only 7 animals (1.9%) 
Herds experiencing primarily oral lesions had an attack rate of 19.8 percent. The attack rate in two of four 
herds with teat lesions was 55.8 percent and in the other two herds 1.6 percent. The clinical course in 
cases with oral lesions was 23.8 days. Mastitis complicated 72% of the cases with teat lesions.  
The total cost to the 13 dairymen was $95,752, which came to an average cost of $253 per case. The 
approximate cost of a case with only oral lesions was $174 in contrast to an average cost of $568 for cases 
with teat lesions. Of the total $95,752 loss, 46 percent was for cows culled; 30 percent was for decreased 
production; 11 percent for deaths; and 11 percent for drugs, labor, weight loss, and veterinary charges.  
Differences Between VS and FMD  
The characteristics of VS are as follows:  
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• Horses affected.  
• Sporadic incidence in the herd (see preceeding).  
• Distribution of lesions in an animal (small percentage of animals have lesions at more than one 
site of predilection; see preceeding). 
• No rumen lesions observed at necropsy.  
• No heart lesions observed at necropsy.  
• Vesicular stomatitis is less severe in young animals.  
• Stabled animals usually not affected.  
In spite of these differences, do not attempt to make a final differential diagnosis in the field; get 
laboratory confirmation of the diagnosis.  
Diagnosis  
See Foot-and-mouth disease.  
Differential Diagnosis  
Differential diagnosis for VS in cattle should include foot-and-mouth disease, foot rot, and chemical and 
thermal burns. In cattle, oral lesions caused by rinderpest, infectious bovine rhinopneumonitis, bovine 
virus diarrhea, malignant catarrhal fever, and bluetongue can be similar to the later lesions in FMD. In 
pigs, the differential diagnosis for VS should include foot-and-mouth disease, swine vesicular disease, 
vesicular exanthema of swine, foot rot, and chemical and thermal burns. In sheep, the differential 
diagnosis for VS lesions should include bluetongue, contagious ecthyma, lip and leg ulceration, and 
footrot.  
Control and Eradication  
• Control movement of animals — no movement from an infected premise, except for slaughter, 
for 30 days after last lesion has healed.  
• Separate infected and healthy animals.  
• Stable animals if possible.  
• Disinfect milking machines between cows.  
• Milk infected cows last.  
• Control insects.  
• Commercial vaccines are available, but efficacy has not been field-tested.  
Public Health:  Vesicular stomatitis (New Jersey and Indiana) infection frequently occurs in man and 
causes influenza-like symptoms but rarely results in vesicles. Other vesicular stomatitis viruses (Piry, 
Isfahan, and Chandipura) are much more infectious for man.  
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2.  PLANT PATHOGENS  
This section introduces the 10 plant pathogens regulated by 7 CFR 121.  Summary reference 
information is provided.  Citations and internet addresses for each pathogen are provided in 
footnotes.  This section includes summary information for the following pathogens: 
• Liberobacter africanus 
• Liberobacter asiaticus 
• Peronosclerospora philippinensis  
• Phakopsora pachyrhizi  
• Plum pox potyvirus 
• Ralstonia solanacearum, race 3, biovar  
• Sclerophthora rayssiae var. zeae  
• Synchytrium endobioticum  
• Xanthomonas oryzae pv. oryzicola  
• Xylella fastidiosa (citrus variegated chlorosis strain) 
2.1 Liberobacter africanus24 
Candidatus Liberibacter 
Disease name: Citrus greening disease  
Other Names:  
• Greening  
• Blotchy mottle  
• Decline (likubin)  
• Dieback  
• Leaf mottle  
• Vein phloem degeneration  
• Yellow branch  
• Yellow shoot (huang lung bin)  
Causative Agent:  An uncharacterized Gram-negative bacterium known as citrus greening disease 
bacterium for which the name Liberibacter, also seen as Candidatus Liberibacter, has been proposed 
Synonyms None Crops Affected Citrus crops Description of the Agent  
The organism is poorly characterized. It is a filamentous Gram-negative organism that has not yet been 
cultured under controlled in the laboratory.  It is transmitted by insects including: 
• Diaporina citri  
• Trioza erytreae  
• and by the plant dodder (Cuscuta spp.) 
Symptoms:  Citrus greening can be a systemic disease, especially in younger trees. The first signs are seen 
in the leaves where yellowing along the veins of leaves or a blotchy mottle of leaves. There is sometimes 
a chlorotic mottle that resembles zinc or iron deficiencies. Fruit is misshapen and bitter. It often falls 
prematurely and fruit that stays on the tree does not color and seeds do not develop. The root systems do 
not develop properly. 
                                                 
24CBWInfo.com, September 2002. Factsheets on Chemical and Biological Warfare Agents, Version 2.1, 
http://www.cbwinfo.com/Biological/PlantPath/CGD.html 
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There are strain differences in symptoms with the Asian strains showing more severe symptoms than the 
African strains. 
Prevention and Treatment: There are relatively few treatments. One of the most effective is heat 
treatment. Graftwood heated to 48-58°C (119-134°F) for several (conditions somewhat similar to 
pasteurization) eleiminate the disaease-causing agent.  
The most effective method of preventing the disease is to control the insect vectors. This can be done by 
use of insecticides or (preferably) with predatory wasps that lay their eggs in the larvae of the vectors. 
Agricultural practices including the careful selection of vector-free production areas, good crop 
husbandry and careful selection of trees. 
Other Comments: Citrus greening disease is capable of being extremely destructive and causing 
catastrophic losses of an important crop. Infection rates of up to 95% have been seen in Thailand and crop 
losses of 100% have been seen in some areas of South Africa and it has eliminated citrus production in 
some parts of the country. 
2.2 Liberobacter asiaticus 
See Liberobacter africanus. 
2.3 Peronosclerospora philippinensis25 
Description: The Peronosporaceae family of microorganisms causes downy mildew diseases. Downy 
mildew primarily attacks young, tender leaves, twigs, and fruits. While a film of water is needed on plant 
tissue for spore germination, and a wet, humid environment and mild temperatures are necessary for 
infection and growth, when conditions are right downy mildew can spread rapidly through fields. 
Symptoms of downy mildew infection include small, pale yellow spots with indefinite borders on the 
upper leaf surface. There may also be purplish discoloration of the upper leaf surface on some hosts. A 
downy growth of fruiting structures and hyphae on the underside of the leaf may be visible directly under 
the spots, or on fruits or stems.  
Exotic target pathogens include: Peronosclerospora philippinensis, which causes downy mildew disease 
of sugarcane and maize  
2.4 Phakopsora pachyrhizi26 
Synonym:  Australasian Soybean Rust 
Description:  Soybean rust is a disease caused by the fungus Phakopsora pachyrhizia.  It is most 
destructive in the tropical and subtropical regions of Asia and Australia. It has recently been found in 
Africa and South America. It is not known to occur in the United States.  
The rust fungus causes lesions on the leaves, stem and pods. The  main effects on the soybean plant is the 
destruction of photosynthetic tissue, premature defoliation and reduction of the number of days to 
maturity. The effect on yield is lower seed weight and fewer pods and seeds. 
The rust pathogen has a wide host range of over 30 legume species. It is an obligate pathogen, which 
means it needs living host cells to survive.   
Disease Cycle and Symptoms:  The most common symptom is brown to reddish brown lesions on the 
leaves.  If you look closely at the lesions you will often see tiny bumps within the lesion. The bumps are 
spore structures called uredinia, which give the leaf the typical "rusty" look.  They are found most 
abundantly on the underside of the leaf, with fewer and smaller uredinia forming on the top of the leaf. 
Masses of clear to yellow-brown microscopic urediniospores are released from the uredinia. They are 
transported by air currents to other soybean plants and can be transported over long distances.   
                                                 
25Cooperative Research Centre for Tropical Plant Protection - http://www.tpp.uq.edu.au/disease/downy.htm  
26Plant Health Initiative, a North Central Soybean Research Program - http://www.planthealth.info/rust/rust.htm  
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Soybean rust can be diagnosed by microscopic examination of infected leaves at a plant disease clinic. 
Environmental factors are critical to the incidence and severity of soybean rust. Long periods of leaf 
wetness are needed for urediospore germination, as well as temperatures between 15 and 30 degrees C 
and a high relative humidity of 75-80%.  Urediospores are able to penetrate the plant cells directly, rather 
than through stomatal openings or wounds in the leaf tissue. Thus infection is relatively quick, about 9-10 
days.  The fungus eventually forms another type of spore called a teliospore. Their role in the 
epidemiology of this rust disease is not clear.  
Rust Management:  The most effective and efficient control measure for rust diseases is the use of 
resistant soybean varieties. Soybean pathologists and breeders at North Central universities and the 
USDA are working to identify the resistance of soybean lines under field conditions at international 
locations where the disease is endemic.   
2.5 Plum pox potyvirus27 
Description:  Plum pox is the most serious disease of plums, apricots and peaches in Europe. It is caused 
by the plum pox virus (PPV). Different strains of the virus occur with variable host susceptibility and 
symptoms. Yield and overall economic losses have been catastrophic to plum and peach growers in many 
countries. 
Disease distribution:  First identified in Bulgaria, plum pox is now reported in most European countries, 
in parts of Asia and northern Africa, and in South America (Chile). In October 1999, the D-strain of PPV 
was discovered on peaches grown in Adams County, Pennsylvania.  
Host plants:  PPV infects virtually all cultivated fruit tree species of the genus Prunus. Severe symptoms 
occur on apricot, plum, and peach trees. Almond trees may be infected occasionally but show few 
symptoms. Sweet and sour cherries are affected by only some strains of PPV. The strain reported in the 
United States does not affect cherries. The disease also affects some wild Prunus species, especially 
blackthorn (Prunus spinosa) which has been a natural source of infection in many countries. 
Symptoms:  Plum pox symptoms can vary greatly, making the disease difficult to recognize. Symptoms 
may appear on the leaves or fruits of infected trees. In some cases, only part of the infected tree or even 
only a single branch will show symptoms. 
Symptoms are easiest to see in the spring when leaves show chlorotic spots, bands, or rings, vein clearing 
and even leaf deformation. Infected fruits show chlorotic spots or rings. Diseased plums and apricots may 
be deformed with internal browning of the flesh and pale rings or spots on the stones. 
Visual symptoms are not always a reliable indicator of disease. The disease may not be visible until 
several months or years after the tree has been infected. However, PPV can also be detected by laboratory 
analysis of tissue samples or by grafting test material to highly susceptible hosts and watching for 
symptoms to develop. 
Biology:  The main source of plum pox is infected trees or budwood. The virus is spread in the field by 
several species of aphids. The aphids acquire the virus during feeding and then transmit it to nearby 
healthy plants. The aphids can only transmit PPV for a short period of time after acquiring it. 
The virus can also survive in roots and may spread by natural root grafting. The suckers produced from 
the remaining roots of rogued infected trees often carry the virus and must be removed. 
Long distance spread of PPV occurs through the movement and use of infected propagative materials 
(grafting and budding of infected material). Some strains of PPV can be transmitted through seed and 
pollen. PPV cannot be spread by mechanical means such as pruning. 
                                                 
27Canadian Food Inspection Agency, Plant Products Directorate, Plant Health and Production Division, Horticulture 
Section.  http://www.inspection.gc.ca/english/plaveg/hort/ppv/infoe.shtml 
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Control:  Plum pox is a difficult disease to control. Once introduced it can quickly spread and become 
established in the native vegetation. Control of the virus requires regular surveys, removal of infected 
trees, and replacement with resistant varieties or non-host crops. There is no anti-virus treatment that can 
be applied to infected trees or orchards. 
The use of disease-free propagative material at all times is crucial in preventing introduction to new areas.  
2.6 Ralstonia solanacearum, race 3, biovar 228 
Background:  There are three races of Bacterial wilt, Ralstonia solanacearum, which have been 
distinguished on the basis of pathogenicity. Race 3 of the pathogen mainly affects potatoes and tomatoes. 
Race 3 is also referred to as upland wilt or Biovar 2 as it has adapted to cooler temperatures and its 
importance in Europe has increased in recent years. The adaptability of the bacterium means that it also 
poses an increased threat to Western Australian potato growers. 
Distribution:  Bacterial wilt of potato occurs throughout Asia, Africa, Europe, Mexico, the Caribbean and 
South America. It has also been recorded in all states of Australia except Tasmania and Western 
Australia. The most serious reports have come from Queensland, New South Wales and Victoria. In these 
states there are areas where the disease is considered endemic. Bacterial wilt was introduced on one or 
more occasions through the planting of uncertified seed. 
Potential impact:  Bacterial wilt can cause losses of up to 75% in potato crops. Disease severity increases 
if R. solanacearum is found in association with root nematodes. Nematode infestation changes the 
physiology of the plants, increasing susceptibility to Bacterial wilt. For further information on state 
quarantine regulations refer to the Potato Industry Protection Plan and Reference Manual. 
Plants affected:  The main host of Bacterial wilt, Ralstonia solanacearum - race 3, is potatoes. Other 
hosts include solanaceous crops such as tomatoes, the garden plant Pelargonium x hortorum and the weed 
Solanum nigrum (blackberry nightshade). 
Season of occurrence:  Bacterial wilt persists in the soil all year round. It is also spread efficiently in 
infected soil as well as in water runoff from irrigation. In general, race 3 of the bacterium survives better 
under conditions of high soil moisture and low temperature. Race 3 will usually decrease in virulence 
when temperatures exceed 35°C. The disease is most severe at 24-35°C and is seldom found in temperate 
climates where the mean temperature for any winter month falls below 10°C. The main pathway for 
spread is by latently infected seed potatoes and other vegetative propagating materials. The greatest risk 
to WA is illegally imported seed potatoes that may be infected with the bacteria. 
Symptoms 
Foliage:  The first visible symptom of Bacterial wilt is a wilting of the leaves at the ends of the branches 
during the heat of the day with recovery at night. This symptom can be mistaken for water stress. Plants 
eventually fail to recover and die. Plants may also look stunted and begin to yellow. 
Stems:  As the disease develops, a streaky brown discolouration of the stem may be observed on stems 
and the leaves have a bronze tint. A white, slimy mass of bacteria exudes from vascular bundles when 
broken or cut. 
Tubers:  External symptoms may be visible depending on the stage of development of the disease. 
Symptoms may be confused with those of ring rot. Bacterial wilt can be distinguished by the ooze that 
often emerges from the eyes and stem-end of infected tubers (‘sore eye’). Cutting the diseased tuber will 
reveal a discolouration of the tissue about 4-5 mm below the skin, browning and necrosis of the vascular 
ring and immediately surrounding tissues up to 0.5 cm each side of the ring. 
                                                 
28©Chief Executive Officer of the Department of Agriculture 2000. This material may be reprinted provided that the 
article and the author(s) are acknowledged. Edited and published by Information Services, Agriculture Western 
Australia, Locked Bag No. 4, Bentley Delivery Centre, WA 6983 By Chris Stansbury, Simon McKirdy, Alison 
Mackie and Greg Power, HortguardTM Initiative AGWEST.  
http://www.agric.wa.gov.au/agency/pubns/factsheets/2001/fs00701.pdf  
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2.7 Sclerophthora rayssiae var. zeae29 
Synonym:  Brown stripe downy mildew  
Causal organism:  Sclerophthora rayssiae var. zeae,  Mastigomycotina (Fungi) 
Description:  Fungal disease which is an only downy mildew disease occurring on corn in Japan. The 
disease begins to occur in the rainy season. The lesion is yellow to yellowish brown, delimited by the leaf 
vein, rectangular to stripe, 0.5-2 cm in length and 3-7 mm in width. The lesion elongates long, and 
becomes purple red, and the entire leaf withers. The damage is limited to lower leaves and not so severe 
now in Japan. About 30 degrees in temperature of the soil is suitable for the occurrence. The pathogen is 
considered to infect fingergrass, too.   
2.8 Synchytrium endobioticum30 
Synchytrium endobioticum (Schilberzky) Percival (Fungi) 
Synonyms: Potato Wart or Potato Canker 
Hosts:  Synchytrium endobioticum is an obligate parasite of certain members of the order Solanaceae with 
potato (Solanum tuberosum) being the only cultivated host. In Mexico some wild Solanum species are 
also known as hosts.  
Distribution 
Asia: Bhutan, China, India, Lebanon, Nepal  
Africa: Algeria, South Africa, Tunisia  
Europe: All countries, except Portugal where it was eradicated.  
North America:Canada (NFLD), USA (eradicated), Mexico.  
Pacific:New Zealand’s south island  
South America: Bolivia, Chile, Falkland Is., Peru, Uruguay  
Biology:  S. endobioticum is a soil borne fungal parasite which does not produce hyphae, but sporangia 
containing anywhere from 200-300 motile zoospores. In the spring, at temperatures above 8·C and given 
sufficient moisture, the overwintering sporangium found in decaying warts in the soil germinate and 
release uninucleate zoospores. The zoospores possess a single flagellum (tail) which enables them to 
move in soil water to reach the host. Once a suitable host cell is encountered, the zoospore will shed it’s 
tail and penetrate the cell. The infected cell swells as the enclosed fungus forms a short-lived but quickly 
reproducing structure, the summer sporangium, from which numerous zoospores are released to infect 
neighbouring cells. This cycle of infection and release may be repeated for as long as conditions are 
suitable, resulting in the host tissue becoming thoroughly infected. The cells surrounding the infected 
ones also swell and the tissue proliferates, producing the characteristic cauliflower-like appearance. 
Under certain conditions of stress, such as water shortage, the zoospores may fuse in pairs to form 
zygotes. In this case, the host cell wall remains closely attached, forming an outer layer to the resistant, 
thick-walled structure called the winter sporangium. Mature winter sporangium are released into the soil 
from rotting warts. They can remain viable for up to 30 years and can be found at depths of up to 50 cm. 
The disease can be spread by infected seed tubers which may have incipient warts, or in infested soil 
attached to tubers. The sporangia can survive digestion by animals, and therefore can be spread by fecal 
material. 
                                                 
29National Institute of Livestock and Grassland Sciences, Japanese site. http://ss.ngri.affrc.go.jp/diseases/de1.htm 
 
30Wallace, S., and R. Favrin, Canadian Food Inspection Agency, Plant Pest Information, Plant Health Survey Unit. 
http://www.inspection.gc.ca/english/ppc/science/pps/datasheets/synende.shtml 
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Detection & Identification 
Symptoms:  The disease appears on all underground parts except the roots. Buds on stems, stolons, and 
tubers are the centres of infection and abnormal growth activity leading to wart formation. Above ground 
symptoms are not usually apparent although there maybe a reduction in plant vigour. 
Identification: The warts vary from very small protuberances to large intricately branched systems. A 
typical wart is initially white in colour, roughly spherical, but it is usually not a solid structure. It is soft 
and pulpy and can be cut more easily than a tuber. Morphologically it consists of distorted, proliferated 
branches and leaves grown together into a mass of hyperplastic tissue resembling the head of a 
cauliflower. Often a developing wart may become exposed at or above the soil line, in which case it will 
turn green. As the warts become older, whether above or below ground, they darken and decay. It is not 
uncommon for the entire tuber to be replaced by the warty proliferation. Warts which develop on potatoes 
in storage may be the same colour as the tuber. 
2.9 Xanthomonas oryzae pv. oryzicola31 
Common name:  Bacterial leaf streak  
Diagnostic summary: Damage to plants - browning and drying of leaves, reduced 1000-grain weight 
under severe condition.  
Signs: Initial symptoms are dark-green and water-soaked streaks on interveins from tillering to booting 
stage streaks later enlarge to become yellowish gray and translucent bacterial exudates on surface of 
lesions - lesions turn brown to grayish white then dry - browning and drying of entire leaves  
Symptoms: Initially, small, dark-green and water-soaked streaks on interveins from tillering to booting 
stage. Streaks dark-green at first and later enlarge to become yellowish gray and translucent. Numerous 
small yellow beads of bacterial exudates on surface of lesions on humid conditions.  Very small yellow 
beads instead of bacterial exudates during dry season.  Lesions turn brown to grayish white then dry when 
disease is severe.  Yellow halo around lesions on susceptible cultivars. Browning and dying of entire 
leaves.  Bleached and grayish white leaves 
Confirmation: The linear streaks or narrow transparent streak can be seen against the sunlight. When the 
advancing part of the streaks are cut and placed in a glass with water, mass of bacterial cells would be 
seen coming out from the leaf making the water turbid after 5 minutes.  
Problems with similar symptoms: BLS is the only leaf spot disease with transparent narrow streaks as 
compared with other leaf diseases like brown spot, narrow brown spot, and bacterial blight. 
At an early stage, the symptom looks similar to that of the narrow brown leaf spot. At a later stage, when 
the streaks coalesced, the symptoms of bacterial leaf streak look the same as those of bacterial blight. 
Bacterial leaf streak can be distinguished from bacterial blight by its thinner translucent lesions with the 
yellow bacterial ooze.  
Why and where it occurs:  The disease is transmitted through seeds to the next planting season. Planting 
of infected seeds, which are collected from diseased fields produce diseased seedlings. The bacteria, 
which is present in the water or those surviving in the debris left after harvest, are also sources of 
inoculum in the next planting season. 
The bacterial cells in beads on leaves when moistened by dew or rain disperse and spread by wind cause 
new infection or damage on the same leaves or other leaves. High temperature and high humidity also 
favor new infection and development of lesions. 
The disease usually occurs during the early stage of planting from maximum tillering to panicle initiation. 
Older plants are more resistant to the disease.  
                                                 
31Suparyono, JLA Catindig, and IP Oña, International Rice Research Institute.  
http://www.knowledgebank.irri.org/ricedoctor_mx/Fact_Sheets/Diseases/Bacterial_Leaf_Streak.htm  
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Causal agent or factor:  The bacteria causing the disease X. oryzae pv. oryzicola occur as rods. They are 
1.2 x 0.3-0.5 µm in dimension. They are single, occasionally in pairs but not in chains. The bacteria have 
no spores and no capsules. They move with the aid of a single polar flagellum. They are Gram-negative 
and aerobic and can grow favorably at 28 °C. 
The bacterial colonies on nutrient agar are pale yellow, circular, smooth, convex, and viscid and have an 
entire margin. Their growth on slant is filiform. Growth in nutrient broth is moderate with a surface ring 
growth without a definite pellicle.  
Factors affecting development of the pest:  Presence of the bacteria on leaves and in the water or those 
surviving in the debris left after harvest  - high temperature and high humidity - early stage of planting 
from maximum tillering to panicle initiation  
Host range:  Species of wild rice such as Oryza spontanea, O. perennis balunga, O. nivara, O. 
breviligulata, O. glaberrima, and Leersia hexandra Sw. (southern cutgrass) are alternate hosts of the 
disease.  
Mechanism of damage: The bacterium penetrates the leaf through natural openings (such as stomata and 
hydatodes), leaf injuries or artificial wounds due to wind, insect bites, or others. Initial infection is 
observed only on the parenchyma cells in between the veins of the leaf. Highest infection occurs at 
midday, during which the leaf stomata are fully opened. After gaining entrance, the bacterium multiplied 
in the substomatal cavity and progressed intercellularly in the parenchyma. Soon after lesions develop, 
bacterial exudates form on the surface of the lesions under moist conditions during the night. Under dry 
conditions, these exudates become small, yellow beads that eventually fall into the irrigation water. When 
the leaves are wet from dew or rain, with the aid of wind, the bacteria is carried from field to field by 
irrigation water.  
Economic importance:  Bacterial leaf streak is widely distributed in Taiwan, southern China, Southeast 
Asian countries, India, and West Africa. The disease is not reported to occur in temperate countries 
including Japan. Losses as high as 32.3% in 1000-grain weight due to BLS were reported. 
At three disease intensities, the estimated yield losses were 8.3%, 13.5%, and 17.1% in the wet season 
and 1.5%, 5.9%, and 2.5% during the dry season.  
Management principles:  The disease can be controlled by proper application of fertilizers and proper 
planting spacing, the use of resistant varieties, and hot water treated seeds. 
Practicing field sanitation is important. Ratoons, straws and volunteer seedlings left after harvest can be 
destroyed to minimize the initial inoculum at the beginning of the season. Providing good drainage 
system especially in seedbeds can also manage this disease. 
Planting of resistant varieties, which are available at IRRI and at National Research Institute, is the most 
effective method of controlling bacterial leaf streak. Fallow field and allowing to dry thoroughly is also 
recommended.  
2.10  Xylella fastidiosa (citrus variegated chlorosis strain)32 
Disease Name: Almond leaf scorch, Citrus variegated chlorosis, Phony peach disease, Pierce's disease, 
Plum leaf scald  
Agent Type:  Bacterium  
Target: Vines,fruit and timber trees  
Related Agents: None  
Listed by the Australia Group: Yes  
                                                 
32CBWInfo.com, September 2002.  Factsheets on Chemical and Biological Warfare Agents, Version 2.1.   
http://www.cbwinfo.com/Biological/Pathogens/SecondaryBW/SecTY.html#TY8  
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Comments: Xylella fastidiosa is a bacterium that lives in the xylem of plants that is crucial for the 
movement of liquids and nutrients. As they block transmission of water the plant begins to die. This starts 
at the edges of leaves and progresses into the central tissues of the plant with the roots also being affected. 
The disease is transmitted rapidly by insects known as sharpshooter leafhoppers and also inadvertently by 
grafting. 
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3.  OVERLAP PATHOGENS AND TOXINS (ANIMAL AND 
HUMAN/ZOONOTIC)  
This section introduces the 20 zoonotic pathogens and toxins regulated by 9 CFR 331 and 42 
CFR 73.  Summary reference information is provided.  Citations and internet addresses for each 
pathogen or toxin are provided in footnotes.  This section includes summary information for the 
following pathogens and toxins:   
• Bacillus anthracis 
• Botulinum neurotoxins (more than 0.5 mg) 
• Botulinum neurotoxin producing species of Clostridium 
• Brucella abortus 
• Brucella melitensis 
• Brucella suis 
• Burkholderia mallei (formerly Pseudomonas mallei) 
• Burkholderia pseudomallei (formerly Pseudomonas pseudomallei) 
• Clostridium perfringens epsilon toxin (more than 100 mg) 
• Coccidioides immitis 
• Coxiella burnetii 
• Eastern equine encephalitis virus 
• Francisella tularensis 
• Hendra virus 
• Nipah virus 
• Rift Valley fever virus (non-vaccine strain (MP-12)) 
• Shigatoxin (more than 100 mg) 
• Staphylococcal enterotoxins (more than 5 mg) 
• T-2 toxin (more than 1,000 mg) 
• Venezuelan equine encephalitis virus (non-vaccine strain (TC-83))  
3.1 Bacillus anthracis33  
Clinical Manifestations:  Anthrax is caused by Bacillus anthracis. Humans acquire the disease directly 
from contact with infected herbivores or indirectly via their products. The clinical forms include (1) 
cutaneous anthrax (eschar with edema), from handling infected material (this accounts for more than 95 
percent of cases); (2) intestinal anthrax, from eating infected meat; and (3) pulmonary anthrax, from 
inhaling spore-laden dust. Several other Bacillus spp, in particular B cereus and to a lesser extent B 
subtilis and B licheniformis, are periodically associated with bacteremia/septicemia, endocarditis, 
meningitis, and infections of wounds, the ears, eyes, respiratory tract, urinary tract, and gastrointestinal 
tract. Bacillus cereus causes two distinct food poisoning syndromes: a rapid-onset emetic syndrome 
characterized by nausea and vomiting, and a slower-onset diarrheal syndrome. 
Structure and Classification:  Bacillus species are rod-shaped, endospore-forming aerobic or 
facultatively anaerobic, Gram-positive bacteria; in some species cultures may turn Gram-negative with 
age. The many species of the genus exhibit a wide range of physiologic abilities that allow them to live in 
every natural environment. Only one endospore is formed per cell. The spores are resistant to heat, cold, 
                                                 
33Turnbull, Peter C. B.  Medical Microbiology, Fourth Edition, Bacillus chapter.  
http://gsbs.utmb.edu/microbook/ch015.htm  
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radiation, desiccation, and disinfectants. Bacillus anthracis needs oxygen to sporulate; this constraint has 
important consequences for epidemiology and control. In vivo, B anthracis produces a polypeptide 
(polyglutamic acid) capsule that protects it from phagocytosis. The genera Bacillus and Clostridium 
constitute the family Bacillaceae. Species are identified by using morphologic and biochemical criteria. 
Pathogenesis:  The virulence factors of B anthracis are its capsule and three-component toxin, both 
encoded on plasmids. Bacillus cereus produces numerous enzymes and aggressins. The principal 
virulence factors are a necrotizing enterotoxin and a potent hemolysin (cereolysin). Emetic food 
poisoning probably results from the release of emetic factors from specific foods by bacterial enzymes. 
Host Defenses:  The reasons for marked differences in susceptibility to anthrax among different animal 
species are not known. The protective actions of the live-spore animal vaccine or the human chemical 
vaccines are based on induction of humoral and cell-mediated immunity to the protective antigen 
component of anthrax toxin. 
Epidemiology:  Individuals at risk for anthrax include those in contact with infected animals or animal 
products. Episodes of B cereus food poisoning occur sporadically worldwide and result from ingestion of 
contaminated food in which the bacteria have multiplied to high levels under conditions of improper 
storage after cooking. 
Diagnosis:  Cutaneous anthrax is diagnosed on the basis of the characteristic papule (early) or eschar 
(later) with extensive surrounding edema, backed by a history of exposure to animals or their products. 
Diagnosis is confirmed by observation of characteristic encapsulated bacilli in polychrome methylene 
blue-stained smears of blood, exudate, lymph, cerebrospinal fluid, etc., and/or by culture. Other Bacillus 
infections are diagnosed by culture of the bacteria. 
Control:  Control in animals is essential for control in humans. In endemic areas, animals that die 
suddenly should be handled cautiously and livestock should be vaccinated annually. A human vaccine is 
available for individuals in high-risk occupations. Anthrax is readily treated with antibiotics (e.g., 
penicillin, tetracycline, chloramphenicol, gentamicin, or erythromycin). 
Pharmaceutical, Agricultural, and Industrial Importance:  Many of the physiologic properties and 
specialized metabolites of Bacillus species are used in the pharmaceutical, agricultural, and food 
industries. On the other hand, the resistance of the spores to sterilization and disinfection makes them 
problem contaminants in foods, medical supplies, surgical procedures, etc. 
3.2 Botulinum neurotoxins34 
Introduction:  Botulinum toxin is very strong poison produced by the microorganism Clostridium 
botulinum. C. botulinum is classified as a single species but consists of at least three genetically 
distinguishable groups of organisms. These are alike in their abilities to produce neurotoxins with similar 
pharmacological activities but diverse serologic properties (toxin types A, B, C, D, E, F, and G). These 
types are defined by the International Standards for Clostridium botulinum Antitoxin. Botulinum toxins 
are the causative agents of botulism, a potentially fatal condition of neuromuscular paralysis. Botulism is 
characterized by symmetric, descending, flaccid paralysis of motor and autonomic nerves, usually 
beginning with the cranial nerves. Blurred vision, dysphagia, and dysarthria are common initial 
complaints. The diagnosis of botulism is based on compatible clinical findings; history of exposure to 
suspect foods; and supportive ancillary testing to rule out other causes of neurological dysfunction that 
mimic botulism, such as stroke, Guillain-Barré syndrome, and myasthenia gravis. Treatment includes 
supportive care and trivalent equine antitoxin, which reduces mortality if administered early.        
                                                 
34Price, Colonel Richard, ed. Applied Science and Analysis, Inc., The ASA Newsletter, ISSN 1057-9419, Botulinum 
Toxin: From Poison to Medicinal Agent by Jiri Patocka (Department of Toxicology, Military Medical Academy, 
Hradec Kralove and Faculty of Health and Social Care University of South Bohemia, Ceské Budejovice) and 
Miroslav Splino (Department of Epidemiology, Military Medical Academy, Hradec Kralove, Czech Republic).  
http://www.asanltr.com/newsletter/02-1/articles/Botulinum.htm  
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Clinicians are the first to treat patients in any type of botulism outbreak. It is important that they know 
how to recognize, diagnose, and treat this rare but potentially lethal disease. Recently, the potential 
terrorist use of botulinum toxin has become an important concern. Human botulism is primarily caused by 
the strains of C. botulinum that produce toxin types A, B, and E. The strains of C. baratii, which produce 
type F toxin and C. butyricum, which produces type E toxin, also have been implicated in human 
botulism. Strains of C. botulinum that produce type C or type D toxin for the most part cause botulism 
only in nonhuman species. All these neurotoxigenic organisms are anaerobic, gram-positive, spore-
forming bacilli and are commonly found in soils throughout the world. C. botulinum organisms cause 
food poisoning because the heat-resistant spores survive food preservation methods that kill non-
sporulating organisms; they subsequently produce a potent neurotoxin under anaerobic, low-acid (pH > 
4.6), and low solute conditions. The toxins affect a broad range of vertebrate species, but the evolutionary 
utility of toxin production to the bacterial host organisms is unclear.  
Epidemiology:  Four clinical forms of botulism occur in humans: foodborne botulism; wound botulism; 
infant botulism; and, rarely, adult infectious botulism. Foodborne botulism is a public health emergency 
because the contaminated food may still be available to other people besides the patient. Studies in 
monkeys indicate that, if aerosolized, botulinum toxin also can be absorbed through the lungs. The 
persistence of botulinum toxin is very high: it remains in nonmoving water and food for weeks. Important 
changes in the epidemiology of botulism have emerged in the past few decades. Recently identified 
vehicles for foodborne botulism include homemade salsa and traditionally prepared salted or fermented 
fish. In recent years, restaurant-associated outbreaks accounted for a large proportion of botulism cases. 
Botulism is not spread from one person to another. Foodborne botulism can occur in all age groups. Infant 
botulism occurs in a small number of susceptible infants each year who harbor C. botulinum in their 
intestinal tract. It usually affects children in the first year of life (mortality 2 %), with the onset of 
obstipation, lethargy, ptosis, swallowing discomfort, hypotonia, general weakness, and distressed 
breathing. It accounts for 5 - 10 % of the Sudden Infant Death Syndrome (SIDS). 
Clinical Features of Botulism:  Foodborne botulism is caused by ingestion of preformed toxin produced 
in food by C. botulinum. The most frequent source is home-canned foods, in which spores that survive an 
inadequate cooking and canning process germinate and produce toxin in the anaerobic environment of the 
canned food. In the event of intentional foodborne poisoning with botulinum toxin, the signs and 
symptoms developing after ingestion would probably resemble those of naturally occurring foodborne 
botulism. If aerosolized toxin was inhaled, the incubation period might be slightly longer and 
gastrointestinal symptoms might not occur. The clinical syndrome of foodborne botulism is dominated by 
neurologic symptoms resulting from a toxin-induced block of the voluntary motor and autonomic 
cholinergic junctions. With foodborne botulism, symptoms begin within 6 hours to 2 weeks (most 
commonly between 12 and 36 hours) after eating toxin-containing food. Although the syndrome is similar 
for each toxin type, type A toxin has been associated with more severe disease and a higher fatality rate 
than type B or type E toxin. Symptoms from any toxin type may range from subtle motor weakness or 
cranial nerve palsies to rapid respiratory arrest. The initial symptoms of foodborne botulism may be 
gastrointestinal and can include nausea, vomiting, abdominal cramps, or diarrhea; after the onset of 
neurologic symptoms, constipation is more typical. Dry mouth, blurred vision, and diplopia are usually 
the earliest neurologic symptoms. These initial symptoms may be followed by dysphonia, dysarthria, 
dysphagia, and peripheral muscle weakness. Symmetric descending paralysis is characteristic of botulism. 
Paralysis begins with the cranial nerves, the upper extremities, the respiratory muscles, and, finally, the 
lower extremities in a proximal-to-distal pattern. Onset usually occurs 18 to 36 hours after exposure. In 
severe cases, extensive respiratory muscle paralysis leads to ventilatory failure and death unless 
supportive care is provided. Patients have required ventilatory support for up to 7 months before the 
return of muscular function, but ventilatory support is most commonly needed for 2 to 8 weeks. Clinical 
recovery generally occurs over weeks to months; electron microscopic evidence suggests that clinical 
recovery correlates with the formation of new presynaptic end plates and neuromuscular junctions. Before 
mechanical ventilation and intensive supportive care, up to 60% of patients died. Death now occurs in 5% 
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to 10% of cases of foodborne botulism; early deaths result from a failure to recognize the severity of 
disease, whereas deaths after 2 weeks result from complications of long-term mechanical ventilatory 
management. Administration of trivalent or heptavalent botulinum antitoxin is recommended as the 
treatment for Botulinum toxin poisoning (in USA, CDC - Center for Disease Control, Atlanta, Georgia). 
Editor's Note: 
1. Botulinum toxins are very potent toxins with real potential as a biological agent for both warfare 
and terrorism. They also have great utility in medicine to treat spasmodic muscle disorders. 
Ironically, the more common they become in medical treatment, the more of a potential threat 
they become because they are produced commercially in relatively large amounts. But to put this 
in perspective, BotoxA is sold in vials of 100 U (20 U = 1 ng) as stated on the package insert. 
Even though it may only take 90 g to contaminate a typical large reservoir, it will take over a 
billion of these vials to contaminate the reservoir to 1 ng/L.  
2. The toxicity of botulinum toxin is usually expressed in mouse unit (U), where one unit (U) of 
Botulinum toxin A is the median intraperitoneal lethal dose (LD50) in mice and is approximately 
20 units/nanogram (1U=about 0.05 ng). The lethal dose in humans is not known, but 
extrapolating monkey data to a 70 kg human implies a parenteral lethal dose of nearly 3000 U, 
i.e., 4.3 µg. According to JAMA, 285, 28 Feb 2001, "Botulinum Toxin as a Biological Weapon" 
by Stephen S. Amon, et. al., the lethal dose for humans, extrapolated from monkey data is 0.09-
0.15 µg of toxin by iv and im., 0.70-0.90 µg by inhalation and 70 µg orally. 
3.3 Botulinum neurotoxin producing species of Clostridium35 
Clostridium botulinum is an anaerobic, Gram-positive, spore-forming rod that produces a potent 
neurotoxin. The spores are heat-resistant and can survive in foods that are incorrectly or minimally 
processed. Seven types (A, B, C, D, E, F and G) of botulism are recognized, based on the antigenic 
specificity of the toxin produced by each strain. Types A, B, E and F cause human botulism. Types C and 
D cause most cases of botulism in animals. Animals most commonly affected are wild fowl and poultry, 
cattle, horses and some species of fish. Although type G has been isolated from soil in Argentina, no 
outbreaks involving it have been recognized.  
See also – Botulinum neurotoxins 
3.4 Brucella abortus36 
Clinical Manifestations:  Brucellosis is a severe acute febrile disease caused by bacteria of the genus 
Brucella. Relapses are not uncommon; focal lesions may occur in bones, joints, genitourinary tract, and 
other sites. Hypersensitivity reactions can follow occupational exposure. Infection may be subclinical. 
Chronic infections may occur. 
Structure:  Brucellae are Gram-negative coccobacilli; non-spore-forming and non-motile; aerobic, but 
may need added CO2. 
Classification and Antigenic Types:  Three species (B melitensis, B abortus, B suis) are important human 
pathogens; B canis is of lesser importance. Species are differentiated by production of urease and H2S, 
dye sensitivity, cell wall antigens and phage sensitivity. The major species are divided into multiple 
biovars. 
                                                 
35U.S. Food & Drug Administration, Center for Food Safety & Applied Nutrition, Foodborne Pathogenic 
Microorganisms and Natural Toxins Handbook - Clostridium botulinum.   
http://vm.cfsan.fda.gov/~mow/chap2.html 
36Alton, G. G., and J.R.L. Forsyth.   Medical Microbiology, Fourth Edition, Brucella chapter. 
http://gsbs.utmb.edu/microbook/ch028.htm  
  
 
99
Pathogenesis:  Portals of entry are the mouth, conjunctivae, respiratory tract and abraded skin. Organisms 
spread, possibly in mononuclear pha gocytes, to reticuloendothelial sites. Small granulomas reveal a 
mononuclear response; hypersensitivity is a major factor. 
Host Defenses:  Effective host defense depends mainly upon cell-mediated immunity.  
Epidemiology:  Brucellosis is a zoonosis, acquired from handling of infected animals or consuming 
contaminated milk or milk products. Exposure is frequently occupational. The disease is now uncommon 
in the United States and Britain but common in the Mediterranean and Arabian Gulf regions, Latin 
America, Africa, and parts of Asia. 
Diagnosis:  Diagnosis can be made clinically if there is a history of exposure. Blood cultures may be 
positive in early disease but serology is mainstay of diagnosis. Interpretation is complicated by subclinical 
infections and persistent levels of antibody. 
Control:  Brucellosis is prevented by pasteurizing milk, eradicating infection from herds and flocks, and 
observing safety precautions (protective clothing and laboratory containment). The disease is treated with 
doxycycline, streptomycin and rifampin. 
3.5 Brucella melitensis  
See Brucella abortus 
3.6 Brucella suis 
See Brucella abortus 
3.7 Burkholderia mallei (formerly Pseudomonas mallei) 
Only two species, P mallei and P pseudomallei, produce specific human diseases: glanders and 
melioidosis.   Unlike most pseudomonads, P mallei and P pseudomallei can cause disease in otherwise 
healthy individuals. Pseudomonas mallei is the agent of glanders, a disease primarily of equines. Humans 
generally become infected by inhalation or by direct contract through abraded skin. These infections are 
frequently fatal within 2 weeks of onset, although chronic infections also have been reported. Today, P 
mallei infections of equines are controlled and are rarely encountered in the western world. Similarly, 
melioidosis, an endemic glanderslike disease of animals and a human pulmonary infection caused by P 
pseudomallei, is rare in the western hemisphere. Melioidosis is still found in Southeast Asia, and travelers 
returning from that area are sometimes infected.37  
Glanders38  
(Droes, Farcy, Malleus)  
Definition:  Glanders is a highly contagious disease of solipeds caused by Pseudomonas mallei and 
characterized by nodular lesions of the lungs and other organs as well as ulcerative lesions of the skin and 
mucous membranes of the nasal cavity and respiratory passages. The disease typically has a progressive 
course and poses a significant human health risk.  
Etiology:   Glanders is caused by the bacteria Pseudomonas mallei. Former names of this pathogen 
include Loefflerella mallei, Pfeifferella mallei, Malleomyces mallei, Actinobacillus mallei, 
Corynebacterium mallei, Mycobacterium mallei, and Bacillus mallei. In experimental infection of guinea 
pigs Ps. mallei produces a tenacious capsule that may serve to protect it from phagocytosis. The organism 
                                                 
37Iglewski, Barbara H.   Medical Microbiology, Fourth Edition, Pseudomonas chapter.   
http://gsbs.utmb.edu/microbook/ch027.htm   
38Committee on Foreign Animal Diseases of the United States Animal Health Association, revised 1998.  Foreign 
Animal Diseases, “The Gray Book,” Part IV, Animal Health Association, Library of Congress Catalog Card 
Number 17-12842, Pat Campbell & Associates and Carter Printing Company, Richmond, VA.   
http://www.vet.uga.edu/vpp/gray_book/FAD/GLA.htm  
  
 
100
is closely related to Ps. pseudomallei, the cause of melioidosis, and is serologically indistinguishable in 
some cases. Genetic homology between Ps. mallei and Ps. pseudomallei approaches 70 percent. Because 
of this many consider them to be biotypes or isotypes.  
The organism is destroyed by direct sunlight and is sensitive to desiccation. It is readily killed by 
common disinfectants. It may survive for up to 6 weeks in infected stables.  
Host Range:  Glanders is primarily a disease of solipeds — particularly horses, donkeys, and mules. 
Traditionally, donkeys have been regarded as most likely to experience the acute form of the disease and 
horses a more chronic form, with mules intermediate in susceptibility. Recent reports suggest that chronic 
and even latent infections are equally likely in mules. Carnivores are susceptible to disease if they 
consume glandered meat; felids appear to more susceptible than canids, and outbreaks of glanders in 
captive wild felids have been reported. Several laboratory animals are susceptible to infection including, 
hamsters and guinea pigs. The susceptibility of the latter species formed the basis of the Strauss reaction 
in the diagnosis of the disease. Humans also are susceptible to infection with glanders, which is an 
important occupational disease of veterinarians, farriers, and other animal workers. Swine and cattle are 
resistant to infection with Ps. mallei, but goats can be infected.  
Geographic Distribution:  Glanders is currently limited to parts of Asia, Africa, the Middle East, and 
Asia (specifically Turkey, Syria, Iraq, Iran, Pakistan, India, Burma, Indonesia, the Philippines, China, and 
Mongolia) and possibly the Balkan states, former Soviet republics, Mexico, and South America. Cross-
reactions with serological tests for Ps. pseudomallei may confound estimates of worldwide distribution. 
Although glanders was once widespread throughout the world, it has been eradicated from many 
countries by diligent test and slaughter programs.  
Transmission:   The disease is introduced into horse populations by diseased or latently infected animals. 
Ingestion of the pathogen, present in secretions from infected animals, constitutes the major route of 
infection in glanders. Experimental evidence suggests that inhalation of the organism is less likely to 
result in typical cases of the disease. Although invasion by way of skin lesions is possible, it is regarded 
as being of minor importance in the natural spread of the disease. Close proximity alone does not usually 
result in transmission of glanders; transmission is facilitated if the animals share feeding troughs or 
watering facilities or if they nuzzle each other.  
Incubation Period:  After artificial infection, a fever, 106 degrees F (41 degrees C), develops in about 3 
days and clinical signs within a week. After natural infection, weeks or months may elapse before 
manifestations of the disease are apparent. Such latent infections are a feature of the epidemiology of 
glanders.  
Clincial Signs:  Classical descriptions of glanders distinguish between cutaneous, nasal, and pulmonary 
forms of the disease, but in most outbreaks these forms are not clearly distinct and may occur 
simultaneously in an animal. Chronic infections with slow progression of an insidious disease are more 
common than the acute form of glanders. The acute form (more common in donkeys and mules than in 
horses) typically progresses to death within about a week.  
The nasal form of glanders is characterized by unilateral or bilateral nasal discharge. The yellowish-green 
exudate is highly infectious. The nasal mucosa has nodules and ulcers. These ulcers may coalesce to form 
large ulcerated areas, or they may heal as stellate scars of the mucosa. In some cases the septum may even 
be perforated. Nasal lesions are accompanied by enlargement and induration, or sometimes rupture and 
suppuration, of regional lymph nodes.  
In the cutaneous form of glanders, multiple nodules may develop in the skin of the legs or other parts of 
the body. These nodules may rupture, leaving ulcers that discharge a yellow exudate to the skin surface 
and heal slowly. Cutaneous lymphatic vessels in the region become involved. They become distended and 
firm by being filled with a tenacious, purulent exudate (These may be referred to as "Farcy pipes.") In the 
pulmonary form of glanders, lesions in the lungs develop in concert with nasal and cutaneous lesions or 
may be the sole manifestation of the disease (typical of latent cases). The lung lesions begin as firm 
nodules or as a diffuse pneumonic process. The nodules are gray or white and firm, surrounded by a 
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hemorrhagic zone, and may become caseous or calcified. Clinical signs in animals with lung lesions may 
only range from inapparent infection to mild dyspnea, or severe coughing and obvious lower respiratory 
tract involvement.  
Lesions may also occur in the liver or spleen and, in male animals, glanderous orchitis is a common 
lesion.  
Gross Lesions:  Nodular lesions of glanders are most consistently found beneath the pleura of the lung. In 
some acute cases, however, a more diffuse form of lobular pneumonia may be present. The nodular 
lesions, typically about 1 cm in diameter, consist of a gray or white core of necrotic material that may 
become calcified and are surrounded by a zone of hyperemia and edema. Similar lesions may be found in 
other viscera. Glanderous orchitis may be seen in intact males.  
Nasal lesions consist of submucosal nodules surrounded by a small zone of hyperemia. These nodules 
may rupture, leaving exudative ulcers. As new lesions develop it is not unusual to find small nodules, 
ulcers, and scars side by side. Lymphadenitis of associated lymph nodes is a consistent finding. In some 
cases laryngeal lesions similar to the nasal lesions may be found.  
Cutaneous lesions consist of cord-like thickening of subcutaneous lymphatics along which are distributed 
chains of nodules, some of which are ulcerated.  
Morbidity and Mortality:  When horses, donkeys, and mules are concentrated, the morbidity can be high.  
Diagnosis  
Field Diagnosis  
Typical nodules, ulcers, scars, and a debilitated condition can be sufficient to diagnose glanders. 
Unfortunately, many cases of glanders are latent and clinically inapparent. Therefore, systematic testing is 
essential to identify all infected animals in an outbreak. The mallein test has been the mainstay of field 
diagnosis. Mallein is a lysate of Ps. mallei containing both endotoxins and exotoxins elaborated by the 
organism. Infected animals are allergic to mallein and exhibit local and systemic hypersensitivity after 
mallein inoculation similar to that exhibited in tuberculin testing. Inoculation with mallein may trigger a 
humoral serologic reaction to the complement fixation test. This seroconversion is thought to be transient 
but may be permanent if the animal undergoes repeated mallein testing. This is extremely important to 
consider if animals are destined for export to countries that depend on the complement fixation test.  
The preferred method of application of mallein is intrapalpebral. The mallein (0.1 ml) is injected into the 
dermis of the lower eyelid. In positive cases marked edema of the eyelid, purulent conjunctivitis, 
photophobia, pain, and depression may be observed within 12 to 72 hours. The test is usually read 48 
hours after injection.  
The ophthalmic mallein test consists of the instillation of mallein into the conjunctival sac. A positive 
reaction is characterized by development of severe purulent conjunctivitis within 6 to 12 hours. A larger 
volume of dilute mallein (2.5 MI) may be injected subcutaneously, causing fever, local swelling, and pain 
in positive animals.  
Specimens for Laboratory  
A whole or section of a lesion and a serum sample should be collected aseptically. The samples should be 
kept cool and shipped on wet ice as soon as possible. Sections of lesions in 10 percent buffered formalin 
and air-dried smears of exudate on glass slides should be submitted for microscopic examination.  
Laboratory Diagnosis  
The causative organism may be cultured from fresh lesions or lymph nodes. It may also be demonstrated 
micoscopically in films made from this material.  
The Strauss reaction is observed when infectious material from glanders patients is injected 
intraperitoneally into male guinea pigs. In positive cases, the guinea pig develops localized peritonitis 
involving the scrotal sac. Glanderous orchitis follows with painful enlargement of the testes. The testis 
becomes enlarged and painful and ultimately necrotic and is discharged through the scrotal skin.  
  
 
102
A variety of serologic tests for glanders have been developed. They are superior to mallein testing in 
sensitivity and specificity. The complement fixation test is widely used and is reported to have an overall 
accuracy of 95 pecent. A counter-immunoelectrophoresis test has been described. Recently a dot enzyme-
linked immunosorbent assay has been developed and found to be superior to all previously described tests 
in its sensitivity. This test is inexpensive, rapid, and easy to perform and is not influenced by 
anticomplement activity. Cross-reactions with Ps. pseudomallei, the cause of melioidosis, are features of 
all of the serological tests for glanders. Therefore, these tests will result in false positive reactions in 
animals from areas where melioidosis is endemic.  
Differential Diagnosis  
Signs of glanders must be distinguished from strangles, epizootic lymphangitis, ulcerative lymphangitis, 
melioidosis, and other forms of pneumonia. Purulent sinusitis, guttural pouch empyema, and other causes 
of nasal catarrh should also be considered. Skin lesions may be similar to those of dermatophilosis or 
dermatomycoses such as sporotrichosis. Knowledge of the progressive debilitating nature of glanders and 
application of serological or mallein tests will serve to distinguish glanders from other similar diseases.  
Strangles is caused by Streptococcus equi. It is characterized by fever, anorexia, and depression with 
swollen submandibular lymph nodes and mucopurulent nasal discharge. The nasal discharge is usually 
bilateral, whereas it is most often unilateral in cases of glanders. Skin nodules and typical lung lesions are 
absent. Animals with strangles will not react to mallein testing or serological tests for glanders. S. equi is 
readily demonstrable. Strangles does not develop into a chronic, debilitating condition, and most infected 
horses recover within a few weeks.  
Epizootic lymphangitis (caused by Histoplasma farciminosum) is characterized by cutaneous nodules 
originating from superficial lymph vessels. In epizootic lymphangitis, conjunctivitis is a common lesion. 
Demonstration of the infectious agent and application of the mallein test and serological testing will help 
distinguish between these diseases.  
Ulcerative lymphangitis (caused by Corynebacterium pseudotuberculosis) is characterized by dermatitis 
and abscess formation predominantly in the pectoral and ventral abdominal regions. Standard diagnostic 
tests are again valuable in distinguishing this disease from glanders.  
Melioidosis (caused by Ps. pseudomallei) is characterized by multiple abscesses in a variety of tissues and 
organs. Unlike glanders, it is not specifically a disease of equids and occurs most often in sheep, goats, 
and swine. It is characterized by dyspnea and lameness, but a wide array of clinical signs may be elicited. 
Diagnosis is confirmed by isolation of the causative organism. Serological cross-reactions occur with Ps. 
mallei.  
Treatment:  Ps. mallei is sensitive to many antimicrobials, but the risk of spreading infection to other 
equids or to people dictates that infected animals be destroyed. This policy has successfully eradicated 
glanders from most parts of the world. Sulfonamides have traditionally been used for the treatment of 
human infection.  
Vaccination:  Protective vaccines have not been developed.  
Control and Eradication:  In endemic areas, routine testing and destruction of positive animals have 
proven successful in the eradication of the disease. Particular care is required where animals are 
congregated — most often for military purposes. In endemic areas, communal feeding and watering sites 
should be avoided.  
Ps. mallei is quite sensitive to heat, desiccation, and common disinfectants. In warm, moist environments, 
however, it may remain viable for several months. In outbreaks it is important to bury or burn all 
contaminated bedding and foodstuffs to prevent infection of susceptible animals. Stalls and harness 
equipment should be thoroughly disinfected. Removal of susceptible species from contaminated premises 
for a period of months is advisable.  
Public Health:  People are susceptible to glanders. The human form of the disease is painful and 
frequently fatal. Laboratory workers and animal attendants are most at risk. Symptoms of glanders in 
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people include nodular eruption on the face, legs, and arms; involvement of the nasal mucosa; and later 
pyemia and metastatic pneumonia. Human glanders may be confused with a variety of other diseases, 
including typhoid fever, tuberculosis, syphilis, erysipelas, lymphangitis, pyemia, yaws, and melioidosis. 
The diagnosis can be confirmed by serology and by isolation of the causative organism.  
3.8 Burkholderia pseudomallei (formerly Pseudomonas pseudomallei)39 
Melioidosis 
(Burkholderia pseudomallei)  
What is melioidosis? Melioidosis, also called Whitmore’s disease, is an infectious disease caused by the 
bacterium Burkholderia pseudomallei. Melioidosis is clinically and pathologically similar to glanders 
disease, but the ecology and epidemiology of melioidosis are different from glanders. Melioidosis is 
predominately a disease of tropical climates, especially in Southeast Asia where it is endemic. The 
bacteria causing melioidosis are found in contaminated water and soil and are spread to humans and 
animals through direct contact with the contaminated source. Glanders is contracted by humans from 
infected domestic animals.  
Why has melioidosis become a current issue? Burkholderia pseudomallei is an organism that has been 
considered as a potential agent for biological warfare and biological terrorism.  
How common is melioidosis and where is it found? Melioidosis is endemic in Southeast Asia, with the 
greatest concentration of cases reported in Vietnam, Cambodia, Laos, Thailand, Malaysia, Myanmar 
(Burma), and northern Australia. Additionally, it is seen in the South Pacific, Africa, India, and the 
Middle East. In many of these countries, Burkholderia pseudomallei is so prevalent that it is a common 
contaminate found on laboratory cultures. Moreover, it has been a common pathogen isolated from troops 
of all nationalities that have served in areas with endemic disease. A few isolated cases of melioidosis 
have occurred in the Western Hemisphere in Mexico, Panama, Ecuador, Haiti, Brazil, Peru, Guyana, and 
in the states of Hawaii and Georgia. In the United States, confirmed cases range from none to five each 
year and occur among travelers and immigrants.  
How is melioidosis transmitted and who can get it? Besides humans, many animal species are 
susceptible to melioidosis. These include sheep, goats, horses, swine, cattle, dogs, and cats. Transmission 
occurs by direct contact with contaminated soil and surface waters. In Southeast Asia, the organism has 
been repeatedly isolated from agriculture fields, with infection occurring primarily during the rainy 
season. Humans and animals are believed to acquire the infection by inhalation of dust, ingestion of 
contaminated water, and contact with contaminated soil especially through skin abrasions, and for 
military troops, by contamination of war wounds. Person-to-person transmission can occur. There is one 
report of transmission to a sister with diabetes who was the caretaker for her brother who had chronic 
melioidosis. Two cases of sexual transmission have been reported. Transmission in both cases was 
preceded by a clinical history of chronic prostatitis in the source patient.  
What are the symptoms of melioidosis? Illness from melioidosis can be categorized as acute or localized 
infection, acute pulmonary infection, acute bloodstream infection, and chronic suppurative infection. 
Inapparent infections are also possible. The incubation period (time between exposure and appearance of 
clinical symptoms) is not clearly defined, but may range from 2 days to many years.  
Acute, localized infection: This form of infection is generally localized as a nodule and results from 
inoculation through a break in the skin. The acute form of melioidosis can produce fever and general 
muscle aches, and may progress rapidly to infect the bloodstream.  
                                                 
39CDC, Division of Mycotic and Bacterials Disease, Disease Information, Melioidosis.  
http://www.cdc.gov/ncidod/dbmd/diseaseinfo/melioidosis_g.htm 
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Pulmonary infection: This form of the disease can produce a clinical picture of mild bronchitis to severe 
pneumonia. The onset of pulmonary melioidosis is typically accompanied by a high fever, headache, 
anorexia, and general muscle soreness. Chest pain is common, but a nonproductive or productive cough 
with normal sputum is the hallmark of this form of melioidosis.  
Acute bloodstream infection: Patients with underlying illness such as HIV, renal failure, and diabetes 
are affected by this type of the disease, which usually results in septic shock. The symptoms of the 
bloodstream infection vary depending on the site of original infection, but they generally include 
respiratory distress, severe headache, fever, diarrhea, development of pus-filled lesions on the skin, 
muscle tenderness, and disorientation. This is typically an infection of short duration, and abscesses will 
be found throughout the body.  
Chronic suppurative infection: Chronic melioidosis is an infection that involves the organs of the body. 
These typically include the joints, viscera, lymph nodes, skin, brain, liver, lung, bones, and spleen.  
How is melioidosis diagnosed? Melioidosis is diagnosed by isolating Burkholderia pseudomallei from 
the blood, urine, sputum, or skin lesions. Detecting and measuring antibodies to the bacteria in the blood 
is another means of diagnosis. 
Can melioidosis be spread from person to person? Melioidosis can spread from person to person by 
contact with the blood and body fluids of an infected person. Two documented cases of male-to-female 
sexual transmission involved males with chronic prostatic infection due to melioidosis.  
Is there a way to prevent infection? There is no vaccine for melioidosis. Prevention of the infection in 
endemic-disease areas can be difficult since contact with contaminated soil is so common. Persons with 
diabetes and skin lesions should avoid contact with soil and standing water in these areas. Wearing boots 
during agricultural work can prevent infection through the feet and lower legs. In health care settings, 
using common blood and body fluid precautions can prevent transmission.  
Is there a treatment for melioidosis? Most cases of melioidosis can be treated with appropriate 
antibiotics. Burkholderia psuedomallei, the organism that causes melioidosis, is usually sensitive to 
imipenem, penicillin, doxycycline, amoxycillin-clavulanic acid, azlocillin, ceftazidime, ticarcillin-vulanic 
acid, ceftriaxone, and aztreonam. Treatment should be initiated early in the course of the disease. 
Although bloodstream infection with melioidosis can be fatal, the other types of the disease are nonfatal. 
The type of infection and the course of treatment can predict any long-term sequelae. 
3.9 Clostridium perfringens epsilon toxin40 
Enterotoxemia is one of the very important diseases and in some areas it is the most prevalent disease of 
goats. Despite the fact that it is also called ''Overeating Disease'' [or Pulpy Kidney Disease] it is not 
caused by overeating. Actually, the cause (etiology) of the disease is the toxin (poison) produced by the 
bacterium Clostridium perfringens type C or type D. 
The bacteria are normally present in the soil and the intestinal tract in relatively small numbers.  Under 
certain conditions the organisms proliferate in the intestine and produce toxin in lethal quantities.  
The Type D infection is probably far more common than Type C. The latter type produces a toxin called 
''Beta Toxin'' which causes intestinal necrosis and severe intestinal hemorrhage. It occurs in adult goats. 
Epsilon toxin is produced by the Type D bacteria. It produces vascular damage and increases the 
permeability (openness) facilitating its own absorption. In the animals that die with neither signs nor     
tissue changes, an extremely large amount of toxin was absorbed very rapidly.  When less toxin is 
produced, the animal lives longer and there is more time for clinical signs and pathological changes to     
develop. 
                                                 
40Ayers, J. L., 1992.   Extension Goat Handbook, National Agricultural Library, ENTEROTOXEMIA; 
Los Olivos, S. B. Guss; Pennsylvania State U., University Park.  
http://www.inform.umd.edu/EdRes/Topic/AgrEnv/ndd/goat/ENTEROTOXEMIA.html  
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The Acute course of disease lasts 4-26 hours and usually ends in death. Initially the temperature may go 
to 105F with severe abdominal pain (the kid cries so loudly it is best described as screaming).  Profuse 
slimy or water diarrhea will occur.  Depression, wobbly gait, recumbancy (lying down on side often with 
head down) occur early. Convulsions often occur intermittently and may be accompanied by continuous 
or intermittent opisthotonos (head thrown straight over back).  The animal may slip into a coma before 
death or die groaning or even crying. These signs occur in kids but can occur in adult milking goats from 
either Type C or D bacteria. 
Tissue Changes:  Type D causes mild to moderate (occasionally severe) inflammation and even 
hemorrhage of the small intestinal mucosa. Petechial hemorrhages may be present anywhere in the body 
but especially on the epicardium and endocardium. The pericardial sac may contain slight excess of 
yellow fluid. Microscopic examination of the brain may reveal degeneration of the vascular endothelium 
with perivascular and intercellular edema with foci of necrosis in several subcortical areas. 
The petechial hemorrhages, especially on the epicardium should make one think of enterotoxemia. 
However, one should look for at least two other signs which together give good presumptive evidence of     
enterotoxemia; these are, glucosuria and the presence of many short, plump gram positive rods on an 
intestinal smear. 
Prevention and Treatment:  Vaccination, with Cl perfringens type C and D toxoid by the following 
schedule along with the good feeding practices of making changes and increases in feed and milk 
gradually, has provided excellent prevention of the disease.  
3.10 Coccidioides immitis41 
Synonym: Coccidioidomycosis, Valley fever, Desert fever 
Characteristics: Dimorphic fungus, reproduces by arthroconidia, swelling of arthroconidia in vivo into 
spherules (which burst and release endospores) 
Pathogenicity: Systemic mycosis beginning as a respiratory infection; primary infection asymptomatic or 
influenza-like; 1/5 clinical cases develop erythema nodosum; rare progression to disseminated disease 
(more common in pregnant women, blacks and filipinos); progressive, frequently fatal granulomatous 
disease with lung lesions and abscesses throughout body. Meningitis common, 90% fatal if not treated. 
Increasingly important in immunocompromised patients. 
Epidemiology: Primary infections common in arid and semiarid areas of Western Hemisphere (California 
to South Texas, northern Argentina, Paraguay, Colombia, Venezuela, Mexico and Central America); 
dusty fomites from endemic areas can transmit infection elsewhere; affects all ages, both sexes and all 
races; most frequent in summer after wind and dust storms 
Host Range: Humans, domestic animals, cattle and horses, sheep, swine, wild desert rodents and other 
animals 
Infectious Dose: Unknown 
Mode of Transmission: Inhalation of infective arthroconidia from soil (arthroconidium is 2-5 µm with 
high propensity for airborne transmission and retention in deep pulmonary spaces); laboratory accidents 
involving cultures are common; parasitic spherules not usually infective (larger size 30-60 µm of spherule 
reduces effectiveness of this form as an airborne pathogen) but accidental inoculation of infected pus or 
other materials can result in granuloma formation. 
Incubation Period: One to 4 weeks in primary infection; disseminated infection may develop insidiously, 
sometimes without recognized symptoms of primary infection. 
Communicability: Not directly transmitted from person to person; parasitic form on dressings or casts 
and in clinical specimen may however change to the infective form after 7 days. 
                                                 
41Office of Laboratory Security, January 2000.  ©Health Canada, Population and Public Health Branch, 
Material and Safety Data Sheet.  http://www.hc-sc.gc.ca/pphb-dgspsp/msds-ftss/msds40e.html 
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Resevoir: Soil; especially in and around indian middens and rodent burrows, in regions with appropriate 
temperature, moisture and soil requirements. 
Zoonosis: Not directly transmitted from animal to humans. 
Vectors: None. 
Drug Suseptibility: Sensitive to Amphotericin B, ketoconazole and itraconazole for chronic infections, 
fluoconazole for meningeal infections. 
Suseptibility to Disinfectanta: Susceptible to 1% sodium hypochlorite, phenolics, glutaraldehyde, 
formaldehyde; susceptibility to 70% ethanol questionable. 
Physical Incapacitation: Spores can withstand dry heat; inactivation by moist heat 121°C for at least 15 
min. 
Survival Outside Host: Arthrospores survive for months to years in soil, dust. 
First Aid/Treatment: Amphotericin B for severe or disseminated forms. 
Immunization: None 
Prophalaxis: None 
Containment Requirements: Biosafety level 3 practices, containment equipment and facilities are 
recommended for all activities with cultures of C. immitis and for processing soil or other materials 
known or likely to contain infectious arthroconidia  
3.11 Coxiella burnetii42 
Q Fever 
Overview:  Q fever is a zoonotic disease caused by Coxiella burnetii, a species of bacteria that is 
distributed globally.  In 1999, Q fever became a notifiable disease in the United States but reporting is not 
required in many other countries. Because the disease is underreported, scientists cannot reliably assess 
how many cases of Q fever have actually occurred worldwide.  Many human infections are inapparent. 
Cattle, sheep, and goats are the primary reservoirs of C. burnetii.  Infection has been noted in a wide 
variety of other animals, including other breeds of livestock and in domesticated pets.  Coxiella burnetii 
does not usually cause clinical disease in these animals, although abortion in goats and sheep has been 
linked to C. burnetii infection.  Organisms are excreted in milk, urine, and feces of infected animals. Most 
importantly, during birthing the organisms are shed in high numbers within the amniotic fluids and the 
placenta.  The organisms are resistant to heat, drying, and many common disinfectants.  These features 
enable the bacteria to survive for long periods in the environment.  Infection of humans usually occurs by 
inhalation of these organisms from air that contains airborne barnyard dust contaminated by dried 
placental material, birth fluids, and excreta of infected herd animals.  Humans are often very susceptible 
to the disease, and very few organisms may be required to cause infection. 
Ingestion of contaminated milk, followed by regurgitation and inspiration of the contaminated food, is a 
less common mode of transmission.  Other modes of transmission to humans, including tick bites and 
human to human transmission, are rare. 
Signs and Symptoms in Humans:  Only about one-half of all people infected with C. burnetii show signs 
of clinical illness. Most acute cases of Q fever begin with sudden onset of one or more of the following: 
high fevers (up to 104-105° F), severe headache, general malaise, myalgia, confusion, sore throat, chills, 
sweats, non-productive cough, nausea, vomiting, diarrhea, abdominal pain, and chest pain. Fever usually 
lasts for 1 to 2 weeks. Weight loss can occur and persist for some time. Thirty to fifty percent of patients 
with a symptomatic infection will develop pneumonia. Additionally, a majority of patients have abnormal 
results on liver function tests and some will develop hepatitis. In general, most patients will recover to 
                                                 
42CDC, Viral and Rickettsial Zoonoses Branch.   http://www.cdc.gov/ncidod/dvrd/qfever/  
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good health within several months without any treatment. Only 1%-2% of people with acute Q fever die 
of the disease. 
Chronic Q fever, characterized by infection that persists for more than 6 months is uncommon but is a 
much more serious disease. Patients who have had acute Q fever may develop the chronic form as soon as 
1 year or as long as 20 years after initial infection. A serious complication of chronic Q fever is 
endocarditis, generally involving the aortic heart valves, less commonly the mitral valve. Most patients 
who develop chronic Q fever have pre-existing valvular heart disease or have a history of vascular graft. 
Transplant recipients, patients with cancer, and those with chronic kidney disease are also at risk of 
developing chronic Q fever. As many as 65% of persons with chronic Q fever may die of the disease.   
The incubation period for Q fever varies depending on the number of organisms that initially infect the 
patient. Infection with greater numbers of organisms will result in shorter incubation periods.  Most 
patients become ill within 2-3 weeks after exposure. Those who recover fully from infection may possess 
lifelong immunity against re-infection. 
Diagnosis:  Because the signs and symptoms of Q fever are not specific to this disease, it is difficult to 
make an accurate diagnosis without appropriate laboratory testing. Results from some types of routine 
laboratory tests in the appropriate clinical and epidemiologic settings may suggest a diagnosis of Q fever.  
For example, a platelet count may be suggestive because persons with Q fever may show a transient 
thrombocytopenia.  Confirming a diagnosis of Q fever requires serologic testing to detect the presence of 
antibodies to Coxiella burnetii antigens. In most laboratories, the indirect immunofluorescence assay 
(IFA) is the most dependable and widely used method. Coxiella burnetii may also be identified in 
infected tissues by using immunohistochemical staining and DNA detection methods. 
Coxiella burnetii exists in two antigenic phases called phase I and phase II. This antigenic difference is 
important in diagnosis. In acute cases of Q fever, the antibody level to phase II is usually higher than that 
to phase I, often by several orders of magnitude, and generally is first detected during the second week of 
illness.  In chronic Q fever, the reverse situation is true.  Antibodies to phase I antigens of C. burnetii 
generally require longer to appear and indicate continued exposure to the bacteria.  Thus, high levels of 
antibody to phase I in later specimens in combination with constant or falling levels of phase II antibodies 
and other signs of inflammatory disease suggest chronic Q fever. Antibodies to phase I and II antigens 
have been known to persist for months or years after initial infection. 
Recent studies have shown that greater accuracy in the diagnosis of Q fever can be achieved by looking at 
specific levels of classes of antibodies other than IgG, namely IgA and IgM.  Combined detection of IgM 
and IgA in addition to IgG improves the specificity of the assays and provides better accuracy in 
diagnosis.  IgM levels are helpful in the determination of a recent infection.  In acute Q fever, patients 
will have IgG antibodies to phase II and IgM antibodies to phases I and II.  Increased IgG and IgA 
antibodies to phase I are often indicative of Q fever endocarditis.   
Treatment:  Doxycycline is the treatment of choice for acute Q fever. Antibiotic treatment is most 
effective when initiated within the first 3 days of illness. A dose of 100 mg of doxycycline taken orally 
twice daily for 15-21 days is a frequently prescribed therapy.  Quinolone antibiotics have demonstrated 
good in vitro activity against C. burnetii and may be considered by the physician. Therapy should be 
started again if the disease relapses. 
Chronic Q fever endocarditis is much more difficult to treat effectively and often requires the use of 
multiple drugs. Two different treatment protocols have been evaluated: 1) doxycycline in combination 
with quinolones for at least 4 years and 2) doxycycline in combination with hydroxychloroquine for 1.5 to 
3 years. The second therapy leads to fewer relapses, but requires routine eye exams to detect 
accumulation of chloroquine. Surgery to remove damaged valves may be required for some cases of C. 
burnetii endocarditis. 
Prevention:  In the United States, Q fever outbreaks have resulted mainly from occupational exposure 
involving veterinarians, meat processing plant workers, sheep and dairy workers, livestock farmers, and 
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researchers at facilities housing sheep. Prevention and control efforts should be directed primarily toward 
these groups and environments. 
• The following measures should be used in the prevention and control of Q fever: 
• Educate the public on sources of infection.  
• Appropriately dispose of placenta, birth products, fetal membranes, and aborted fetuses at 
facilities housing sheep and goats.  
• Restrict access to barns and laboratories used in housing potentially infected animals.  
• Use only pasteurized milk and milk products.  
• Use appropriate procedures for bagging, autoclaving, and washing of laboratory clothing.  
• Vaccinate (where possible) individuals engaged in research with pregnant sheep or live C. 
burnetii.  
• Quarantine imported animals.  
• Ensure that holding facilities for sheep should be located away from populated areas.  Animals 
should be routinely tested for antibodies to C. burnetii, and measures should be implemented to 
prevent airflow to other occupied areas.  
• Counsel persons at highest risk for developing chronic Q fever, especially persons with pre-
existing cardiac valvular disease or individuals with vascular grafts.  
• A vaccine for Q fever has been developed and has successfully protected humans in occupational 
settings in Australia. However, this vaccine is not commercially available in the United States. 
Persons wishing to be vaccinated should first have a skin test to determine a history of previous 
exposure. Individuals who have previously been exposed to C. burnetii should not receive the 
vaccine because severe reactions, localized to the area of the injected vaccine, may occur. A 
vaccine for use in animals has also been developed, but it is not available in the United States. 
Significance for Bioterrorism:  Coxiella burnetii is a highly infectious agent that is rather resistant to 
heat and drying. It can become airborne and inhaled by humans. A single C. burnetii organism may cause 
disease in a susceptible person.  This agent could be developed for use in biological warfare and is 
considered a potential terrorist threat.    
3.12 Eastern equine encephalitis virus43 
Clinical Features:  Symptoms range from mild flu-like illness to frank encephalitis, coma and death.  
Etiologic Agent:  Eastern equine encephalitis virus, member of the family Togaviridae, genus Alphavirus.  
Closely related to western and Venezuelan equine encephalitis viruses.  
Incidence:  153 confirmed cases in the U.S. since 1964.  
Sequelae:  Mild to severe neurologic deficits in survivors.  
Costs:  Total case costs range from $21,000 for transiently infected individuals to $3 million for severely 
infected individuals.  Insecticide applications can cost as much as $1.4 million depending on the size of 
area treated.  
Transmission:  Mosquito-borne  
Risk Groups:  Residents of endemic areas and visitors.  Persons with outdoor work and recreational 
activities.  
Surveillance:  National Notifiable Diseases Surveillance System  
Trends:  Risk exposure increases as population expands into endemic areas  
                                                 
43CDC, Division of Vector-Borne Infectious Diseases, Arboviral Encephalitides, Fact Sheet 
http://www.cdc.gov/ncidod/dvbid/arbor/eeefact.htm  
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Challenges:   
• No licensed vaccine for human use 
• No effective therapeutic drug  
• Unknown overwintering cycle  
• Control measures expensive  
• Limited financial support of surveillance and prevention  
3.13 Francisella tularensis44 
Tuleramia 
Background:  Tularemia, a bacterial zoonosis, is caused by Francisella tularensis, one of the most 
infectious pathogenic bacteria known. It requires inoculation or inhalation of as few as 10 organisms to 
cause disease. 
F. tularensis is a small, nonmotile, aerobic, gram-negative coccobacillus. It has a thin lipopolysaccharide-
containing envelope and is a hard, non-spore-forming organism that survives for weeks at low 
temperatures in water, moist soil, hay, straw, and decaying animal carcasses. 
Tularemia occurs throughout much of North America and Eurasia. In the U.S., human cases have been 
reported from every state except Hawaii, with the majority occurring in south-central and western states. 
F. tularensis is found in widely diverse animal hosts and habitats and can be recovered from 
contaminated water, soil, and vegetation. A variety of small mammals, including voles, mice, water rats, 
squirrels, rabbits, and hares are natural reservoirs of infection. They acquire infection through tick, fly, 
and mosquito bites and by contact with contaminated environments. Epizootics with sometimes extensive 
die-offs of animal hosts may herald outbreaks of tularemia in humans. 
Humans can become incidentally infected through diverse environmental exposures: bites by infected 
arthropods; handling infectious animal tissues or fluids; direct contact with or ingestion of contaminated 
food, water, or soil; and inhalation of infective aerosols. Humans can develop severe and sometimes fatal 
illness, but do not transmit the disease to others. 
Worldwide incidence of naturally occurring tularemia is unknown. It is likely that the disease is greatly 
under-recognized and under-reported. In the U.S., reported cases have dropped sharply from several 
thousand/year prior to 1950 to fewer than 200/year in the 1990s. Between 1985 and 1992, 1409 cases and 
20 deaths were reported in the U.S., a case fatality rate of 1.4%. Most U.S. cases occur June–September, 
when arthropod-borne transmission is most common. Cases in winter most commonly occur among 
hunters and trappers who handle infected animal carcasses. 
F. tularensis could be used as a biological weapon in a number of ways, but an aerosol release would 
likely have the greatest adverse medical and public health consequences. 
Airborne F. tularensis would be expected to principally cause pleuropneumonitis, but some exposures 
might contaminate the eye, resulting in ocular tularemia; penetrate broken skin, resulting in 
ulceroglandular or glandular disease; or cause oropharyngeal disease with cervical lymphadenitis. 
                                                 
44Abstracted from Dennis, D.T., T. V. Inglesby, D. A. Henderson et al., Journal of the American Medical 
Association, June 6, 2001; vol. 285, no. 21:2763-2773.  CDC, Abstract: Tularemia as a Biological Weapon: 
Medical and Public Health Management.   
http://www.bt.cdc.gov/Agent/Tularemia/tularemia-biological-weapon-abstract.asp 
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Release in a densely populated area would be expected to result in an abrupt onset of large numbers of 
acute, nonspecific febrile illness beginning 3–5 days later (incubation range 1–14 days), with 
pleuropneumonitis developing in a significant proportion of cases during the ensuing days and weeks. 
Pathogenesis and clinical manifestations of tularemia:  F. tularensis can infect humans through the 
skin, mucous membranes, gastrointestinal tract, and lungs. It is a facultative intracellular bacterium that 
multiplies within macrophages. The major target organs are the lymph nodes, lungs and pleura, spleen, 
liver, and kidney. Untreated, bacilli inoculated into skin or mucous membranes multiply, spread to 
regional lymph nodes and further multiply, and then may disseminate to organs throughout the body. 
Bacteremia may be common in the early phase of infection. The initial tissue reaction to infection is a 
focal, intensely suppurative necrosis consisting largely of accumulations of polymorphonuclear 
leukocytes, followed by invasion of macrophages, epithelioid cells, and lymphocytes. 
Suppurative lesions become granulomatous, and histopathological examination of the granulomas shows 
a central necrotic, sometimes caseating, zone surrounded by a layer of epithelioid cells, multinucleated 
giant cells, and fibroblasts in a radial arrangement, typical of other granulomatous conditions such as 
tuberculosis and sarcoidosis. 
Humans with inhalational exposures also develop hemorrhagic inflammation of the airways early in the 
course of illness, which may progress to bronchopneumonia. Histopathological examination of the lungs 
shows alveolar spaces filled with an exudate of mononuclear cells. Pleuritis with adhesions and effusion 
and hilar lymphadenopathy are common in radiological and pathological findings. 
Primary clinical forms vary in severity and presentation according to virulence of the infecting organism, 
dose, and site of inoculum. 
The onset of tularemia is usually abrupt, with fever (38 degrees C–40 degrees C), headache, chills and 
rigors, generalized body aches (often prominent in the low back), coryza, and sore throat. A pulse-
temperature dissociation has been noted in as many as 42% of patients. A dry or slightly productive cough 
and substernal pain or tightness frequently occur with or without objective signs of pneumonia, such as 
purulent sputum, dyspnea, tachypnea, pleuritic pain, or hemoptysis. Nausea, vomiting, and diarrhea may 
occur. 
Sweats, fever, chills, progressive weakness, malaise, anorexia, and weight loss characterize the continuing 
illness. 
In general, tularemia would be expected to have a slower progression of illness and a lower case-fatality 
rate than either inhalational plague or anthrax. Milder forms of inhalational tularemia would be 
indistinguishable from Q fever; another potential bioterrorism agent; establishing a diagnosis of either 
would be problematic without reference laboratory testing. 
Diagnosis:  Rapid diagnostic testing for tularemia is not widely available. Physicians who suspect 
inhalational tularemia in patients presenting with atypical pneumonia, pleuritis, and hilar 
lymphadenopathy should promptly collect specimens of respiratory secretions and blood and alert the 
laboratory to the need for special diagnostic and safety procedures. 
F. tularensis may be identified through direct examination of secretions, exudates, or biopsy specimens 
using Gram stain, direct fluorescent antibody,  or immunohistochemical stains. Microscopic 
demonstration of F. tularensis using fluorescent-labeled antibodies is a rapid diagnostic procedure 
performed in designated reference laboratories in the National Public Health Laboratory Network; test 
results can be available within several hours of receiving the specimens, if the laboratory is alerted and 
prepared. 
Growth of F. tularensis in culture is the definitive means of confirming the diagnosis of tularemia. It can 
be grown from pharyngeal washings, sputum specimens, and even fasting gastric aspirates in a high 
proportion of patients with inhalational tularemia. It is only occasionally isolated from blood. 
Vaccination:  In the United States, a live attenuated vaccine derived from avirulent F. tularensis biovar 
palaearctica (type B) has been used to protect laboratorians routinely working with the bacterium. Until 
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recently, this vaccine was available as an investigational new drug. It is currently under review by the 
Food and Drug Administration. 
Treatment:  In a contained casualty setting, where individual patient management is possible, the working 
group recommends parenteral antimicrobial therapy. Streptomycin is the drug of choice. Gentamicin, 
which is more widely available and can be used intravenously, is an acceptable alternative. Treatment 
with aminoglycosides should be continued for 10 days. Tetracyclines and chloramphenicol are also used, 
but relapses and primary treatment failures occur at a higher rate with these bacteriostatic agents than with 
aminogylcosides, and they should be given for at least 14 days to avoid relapse. Both streptomycin and 
gentamicin are recommended as first-line treatment of tularemia in children. 
In a mass casualty setting, doxycycline and ciprofloxacin, administered orally, are the preferred choices 
for treatment of both adults and children. 
Since it is unknown whether drug-resistant organisms might be used in a bioterrorist event, antimicrobial 
susceptibility testing of isolates should be conducted quickly and treatments altered according to test 
results and clinical responses. 
Antibiotics for treating patients infected with tularemia in a bioterrorist event are included in the national 
pharmaceutical stockpile maintained by CDC, as are ventilators and other emergency equipment. 
Postexposure prophylaxis:  Persons beginning treatment with streptomycin, gentamicin, doxycycline, or 
ciprofloxacin in the incubation period of tularemia and continuing treatment daily for 14 days might be 
protected against symptomatic infection. Therefore, if an attack is discovered before individuals become 
ill, exposed persons should be prophylactically treated with 14 days of oral doxycycline or ciprofloxacin. 
If an attack is discovered only after individuals become ill, persons potentially exposed should begin a 
fever watch. Those who develop an otherwise unexplained fever or flu-like illness within 14 days of 
presumed exposure should begin treatment as outlined above. 
Postexposure prophylactic treatment of close contacts of tularemia patients is not recommended because 
person-to-person transmission is not known to occur. 
Infection control and environmental decontamination:  Isolation is not recommended for tularemia 
patients, given the lack of person-to-person transmission. In hospitals, standard precautions are 
recommended. 
Laboratory personnel should be alerted when tularemia is suspected. Routine diagnostic procedures can 
be performed in biosafety level 2 conditions. Examination of cultures in which F. tularensis is suspected 
should be done in a biological safety cabinet. Manipulation of cultures and other procedures that might 
produce aerosols or droplets (e.g., grinding, centrifuging, vigorous shaking, animal studies) should be 
conducted under biosafety level 3 conditions. 
Bodies of patients who die of tularemia should be handled using standard precautions. Autopsy 
procedures likely to produce aerosols or droplets should be avoided. 
Clothing or linens contaminated with body fluids of patients with tularemia should be disinfected per 
standard hospital procedure. 
Under natural conditions, F. tularensis can survive for extended periods in a cold, moist environment. 
Information is not available about survivability of an intentionally released aerosol form of F. tularensis, 
but the working group predicts a short half-life due to desiccation, solar radiation, oxidation, and other 
environmental factors and a very limited risk from secondary dispersal. Following an urban release, the 
risk to humans of acquiring tularemia from infected animals or arthropods is likely small and can be 
reduced by educating the public to avoid sick or dead animals and to take precautions to protect against 
biting arthropods. 
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3.14 Hendra virus45 
Equine Morbillivirus Pneumonia 
(Note: Equine morbillivirus pneumonia has been renamed "Hendra virus disease") 
(Acute respiratory syndrome)  
Definition:  Equine morbillivirus pneumonia (EMP) is an acute febrile respiratory infection of horses 
characterized by fever, increased respiratory and heart rates, respiratory distress, and death.  
Etiology:  The cause of EMP is a newly recognized virus in the genus Morbillivirus and was named 
equine morbillivirus (EMV). When EMV was tested against antisera to a range of paramyxoviruses, 
morbilliviruses, and pneumoviruses there was a very weak reaction with only rinderpest virus.  
History:  Equine morbillivirus pneumonia has been reported only in Australia. The disease was first 
recognized on one property in Hendra, Australia, in September 1994. In this outbreak, 20 horses were sick 
and 13 died, and 2 humans were infected and 1 died. A retrospective diagnosis of EMP was made for 
horses that died in August 1994 on a property in Mackay about 1,100 km from the first reported case of 
EMP. In this outbreak four horses were infected and two died; the farmer became ill, recovered, had a 
relapse, and died of EMV infection 13 months later. There was no evidence of epidemiological 
association between these outbreaks.  
Host Range:  Equine morbillivirus has naturally caused disease in horses and humans. Experimentally, 
cats and guinea pigs have been infected. The disease in cats is very similar to the disease in horses. The 
recent detection of neutralizing antibody to EMV in the native Australian fruit-bats suggests a possible 
resevoir for EMV.  
Geographic Distribution:  Equine morbillivirus pneumonia has been reported only in Australia.  
Transmission:  On the basis of epidemiologic findings and experimental results with cats, EMV is not 
readily transmissible. In the field, very few horses in contact with infected horses became ill, and even 
horses placed in uncleaned stalls previously occupied by an infected horse did not become ill. For both 
animals and humans, EMV seems to require direct contact with respiratory secretions of infected animals. 
If a fruit-bat is the reservoir, the mechanism for spread to the horse is not known.  
Incubation Period:  The incubation period in horses is 8 to 14 days.  
Clinical Signs:  The initial case of EMP in both outbreaks was a pregnant mare on pasture. Clinical signs 
in field cases at Hendra were fever up to 105.8 degrees F (41 degrees C), severe respiratory distress, and 
death. Two horses that recovered had mild myoclonic twitching. In the Mackay outbreak, the pregnant 
mare had "severe respiratory distress, ataxia, and marked swelling of the head — particularly of the 
infraorbital fossa and cheeks. The second horse, a stallion (horse B), reportedly showed aimless pacing, 
muscle trembling and a haemorrhagic nasal discharge" and died.  
In experimentally infected horses, the first sign of disease was fever that ranged from 102.2 to 106 
degrees F (39 to 41.2 degrees C). In some animals, as the disease progressed, heart and respiratory rates 
increased up to 72 and 60 per minute, respectively, breathing became labored, and the animal's demeanor 
varied from somnolence to mild agitation.  
Gross Lesions:  The most distinctive gross lesion in EMP is a bilateral "pulmonary edema characterized 
by gelatinous distention of subpleural lymphatics." The lungs are heavy and congested; the edema is more 
prominent in the ventral parts and the lungs vary from a mottled yellowish-brown to dark blue. The major 
air passages are essentially normal. In one experimental horse, there was also a bilateral dilation of the 
pulmonary lymphatics and a very enlarged dark spleen.  
                                                 
45Committee on Foreign Animal Diseases of the United States Animal Health Association, revised 1998.  Foreign 
Animal Diseases, “The Gray Book,” Part IV, Library of Congress Catalog Card Number 17-12842, Pat Campbell 
& Associates and Carter Printing Company, Richmond, VA.  
http://www.vet.uga.edu/vpp/gray_book/FAD/EMP.htm  
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Morbidity and Mortality:  The number of animals that have been infected naturally and experimentally is 
small, but using these numbers, mortality is high in animals infected. Owing to the low transmissibility of 
EMV, morbidity has been low.  
Diagnosis  
Field Diagnosis  
Equine morbillivirus pneumonia should be suspected when a horse that dies has been febrile and the 
necropsy findings include a pulmonary edema characterized by gelatinous distention of subpleural 
lymphatics.  
Specimens for Laboratory  
Specimens sent to the laboratory for culture should consist of pieces of lung, liver, spleen, kidney, lymph 
nodes, brain, and heparinized blood. For serology, serum samples from acute and convalescent animals 
should be submitted. For histopathologic examination, send a complete set of tissues in 10 percent 
formalin.  
Laboratory Diagnosis  
To confirm a suspected diagnosis of EMP, the virus has to be isolated and identified. The disease can 
tentatively be diagnosed by histopathology as well as histochemical and molecular biological techniques.  
Differential Diagnosis  
Because of the pulmonary edema, African horse sickness is a primary consideration in a differential 
diagnosis.  
Other causes of acute death are poisons, intoxications (botulism), and acute bacterial diseases such as 
anthrax.  
Treatment:  There is no treatment for the primary disease.  
Vaccination:  There is no vaccine.  
Control and Eradication:  In Australia, disease control and eradication procedures consisted of slaughter 
of known infected horses and extensive serological surveillance. No antibody to EMV was detected in 
sera from 98 horses remaining on the Hendra property, in sera from horses on adjacent properties, nor in 
sera from horses on trace-back and trace-forward properties. No EMV antibody was detected in sera 
collected from the Queensland population of nonracing horses selected using a stratified proportional 
approach.  
Public Health:  If one considers that there have been three human infections and two human deaths in 
only two outbreaks of this disease, maximum precautions should be used if this disease is suspected. The 
three individuals infected had extensive contact with the infected horses and "assisted in their necropsies 
without gloves, mask, or protective eyeware". It should be noted, however, that others also had contact 
with the animals and conducted or participated in necropsies and did not get infected; thus it is suspected 
that "direct contact with respiratory secretions of infected animals seems to be necessary for 
transmission".  
3.15 Nipah virus46 
Overview: Nipah virus is a newly recognized zoonotic virus. The virus was ‘discovered’ in 1999. It has 
caused disease in animals and in humans, through contact with infectious animals. The virus is named 
after the location where it was first detected in Malaysia. Nipah is closely related to another newly 
recognized zoonotic virus (1994), called Hendra virus, named after the town where it first appeared in 
Australia. Both Nipah and Hendra are members of the virus family Paramyxoviridae. Although members 
of this group of viruses have only caused a few focal outbreaks, the biologic property of these viruses to 
                                                 
46World Health Organizaion, Nipah Virus Factsheet. http://www.who.int/inf-fs/en/fact262.html  
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infect a wide range of hosts and to produce a disease causing significant mortality in humans has made 
this emerging viral infection a public heath concern. 
Natural Host: It is currently believed that certain species of fruit bats are the natural hosts of both Nipah 
and Hendra viruses. They are distributed across an area encompassing northern, eastern and south-eastern 
areas of Australia, Indonesia, Malaysia, the Philippines and some of the Pacific Islands. The bats appear 
to be susceptible to infection with these viruses, but do not themselves become ill. It is not known how 
the virus is transmitted from bats to animals. 
Transmission: The mode of transmission from animal to animal, and from animal to human is uncertain, 
but appears to require close contact with contaminated tissue or body fluids from infected animals. Nipah 
antibodies have been detected in pigs, other domestic and wild animals. The role of species other than 
pigs in transmitting infection to other animals has not yet been determined. 
It is unlikely that Nipah virus is easily transmitted to man, although previous outbreak reports suggest that 
Nipah virus is transmitted from animals to humans more readily than Hendra virus. Despite frequent 
contact between fruit bats and humans there is no serological evidence of human infection among bat 
carers. Pigs were the apparent source of infection among most human cases in the Malaysian outbreak of 
Nipah, but other sources, such as infected dogs and cats, cannot be excluded. Human-to-human 
transmission of Nipah virus has not been reported. 
Clinical features: The incubation period is between 4 and 18 days. In many cases the infection is mild or 
inapparent (sub-clinical). In symptomatic cases, the onset is usually with "influenza-like" symptoms, with 
high fever and muscle pains (myalgia). The disease may progress to inflammation of the brain 
(encephalitis) with drowsiness, disorientation, convulsions and coma. Fifty percent of clinically apparent 
cases die. 
Treatment: No drug therapies have yet been proven to be effective in treating Nipah infection. Treatment 
relies on providing intensive supportive care. There is some evidence that early treatment with the 
antiviral drug, ribavirin, can reduce both the duration of feverish illness and the severity of disease. 
However, the efficacy of this treatment in curing disease or improving survival is still uncertain. 
Protection of Health Care Professionals: The risk of transmission of Nipah virus from sick animals to 
humans is thought to be low, and transmission from person-to-person has not yet been documented, even 
in the context of a large outbreak. Therefore, the risk of transmission of Nipah virus to health care 
workers is thought to be low. However, transmission without percutaneous exposure (through a break in 
the skin barrier) is theoretically possible, as respiratory secretions contain the virus. This is why it has 
been categorized as a biohazardous agent that should be managed in a high-level biosecurity laboratory. It 
is recommended that close contact with body fluids and infected tissues be avoided if Nipah infection is 
suspected. 
Outbreaks of Nipah and Hendra Viruses:  From September 1998 - April 1999, there was a large 
outbreak of encephalitis in Malaysia. During the investigation of this outbreak, Nipah virus, a previously 
unrecognized virus, was identified as the causal agent. A total of 265 people were infected, of whom 105 
died. Ninety-three percent of cases had occupational exposure to pigs. An associated outbreak among 
abattoir workers in Singapore during March 1999 led to 11 cases, with 1 death. These workers had been 
handling pigs that had been imported from the outbreak areas in Malaysia. 
There have been 3 recognized outbreaks of Hendra virus in Australia in 1994, 1995 and1999. Three 
human cases, leading to 2 deaths were recorded in the 1994 and 1995 outbreaks. In 1995 a horse was 
infected, with associated human cases. The precise mode of virus transmission to the three Australian 
patients is not fully understood. All 3 individuals appear to have acquired their infection as a result of 
close contact with horses which were ill and later died. 
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3.16 Rift Valley fever virus47 
(Infectious enzootic hepatitis of sheep and cattle)  
Definition:  Rift Valley fever (RVF) is an arthropod-borne (primarily mosquito), acute, febrile, viral 
disease of sheep, cattle, and goats. The disease in these species is characterized by high abortion rates, 
high mortality in neonates, and hepatic necrosis. Humans are highly susceptible. Symptoms in humans in 
most cases are those of an acute undifferentiated febrile disease; severe cases (about 1 percent) resemble a 
dengue-like disease accompanied by hemorrhage, meningoencephalitis, retinopathy, and sometimes 
death.  
Etiology:  Rift Valley fever is caused by a three-stranded RNA virus in the Phlebovirus genus of the 
family Bunyaviridae. All isolates are serologically similar. Detection of differences between isolates 
requires RNA fingerprinting.  
Rift Valley fever virus is inactivated by lipid solvents, detergents, and low pH. At neutral or alkaline pH 
in the presence of protein such as serum, the virus can remain viable for up to 4 months at 4 degrees C. 
Specimens stored below 0 degrees C will retain infectivity for 8 years. Rift Valley fever virus in aerosols 
has a half-life in excess of 77 minutes at 25 degrees C and 30 percent relative humidity. Humans have 
been infected by aerosols generated during the slaughtering procedure, by handling aborted fetuses, 
performing necropsies, and conducting laboratory procedures.  
Contaminated surfaces should be washed to remove large amounts of organic matter and disinfected using 
strong solutions of sodium or calcium hypochlorite; residual chorine should exceed 5,000 ppm. Solutions 
having a pH of 6.2 (acetic acid) or lower are also effective.  
Host Range:  Rift Valley fever virus infects many species of animals and humans. Neonatal lambs, kids, 
calves, and puppies are highly susceptible and have a high mortality. Sheep and cattle are the primary 
species affected and the primary amplifiers of the virus. Humans are highly susceptible to RVF virus 
infection and are readily infected by mosquitoes and aerosols. Humans develop a sufficient viremia to be 
a source of infection for mosquitoes and thus could introduce the disease into uninfected areas.  
Geographic Distribution:  Rift Valley fever has been found to occur in most of Africa.  
Transmission:  Historically, explosive outbreaks of the disease have occurred simultaneously over a wide 
area of Africa at 5 to 15 year intervals. The outbreaks have generally occurred in otherwise dry areas 
following periods of heavy rainfall. The long interval between outbreaks in animals allows for the 
development of a susceptible population. For many years, the reservoir during the interepidemic periods 
was unknown. Then researchers found RVF virus to be present in dormant eggs of the mosquito Aedes 
lineatopinnis located in the soil of grassland depressions known as dambos. When these depressions 
become full of water, the eggs hatch, and infected mosquitoes develop. These mosquitoes infect an 
amplifying host (ruminant), which serves as a source of infection for many other genera of mosquitos that 
rapidly spread the disease. If the area of infected mosquitoes extends into areas of susceptible animals, 
there are many clinical cases. In contrast, in most areas of Africa the disease is enzootic and best 
monitored by the use of sentinel animals.  
In Africa, many of the species of mosquitoes in the genera Aedes, Anopheles, Culex, Eretmapoites, and 
Mansonia can transmit RFV. In North America, mosquitoes in the genera Aedes, Anopheles, and Culex 
experimentally are capable vectors of RFV. Experimentally, Culex pipiens, an important vector in Egypt, 
was shown to feed preferentially on febrile rather than normal sheep. Experimentally, vector competence 
of Culex pipiens also increased with increasing holding temperature.  
                                                 
47Committee on Foreign Animal Diseases of the United States Animal Health Association, revised 1998.  Foreign 
Animal Diseases, “The Gray Book,” Part IV, Library of Congress Catalog Card Number 17-12842, Pat Campbell 
& Associates and Carter Printing Company, Richmond, VA.  
http://www.vet.uga.edu/vpp/gray_book/FAD/RVF.htm  
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Incubation Period:  Experimentally, the incubation period in newborn lambs, kids, calves, and puppies, is 
about 12 hours. In adult sheep, cattle, goats, and dogs the incubation period may be as long as 3 days. In 
humans, the incubation period is 4 to 6 days.  
Clincial Signs:  Clinical signs depend on the species affected and physiologic conditions such as age and 
pregnancy. Lambs develop a fever of 104-107 degrees F (40-42 degrees C) accompanied by anorexia and 
become weak and die about 36 hours after inoculation. Mortality in lambs under 1 week of age exceeds 
90 percent. Mortality in lambs over a week old is greater than 20 percent. Adult sheep develop a fever of 
104-106 degrees F (40-41 degrees C), along with a mucopurulent nasal discharge, and they may vomit. If 
animals are pregnant, abortion will be the most prominent sign. Mortality, particularly in ewes that abort, 
may reach 20 to 30 percent. Calves develop a fever of 104-106 degrees F (40-41.1 degrees C) and become 
depressed. Mortality can range from 10 to 70 percent. Adult cattle develop a fever of 104-106 degrees F 
(40-41.1 degrees C), have excessive salivation, anorexia, and weakness; some may develop a fetid 
diarrhea. If animals are pregnant, abortion will be the most prominent sign. Mortality is usually less than 
10 percent.  
Humans develop influenza-like symptoms with fever of 100-104 degrees F (37.8-40 degrees C), 
headache, muscular pain, weakness, and nausea plus epigastric discomfort and photophobia. Most people 
recover in 4 to 7 days; however, a small percentage of infected individuals will develop complications. 
Some may develop a hemorrhagic syndrome of jaundice, hematemesis, melena, and petechiae 2 to 4 days 
after becoming febrile and die. Others will develop a meningoencephalitis, and a third group a retinopathy 
5 to 15 days after becoming febrile.  
Gross Lesions:  The primary lesion in RVF is hepatic necrosis. In aborted fetuses and in neonatal 
animals, particularly lambs and calves, hepatic necrosis can be massive. The liver may be enlarged and 
yellowish, have petechial hemorrhages, and be friable. Older animals may have a focal hepatic necrosis; 
this may be visible as small pale foci in the parenchyma or be seen only by histopathologic examination. 
In both neonatal and older animals that die, there may be widespread cutaneous hemorrhages, petechial to 
ecchymotic hemorrhages on parietal and visceral serosal membranes, and a hemorrhagic enteritis.  
Morbidity and Mortality:  Rift Valley fever causes a high mortality in young lambs, calves, and kids. 
Mortality in adult sheep is about 20 percent and in adult cattle about 10 percent. A high percentage of 
pregnant animals may abort.  
Vaccination:  Several vaccines have been used to protect against RVF infection. Rift Valley fever virus 
was first attenuated by serial intracerebral inoculation of mice (Smithburn strain). One inoculation of this 
vaccine produced protection in 6 to 7 days and immunity that lasted at least 3 years. However, when 
administered to pregnant ewes, it caused abortion, and the vaccine was pathogenic for man. Because of 
these problems with the attenuated vaccine, inactivated vaccines produced from cell-culture-propagated 
virus were developed. These vaccines protected; however, they had the disadvantages of requiring two 
inoculations for protection, annual vaccination, and large amounts of antigen. When the epizootic 
occurred in Egypt, enough inactivated vaccine could be produced to vaccinate only the more valuable 
breeding stock. Recently a mutagen-attenuated Vero-cell-propagated vaccine has been developed for use 
in people. The vaccine has also been tested in sheep and cattle. The vaccine causes no adverse effect in 
neonatal lambs, calves, or pregnant sheep or cattle. Bovine fetuses inoculated with the vaccine via a 
laparotomy continued a normal development and were seropositive when born. This vaccine also has the 
advantage that one inoculation induces rapid immunity, and as few as 10 plaque-forming units of the 
virus induce protection. Thus, many doses of vaccine can be produced quickly.  
Attenuated vaccines induce a higher and more persistent serum antibody neutralizing titer than inactivated 
vaccines. Animals and people vaccinated with inactivated vaccine should have their RVF neutralizing 
antibody titer determined annually or be revaccinated. A serum neutralization titer of 20 or greater is 
protective. Lambs and calves that receive colostrum from a convalescent dam or dam vaccinated with an 
attenuated virus are passively protected for about 3 months.  
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Control and Eradication:  In RVF enzootic areas, vaccination is the only practical method of preventing 
low-level losses. Movement of animals from an enzootic area to RVF-free areas during the period of virus 
activity should be discouraged to prevent an epizootic. Mosquito control during an epizootic is logical but 
not practical for large areas; it could be used to reduce human exposure in limited areas. Slaughter of sick 
animals is not recommended because of the risk of human infection from aerosols of blood and body 
fluids. In an epizootic, widespread vaccination of all susceptible animals to prevent infection of 
amplifying hosts and thus infection of vectors is the only way to prevent infection of animals and man.  
Public Health:  Humans are highly susceptible to infection. In an enzootic or epizootic area, protective 
measures should be taken to prevent infection by mosquitoes. Of even more importance, protective 
measures should be taken to prevent infection by aerosols produced during the handling of infected 
fetuses and tissues and in laboratory procedures. People who could be exposed to the virus should be 
vaccinated.  
3.17 Shigatoxin48 
Shiga Toxin-Producing Escherichia coli (STEC) 
What is Shiga toxin-producing Escherichia coli?  Shiga toxin-producing Escherichia coli is a type of 
enterohemorrhagic E. coli (EHEC) bacteria that can cause illness ranging from mild intestinal disease to 
severe kidney complications. Other types of enterohemorrhagic E. coli include the relatively important 
serotype E. coli O157:H7, and more than 100 other non-O157 strains such as O111 and O26. 
What are the symptoms?  Typical symptoms include severe abdominal cramping, sudden onset of watery 
diarrhea, frequently bloody, and sometimes vomiting and a low-grade fever. Most often the illness is mild 
and self-limited generally lasting 1-3 days. However, serious complications such as hemorrhagic colitis, 
Hemolytic Uremic Syndrome (HUS), or postdiarrheal thrombotic thrombocytopenic purpura (TTP) can 
occur in up to 10% of cases. 
How soon do the symptoms appear?  The incubation period ranges from 1 to 8 days, though typically it 
is 3 to 5 days. 
How do you get Shiga toxin-producing Escherichia coli?  Cases and outbreaks of Shiga toxin-producing 
Escherichia coli have been associated with the consumption of undercooked beef (especially ground 
beef), raw milk, unpasteurized apple juice, contaminated water, red leaf lettuce, alfalfa sprouts, and 
venison jerky. The bacteria have also been isolated from poultry, pork and lamb. Person-to- person 
spread, via fecal->oral transmission, may occur in high-risk settings like day care centers and nursing 
homes. Further studies are being done to better understand the modes of transmission. 
Who gets infected with Shiga toxin-producing Escherichia coli?  Although anyone can get infected, the 
highest infection rates are in children under age 5. Elderly patients also account for a large number of 
cases. Outbreaks have occurred in child-care facilities and nursing homes. 
How is it treated?  For mild illness, antibiotics have not been shown to shorten the duration of symptoms 
and may make the illness more severe in some people. Severe complications, such as Hemolytic Uremic 
Syndrome, require hospitalization. 
How can you keep from getting it?  
• COOK meats and poultry thoroughly. Ground beef should reach at least 155 degrees F (until the 
meat is no longer pink and juices run clear).  
• DO NOT consume raw milk or unpasteurized dairy products.  
• WASH YOUR HANDS after using the bathroom or changing diapers and before preparing or 
eating food. 
                                                 
48Communicable Disease Epidemiology Program (303 692-2700), March 2001.  Colorado Department of Public 
Health & Environment.  http://www.cdphe.state.co.us/dc/Epidemiology/stec_fs.html  
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3.18 Staphylococcal enterotoxins49 
Overview:  S aureus can express two different types of toxin with superantigen activity, enterotoxins, of 
which there are six serotypes (A, B, C, D, E and G) and toxic shock syndrome toxin (TSST-1). 
Enterotoxins cause diarrhea and vomiting when ingested and are responsible for staphylococcal food 
poisoning. When expressed systemically, enterotoxins can cause toxic shock syndrome (TSS) - indeed 
enterotoxins B and C cause 50% of non-menstrual TSS. TSST-1 is very weakly related to enterotoxins 
and does not have emetic activity. TSST-1 is responsible for 75% of TSS, including all menstrual cases. 
TSS can occur as a sequel to any staphylococcal infection if an enterotoxin or TSST-1 is released 
systemically and the host lacks appropriate neutralizing antibodies. Tampon-associated TSS is not a true 
infection, being caused by growth of S aureus in a tampon and absorption of the toxin into the blood 
stream. TSS came to prominence with the introduction of super-absorbent tampons; and although the 
number of such cases has decreased dramatically, they still occur despite withdrawal of certain types of 
tampons from the market.  
Superantigens stimulate T cells non-specifically without normal antigenic recognition. Up to one in five T 
cells may be activated, whereas only 1 in 10,000 are stimulated during antigen presentation. Cytokines are 
released in large amounts, causing the symptoms of TSS. Superantigens bind directly to class II major 
histocompatibility complexes of antigen-presenting cells outside the conventional antigen-binding grove. 
This complex recognizes only the Vb element of the T cell receptor. Thus any T cell with the appropriate 
Vb element can be stimulated, whereas normally antigen specificity is also required in binding.50 
Staphylococcal enterotoxin B50 
Staphylococcus aureus produces a number of exotoxins, one of which is Staphylococcal enterotoxin B, or 
SEB. Such toxins are referred to as exotoxins since they are excreted from the organism, and since they 
normally exert their effects on the intestines they are called enterotoxins. SEB is one of the pyrogenic 
toxins that commonly causes food poisoning in humans after the toxin is produced in improperly handled 
foodstuffs and subsequently ingested. SEB has a very broad spectrum of biological activity. This toxin 
causes a markedly different clinical syndrome when inhaled than it characteristically produces when 
ingested. Significant morbidity is produced in individuals who are exposed to SEB by either portal of 
entry to the body.  
SEB is the second most common source of outbreaks of food poisoning. Often these outbreaks occur in a 
setting such as a church picnic or other community event, due to common source exposure in which 
contaminated food is consumed. Although an aerosolized SEB toxin weapon would not likely produce 
significant mortality, it could render 80 percent or more of exposed personnel clinically ill and unable to 
perform their mission for 1-2 weeks. The demand on the medical and logistical systems could be 
overwhelming. For these reasons, SEB was one of the 7 biological agents stockpiled by the U.S. during 
its old bioweapons program, which was terminated in 1969.  
Mechanism of Toxicity:  Staphylococcal enterotoxins belong to a class of potent immune stimulants 
known as bacterial superantigens. Superantigens bind to monocytes at major histocompatibility complex 
type II receptors rather than the usual antigen binding receptors. This leads to the direct stimulation of 
large populations of T-helper cells while bypassing the usual antigen processing and presentation. This 
induces a brisk cascade of pro-inflammatory cytokines (such as tumor necrosis factor, interferon, 
interleukin-1 and interleukin-2), with recruitment of other immune effector cells, and relatively deficient 
activation of counter-regulatory negative feedback loops. This results in an intense inflammatory response 
that injures host tissues. Released cytokines are thought to mediate many of the toxic effects of SEB.  
                                                 
49Foster, Timothy.   Medical Microbiology, Fourth Edition, Staphylococcus chapter. 
http://gsbs.utmb.edu/microbook/ch012.htm  
 
50© The University of Iowa, Virtual Naval Hospital, USAMRIID’s Medical Management of Biological Casualties 
Handbook,  Staphylococcal Enterotoxin B,  U.S. Army Medical Research, Institute of Infectious Diseases, 1997-
2003.  http://www.vnh.org/BIOCASU/19.html  
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Signs and Symptoms: Latent period of 3-12 hours after aerosol exposure is followed by sudden onset of 
fever, chills, headache, myalgia, and nonproductive cough. Some patients may develop shortness of 
breath and retrosternal chest pain. Patients tend to plateau rapidly to a fairly stable clinical state. Fever 
may last 2 to 5 days, and cough may persist for up to 4 weeks. Patients may also present with nausea, 
vomiting, and diarrhea if they swallow the toxin. Presumably, higher exposure can lead to septic shock 
and death.  
Diagnosis: Diagnosis is clinical. Patients present with a febrile respiratory syndrome without CXR 
abnormalities. Large numbers of patients presenting in a short period of time with typical symptoms and 
signs of SEB pulmonary exposure would suggest an intentional attack with this toxin.  
Treatment: Treatment is limited to supportive care. Artificial ventilation might be needed for very severe 
cases, and attention to fluid management is important.  
Prophylaxis: Use of protective mask. There is currently no human vaccine available to prevent SEB 
intoxication.  
Isolation and Decontamination: Standard Precautions for healthcare workers. SEB is not dermally active 
and secondary aerosols are not a hazard from patients. Decon with soap and water. Destroy any food that 
may have been contaminated.  
Clinincal Features:  Symptoms of SEB intoxication begin after a latent period of 3-12 hours after 
inhalation, or 4-10 hours after ingestion. Symptoms include nonspecific flu-like symptoms (fever, chills, 
headache, myalgias), and specific features dependent on the route of exposure. Oral exposure results in 
predominantly gastrointestinal symptoms: nausea, vomiting, and diarrhea. Inhalation exposures produce 
predominantly respiratory symptoms: nonproductive cough, retrosternal chest pain, and dyspnea. GI 
symptoms may accompany respiratory exposure due to inadvertent swallowing of the toxin after normal 
mucocilliary clearance.  
The fever may last up to five days and range from 103 to 106 degrees F, with variable degrees of chills 
and prostration. The cough may persist up to four weeks, and patients may not be able to return to duty 
for two weeks.  
Diagnosis:  Diagnosis of SEB intoxication is based on clinical and epidemiologic features. Because the 
symptoms of SEB intoxication may be similar to several respiratory pathogens such as influenza, 
adenovirus, and mycoplasma, the diagnosis may initially be unclear. All of these might present with 
fever, nonproductive cough, myalgia, and headache. SEB attack would cause cases to present in large 
numbers over a very short period of time, probably within a single 24-hour period. Naturally occurring 
pneumonias or influenza would involve patients presenting over a more prolonged interval of time. 
Naturally occurring staphylococcal food poisoning cases would not present with pulmonary symptoms. 
SEB intoxication tends to plateau rapidly to a fairly stable clinical state, whereas inhalational anthrax, 
tularemia pneumonia, or pneumonic plague would all continue to progress if left untreated. Tularemia and 
plague, as well as Q fever, would be associated with infiltrates on chest radiographs. Other diseases, 
including Hantavirus pulmonary syndrome, Chlamydia pneumonia, and CW agent inhalation (mustard, 
phosgene), should also be considered.  
Medical Management:  Currently, therapy is limited to supportive care. Close attention to oxygenation 
and hydration is important, and in severe cases with pulmonary edema, ventilation with positive end 
expiratory pressure, vasopressors and diuretics might be necessary. Acetaminophen for fever, and cough 
suppressants may make the patient more comfortable. The value of steroids is unknown. Most patients 
would be expected to do quite well after the initial acute phase of their illness, but generally would be 
unfit for duty for one to two weeks. Severe cases risk death from pulmonary edema and respiratory 
failure.  
Prophylaxis:  Although there is currently no human vaccine for immunization against SEB intoxication, 
several vaccine candidates are in development. Preliminary animal studies have been encouraging. A 
vaccine candidate is nearing transition to advanced development for safety and immunogenicity testing in 
man. Superantigens: enterotoxins and toxic shock syndrome toxin 
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3.19 T-2 toxin51 
Tricothecene Mycotoxicosis 
Description of Agent: The tricothecene mycotoxins are a large group of low-molecular-weight toxins 
produced by several species of filamentous fungi. Most are potent inhibitors of eukaryotic protein 
synthesis and of mitochondrial respiration. Those toxins most frequently isolated from agricultural 
products, and likewise mentioned most often in the context of belligerent use, include diacetoxyscirpenol 
(DAS), Nivalenol, 4-Deoxynivalenol (DON), and especially T-2. T-2 is one of the most stable of these 
toxins, and thus, perhaps, the most likely to be employed in a terrorist or warfare application. Naturally-
occurring mycotoxicosis presents as Alimentary Toxic Aleukia, a lethal condition related to the 
consumption of moldy grains. Intentional use of T-2 by belligerents might involve aerosolization or the 
deliberate contamination of foodstuffs. Disease results from inhalation, ingestion, or skin contact, since T-
2, unlike other BW agents, possesses significant vesicant properties.  
Signs and Symptoms: Dermal exposure leads to symptoms within minutes and manifests as erythema 
accompanied by pain and a burning sensation. Blisters form and progress to necrosis with a leathery 
blackening of he skin. Inhalational exposure produces a rapid onset of nose and throat pain, with nasal 
discharge, cough, dyspnea, wheezing, chest pain, and hemoptysis. Eyes are likewise affected with intense 
burning and a foreign body sensation. Gastrointestinal exposure leads to anorexia, nausea, abdominal 
cramping, and hematemesis and hematochaezia. Systemic toxicity may follow exposure by any route and 
is manifest by weakness and ataxia, followed, in fatal cases, by tachycardia, hypothermia, and 
hypotension. Survivors of acute illness may manifest hematologic toxicity in the subacute phase.  
Diagnosis: Prompt diagnosis is based on clinical and epidemiologic grounds. Blood, tissue, and 
environmental samples may be assayed for confirmatory evidence using gas-liquid chromatography and 
mass spectrometry.  
Treatment: Therapy is largely supportive. Standard poison management techniques, such as the use of 
superactivated charcoal, are useful when administered early to casualties with gastrointestinal exposure.  
Prophylaxis: Physical means, such as protective masks, are the only available protection. Unlike the 
situation with most other BW agents, the skin must also be protected against mycotoxin attack.  
Decontamination and Isolation: Clothing of T-2 victims should be removed and treated (exposed to 5% 
hypochlorite for 6-10 hours) or destroyed. Skin may be decontaminated with soap and water. Eye 
exposure should be managed with copious saline irrigation. Isolation is not required. Instruments and 
surfaces should be decontaminated by heating to 500(F for 30 minutes or by brief exposure to 1N NaOH. 
Standard disinfectants effective against most other BW agents are often inadequate to inactivate the very 
stable mycotoxins.  
Outbreak Control: Mycotoxin-induced disease is not contagious, but the stability of the toxins in the 
presence of heat and ultraviolet light make for the possibility of persistence in the environment following 
release.  
3.20 Venezuelan equine encephalitis virus52 
Venezuelan Equine Encephalitis 
Description of Agent: Venezuelan Equine Encephalitis (VEE) is a mosquito borne alphavirus disease 
maintained in nature predominantly in a horse-mosquito-horse cycle, although thousands of natural 
human infections also occur each year. Large equine epizootics typically precede the appearance of 
                                                 
51United States Army Institute of Infectious Diseases, Biological Agent Information Papers, Tricothecene 
Mycotoxicosis.   
 http://www.nbc-med.org/SiteContent/MedRef/OnlineRef/GovDocs/BioAgents.html#TRICOTHECENE 
 
52United States Army Institute of Infectious Diseases,Biological Agent Information Papers. 
 http://www.nbc-med.org/SiteContent/MedRef/OnlineRef/GovDocs/BioAgents.html#VENEZUELAN  
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human cases. Use of VEE as a weapon would presumably involve aerosolization, and such usage might 
be suspected on the basis of a preponderance of human cases and/or the presence of VEE outside of its 
typically well-localized focus in the Americas.  
Signs and Symptoms: VEE may be thought of as an incapacitating agent with a mortality rate (in 
naturally-occurring disease) of less than 1%. Susceptibility is nearly 100%, and disease is characterized 
by its sudden onset following a 1-5 day incubation period. Initial symptoms include generalized malaise, 
severe headache, fever and rigors, photophobia, and myalgias. Cough, sore throat, and vomiting and 
diarrhea may follow. Only a small percentage of cases actually progress to encephalitis, which is more 
frequent in young children and is marked by meningismus, convulsions, coma, and paralysis. Route of 
exposure probably has little effect on the proportion of cases developing neurologic disease. In the 
majority of cases without neurologic sequelae, full recovery occurs in 1-2 weeks.  
Diagnosis: The diagnosis of VEE is largely clinical. Naturally-occurring disease can often be suspected 
on epidemiologic grounds given its geographic specificity and the likely presence of concomitant disease 
in equines. Significant leukopenia and lymphopenia is often present. Virus may be cultured from serum 
and a VEE-specific IgM ELISA is available.  
Treatment: Treatment of VEE is largely supportive. Ribavirin has some in vitro activity, but appears of 
little benefit clinically.  
Prophylaxis: Prevention of naturally-occurring VEE is dependent largely upon mosquito control efforts 
and the immunization of horses. A human vaccine, TC-83, is available as an investigational product 
through USAMRIID (Ft Detrick MD 21702), and has been given to a large number of laboratory workers 
as a single 0.5 ml SQ dose. A second investigational vaccine, formalin-inactivated C-84, has been used to 
boost (0.5 ml SQ) serologic non-responders.  
Decontamination and Isolation: Universal precautions should be practiced when dealing with VEE 
patients. Virus may be destroyed by heat (80 degrees C for 30 minutes) and by ordinary disinfectants 
(such as 0.5% hypochlorite).  
Outbreak Control: Humans are infectious for mosquitoes for at least 72 hours after the onset of 
symptoms. Efforts at mosquito control thus become paramount to the prevention of secondary VEE cases 
following intentional or natural VEE outbreaks. In the event of intentional release of VEE virus by 
belligerents, the potential would be high for the development of an equine epizootic if the proper 
mosquito vector were present; veterinary vaccination would be useful in such circumstances.  
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4.  HUMAN PATHOGENS AND TOXINS 
This section introduces the 29 human pathogens and toxins regulated by 42 CFR 73.  Summary 
reference information is provided.  Citations and internet addresses for each pathogen or toxin 
are provided in footnotes.  This section includes summary information for the following 
pathogens and toxins:   
• Abrin (more than 100 mg) 
• Cercopithecine herpesvirus 1 (Herpes B virus) 
• Coccidioides posadasii 
• Conotoxins (more than 100 mg) 
• Crimean-Congo haemorrhagic fever virus 
• Diacetoxyscirpenol (more than 1,000 mg) 
• Ebola viruses 
• Lassa fever virus 
• Marburg virus 
• Monkeypox virus 
• Ricin (more than 100 mg) 
• Rickettsia prowazekii 
• Rickettsia rickettsii 
• Saxitoxin (more than 100 mg) 
• Shiga-like ribosome inactivating proteins (more than 100 mg) 
• South American haemorrhagic fever viruses (Junin (non-vaccine strain (Candid #1)), 
Machupo, Sabia, Flexal, Guanarito) 
• Tetrodotoxin (more than 100 mg) 
• Tick-borne encephalitis complex (flavi) viruses (Central European Tick-borne 
encephalitis, Far Eastern Tick-borne encephalitis, [Russian Spring and Summer 
encephalitis, Kyasanur Forest disease, Omsk Hemorrhagic Fever]) 
• Variola major virus (Smallpox virus) 
• Variola minor virus (Alastrim) 
• Yersinia pestis 
4.1 Abrin53 
Abrin is a potent toxin that has been isolated from the seeds of Abrus precatorius (or Rosary pea). Its use 
as a tool for research was described in 1972 by Sharon and Lis. Abrin exists in two forms, abrin a and 
abrin b. Both are composed of two chains, an A-chain and a B-chain. A disulfide bond between Cys247 
of the A-chain and Cys8 of the B-chain links the A and B chains. The A-chain is 251 residues and is 
divided into 3 folding domains. The A-chain catalytically inactivates 60S ribosomal subunits by removing 
adenine from positions 4 and 324 of 28S rRNA therefore inhibiting protein synthesis. The B-chain is a 
galactose specific lectin that facilitates the binding of abrin to cell membranes. The B-chain of both forms 
of abrin consist of 268 amino acid residues and share 256 identical residues. Comparison of their 
sequences with that of the ricin's B-chain shows that 60% of the residues of abrin's B-chain are identical 
to those of the ricin's B-chain and that two saccharide-binding sites in ricin B-chain identified by a 
crystallographic study are highly conserved in abrin B-chain. 
                                                 
53Patocka, Jiri.   Department of Toxicology, Military Medical Academy, Hradec Kralove, Czech Republic, Abrin 
and Ricin - Two Dangerous Poisonous Proteins. 
http://www.asanltr.com/newsletter/01-4/articles/Abrin&RicinRev.htm  
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The mechanism of toxic action of abrin is identical to that of ricin, but the toxicity of abrin in mice is 75 
times that of ricin (0.04 µg/kg for abrin compared to3 µg/kg for ricin.) The diagnosis, clinical features, 
treatment, protection, prophylaxis and so on is also the same for both abrin and ricin intoxications. 
Rosary Pea, Precatory beans, crabs eye, jequirity bean 54 
Abrus precatorius, legume or pea family  
Toxicity Rating:  High. Even one bean can kill.  
Animals Affected: All animals may be affected, although the primary risk is to pets.  
Dangerous Parts of the Plan: The beans are the primary risk.  
Class of Signs: Severe gastrointestinal irritation, vomiting, diarrhea, abdominal pain, collapse, death.  
Plant Description: Twisting perennial vine, grows naturally in tropical climates. Rosary pea is established 
in certain areas of southern Florida. The leaves are alternate and compound, with 8 to 15 leaflets. The 
flowers are small, and can be any shade of white to red to purple. The seed pod is about 1 and 1/2 inches 
long, containing several seeds, bright red with a black spot.  
Signs: The toxic signs resulting from rosary pea ingestion are very similar to those of castorbean, except 
rosary pea contains a more powerful toxin. It is reported that one seed if well-chewed can kill an adult 
human. The toxins are a protein called abrin and a glycoside called abric acid, which cause severe 
gastrointestinal signs: vomiting (if the species can vomit), diarrhea (which may be bloody) and abdominal 
pain. This progresses to weakness, shock and death within a short period of time.  
The plant does not grow in Indiana, but sometimes seeds are imported to make jewelry and rosaries. If the 
seed is swallowed without damage to the seed coat, poisoning is unlikely, and the seed will tend to pass 
without incident. In cases where the seed coat is chewed or opened (as in drilling to make jewelry), toxic 
signs and death are likely.  
First Aid: If rosary pea was ingested, contact a veterinarian immediately. Prevent further exposure and 
get other animals away from the source. Emergency measures may be used to eliminate the toxin from the 
stomach and intestines. Once gastrointestinal signs appear, it may be inadvisable to try to evacuate the 
stomach and intestines for fear of doing even greater damage, but a veterinarian will decide this. Beyond 
this, care is symptomatic and supportive of the digestive upset, weakness, and shock. Affected animals 
are likely to die even with care.  
Prevention: Rosary pea should never be allowed around the home or pasture for the safety of animals and 
humans alike. If jewelry or rosaries are made of rosary pea, discard them immediately.  
4.2 Cercopithecine herpesvirus 155  
(Herpes B virus) 
Name: Cercopithecine Herpes Virus 1 
Synonym or Cross Reference: B virus, Monkey B virus; Herpesviridae, Alphaherpesvirinae, Herpes 
simiae, CHV-1, Simian B disease, Genus Simplexvirus: 
Characteristics: Herpesvirus, dsDNA, envelope, 100 nm diameter, icosahedral capsid 
Pathogenicity: Acute, usually fatal, ascending encephalmyelitis; febrile onset with headache, vesicular 
skin lesions at site of exposure and variable neurological patterns; involvement of the respiratory centre 
and death 1 day to 3 weeks after onset of symptoms in over 70% of cases; occasional recoveries with 
considerable residual disability. 
                                                 
54Cooperative Extension Service, Purdue University.  Indiana Plants Poisonous to Livestock and Pets. 
http://www.vet.purdue.edu/depts/addl/toxic/plant53.htm  
55Office of Laboratory Security, June 2001.  © Health Canada, Population and Public Health Branch, Material and 
Safety Data Sheet.  http://www.hc-sc.gc.ca/pphb-dgspsp/msds-ftss/msds81e.html  
  
 
124
Epidemiology: Occurs in veterinarians, laboratory workers and others handling Eastern Hemisphere (Old 
World) monkeys or tissue cultures derived from monkeys; 31 reported cases with 68% mortality; 
naturally occurring alpha herpes virus infecting free - living or captive macaques; biological counterpart 
of herpes simplex virus in humans. 
Host Range: Humans, monkeys, rabbits, guinea pigs, mice 
Infectious Dose: Unknown 
Mode of Transmission: B virus occurs in monkeys as a latent infection and is reactivated spontaneously 
resulting in shedding of virus in saliva, during periods of stress, higher rates of virus shedding occur; 
transmission to man occurs after a monkey bite or by direct or indirect contact / exposure of naked skin 
(broken or mucous membranes) to infected saliva, tissues, tissue fluid or monkey cell cultures; splashes or 
droplets of infected fluids to eye; aerosols exposure of CHV-1 is likely to be minimal; human-to-human 
transmission has been documented in one case. 
Incubation Period: 3 days up to 4 weeks 
Communicability: One reported case where virus was transmitted from person-to-person via direct 
contact of broken skin with monkey bite of another individual. 
Reservoir: Most commonly found in macaque monkeys and other Old World monkeys frequent enzootic 
infection of captive Macaca mulatta (rhesus) and M. fascicularis (cynomolgus) monkeys. 
Zoonosis: Yes 
Vectors: None 
Drug Susceptibility: Efficacy of acyclovir under investigation and reported to be effective. 
Susceptibility to Disinfectants: Susceptible 1% sodium hypochlorite, 70% ethanol, 2% glutaraldehyde, 
formaldehyde. 
Physical Inactivation: Inactivated by heat (50-60° C for at least 30 min), sensitive to lipid solvents, acidic 
pH and detergent solutions. 
Survival Outside Host: Virus can remain viable in monkey saliva, CNS tissue and monkey kidney cell 
cultures; may survive for up to 7 days at 37° C, weeks at 4° C, very stable at -70° C. 
Surveillance: Monitor for symptoms after exposure to bites by a monkey with known or suspicious lesion 
of B-virus; serological confirmation, PCR. 
First Aid/Treatment: Wash and scrub exposed area / wound thoroughly with soap, concentrated solution 
of detergent, povidone-iodine or chlorhexidine and water, irrigate area with running water for 15-20 
minutes; antiviral therapy should be administered. 
Immunization: None available. 
Prophylaxis: Administration of specific IG, if available may be effective; acyclovir or ganciclovir may be 
effective.  
Laboratory-Acquired Infections: 36 reported cases with 64% deaths (23 died); most cases associated 
with individuals working directly with living Old World Monkeys; exposure to in vitro monkey tissues 
(primary rhesus monkey kidney) has been associated with laboratory infection. Other cases occurred 
following the cleaning of a monkey skull, puncture with contaminated needle or cut by infected glass, 
researcher died of CHV-1 after having been splashed in eye when moving a monkey cage. 
Sources/Specimens: Oral secretions, thoracic and abdominal viscera and CNS tissues of naturally 
infected macaques. 
Primary Hazards: Bites from monkeys with oral herpes lesions; exposures of broken skin or mucous. 
membranes to oral secretions or to infectious culture fluids; importance of aerosol exposure is not known 
Special Hazards: Infected monkey cell cultures are a potential hazard. 
Containment Requirements: Biosafety level 4 practices, containment equipment and facilities are 
recommended for activities involving manipulation of the virus. 
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Protective Clothing: Street clothing is removed and complete laboratory clothing is used the nature of 
which depends on the level 4 design (suit laboratory/cabinet line). 
Other Precautions: Proper methods of restraint and protective clothing (longed sleeved garments, face 
shield or surgical mask and goggles or glasses) to help prevent bites and scratches of handlers hands. 
Spills: Allow aerosols to settle; wearing protective clothing, gently cover spill with paper towel and apply 
1% sodium hypochlorite, starting at perimeter and working towards the centre; allow sufficient contact 
time before clean up (30 min). 
Disposal: Decontaminate all materials removed from the containment laboratory by steam sterilization, 
chemical disinfection, incineration or by gaseous methods; these include liquid and solid wastes. 
Storage: In sealed containers that are appropriately labelled and contained within the level 4 facility. 
4.3 Coccidioides posadasii56 
Coccidioidomycosis (Posada's disease, desert rheumatism, desert fever) 
Area of endemicity is southwest USA, northern Mexico, South America  
Agents: Coccidioides immitis and C. posadasii (considered by some to be the most virulent fungus). 1992 
is the centennial of the first description of the disease.  
Epidemiology:  Susceptibility to disseminated coccidioidomycosis is race dependent:  Filipinos > blacks 
> whites  
Lifecycle:  Grows as septated, filamentous fungus in desert soil.  Produces aerobuoyant arthroconidia 
conidia grow to form spherules in tissue (which are somewhat similar to sporangia in appearance).  
Spherules are sac-like thick-walled structures containing roughly 100-500 endospores. When the 
spherules lyse, they release the endospores that can then travel to other tissue sites and begin a new round 
of spherule production.  
Disease:  Mostly asymptomatic to mild pulmonary disease incubation period is 10-16 days after 
inhalation.  May manifest allergic reactions, patient becomes skin test positive even if asymptomatic. 
Desert bumps: erythema nodosum (but may see erythema multiforme) 
Desert rheumatism: arthralgias and arthritis 
Secondary coccidioidomycosis:  ca: 2-8% of symptomatic infections and pulmonary cavity may be seen; 
see calcifications with resolution of 2° forms of disease.  
Disseminated coccidioidomycosis: usually resolves spontaneously; acute meningitis; multiple cutaneous 
and subcutaneous bone lesions; may follow reactivation due to steroid therapy; chronic pulmonary 
disease usually shows "coin" lesion on X-ray.  
Diagnosis:  History of travel in endemic areas; coccidioidin skin test; examine sputum for spherules 
(biopsy material may be required); comp fix versus coccidiodin (serology of cocci is improving because 
of spherule antigens available); X-ray of chest may not be helpful.  
4.4 Conotoxins57 
Pathophysiology: Envenomation is associated with 18 species of conus. Venom from a cone shell is 
delivered via a detachable radula (a dartlike barb) formed in the radular sheath and delivered, after 
receiving venom in the pharynx, by an extensible proboscis. Cone shells’ venom is a neurotoxin.  
                                                 
56University of VA Health System, Medial Microbiology, Mycology 2:  Lifecycles and Pathogenesis, Systemic 
Mycoses.   http://hsc.VA.edu/med-ed/micro/myc/myc2.html#vir  
57Shepherd, Suzanne (MD, MS, DTM&H, FACEP, Program Director, Associate Professor, Department of 
Emergency Medicine, University of Pennsylvania Medical Center) and James Martin (MD, Fellow, Department of 
Emergency Medicine, Division of Hyperbaric Medicine, Hospital of the University of Pennsylvania). eMedicine 
article “Conidae.”  http://www.emedicine.com/emerg/topic109.htm  
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Types of conotoxins and their effects: 
• W-conotoxin - Hinders the voltage-dependent entry of calcium into the nerve terminal and 
inhibits acetylcholine release  
• M-conotoxin - Modifies muscle sodium channels  
• A-conotoxin - Blocks the nicotinic acetylcholine receptor  
• Sleeper peptide - Found primarily in Conus geographus, induces a deep sleep state in test animals 
A sting most commonly occurs on the hand and/or fingers of an unsuspecting handler, as well as on the 
feet of swimmers in shallow tropical waters. Local paresthesias and ischemia characterize minor stings. 
Serious envenomations may result in paralysis and respiratory failure. Death is typically secondary to 
cardiac failure. C geographus may produce rapid cerebral edema, coma, respiratory arrest, and cardiac 
failure. Disseminated intravascular coagulation (DIC) also may be evident. 
Mortality/Morbidity: A high risk of death is associated with envenomation by certain species of cones, 
particularly C geographus. Morbidity includes mild symptoms (eg, nausea, weakness, diplopia) lasting 
several hours. Two to 3 weeks of symptoms may be associated with more severe exposures.  
Symptoms: Sharp burning or stinging sensation, local paresthesias, perioral paresthesias, generalized 
paresthesias, nausea, diplopia, malaise, weakness, dysphagia, areflexia, aphonia, paralysis, apnea, pruritus 
No antivenin is available for cone shell envenomation. 
4.5 Crimean-Congo haemorrhagic fever virus58 
Crimean-Congo haemorrhagic fever (CCHF) is a viral haemorrhagic fever of the Nairovirus group. 
Although primarily a zoonosis, sporadic cases and outbreaks of CCHF affecting humans do occur. The 
disease is endemic in many countries in Africa, Europe and Asia, and during 2001, cases or outbreaks 
have been recorded in Kosovo, Albania, Iran, Pakistan, and South Africa. 
The disease was first described in the Crimea in 1944 and given the name Crimean haemorrhagic fever. In 
1969 it was recognized that the pathogen causing Crimean haemorrhagic fever was the same as that 
responsible for an illness identified in 1956 in the Congo, and linkage of the 2 place names resulted in the 
current name for the disease and the virus. CCHF is a severe disease in humans, with a high mortality 
rate. Fortunately, human illness occurs infrequently, although animal infection may be more common. 
The geographical distribution of the virus, like that of its tick vector, is widespread. Evidence of CCHF 
virus has been found in Africa, Asia, the Middle East and Eastern Europe. Healthcare workers in endemic 
areas should be aware of the illness and the correct infection control procedures to protect themselves and 
their patients from the risk of nosocomial (hospital-acquired) infection. 
CCHF Virus:  The virus which causes CCHF is a Nairovirus, a group of related viruses forming one of 
the five genera in the Bunyaviridae family of viruses. All of the 32 members of the Nairovirus genus are 
transmitted by argasid or ixodid ticks, but only three have been implicated as causes of human disease: 
the Dugbe and Nairobi sheep viruses, and CCHF, which is the most important human pathogen amongst 
them. 
CCHF Reservoirs and Vectors:  The CCHF virus may infect a wide range of domestic and wild animals. 
Many birds are resistant to infection, but ostriches are susceptible and may show a high prevalence of 
infection in endemic areas. Animals become infected with CCHF from the bite of infected ticks.  
A number of tick genera are capable of becoming infected with CCHF virus, but the most efficient and 
common vectors for CCHF appear to be members of the Hyalomma genus. Trans-ovarial (transmission of 
the virus from infected female ticks to offspring via eggs) and venereal transmission have been 
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demonstrated amongst some vector species, indicating one mechanism which may contribute to 
maintaining the circulation of the virus in nature.  
However, the most important source for acquisition of the virus by ticks is believed to be infected small 
vertebrates on which immature Hyalomma ticks feed. Once infected, the tick remains infected through its 
developmental stages, and the mature tick may transmit the infection to large vertebrates, such as 
livestock. Domestic ruminant animals, such as cattle, sheep and goats, are viraemic (virus circulating in 
the bloodstream) for around one week after becoming infected.  
Humans who become infected with CCHF acquire the virus from direct contact with blood or other 
infected tissues from livestock during this time, or they may become infected from a tick bite. The 
majority of cases have occurred in those involved with the livestock industry, such as agricultural 
workers, slaughterhouse workers and veterinarians.  
Clinical Features:  The length of the incubation period for the illness appears to depend on the mode of 
acquisition of the virus. Following infection via tick bite, the incubation period is usually one to three 
days, with a maximum of nine days. The incubation period following contact with infected blood or 
tissues is usually five to six days, with a documented maximum of 13 days.  
Onset of symptoms is sudden, with fever, myalgia (aching muscles), dizziness, neck pain and stiffness, 
backache, headache, sore eyes and photophobia (sensitivity to light). There may be nausea, vomiting and 
sore throat early on, which may be accompanied by diarrhoea and generalised abdominal pain. Over the 
next few days, the patient may experience sharp mood swings, and may become confused and aggressive. 
After two to four days, the agitation may be replaced by sleepiness, depression and lassitude, and the 
abdominal pain may localize to the right upper quadrant, with detectable hepatomegaly (liver 
enlargement).  
Other clinical signs which emerge include tachycardia (fast heart rate), lymphadenopathy (enlarged 
lymph nodes), and a petechial rash (a rash caused by bleeding into the skin), both on internal mucosal 
surfaces, such as in the mouth and throat, and on the skin. The petechiae may give way to ecchymoses 
(like a petechial rash, but covering larger areas) and other haemorrhagic phenomena such as melaena 
(bleeding from the upper bowel, passed as altered blood in the faeces), haematuria (blood in the urine), 
epistaxis (nosebleeds) and bleeding from the gums. There is usually evidence of hepatitis. The severely ill 
may develop hepatorenal (i.e., liver and kidney) and pulmonary failure after the fifth day of illness.  
The mortality rate from CCHF is approximately 30%, with death occurring in the second week of illness. 
In those patients who recover, improvement generally begins on the ninth or tenth day after the onset of 
illness.  
Diagnosis:  Diagnosis of suspected CCHF is performed in specially-equipped, high biosafety level 
laboratories. IgG and IgM antibodies may be detected in serum by enzyme-linked immunoassay (the 
"ELISA" or "EIA" methods) from about day six of illness. IgM remains detectable for up to four months, 
and IgG levels decline but remain detectable for up to five years.  
Patients with fatal disease do not usually develop a measurable antibody response and in these 
individuals, as well as in patients in the first few days of illness, diagnosis is achieved by virus detection 
in blood or tissue samples. There are several methods for doing this. The virus may be isolated from 
blood or tissue specimens in the first five days of illness, and grown in cell culture. Viral antigens may 
sometimes be shown in tissue samples using immunofluorescence or EIA.  
More recently, the polymerase chain reaction (PCR), a molecular method for detecting the viral genome, 
has been successfully applied in diagnosis.  
Treatment:  General supportive therapy is the mainstay of patient management in CCHF. Intensive 
monitoring to guide volume and blood component replacement is required.  
The antiviral drug ribavirin has been used in treatment of established CCHF infection with apparent 
benefit. Both oral and intravenous formulations seem to be effective.  
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The value of immune plasma from recovered patients for therapeutic purposes has not been demonstrated, 
although it has been employed on several occasions.  
Prevention and Control:  Although an inactivated, mouse brain-derived vaccine against CCHF has been 
developed and used on a small scale in Eastern Europe, there is no safe and effective vaccine widely 
available for human use. The tick vectors are numerous and widespread and tick control with acaricides 
(chemicals intended to kill ticks) is only a realistic option for well-managed livestock production 
facilities.  
Persons living in endemic areas should use personal protective measures that include avoidance of areas 
where tick vectors are abundant and when they are active (Spring to Fall); regular examination of clothing 
and skin for ticks, and their removal; and use of repellents.  
Persons who work with livestock or other animals in the endemic areas can take practical measures to 
protect themselves. These include the use of repellents on the skin (e.g. DEET) and clothing (e.g. 
permethrin) and wearing gloves or other protective clothing to prevent skin contact with infected tissue or 
blood.  
When patients with CCHF are admitted to hospital, there is a risk of nosocomial spread of infection. In 
the past, serious outbreaks have occurred in this way and it is imperative that adequate infection control 
measures be observed to prevent this disastrous outcome.  
Patients with suspected or confirmed CCHF should be isolated and cared for using barrier nursing 
techniques. Specimens of blood or tissues taken for diagnostic purposes should be collected and handled 
using universal precautions. Sharps (needles and other penetrating surgical instruments) and body wastes 
should be safely disposed of using appropriate decontamination procedures.  
Healthcare workers are at risk of acquiring infection from sharps injuries during surgical procedures and, 
in the past, infection has been transmitted to surgeons operating on patients to determine the cause of the 
abdominal symptoms in the early stages of (at that moment undiagnosed) infection. Healthcare workers 
who have had contact with tissue or blood from patients with suspected or confirmed CCHF should be 
followed up with daily temperature and symptom monitoring for at least 14 days after the putative 
exposure. 
4.6 Diacetoxyscirpenol59 
DAS 
Trichothecene Mycotoxins (see also T-2 Toxin) 
Trichothecene (pronounced “tri-ko-thee-seen”) mycotoxins are a large family of fungal toxins that 
produce nausea, vomiting, diarrhea, skin irritation, and internal bleeding. Fusarium, Stachybotrys, and 
other trichothecene-producing molds can infect food grains such as corn, rye, barley, oats, and millet, as 
well as straw and hay. Historically, trichothecene mycotoxins have been known to cause severe health 
problems in humans and animals who have eaten contaminated food. In 1944, for example, 30 percent of 
the population of Orenburg district, near Siberia, was affected by alimentary toxic aleukia (ATA), an 
often fatal disease caused by the ingestion of trichothecenes. 
T-2 toxin and diacetoxyscirpenol (DAS) are the most potent members of the trichothecene family. They 
have an estimated lethal dose in humans of 3 to 35 milligrams (thousands of a gram), making them 
moderately toxic compared to chemical nerve agents such as sarin. Nevertheless, microgram doses of T-2 
toxin and DAS are sufficient to cause vomiting, sustained nausea, and skin and eye irritation. According 
to one source, trichothecenes are approximately 10 to 500 times more potent than mustard gas in inducing 
skin necrosis. 
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Harvesting and extraction of infected grain can yield large quantities of trichothecenes for warfare 
purposes. Crude extracts of Fusarium containing a mixture of trichothecenes are more potent than pure T-
2 toxin, and aflatoxin interacts synergistically with trichothecenes to increase their combined toxicity.  
Military dissemination of these toxins would probably be in the form of a powder or smoke aerosol or, 
alternatively, sprayed in large, liquid drops as a ground contaminant. Trichothecenes can enter the body 
by absorption through the skin or eyes, inhalation (in aerosol form), or ingestion in contaminated food or 
water. When solubilized in the solvent dimethylsulfoxide (DMSO), T-2 toxin and DAS are readily 
absorbed through the skin.  It is also known that trichothecenes are about 10 times more toxic when 
inhaled as an aerosol than by oral or subcutaneous administration.  
An advantage of the trichothecenes from a military standpoint are that they are extremely stable, 
particularly in dry powder form. They can be stored for years at room temperature with no loss of activity 
and retain their full potency even after being boiled in water for an hour. Accordingly, these toxins are 
difficult to decontaminate from clothing and equipment and are highly persistent in the environment, 
although they are eventually broken down by soil bacteria.  
Symptoms of Trichothecene Poisoning:   Trichothecenes exert their toxic effects by inhibiting protein 
synthesis, and are therefore able to harm multiple organ systems simultaneously. They do the most 
damage to rapidly dividing cells such as those in the lining of the gastrointestinal tract, the bone marrow, 
and the lymph nodes, giving rise to symptoms similar to those of radiation poisoning. Because there is a 
large gap between the incapacitating dose and the lethal dose of trichothecenes, many casualties will 
become sick but not die. The delay in the appearance of symptoms after exposure depends on the dose 
and the means of delivery. Initial symptoms may occur within an hour of inhalation or as long as 12-24 
hours after skin contact. After a single low-level exposure, the peak effects tend to occur in one to three 
days.  
Initial symptoms of trichothecene poisoning are burning and irritation of the mucous membranes, 
including conjunctivitis (eye inflammation), nasal irritation (with or without bleeding), and sore throat. If 
the agent is delivered as an aerosol, coughing and shortness of breath are accompanied by burning of the 
lungs and secondary pulmonary edema. Nausea and persistent vomiting are common, as are diarrhea 
(which may be bloody) and dehydration. Damage to exposed areas of skin is often extensive: the 
symptoms range from redness and inflammation to the formation within several hours of small (1 
centimeter diameter), hard, fluid-filled blisters.  Other early symptoms are shortness of breath, dizziness, 
chest pain, low blood pressure and rapid heartbeat. 
Delayed symptoms of high-dose trichothecene exposure include hemorrhage and necrosis of the mucous 
membranes, such as the lining of the gastrointestinal tract, resulting in bloody diarrhea; neurological 
disorders, and depressed bone-marrow activity leading to immune-system impairment and increased 
susceptibility to multiple bacterial and viral infections.  
Because there are no known antidotes to the trichothecenes, treatment is limited to supportive care. 
Decontamination is possible if the victim washes extensively with large amounts of soap and water, but 
must be performed immediately after exposure.  Although T-2 toxin and DAS are broken down by the 
body, some of the resulting metabolic products--such as HT-2 toxin--are also highly toxic. (HT-2 toxin is 
about two-thirds as toxic as T-2 toxin.  Studies have also shown that both T-2 toxin and DAS are lipid-
soluble and may persist for weeks in skin and fat tissue.  Unfortunately, little research has been done on 
the chronic effects of sublethal trichothecene exposures. 
4.7 Ebola viruses60 
Ebola Hemorrhagic Fever 
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What is Ebola hemorrhagic fever?  Ebola hemorrhagic fever (Ebola HF) is a severe, often-fatal disease 
in humans and nonhuman primates (monkeys, gorillas, and chimpanzees) that has appeared sporadically 
since its initial recognition in 1976. 
The disease is caused by infection with Ebola virus, named after a river in the Democratic Republic of the 
Congo (formerly Zaire) in Africa, where it was first recognized. The virus is one of two members of a 
family of RNA viruses called the Filoviridae. There are four identified subtypes of Ebola virus. Three of 
the four have caused disease in humans: Ebola-Zaire, Ebola-Sudan, and Ebola-Ivory Coast. The fourth, 
Ebola-Reston, has caused disease in nonhuman primates, but not in humans. 
Where is Ebola virus found in nature?  The exact origin, locations, and natural habitat (known as the 
"natural reservoir") of Ebola virus remain unknown. However, on the basis of available evidence and the 
nature of similar viruses, researchers believe that the virus is zoonotic (animal-borne) and is normally 
maintained in an animal host that is native to the African continent. A similar host is probably associated 
with Ebola-Reston which was isolated from infected cynomolgous monkeys that were imported to the 
United States and Italy from the Philippines. The virus is not known to be native to other continents, such 
as North America.  
Where do cases of Ebola hemorrhagic fever occur?  Confirmed cases of Ebola HF have been reported in 
the Democratic Republic of the Congo, Gabon, Sudan, the Ivory Coast, Uganda, and the Republic of the 
Congo. An individual with serologic evidence of infection but showing no apparent illness has been 
reported in Liberia, and a laboratory worker in England became ill as a result of an accidental needle-
stick. No case of the disease in humans has ever been reported in the United States. Ebola-Reston virus 
caused severe illness and death in monkeys imported to research facilities in the United States and Italy 
from the Philippines; during these outbreaks, several research workers became infected with the virus, but 
did not become ill. 
Ebola HF typically appears in sporadic outbreaks, usually spread within a health-care setting (a situation 
known as amplification). It is likely that sporadic, isolated cases occur as well, but go unrecognized.  A 
table showing a chronological list of known cases and outbreaks is available. 
How is Ebola virus spread?  Infections with Ebola virus are acute. There is no carrier state. Because the 
natural reservoir of the virus is unknown, the manner in which the virus first appears in a human at the 
start of an outbreak has not been determined. However, researchers have hypothesized that the first 
patient becomes infected through contact with an infected animal.     
Treating patients with Ebola HF during outbreak of the disease in Kikwit, Democratic Republic of the 
Congo, in 1995.  
After the first case-patient in an outbreak setting is infected, the virus can be transmitted in several ways. 
People can be exposed to Ebola virus from direct contact with the blood and/or secretions of an infected 
person. Thus, the virus is often spread through families and friends because they come in close contact 
with such secretions when caring for infected persons. People can also be exposed to Ebola virus through 
contact with objects, such as needles, that have been contaminated with infected secretions. 
Nosocomial transmission refers to the spread of a disease within a health-care setting, such as a clinic or 
hospital. It occurs frequently during Ebola HF outbreaks. It includes both types of transmission described 
above. In African health-care facilities, patients are often cared for without the use of a mask, gown, or 
gloves. Exposure to the virus has occurred when health care workers treated individuals with Ebola HF 
without wearing these types of protective clothing. In addition, when needles or syringes are used, they 
may not be of the disposable type, or may not have been sterilized, but only rinsed before reinsertion into 
multi-use vials of medicine. If needles or syringes become contaminated with virus and are then reused, 
numerous people can become infected. 
Ebola-Reston appeared in a primate research facility in Virginia, where it may have been transmitted from 
monkey to monkey through the air. While all Ebola virus species have displayed the ability to be spread 
through airborne particles (aerosols) under research conditions, this type of spread has not been 
documented among humans in a real-world setting, such as a hospital or household. 
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What are the symptoms of Ebola hemorrhagic fever?  The incubation period for Ebola HF ranges from 2 
to 21 days. The onset of illness is abrupt and is characterized by fever, headache, joint and muscle aches, 
sore throat, and weakness, followed by diarrhea, vomiting, and stomach pain. A rash, red eyes, hiccups 
and internal and external bleeding may be seen in some patients.  
Researchers do not understand why some people are able to recover from Ebola HF and others are not. 
However, it is known that patients who die usually have not developed a significant immune response to 
the virus at the time of death. 
How is Ebola hemorrhagic fever clinically diagnosed?  Diagnosing Ebola HF in an individual who has 
been infected only a few days is difficult because early symptoms, such as red eyes and a skin rash, are 
nonspecific to the virus and are seen in other patients with diseases that occur much more frequently. 
However, if a person has the constellation of symptoms described above, and infection with Ebola virus is 
suspected, isolate the patient and notify local and state health departments and the CDC. 
What laboratory tests are used to diagnose Ebola hemorrhagic fever?  Antigen-capture enzyme-linked 
immunosorbent assay (ELISA) testing, IgM ELISA, polymerase chain reaction (PCR), and virus isolation 
can be used to diagnose a case of Ebola HF within a few days of the onset of symptoms. Persons tested 
later in the course of the disease or after recovery can be tested for IgM and IgG antibodies; the disease 
can also be diagnosed retrospectively in deceased patients by using immunohistochemistry testing, virus 
isolation, or PCR. 
How is Ebola hemorrhagic fever treated?  There is no standard treatment for Ebola HF. Patients receive 
supportive therapy. This consists of balancing the patient’s fluids and electrolytes, maintaining their 
oxygen status and blood pressure, and treating them for any complicating infections.  
How is Ebola hemorrhagic fever prevented?  The prevention of Ebola HF in Africa presents many 
challenges. Because the identity and location of the natural reservoir of Ebola virus are unknown, there 
are few established primary prevention measures. 
If cases of the disease do appear, current social and economic conditions often favor the spread of an 
epidemic within health-care facilities. Therefore, health-care providers must be able to recognize a case of 
Ebola HF should one appear. They must also have the capability to perform diagnostic tests and be ready 
to employ practical viral hemorrhagic fever isolation precautions, or barrier nursing techniques. These 
techniques include the wearing of protective clothing, such as masks, gloves, gowns, and goggles; the use 
of infection-control measures, including complete equipment sterilization; and the isolation of Ebola HF 
patients from contact with unprotected persons. The aim of all of these techniques is to avoid any person’s 
contact with the blood or secretions of any patient. If a patient with Ebola HF dies, it is equally important 
that direct contact with the body of the deceased patient be prevented. 
CDC has developed a set of tools to meet health-care facilities' needs. In conjunction with the World 
Health Organization, CDC has developed practical, hospital-based guidelines, entitled Infection Control 
for Viral Haemorrhagic Fevers In the African Health Care Setting. The manual describes how to 
recognize cases of viral hemorrhagic fever, such as Ebola HF, and prevent further nosocomial 
transmission by using locally available materials and few financial resources. Similarly, a practical 
diagnostic test that uses tiny samples from patients’ skin has been developed to retrospectively diagnose 
Ebola HF in suspected case-patients who have died. 
4.8 Lassa fever virus61 
Lassa Fever 
What is Lassa fever?  Lassa fever is an acute viral illness that occurs in West Africa. The illness was 
discovered in 1969 when two missionary nurses died in Nigeria, West Africa. The cause of the illness was 
found to be Lassa virus, named after the town in Nigeria where the first cases originated. The virus, a 
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member of the virus family Arenaviridae, is a single-stranded RNA virus and is zoonotic, or animal-
borne. 
In areas of Africa where the disease is endemic (that is, constantly present), Lassa fever is a significant 
cause of morbidity and mortality. While Lassa fever is mild or has no observable symptoms in about 80% 
of people infected with the virus, the remaining 20% have a severe multisystem disease. Lassa fever is 
also associated with occasional epidemics, during which the case-fatality rate can reach 50%. 
Where is Lassa fever found?  Lassa fever is an endemic disease in portions of West Africa. It is 
recognized in Guinea, Liberia, Sierra Leone, as well as Nigeria. However, because the rodent species 
which carry the virus are found throughout West Africa, the actual geographic range of the disease may 
extend to other countries in the region.  
How many people become infected?  The number of Lassa virus infections per year in West Africa is 
estimated at 100,000 to 300,000, with approximately 5,000 deaths. Unfortunately, such estimates are 
crude, because surveillance for cases of the disease is not uniformly performed. In some areas of Sierra 
Leone and Liberia, it is known that 10%-16% of people admitted to hospitals have Lassa fever, which 
indicates the serious impact of the disease on the population of this region. 
In what animal host is Lassa virus maintained? The reservoir, or host, of Lassa virus is a rodent known 
as the "multimammate rat" of the genus Mastomys. It is not certain which species of Mastomys are 
associated with Lassa; however, at least two species carry the virus in Sierra Leone. Mastomys rodents 
breed very frequently, produce large numbers of offspring, and are numerous in the savannas and forests 
of West, Central, and East Africa. In addition, Mastomys generally readily colonize human homes. All 
these factors together contribute to the relatively efficient spread of Lassa virus from infected rodents to 
humans. 
How do humans get Lassa fever?  There are a number of ways in which the virus may be transmitted, or 
spread, to humans. The Mastomys rodents shed the virus in urine and droppings. Therefore, the virus can 
be transmitted through direct contact with these materials, through touching objects or eating food 
contaminated with these materials, or through cuts or sores. Because Mastomys rodents often live in and 
around homes and scavenge on human food remains or poorly stored food, transmission of this sort is 
common. Contact with the virus also may occur when a person inhales tiny particles in the air 
contaminated with rodent excretions. This is called aerosol or airborne transmission. Finally, because 
Mastomys rodents are sometimes consumed as a food source, infection may occur via direct contact when 
they are caught and prepared for food. 
Lassa fever may also spread through person-to-person contact. This type of transmission occurs when a 
person comes into contact with virus in the blood, tissue, secretions, or excretions of an individual 
infected with the Lassa virus. The virus cannot be spread through casual contact (including skin-to-skin 
contact without exchange of body fluids). Person-to-person transmission is common in both village and 
health care settings, where, along with the above-mentioned modes of transmission, the virus also may be 
spread in contaminated medical equipment, such as reused needles (this is called nosocomial 
transmission). 
What are the symptoms of Lassa fever?  Signs and symptoms of Lassa fever typically occur 1-3 weeks 
after the patient comes into contact with the virus. These include fever, retrosternal pain (pain behind the 
chest wall), sore throat, back pain, cough, abdominal pain, vomiting, diarrhea, conjunctivitis, facial 
swelling, proteinuria (protein in the urine), and mucosal bleeding. Neurological problems have also been 
described, including hearing loss, tremors, and encephalitis. Because the symptoms of Lassa fever are so 
varied and nonspecific, clinical diagnosis is often difficult. 
How is the disease diagnosed in the laboratory?  Lassa fever is most often diagnosed by using enzyme-
linked immunosorbent serologic assays (ELISA), which detect IgM and IgG antibodies as well as Lassa 
antigen. The virus itself may be cultured in 7 to 10 days. Immunohistochemistry performed on tissue 
specimens can be used to make a post-mortem diagnosis. The virus can also be detected by reverse 
transcription-polymerase chain reaction (RT-PCR); however, this method is primarily a research tool. 
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Are there complications after recovery?  The most common complication of Lassa fever is deafness. 
Various degrees of deafness occur in approximately one-third of cases, and in many cases hearing loss is 
permanent. As far as is known, severity of the disease does not affect this complication: deafness may 
develop in mild as well as in severe cases.  Spontaneous abortion is another serious complication. 
What proportion of people die from the illness?  Approximately 15%-20% of patients hospitalized for 
Lassa fever die from the illness. However, overall only about 1% of infections with Lassa virus result in 
death. The death rates are particularly high for women in the third trimester of pregnancy, and for fetuses, 
about 95% of which die in the uterus of infected pregnant mothers. 
How is Lassa fever treated?  Ribavirin, an antiviral drug, has been used with success in Lassa fever 
patients. It has been shown to be most effective when given early in the course of the illness. Patients 
should also receive supportive care consisting of maintenance of appropriate fluid and electrolyte balance, 
oxygenation and blood pressure, as well as treatment of any other complicating infections. 
What groups are at risk for getting the illness?  Individuals at risk are those who live or visit areas with a 
high population of Mastomys rodents infected with Lassa virus or are exposed to infected humans. 
Hospital staff are not at great risk for infection as long as protective measures are taken.  
How is Lassa fever prevented?  Primary transmission of the Lassa virus from its host to humans can be 
prevented by avoiding contact with Mastomys rodents, especially in the geographic regions where 
outbreaks occur. Putting food away in rodent-proof containers and keeping the home clean help to 
discourage rodents from entering homes. Using these rodents as a food source is not recommended. 
Trapping in and around homes can help reduce rodent populations. However, the wide distribution of 
Mastomys in Africa makes complete control of this rodent reservoir impractical.  
When caring for patients with Lassa fever, further transmission of the disease through person-to-person 
contact or nosocomial routes can be avoided by taking preventive precautions against contact with patient 
secretions (together called VHF isolation precautions or barrier nursing methods). Such precautions 
include wearing protective clothing, such as masks, gloves, gowns, and goggles; using infection control 
measures, such as complete equipment sterilization; and isolating infected patients from contact with 
unprotected persons until the disease has run its course. 
4.9 Marburg virus62 
Marburg Hemorrhagic Fever 
What is Marburg hemorrhagic fever?  Marburg hemorrhagic fever is a rare, severe type of hemorrhagic 
fever which affects both humans and non-human primates. Caused by a genetically unique zoonotic (that 
is, animal-borne) RNA virus of the filovirus family, its recognition led to the creation of this virus family. 
The four species of Ebola virus are the only other known members of the filovirus family. 
Marburg virus was first recognized in 1967, when outbreaks of hemorrhagic fever occurred 
simultaneously in laboratories in Marburg and Frankfurt, Germany and in Belgrade, Yugoslavia (now 
Serbia). A total of 37 people became ill; they included laboratory workers as well as several medical 
personnel and family members who had cared for them. The first people infected had been exposed to 
African green monkeys or their tissues. In Marburg, the monkeys had been imported for research and to 
prepare polio vaccine. 
Where do cases of Marburg hemorrhagic fever occur?  Recorded cases of the disease are rare, and have 
appeared in only a few locations. While the 1967 outbreak occurred in Europe, the disease agent had 
arrived with imported monkeys from Uganda. No other case was recorded until 1975, when a traveler 
most likely exposed in Zimbabwe became ill in Johannesburg, South Africa – and passed the virus to his 
traveling companion and a nurse. 1980 saw two other cases, one in Western Kenya not far from the 
Ugandan source of the monkeys implicated in the 1967 outbreak. This patient’s attending physician in 
Nairobi became the second case. Another human Marburg infection was recognized in 1987 when a 
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young man who had traveled extensively in Kenya, including western Kenya, became ill and later died. In 
1998, an outbreak occurred in Durba, Democratic Republic of the Congo. Cases were linked to 
individuals working in a gold mine. After the outbreak subsided, there were still some sporadic cases that 
occurred in the region.  
Where is Marburg virus found?  Marburg virus is indigenous to Africa. While the geographic area to 
which it is native is unknown, this area appears to include at least parts of Uganda and Western Kenya, 
and perhaps Zimbabwe. As with Ebola virus, the actual animal host for Marburg virus also remains a 
mystery. Both of the men infected in 1980 in western Kenya had traveled extensively, including making a 
visit to a cave, in that region. The cave was investigated by placing sentinels animals inside to see if they 
would become infected, and by taking samples from numerous animals and arthropods trapped during the 
investigation. The investigation yielded no virus: The sentinel animals remained healthy and no virus 
isolations from the samples obtained have been reported. 
How do humans get Marburg hemorrhagic fever?  Just how the animal host first transmits Marburg 
virus to humans is unknown. However, as with some other viruses which cause viral hemorrhagic fever, 
humans who become ill with Marburg hemorrhagic fever may spread the virus to other people. This may 
happen in several ways. Persons who have handled infected monkeys and have come in direct contact 
with their fluids or cell cultures, have become infected. Spread of the virus between humans has occurred 
in a setting of close contact, often in a hospital. Droplets of body fluids, or direct contact with persons, 
equipment, or other objects contaminated with infectious blood or tissues are all highly suspect as sources 
of disease. 
What are the symptoms of the disease?  After an incubation period of 5-10 days, the onset of the disease 
is sudden and is marked by fever, chills, headache, and myalgia. Around the fifth day after the onset of 
symptoms, a maculopapular rash, most prominent on the trunk (chest, back, stomach), may occur. 
Nausea, vomiting, chest pain, a sore throat, abdominal pain, and diarrhea then may appear. Symptoms 
become increasingly severe and may include jaundice, inflammation of the pancreas, severe weight loss, 
delirium, shock, liver failure, massive hemorrhaging, and multi-organ dysfunction. 
Because many of the signs and symptoms of Marburg hemorrhagic fever are similar to those of other 
infectious diseases, such as malaria or typhoid fever, diagnosis of the disease can be difficult, especially if 
only a single case is involved. 
Antigen-capture enzyme-linked immunosorbent assay (ELISA) testing, IgM-capture ELISA, polymerase 
chain reaction (PCR), and virus isolation can be used to confirm a case of Marburg hemorrhagic fever 
within a few days of the onset of symptoms. The IgG-capture ELISA is appropriate for testing persons 
later in the course of disease or after recovery. The disease is readily diagnosed by 
immunohistochemistry, virus isolation, or PCR of blood or tissue specimens from deceased patients. 
Are there complications after recovery?  Recovery from Marburg hemorrhagic fever may be prolonged 
and accompanied by orchititis, recurrent hepatitis, transverse myelitis or uvetis. Other possible 
complications include inflammation of the testis, spinal cord, eye, parotid gland, or by prolonged 
hepatitis.  
Is the disease ever fatal?  Yes. The case-fatality rate for Marburg hemorrhagic fever is between 23-25%. 
How is Marburg hemorrhagic fever treated?  A specific treatment for this disease is unknown. However, 
supportive hospital therapy should be utilized. This includes balancing the patient’s fluids and 
electrolytes, maintaining their oxygen status and blood pressure, replacing lost blood and clotting factors 
and treating them for any complicating infections. 
Sometimes treatment also has used transfusion of fresh-frozen plasma and other preparations to replace 
the blood proteins important in clotting. One controversial treatment is the use of heparin (which blocks 
clotting) to prevent the consumption of clotting factors. Some researchers believe the consumption of 
clotting factors is part of the disease process.   
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Who is at risk for the illness?  People who have close contact with a human or non-human primate 
infected with the virus are at risk. Such persons include laboratory or quarantine facility workers who 
handle non-human primates that have been associated with the disease. In addition, hospital staff and 
family members who care for patients with the disease are at risk if they do not use proper barrier nursing 
techniques. 
How is Marburg hemorrhagic fever prevented?  Due to our limited knowledge of the disease, preventive 
measures against transmission from the original animal host have not yet been established. Measures for 
prevention of secondary transmission are similar to those used for other hemorrhagic fevers. If a patient is 
either suspected or confirmed to have Marburg hemorrhagic fever, barrier nursing techniques should be 
used to prevent direct physical contact with the patient. These precautions include wearing of protective 
gowns, gloves, and masks; placing the infected individual in strict isolation; and sterilization or proper 
disposal of needles, equipment, and patient excretions. 
In conjunction with the World Health Organization, CDC has developed practical, hospital-based 
guidelines, titled Infection Control for Viral Haemorrhagic Fevers In the African Health Care Setting. The 
manual can help health-care facilities recognize cases and prevent further hospital-based disease 
transmission using locally available materials and few financial resources. 
4.10 Monkeypox virus63 
Monkeypox is a viral disease with a clinical presentation in humans similar to that seen in the past in 
smallpox patients. Smallpox no longer occurs, following its worldwide eradication in 1980, whereas 
monkeypox is still seen as a sporadic disease in parts of Africa. 
The virus responsible for monkeypox is related to the virus that used to cause smallpox (both are 
orthopoxviruses). Vaccination against smallpox (no longer necessary) also gave protection against 
monkeypox. Before the eradication of smallpox, vaccination was widely practised and protected against 
both diseases. However, children born after 1980 have not been vaccinated against smallpox and are 
likely to be more susceptible to monkeypox than older members of the population. The death rate from 
monkeypox is highest in young children, reaching about 10%. 
Most cases occur in remote villages of Central and West Africa close to tropical rainforests where there is 
frequent contact with infected animals. Monkeypox is usually transmitted to humans from squirrels and 
primates through contact with the animal's blood or through a bite.  
Following reports of ongoing cases of human monkeypox in the Democratic Republic of the Congo 
("DRC", formerly Zaire) representing a new pattern of the disease, the Ministry of Health in DRC and the 
World Health Organization (WHO) organized two investigations in February and October 1997.  
In the past, an outbreak of monkeypox in DRC would have been limited to the village and would not last 
long because it did not spread extensively after the first patients recovered. However, the present study 
indicates that monkeypox disease is changing its pattern of infection in humans. The outbreak had a much 
higher rate of person to person transmission than seen previously, and spread through many generations 
of transmission, thus maintaining the outbreak for more than a year. 
Previous studies over a twenty-year period had shown that the rate of transmission of monkeypox within 
households was low, suggesting that the disease had a low potential for transmission from person to 
person. Outbreaks were generally self-limiting after one or two sequential transmissions. However, the 
two recent WHO studies have to-date shown that: 
• The outbreak in DRC presents the largest cluster of monkeypox cases - albeit with less severe 
clinical disease - ever reported: 511 suspect cases were identified with onset of disease between 
February 1996 and October 1997; some of these suspect cases are thought to be chickenpox and 
laboratory confirmation studies are underway; 
                                                 
63World Health Organization, revised December 1997.  Fact Sheet No. 161.   
http://www.who.int/inf-fs/en/fact161.html  
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• The proportion of suspect cases who were 16 years of age or older (21%) was higher than 
previously reported (8%). Young children had mostly been affected in previous outbreaks; 
• The percentage of suspect cases from person to person transmission (78%) was higher than 
previously reported (30%). This was associated with the clustering of cases in household 
compounds and prolonged chains of transmission from person to person; 
• Secondary attack rates among contacts of primary cases (those thought to be infected by animal 
contact) have been calculated, on a preliminary basis, at 8%, which is similar to secondary attack 
rates of 4-12% estimated in Zaire in the early 1980s; 
• The proportion of deaths (2%) was lower than previously reported (10%); all were aged under 
eight years and died within three weeks of disease onset.  
The ending of vaccination programmes against smallpox in the late 1970's has probably led to an increase 
in susceptibility to monkeypox and could explain the larger size of the most recent outbreak, the higher 
proportion of patients aged 15 and over, and the spread through many generations of transmission. 
WHO is concerned that monkeypox could pose a public health problem in this region of DRC and 
therefore vigilance must be maintained by strengthening detection systems for monkeypox and 
completely investigating future outbreaks. 
4.11 Ricin64 
Ricin is a potent protein cytotoxin derived from the beans of the castor plant (Ricinus communis). Castor 
beans are ubiquitous worldwide, and the toxin is fairly easy to extract; Therefore, ricin is potentially 
widely available. When inhaled as a small particle aerosol, this toxin may produce pathologic changes 
within 8 hours and severe respiratory symptoms followed by acute hypoxic respiratory failure in 36-72 
hours. When ingested, ricin causes severe gastrointestinal symptoms followed by vascular collapse and 
death. This toxin may also cause disseminated intravascular coagulation, microcirculatory failure and 
multiple organ failure if given intravenously in laboratory animals. 
Ricin’s significance as a potential biological warfare toxin relates in part to its wide availability. 
Worldwide, one million tons of castor beans are processed annually in the production of castor oil; the 
waste mash from this process is 5% ricin by weight. The toxin is also quite stable and extremely toxic by 
several routes of exposure, including the respiratory route.  
Ricin is actually made up of two hemagglutinins and two toxins. The toxins, RCL III and RCL IV, are 
dimers with molecular weights of about 66,000 daltons. The toxins are made up of two polypeptide 
chains, an A chain and a B chain, which are joined by a disulfide bond. Ricin can be produced relatively 
easily and inexpensively in large quantities in a fairly low technology setting. Ricin can be prepared in 
liquid or crystalline form, or it can be lyophilized to make a dry powder. It could be disseminated as an 
aerosol, injected into a target, or used to contaminate food or water on a small scale. Ricin is stable under 
ambient conditions, but is detoxified by heat (80OC for 10 min., or 50OC for about an hour at pH 7.8) 
and chlorine (>99.4% inactivation by 100 mg/L FAC in 20 min.). Low chlorine concentrations, such as 
10 mg/L FAC, as well as iodine at up to 16 mg/L, have no effect on ricin. Ricin's toxicity is marginal 
when comparing its LD50 to other toxins, such as botulinum and SEB (incapacitating dose). An enemy 
would need to produce it in large quantities to cover a significant area on the battlefield, thus potentially 
limiting large-scale use of ricin by an adversary. 
Mechanism of Toxicity:  Ricin is very toxic to cells. It acts by inhibiting protein synthesis. The B chain 
binds to cell surface receptors and the toxin-receptor complex is taken into the cell; the A chain has 
endonuclease activity and extremely low concentrations will inhibit DNA replication and protein 
synthesis. In rodents, the histopathology of aerosol exposure is characterized by necrosis of upper and 
                                                 
64U.S. Army Medical Research Institute of Infectious Diseases.  RICIN, A Chapter from Medical Management of 
Biological Casualities Handbook.    http://www.healthri.org/environment/biot/ricin_chapter.htm  
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lower respiratory epithelium, causing tracheitis, bronchitis, bronchiolitis, and interstitial pneumonia with 
perivascular and alveolar edema. There is a latent period of 8 hours post-inhalation exposure before 
histologic lesions are observed in animal models. In rodents, ricin is more toxic by the aerosol route than 
by other routes of exposure. 
Clinical Features:  The clinical picture in intoxicated victims would depend on the route of exposure. 
After aerosol exposure, signs and symptoms would depend on the dose inhaled. Accidental sublethal 
aerosol exposures which occurred in humans in the 1940’s were characterized by acute onset of the 
following symptoms in 4 to 8 hours: fever, chest tightness, cough, dyspnea, nausea, and arthralgias. The 
onset of profuse sweating some hours later was commonly the sign of termination of most of the 
symptoms. Although lethal human aerosol exposures have not been described, the severe 
pathophysiologic changes seen in the animal respiratory tract, including necrosis and severe alveolar 
flooding, are probably sufficient to cause death from ARDS and respiratory failure. Time to death in 
experimental animals is dose dependent, occurring 36-72 hours post inhalation exposure. Humans would 
be expected to develop severe lung inflammation with progressive cough, dyspnea, cyanosis and 
pulmonary edema. 
By other routes of exposure, ricin is not a direct lung irritant; however, intravascular injection can cause 
minimal pulmonary perivascular edema due to vascular endothelial injury. Ingestion causes necrosis of 
the gastrointestinal epithelium, local hemorrhage, and hepatic, splenic, and renal necrosis. Intramuscular 
injection causes severe local necrosis of muscle and regional lymph nodes with moderate visceral organ 
involvement. 
Signs and Symptoms: Acute onset of fever, chest tightness, cough, dyspnea, nausea, and arthralgias 
occurs 4 to 8 hours after inhalational exposure. Airway necrosis and pulmonary capillary leak resulting in 
pulmonary edema would likely occur within 18-24 hours, followed by severe respiratory distress and 
death from hypoxemia in 36-72 hours. 
Diagnosis:  An attack with aerosolized ricin would be primarily diagnosed by the clinical and 
epidemiological setting. Acute lung injury affecting a large number of geographically clustered cases 
should raise suspicion of an attack with a pulmonary irritant such as ricin, although other pulmonary 
pathogens could present with similar signs and symptoms. Other biological threats, such as SEB, Q fever, 
tularemia, plague, and some chemical warfare agents like phosgene, need to be included in the differential 
diagnosis. Ricin-induced pulmonary edema would be expected to occur much later (1-3 days post 
exposure) compared to that induced by SEB (about 12 hours post exposure) or phosgene (about 6 hours 
post exposure). Ricin intoxication would be expected to progress despite treatment with antibiotics, as 
opposed to an infectious process. There would be no mediastinitis as seen with inhalation anthrax. Ricin 
patients would not be expected to plateau clinically as occurs with SEB intoxication. 
Treatment: Management is supportive and should include treatment for pulmonary edema. Gastric lavage 
and cathartics are indicated for ingestion, but charcoal is of little value for large molecules such as ricin. 
Prophylaxis: There is currently no vaccine or prophylactic antitoxin available for human use, although 
immunization appears promising in animal models. Use of the protective mask is currently the best 
protection against inhalation. 
Isolation and Decontamination: Standard Precautions for healthcare workers. Ricin is non-vloatile, and 
secondary aerosols are not expected to be a danger to health care providers. Decontaminate with soap and 
water. Hypochlorite solutions (0.1% sodium hypochlorite) can inactivate ricin. 
4.12 Rickettsia prowazekii65  
Name: Rickettsia prowazekii, Rickettsia canadensis (Formerly R. canada) 
                                                 
65Office of Laboratory Security, January 2001.  © Health Canada, Population and Public Health Branch, Material 
and Safety Data Sheet.  http://www.hc-sc.gc.ca/pphb-dgspsp/msds-ftss/msds128e.html  
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Synonym or Cross Reference: Louse-borne typhus fever, Epidemic typhus, Typhus exanthematicus, 
Classical typhus fever, Brill-zinsser disease. 
Characteristics: Pleomorphic, gram-negative bacterium, obligate intracellular 
Pathogenicity: Variable onset, often sudden with headache, chills, fever, prostration, and general pains; 
macular eruption on the 5 and 6th day on upper trunk and spreading to entire body (except face, palms or 
soles); pronounced toxemia; disease terminates approximately 2 weeks after onset of fever; case fatality 
rate from 10-40% in absence of treatment; may recrudesce years later as Brill-Zissner disease. 
Epidemiology: Occurs in areas of poor hygiene and that are louse-infected; endemic foci in mountainous 
regions of Central and South America, in Africa and Asia; in USA, last louse-borne outbreak was in 1921 
and now exists as a zoonosis of flying squirrels (33 infections between 1976 and 1984). 
Host Range: Humans, squirrels 
Infectious Dose: <10 organisms 
Mode of Transmission: The body louse is infected by feeding on the blood of a patient with acute typhus 
fever; infected lice excrete rickettsiae in their feces and defecate at time of feeding; man is infected by 
rubbing feces or crushed lice into the bite or into superficial abrasions; inhalation of infective louse feces 
from dust; transmission from squirrel may be the bite of squirrel flea. 
Incubation Period: From 1 to 2 weeks, commonly 12 days 
Communicability: Not directly transmitted from person-to-person; patients are infective for lice during 
the febrile illness and possibly for 2 to 3 days after temperature returns to normal; louse is infective within 
2 to 6 days after infected meal (infective earlier if crushed). 
Reservoir: Humans maintain the infection during inter-epidemic periods; importance of flying squirrel 
has not yet been demonstrated. 
Zoonosis: Possibly by flying squirrel 
Vectors: Body louse - Pediculus humanus 
Drug Susceptibility: Sensitive to tetracyclines, chloramphenicol doxycycline 
Susceptibility to Disinfectants: Susceptible to 1% sodium hypochlorite, 70% ethanol, glutaraldehyde, 
formaldehyde 
Physical Inactivation: Susceptible to moist heat (121° C for at least 15 min) and dry heat (160-170° C for 
at least 1 hour). 
Survival Outside Host: Rickettsia may remain viable in louse fecal material and the dead louse for weeks. 
Surveillance: All immediate contacts should be observed for 2 weeks for symptoms of illness; R. 
prowazekkii is cross reactive with R. typhi. 
First Aid/Treatment: For seriously ill patient with possible typhus, antibiotic therapy should begin 
without waiting for laboratory confirmation; treatment with chloramphenicol or tetracyclines 
Immunization: No commercially available vaccine for use (persons entering high endemic areas are 
immunized eg. military); live vaccine prepared from the attenuated strain E of R. prowazekii has shown 
promise 
Prophylaxis: Use of residual insecticide applied to clothing and treatment of hair for louse eggs 
Primary Hazards: Accidental parenteral inoculation and exposure to infectious aerosols 
Containment Requirements: Biosafety level 2 practices and containment for non-propagative activities 
(serological procedures, smears); biosafety level 3 for all manipulations of infectious materials, including 
animal necropsy, and the inoculation, incubation and harvesting of embryonated eggs or tissue cultures; 
arthropods and flying squirrels should be handled using biosafety level 3 practices and facilities 
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4.13 Rickettsia rickettsii66 
Name: Rickettsia rickettsii 
Synonym or Cross Reference: Rocky Mountain Spotted Fever (RMSF), New World spotted fever, Tick-
borne typhus fever, Sao Paulo fever 
Characteristics: Pleomorphic gram-negative obligate intracellular bacterium 0.3-1.5 µm in size 
Pathogenicity: Sudden onset with moderate to high fever persisting 2 to 3 weeks, malaise, deep muscle 
pain, severe headache, chills and conjunctival injection; maculopapular rash appears on extremities 3rd 
day and spreads rapidly; hemorrhages are common; 15-20% case fatality rate in absence of therapy but 
with treatment death is uncommon; clinical syndrome may be confused with atypical measles, 
ehrlichiosis, meningococcemia and enteroviral infection. 
Epidemiology: Occurs through USA during spring, summer and fall; many cases along eastern seaboard 
and the Rocky Mountain region; adult males infected most frequently in western USA and in East, 
incidence is higher in children; some infections in Canada, Central and South America. 
Host Range: Humans, dogs, rodents, various other small animals 
Infectious Dose: < 10 organisms 
Mode of Transmission: Ordinarily by bite of an infected tick; several hours of attachment are required 
before the rickettsiae become reactivated to infect humans; by contamination of skin with crushed tissues 
or feces of tick. 
Incubation Period: From 3 to 14 days 
Communicability: Not directly transmitted from person-to-person; tick remains infectious for life, 
approximately 18 months. 
Reservoir: Maintained in nature in ticks by transovarian and transstadial passage; transmitted to humans, 
dogs, various rodents and animals. 
Zoonosis: Yes - bite from ticks from infected animals; contamination of broken skin or mucous 
membranes with feces or internal contents of crushed tick from infected animal. 
Vectors: Ticks: 
• East and South USA - dog tick, Dermancentor variabilis 
• Northwest USA - wood tick, D.andersoni 
• Southwest USA - Lone Star tick, Amyblyomma americanum 
• Latin America - A. cajennense 
Drug Susceptibility: Sensitive to tetracyclines and chloramphenicol 
Susceptibility to Disinfectants: Susceptible to 1% sodium hypochlorite, 70% ethanol, glutaraldehyde, 
formaldehyde. 
Physical Inactivation: Sensitive to moist heat (121° C for at least 15 min) and dry heat (160-170° C for at 
least 1 hour). 
Survival Outside Host: Organism is stable in tick tissues or blood under ambient environmental 
conditions, surviving up to 1 year; sensitive to drying-feces of infected ticks quickly lose their infectivity 
on drying. 
Surveillance: Monitor for febrile illness and report symptoms immediately; confirm with IF, IgG does not 
appear until 7 to 10 days after onset. 
First Aid/Treatment: Appropriate antibiotic therapy in the early stages of infection should be initiated on 
clinical and epidemiologic considerations without waiting for laboratory confirmation of the diagnosis. 
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140
Immunization: None licensed; but may be available as killed experimental product from U.S. CDC 
Prophylaxis: Early antibiotic treatment lead to delayed onset of illness or relapse (tetracyclines and 
chloramphenicol do not kill Rickettsia). 
Primary Hazards: Accidental parenteral inoculation and exposure to infectious aerosols (successful 
aerosol transmission documented in non-human primates). 
Containment Requirements: Biosafety level 2 practices, containment and facilities for all non-
propagative laboratory procedures including serological and fluorescent antibody tests, and staining of 
impression smears; biosafety level 3 for all other manipulations of known or potentially infectious 
materials, including necropsy of infected animals and trituration of their tissues, and inoculation, 
incubation and harvesting of embryonated eggs or tissue culture. 
Other Precautions: Animal biosafety level 2 practices and facilities are recommended for holding of 
experimentally infected rodents, however, all necropsy and manipulation of tissue should be conducted at 
Biosafety level 3. 
4.14 Saxitoxin67 
Characteristics:   Saxitoxin is the parent compound of a family of chemically related neurotoxins. In 
nature they are predominantly produced by marine dinoflagellates, although they have also been 
identified in association with such diverse organisms as blue-green algae, crabs, and the blue-ringed 
octopus. Human intoxications are principally due to ingestion of bivalve molluscs which have 
accumulated dinoflagellates during filter feeding. 
The resulting intoxication, known as paralytic shellfish poisoning (PSP), is known throughout the world 
as a severe, life-threatening illness requiring immediate medical intervention.  
Saxitoxin and its derivatives are water-soluble compounds that bind to the voltage-sensitive sodium 
channel, blocking propagation of nerve-muscle action potentials. Consistent with this mechanism of 
action, victims typically present with neurological symptoms and in severe cases, death results from 
respiratory paralysis.  
The natural route of exposure to these toxins is oral. In a BW scenario, the most likely route of delivery is 
by inhalation or toxic projectile. In addition, saxitoxin could be used in a confined area to contaminate 
water supplies.  
Clinical Features: After oral exposure, absorbtion of toxins from the gastrointestinal tract is rapid. Onset 
of symptoms typically begins 10-60 minutes after exposure, but may be delayed several hours depending 
upon the dose and individual idiosyncrasy. Initial symptoms are numbness or tingling of the lips, tongue 
and fingertips, followed by numbness of the neck and extremities and general muscular incoordination. 
Nausea and vomiting may be present, but typically occur in a minority of cases. Other symptoms may 
include a feeling of light headedness, or floating, dizziness, weakness, aphasia, incoherence, visual 
disturbances, memory loss and headache. Cranial nerves are often involved, especially those responsible 
for ocular movements, speech, and swallowing. Induced reflexes are normal and the patient remains 
conscious. Respiratory distress and flaccid muscular paralysis are the terminal stages and can occur 2-12 
hours after intoxication. Death results from respiratory paralysis. Clearance of the toxin is rapid and 
survivors for 12-24 hours will usually recover. Complete recovery may require 7-14 days. There are no 
known cases of inhalation exposure to saxitoxin in the medical literature, but data from animal 
experiments suggest the entire syndrome is compressed and death may occur in minutes.  
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Diagnosis:  Routine Laboratory Findings. Routine laboratory evaluation is not particularly helpful. 
Cardiac conduction defects may develop. Elevation of serum creatine kinase levels in some patients has 
been reported.  
Differential Diagnosis:  Exposure to tetrodotoxin or the ciguatera toxins can manifest very similar signs 
and symptoms. Ciguatoxins (by oral exposure) typically demonstrate a much greater degree of 
gastrointestinal involvement, and can also be differentiated by a history of eating finfish rather than 
shellfish. Tetrodotoxin intoxication is nearly identical to that caused by the saxitoxins except that 
hypotension typically plays a greater role in severe intoxication. Differential diagnosis may require toxin 
detection. Gas chromatographic analysis of food or stomach contents can rule out pesticide exposure.  
Therapy: Management is supportive and standard management of poison ingestion should be employed if 
intoxication is by the oral route. Toxins are rapidly cleared and excreted in the urine, so diuresis may 
increase elimination. Charcoal hemoperfusion has been advocated, but remains unproven in its utility. 
Intubation and mechanical respiratory support may be required in severe intoxication. Timely 
resuscitation would be imperative, albeit very difficult, after inhalation exposure on the battlefield. 
Specific antitoxin therapy has been successful in animal models, but is untested in humans.  
Prophylaxis: No vaccine against saxitoxin exposure has been developed for human use.  
4.15 Shiga-like ribosome inactivating proteins68 
Name of the Organism: Shigella spp. (Shigella sonnei, S. boydii, S. flexneri, and S. dysenteriae)   
Shigella are Gram-negative, nonmotile, nonsporeforming rod-shaped bacteria. The illness caused by 
Shigella (shigellosis) accounts for less than 10% of the reported outbreaks of foodborne illness in this 
country. Shigella rarely occurs in animals; principally a disease of humans except other primates such as 
monkeys and chimpanzees. The organism is frequently found in water polluted with human feces.  
Name of Disease:  Shigellosis (bacillary dysentery).  
Nature of Disease:  Symptoms -- Abdominal pain; cramps; diarrhea; fever; vomiting; blood, pus, or 
mucus in stools; tenesmus. Onset time -- 12 to 50 hours. Infective dose -- As few as 10 cells depending on 
age and condition of host. The Shigella spp. are highly infectious agents that are transmitted by the fecal-
oral route. The disease is caused when virulent Shigella organisms attach to, and penetrate, epithelial cells 
of the intestinal mucosa. After invasion, they multiply intracellularly, and spread to contiguous epitheleal 
cells resulting in tissue destruction. Some strains produce enterotoxin and Shiga toxin (very much like the 
verotoxin of E. coli O157:H7).  
Diagnosis of Human Illness:  Serological identification of culture isolated from stool.  
Associated Foods:  Salads (potato, tuna, shrimp, macaroni, and chicken), raw vegetables, milk and dairy 
products, and poultry. Contamination of these foods is usually through the fecal-oral route. Fecally 
contaminated water and unsanitary handling by food handlers are the most common causes of 
contamination.  
Relative Frequency of Disease:  An estimated 300,000 cases of shigellosis occur annually in the U.S. The 
number attributable to food is unknown, but given the low infectious dose, it is probably substantial.   
Complications:  Infections are associated with mucosal ulceration, rectal bleeding, drastic dehydration; 
fatality may be as high as 10-15% with some strains. Reiter's disease, reactive arthritis, and hemolytic 
uremic syndrome are possible sequelae that have been reported in the aftermath of shigellosis.  
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Target Populations:  Infants, the elderly, and the infirm are susceptible to the severest symptoms of 
disease, but all humans are susceptible to some degree. Shigellosis is a very common malady suffered by 
individuals with acquired immune deficiency syndrome (AIDS) and AIDS-related complex, as well as 
non-AIDS homosexual men.  
Food Analysis:  Organisms are difficult to demonstrate in foods because methods are not developed or 
are insensitive. A genetic probe to the virulence plasmid has been developed by FDA and is currently 
under field test. However, the isolation procedures are still poor.  
Selected Outbreaks:  In 1985, a huge outbreak of foodborne shigellosis occurred in Midland-Odessa, 
Texas, involving perhaps as many as 5,000 persons. The implicated food was chopped, bagged lettuce, 
prepared in a central location for a Mexican restaurant chain. FDA research subsequently showed that S. 
sonnei, the isolate from the lettuce, could survive in chopped lettuce under refrigeration, and the lettuce 
remained fresh and appeared to be quite edible. In 1985-1986, several outbreaks of shigellosis occurred 
on college campuses, usually associated with fresh vegetables from the salad bar. Usually an ill food 
service worker was shown to be the cause. In 1987, several very large outbreaks of shigellosis (S. sonnei) 
occurred involving thousands of persons, but no specific food vector could be proven. In 1988, numerous 
individuals contracted shigellosis from food consumed aboard Northwest Airlines flights; food on these 
flights had been prepared in one central commisary. No specific food item was implicated, but various 
sandwiches were suspected. **NOTE - Although all Shigella spp. have been implicated in foodborne 
outbreaks at some time, S. sonnei is clearly the leading cause of shigellosis from food. The other species 
are more closely associated with contaminated water. One in particular, S. flexneri, is now thought to be 
in large part sexually transmitted.  
4.16 South American haemorrhagic fever viruses69 
Junin (Candid #1), Machupo, Sabia, Flexal, Guanarito  
Arenaviruses 
What are the Arenaviridae?   Vero E6 tissue culture cell infected with an arenavirus.  Image shows 
extracellular virus particles budding from the cell surface. Click the image to see a high-resolution 
version.   Image courtesy Cynthia Goldsmith, MS, Infectious Disease Pathology Activity, DVRD, NCID, 
CDC.  Go to high-resolution version.  
The Arenaviridae are a family of viruses whose members are generally associated with rodent-transmitted 
disease in humans. Each virus usually is associated with a particular rodent host species in which it is 
maintained. Arenavirus infections are relatively common in humans in some areas of the world and can 
cause severe illnesses. 
The virus particles are spherical and have an average diameter of 110-130 nanometers. All are enveloped 
in a lipid (fat) membrane. Viewed in cross-section, they show grainy particles that are ribosomes acquired 
from their host cells. It is this characteristic that gave them their name, derived from the Latin "arena," 
which means "sandy." Their genome, or genetic material, is composed of RNA only, and while their 
replication strategy is not completely understood, we know that new viral particles, called virions, are 
created by budding from the surface of their hosts’ cells. 
When were the members of this virus family recognized?  The first arenavirus, lymphocytic 
choriomeningitis virus (LCMV), was isolated in 1933 during a study of an epidemic of  St. Louis 
encephalitis. Although not the cause of the outbreak, LCMV was found to be a cause of aseptic 
(nonbacterial) meningitis. By the 1960s, several similar viruses had been discovered and they were 
classified into the new family Arenaviridae. Since Tacaribe virus was found in 1956, new arenaviruses 
have been discovered on the average of every one to three years. A number of arenaviruses cause 
hemorrhagic disease. Junin virus, isolated in 1958, was the first of these to be recognized. This virus 
causes Argentine hemorrhagic fever in a limited agricultural area of the pampas in Argentina. Several 
                                                 
69CDC, Special Pathogens Branch.   http://www.cdc.gov/ncidod/dvrd/spb/mnpages/dispages/arena.htm    
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years later, in 1963, in the remote savannas of the Beni province of Bolivia, Machupo virus was isolated. 
The next member of the virus family to be associated with an outbreak of human illness was Lassa virus 
in Africa in 1969. Most recently, Guanarito and Sabia viruses were added to this family. 
What viruses are included in the virus family?   The arenaviruses are divided into two groups: the New 
World or Tacaribe complex and the Old World or LCM/Lassa complex. Viruses in these groups that 
cause illness in humans are listed below: 
Virus Disease 
Lassa virus  Lassa fever 
Junin virus  Argentine hemorrhagic fever 
Machupo virus Bolivian hemorrhagic fever  
Guanarito virus Venezuelan hemorrhagic fever 
Sabia Brazilian hemorrhagic fever 
 
What kinds of animal hosts do these viruses have?  These viruses are zoonotic, meaning that, in nature, 
they are found in animals. Each virus is associated with either one species or a few closely related 
rodents, which constitute the virus’ natural reservoir. Tacaribe complex viruses are generally associated 
with the New World rats and mice (family Muridae, subfamily Sigmodontinae). The LCM/Lassa complex 
viruses are associated with the Old World rats and mice (family Muridae, subfamily Murinae). Taken 
together, these types of rodents are located across the greater proportion of the earth’s land mass, 
including Europe, Asia, Africa, and the Americas. One notable exception is Tacaribe virus, found in 
Trinidad, which was isolated from a bat. 
How are arenaviruses spread?  The rodent hosts of arenaviruses are chronically infected with the 
viruses; however, the viruses do not appear to cause obvious illness in them. Some Old World 
arenaviruses appear to be passed from mother rodents to their offspring during pregnancy, and thus 
remain in the rodent population generation after generation. Some New World arenaviruses are 
transmitted among adult rodents, likely via fighting and inflicting bites. Only a portion of the rodents in 
each host species is infected at any one time, and in many cases only in a limited portion of the host’s 
geographical range. The viruses are shed into the environment in the urine or droppings of their infected 
hosts. 
Human infection with arenaviruses is incidental to the natural cycle of the viruses and occurs when an 
individual comes into contact with the excretions or materials contaminated with the excretions of an 
infected rodent, such as ingestion of contaminated food, or by direct contact of abraded or broken skin 
with rodent excrement. Infection can also occur by inhalation of tiny particles soiled with rodent urine or 
saliva (aerosol transmission). The types of incidental contact depend on the habits of both humans and 
rodents. For example, where the infected rodent species prefers a field habitat, human infection is 
associated with agricultural work. In areas where the rodent species’ habitat includes human homes or 
other buildings, infection occurs in domestic settings. 
Some arenaviruses, such as Lassa and Machupo viruses, are associated with secondary person-to-person 
and nosocomial (health-care setting) transmission. This occurs when a person infected by exposure to the 
virus from the rodent host spreads the virus to other humans. This may occur in a variety of ways. Person-
to-person transmission is associated with direct contact with the blood or other excretions, containing 
virus particles, of infected individuals. Airborne transmission has also been reported in connection with 
certain viruses. Contact with objects contaminated with these materials, such as medical equipment, is 
also associated with transmission. In these situations, use of protective clothing and disinfection 
procedures (together called barrier nursing) help prevent further spread of illness. 
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The other arenaviruses: Ampari, Flexal, Ippy, Mobala, Mopeia, Latino, Parana, Pichinde, Tacaribe, and 
Tamiamican cause infections in laboratory personnel, especially when high concentrations of virus are 
being processed.70  
4.17 Tetrodotoxin71 
Name of the Organism: Tetrodotoxin (anhydrotetrodotoxin 4-epitetrodotoxin, tetrodonic acid)  
Nature of Acute Disease: Pufferfish Poisoning, Tetradon Poisoning, Fugu Poisoning  
Nature of Disease: Fish poisoning by consumption of members of the order Tetraodontiformes is one of 
the most violent intoxications from marine species. The gonads, liver, intestines, and skin of pufferfish 
can contain levels of tetrodotoxin sufficient to produce rapid and violent death. The flesh of many 
pufferfish may not usually be dangerously toxic. Tetrodotoxin has also been isolated from widely 
differing animal species, including the California newt, parrotfish, frogs of the genus Atelopus, the blue-
ringed octopus, starfish, angelfish, and xanthid crabs. The metabolic source of tetrodotoxin is uncertain. 
No algal source has been identified, and until recently tetrodotoxin was assumed to be a metabolic 
product of the host. However, recent reports of the production of tetrodotoxin/anhydrotetrodotoxin by 
several bacterial species, including strains of the family Vibrionaceae, Pseudomonas sp., and 
Photobacterium phosphoreum, point toward a bacterial origin of this family of toxins. These are relatively 
common marine bacteria that are often associated with marine animals. If confirmed, these findings may 
have some significance in toxicoses that have been more directly related to these bacterial species.  
Diagnosis of Human Illness: The diagnosis of pufferfish poisoning is based on the observed 
symptomology and recent dietary history.  
Associated Foods: Poisonings from tetrodotoxin have been almost exclusively associated with the 
consumption of pufferfish from waters of the Indo-Pacific ocean regions. Several reported cases of 
poisonings, including fatalities, involved pufferfish from the Atlantic Ocean, Gulf of Mexico, and Gulf of 
California. There have been no confirmed cases of poisoning from the Atlantic pufferfish, Spheroides 
maculatus. However, in one study, extracts from fish of this species were highly toxic in mice. The 
trumpet shell Charonia sauliae has been implicated in food poisonings, and evidence suggests that it 
contains a tetrodotoxin derivative. There have been several reported poisonings from mislabelled 
pufferfish and at least one report of a fatal episode when an individual swallowed a California newt.  
Relative Frequency of Disease: From 1974 through 1983 there were 646 reported cases of pufferfish 
poisoning in Japan, with 179 fatalities. Estimates as high as 200 cases per year with mortality 
approaching 50% have been reported. Only a few cases have been reported in the United States, and 
outbreaks in countries outside the Indo-Pacific area are rare.  
Course of Disease and Complications: The first symptom of intoxication is a slight numbness of the lips 
and tongue, appearing between 20 minutes to three hours after eating poisonous pufferfish. The next 
symptom is increasing paraesthesia in the face and extremities, which may be followed by sensations of 
lightness or floating. Headache, epigastric pain, nausea, diarrhea, and/or vomiting may occur. 
Occasionally, some reeling or difficulty in walking may occur. The second stage of the intoxication is 
increasing paralysis. Many victims are unable to move; even sitting may be difficult. There is increasing 
respiratory distress. Speech is affected, and the victim usually exhibits dyspnea, cyanosis, and 
hypotension. Paralysis increases and convulsions, mental impairment, and cardiac arrhythmia may occur. 
The victim, although completely paralyzed, may be conscious and in some cases completely lucid until 
shortly before death. Death usually occurs within 4 to 6 hours, with a known range of about 20 minutes to 
8 hours.  
                                                 
70Pfau, Charles J.  Medical Microbiology, Fourth Edition, Arenaviruses chapter.  
 http://gsbs.utmb.edu/microbook/ch057.htm  
71U.S. Food & Drug Administration, Center for Food Safety & Applied Nutrition, Foodborne Pathogenic 
Microorganisms and Natural Toxins Handbook, Bad Bug Book.  http://vm.cfsan.fda.gov/~mow/chap39.html  
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Target Populations: All humans are susceptible to tetrodotoxin poisoning. This toxicosis may be avoided 
by not consuming pufferfish or other animal species containing tetrodotoxin. Most other animal species 
known to contain tetrodotoxin are not usually consumed by humans. Poisoning from tetrodotoxin is of 
major public health concern primarily in Japan, where "fugu" is a traditional delicacy. It is prepared and 
sold in special restaurants where trained and licensed individuals carefully remove the viscera to reduce 
the danger of poisoning. Importation of pufferfish into the United States is not generally permitted, 
although special exceptions may be granted. There is potential for misidentification and/or mislabelling, 
particularly of prepared, frozen fish products.  
4.18 Tick-borne encephalitis complex (flavi) viruses  
(Central European Tick-borne encephalitis, Far Eastern Tick-borne encephalitis, [Russian Spring and 
Summer encephalitis, Kyasanur Forest disease, Omsk Hemorrhagic Fever]) 
European Tick Borne Encephalitis72 
European tick-borne encephalitis is the most important recognized arboviral illness in Europe. Widely 
scattered areas have reported cases of encephalitis following tick bites. These include the east coast of 
Sweden, rural areas of Poland, Czechoslovakia and Central Europe including Austria, Bavaria, Hungary, 
and the former Soviet Republics.  
Travellers to Austria are particularly concerned to read signs in airports, other public places, and 
pharmacies asking "Have you been vaccinated against encephalitis?" The following information is, 
therefore, being made available.  
Agent and Epidemiology:  This encephalitis is caused by group B arbovirus or flavivirus, whose family 
also includes the agents of yellow fever, dengue, and St. Louis encephalitis. It is similar to the Powassan 
virus, a sporadic cause of tick-borne encephalitis in North America. It is tick-borne, with the tick found in 
forested areas. The virus is excreted in milk, and can be spread via unpasteurized cow, goat or sheep milk 
products.  
Clinical Features:  The incubation period is 7-14 days. The disease has a diphasic form in 50% of the 
cases with a non-specific influenza-like illness lasting about a week, then a 1-3 day asymptomatic phase, 
followed by a central nervous system phase. There is an abrupt onset of signs of encephalitis such as 
tremor, dizziness and altered sensorium. Twenty percent of cases have minor neuropsychiatric sequelae 
and 1-5% die.  
Advice to Travellers:  The risk from a single tick exposure is very low and would be mainly to those 
travelling in wooded areas. The most practical advice is to take precautions against being bitten by ticks 
(e.g., wear long-sleeved clothing, no shorts or sandals, and use insect repellents). As well, unpasteurized 
cow, goat and sheep milk products should be avoided.  
If bitten by a tick, it is prudent to consult a local physician. In Austria, immune globulin is administered 
for certain types of exposure. To be effective, it must be immune globulin obtained in Austria, as there 
would be insufficient appropriate antibodies in any North American product. There are no specific 
gamma globulins in Canada and the United States.  
A vaccine, FSME-IMMUN®, is manufactured in Austria and should be considered for long-term 
travellers, but the time factor would preclude its use for short-term tourists. The recommended regime is 3 
doses of vaccine, the second dose usually being given 1-3 months after the first (but this can be shortened 
to 2 weeks) and the third after 9-12 months. The vaccine is not approved for marketing in Canada, but is 
available under Health Canada's Special Access Programme (SAP). The mandate of the SAP is to provide 
practitioners with access to non-marketed drugs for patients facing serious or life-threatening conditions 
when conventional therapy has failed, is unsuitable or unavailable.  
                                                 
72Health Canada, Population and Public Health Branch, July 23, 2002.   
http://www.hc-sc.gc.ca/pphb-dgspsp/tmp-pmv/travel/tick_e.html  
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Health Canada's Special Access Program has found that the human serum albumin (HAS), used as a 
stabilizer in this vaccine, was prepared from plasma collected from European donors. These donors are 
properly screened according to European guidelines and criteria, and the FSME-IMMUN® is marketed 
and commonly used in Europe. However, due to the prevalence of Bovine Spongiform Encephalopathy 
(BSE) in European countries, there is a theoretical possibility that donors living in these countries may be 
silent carriers of prion agents through their exposure to BSE-infected beef products.  
It is well known and recognized that, to date, the risk of transmission of vCJD by blood and blood 
products, is strictly theoretical, as no case of CJD or vCJD has been shown to be related to the 
administration of blood or blood products to a patient. The theoretical risk of vCJD to the Canadian 
population for vaccines manufactured with human albumin has been estimated by the Population and 
Public Health Branch of Health Canada to be 1 in 100 million per treatment, per person vaccinated.  
Tick-borne encephalitis73:  Tick-borne encephalitis virus circulates in small wild animals, mostly rodents, 
and is transmitted by Ixodes ticks. Humans may also become infected by drinking goat's milk.   
It has a wide area of distribution across Europe and the former USSR, and its seasonal incidence is 
reflected in one of the many pseudonyms 'Russian spring-summer encephalitis'. Genetic sequencing has 
allowed Western tick-borne encephalitis virus, which is endemic in Germany, Austria and much of 
Europe, to be distinguished from Far-Eastern tick-borne encephalitis virus which is found across the 
former Soviet Union.   
After one to two weeks incubation the virus causes a sudden onset of fever, headache nausea and 
photophobia. In mild cases this resolves after a week, but in more severe cases there is a second phase of 
illness with meningoencephalitis, or myelitis. The latter tends to cause flaccid paralysis of the upper limb 
and shoulder girdle. Respiratory muscle and bulbar (brainstem) involvement lead to respiratory failure 
and death.  
Far Eastern tick-borne encephalitis has a higher case fatality rate, but the Western form is often associated 
with sequelae (after effects).  
A formalyn inactivated vaccine given as two doses 4-6 weeks apart, has been recommended for those 
likely to be exposed in the endemic forested areas of Europe and the former USSR. 
4.19 Variola virus74  
Variola major virus (Smallpox virus) 
Variola minor virus (Alastrim) 
The Disease:  Smallpox is a serious, contagious, and sometimes fatal infectious disease. There is no 
specific treatment for smallpox disease, and the only prevention is vaccination. The name smallpox is 
derived from the Latin word for “spotted” and refers to the raised bumps that appear on the face and body 
of an infected person. 
There are two clinical forms of smallpox. Variola major is the severe and most common form of 
smallpox, with a more extensive rash and higher fever. There are four types of variola major smallpox: 
ordinary (the most frequent type, accounting for 90% or more of cases); modified (mild and occurring in 
previously vaccinated persons); flat; and hemorrhagic (both rare and very severe). Historically, variola 
major has an overall fatality rate of about 30%; however, flat and hemorrhagic smallpox usually are fatal. 
Variola minor is a less common presentation of smallpox, and a much less severe disease, with death rates 
historically of 1% or less. 
                                                 
73Solomon, Tom (Lecturer in Neurology and Medical Microbiology University of Liverpool), 2002.  The 
Encephalitis Support Group 2002, Tick-borne encephalitis.  
http://www.esg.org.uk/ESG/Support/the_illness/Types%20of%20Encephalitis/Tic.htm  
74CDC, December 9, 2002 Public Health Emergency Preparedness & Response, Smallpox Fact Sheet.  
http://www.bt.cdc.gov/agent/smallpox/overview/disease-facts.asp  
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Smallpox outbreaks have occurred from time to time for thousands of years, but the disease is now 
eradicated after a successful worldwide vaccination program. The last case of smallpox in the United 
States was in 1949. The last naturally occurring case in the world was in Somalia in 1977. After the 
disease was eliminated from the world, routine vaccination against smallpox among the general public 
was stopped because it was no longer necessary for prevention. 
Where Smallpox Comes From:  Smallpox is caused by the variola virus that emerged in human 
populations thousands of years ago. Except for laboratory stockpiles, the variola virus has been 
eliminated. However, in the aftermath of the events of September and October, 2001, there is heightened 
concern that the variola virus might be used as an agent of bioterrorism. For this reason, the U.S. 
government is taking precautions for dealing with a smallpox outbreak. 
Transmission:  Generally, direct and fairly prolonged face-to-face contact is required to spread smallpox 
from one person to another. Smallpox also can be spread through direct contact with infected bodily 
fluids or contaminated objects such as bedding or clothing. Rarely, smallpox has been spread by virus 
carried in the air in enclosed settings such as buildings, buses, and trains. Humans are the only natural 
hosts of variola. Smallpox is not known to be transmitted by insects or animals. 
A person with smallpox is sometimes contagious with onset of fever (prodrome phase), but the person 
becomes most contagious with the onset of rash. At this stage the infected person is usually very sick and 
not able to move around in the community. The infected person is contagious until the last smallpox scab 
falls off. 
Smallpox Disease 
Incubation Period 
(Duration: 7 to 17 days) 
Not contagious 
Exposure to the virus is followed by an incubation period during which people do not 
have any symptoms and may feel fine. This incubation period averages about 12 to 14 days 
but can range from 7 to 17 days. During this time, people are not contagious. 
Initial Symptoms 
(Prodrome) 
(Duration: 2 to 4 days) 
Sometimes 
contagious* 
The first symptoms of smallpox include fever, malaise, head and body aches, and 
sometimes vomiting. The fever is usually high, in the range of 101 to 104 degrees 
Fahrenheit. At this time, people are usually too sick to carry on their normal activities. This 
is called the prodrome phase and may last for 2 to 4 days. 
Early Rash 
(Duration: about 4 days) 
Most contagious 
Rash distribution: 
A rash emerges first as small red spots on the tongue and in the mouth. 
These spots develop into sores that break open and spread large amounts of the virus into 
the mouth and throat. At this time, the person becomes most contagious. 
Around the time the sores in the mouth break down, a rash appears on the skin, starting on 
the face and spreading to the arms and legs and then to the hands and feet. Usually the rash 
spreads to all parts of the body within 24 hours. As the rash appears, the fever usually falls 
and the person may start to feel better. 
By the third day of the rash, the rash becomes raised bumps. 
By the fourth day, the bumps fill with a thick, opaque fluid and often have a depression in 
the center that looks like a bellybutton. (This is a major distinguishing characteristic of 
smallpox.) 
Fever often will rise again at this time and remain high until scabs form over the bumps. 
Pustular Rash 
(Duration: about 5 days) 
Contagious 
The bumps become pustules—sharply raised, usually round and firm to the touch as if 
there’s a small round object under the skin. People often say the bumps feel like BB pellets 
embedded in the skin. 
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Pustules and Scabs 
(Duration: about 5 days) 
Contagious 
The pustules begin to form a crust and then scab.  
By the end of the second week after the rash appears, most of the sores have scabbed over. 
Resolving Scabs 
(Duration: about 6 days) 
Contagious 
The scabs begin to fall off, leaving marks on the skin that eventually become pitted scars. 
Most scabs will have fallen off three weeks after the rash appears. 
The person is contagious to others until all of the scabs have fallen off. 
Scabs resolved 
Not contagious 
Scabs have fallen off. Person is no longer contagious. 
* Smallpox may be contagious during the prodrome phase, but is most infectious during the first 7 to 10 
days following rash onset. 
4.20 Yersinia pestis75  
Plague 
Clinical Features: 
• Bubonic plague: enlarged, tender lymph nodes, fever, chills and prostration  
• Septicemic plague: fever, chills, prostration, abdominal pain, shock and bleeding into skin and 
other organs  
• Pneumonic plague: fever, chills, cough and difficulty breathing; rapid shock and death if not 
treated early  
Etiologic Agent:  Yersinia pestis - bacillus  
Incidence:  In the U.S., 1 to 40 cases reported annually (avg = 13 cases) by western states, 1971-1995; 
Worldwide, 2861 cases reported by 10 countries to WHO in 1995  
Sequelae:  Rare, consequences of disseminated intravascular coagulation, lung damage.  Mortality 50-
90% if untreated; 15% when diagnosed and treated.  
Transmission:  Flea-borne, from infected rodents to humans; direct contact with infected tissues or fluids 
from handling sick or dead animals; respiratory droplets from cats and humans with pneumonic plague  
Reservoirs:  Primarily wild rodents in U.S. (especially rock squirrels, ground squirrels, prairie dogs, other 
burrowing rodents); commensal rats may be important elsewhere  
Risk Groups:  In the U.S., persons exposed to rodent fleas, wild rodents, or other susceptible animals in 
enzootic areas of western states  
Most cases occur in southwestern states of NM, AZ, CO, and in CA  
Highest rates in Native Americans, especially Navajos; other risk groups: hunters; veterinarians and pet 
owners handling infected cats; campers or hikers entering areas with outbreaks of animal plague  
Surveillance:  National Notifiable Disease Surveillance System (NNDSS) for animal plague surveillance, 
for reports of human cases, and laboratory testing of fleas, animal tissues and serum specimens, and 
serosurveys of carnivores  
CDC, Fort Collins, is a WHO Collaborating Center for Reference and Research on Plague Control, and 
reports all human plague cases in the U.S. to WHO  
                                                 
75CDC, June 22, 2001.  Division of Vector-Borne Infectious Diseases, Plague Fact Sheet.     
http://www.cdc.gov/ncidod/dvbid/plague/facts.htm  
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5.  BW AGENT CHARACTERISTICS (SUBSET)76 
  
 
Disease 
Transmit 
Man to 
Man 
 
Infective Dose 
(Aerosol) 
 
ncubation 
Period 
 
Duration of 
Illness 
 
Lethality (approx. 
case fatality rates)
 
Persistence of 
Organism 
 
Vaccine Efficacy 
(aerosol exposure)
Inhalation 
anthrax 
No 8,000-50,000 
spores 
1-6 days 3-5 days (usually 
fatal if untreated) 
High Very stable - 
spores remain 
viable for > 40 
years in soil 
2 dose efficacy 
against up to 1,000 
LD50 in monkeys 
Brucellosis No 10 -100 
organisms 
5-60 days  
(usually 1-2 
months) 
Weeks to months <5% untreated Very stable No vaccine 
Cholera Rare 10-500 
organisms 
4 hours -  
5 days 
(usually 2-3 
days) 
> 1 week Low with 
treatment, high 
without 
Unstable in 
aerosols & fresh 
water; stable in 
salt water 
No data on aerosol 
Glanders Low Assumed low 10-14 days 
via aerosol 
Death in 7-10 days 
in septicemic form
> 50% Very stable No vaccine 
Pneumonic 
Plague 
High 100-500 
organisms 
2-3 days 1-6 days 
(usually fatal) 
High unless treated
within 12-24 hours
For up to 1 year in 
soil; 270 days in 
live tissue 
3 doses not protective 
against 118 LD50 in 
monkeys 
Tularemia No 10-50 organisms 2-10 days 
(average 3-
5) 
> 2 weeks Moderate if 
untreated 
For months in 
moist soil or other 
media 
80% protection 
against  
1-10 LD50 
Q Fever Rare 1-10 organisms 10-40 days 2-14 days Very low For months on 
wood and sand 
94% protection 
against 3,500 LD50 in 
guinea pigs 
Smallpox High Assumed low 
(10-100 
organisms) 
7-17 days 
(average 
12) 
4 weeks High to moderate Very stable Vaccine protects 
against large doses in 
primates 
Venezuelan 
Equine 
Encephalitis 
Low 10-100 
organisms 
2-6 days Days to weeks Low Relatively 
unstable 
TC 83 protects 
against 30-500 LD50 
in hamsters 
Viral 
Hemorrhagic 
Fevers 
Moderate 1-10 organisms 4-21 days Death between 7-
16 days 
High for Zaire 
strain, moderate 
with Sudan 
Relatively 
unstable - 
depends on agent 
No vaccine 
Botulism No 0.001 mg/kg is 
LD50 for type A 
1-5 days Death in 24-72 
hours; lasts months 
if not lethal 
High without 
respiratory support
For weeks in 
nonmoving water 
and food 
3 dose efficacy 100% 
against 25-250 LD50 
in primates 
Staph 
Enterotoxin 
B 
No 0.03 mg/person 
incapacitation 
3-12 hours 
after 
inhalation 
Hours < 1%  Resistant to 
freezing 
No vaccine 
Ricin No 3-5 mg/kg is 
LD50 
in mice  
18-24 hours Days - death within 
10-12 days for 
ingestion 
High Stable No vaccine 
T-2 
Mycotoxins 
No Moderate 2-4 hours Days to months Moderate For years at room 
temperature 
No vaccine 
 
 
                                                 
76http://www.mold-survivor.com/biowarfare.htm  
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